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Epilepsy and Sudden Unexpected Death in Epilepsy 
Epilepsy is defined as ‘recurrent (two or more) epileptic seizures, 
unprovoked by any immediate identifiable cause. The epileptic seizure is 
defined as the clinical manifestation of an abnormal and excessive discharge 
of a set of brain neurones. The manifestation is a sudden transient 
phenomenon that may include alteration of consciousness, motor, sensory, 
autonomic or psychic events which are perceived either by the individual or 
by an observer ‘(International League Against Epilepsy 1989). 
Classification of epilepsy is grouped into generalised epilepsies and focal 
epilepsies. Seizures can begin as a focal seizure and then become generalised 
(secondary generalised). Focal seizures can affect any part of the brain and 
may or may not lead to impairment of consciousness (simple or complex 
focal seizure) or complete loss of consciousness. Classification tables have 
changed over the years in the attempt to arrive at an internationally agreed 
description of all seizure types known. (International League Against 
Epilepsy 2005 appendix). For the purposes of this study for seizure alarm 
trigger levels, distinction is made for simple focal and complex focal seizures 
and are further categorised into temporal or frontal seizures and laterality.  
Depending on which area of brain is involved during the epileptic discharge 
various clinical manifestations occur. The semiology of the seizure can 
sometimes provide indications as to what seizure type is involved. 
Electroencephalographic changes can also give supporting evidence in 
determining the seizure type.  
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The prevalence of seizure disorders in children is estimated at 15-20 per 
thousand of the general population (Wheless et al. 2002) compared to that of 
7 per thousand of adults (Brown et al. 1991).  
Each year several children are admitted to hospital having been found by 
their parents in the morning after convulsing for an unknown time in the 
night. Undetected prolonged nocturnal seizures can be fatal or result in 
significant morbidity due to hypoxic brain damage (Brown et al 1991). 
Parents have a constant dread of their children having seizures in the night, 
which are undetected and they have voiced the need for a reliable alarm 
system. 
The diagnosis of epilepsy carries an excess mortality that is 2-3 times higher 
than the general population (Cockerall et al 1994) and official statistics report 
around 1000 deaths due to epilepsy in the UK each year. In chronic epilepsy 
sudden unexplained death in epilepsy (SUDEP) is a major cause of excess 
mortality and risk of premature death from SUDEP in individuals with 
intractable epilepsy is 1:200/year (Nashef et al 1995). The following definition 
of sudden unexpected death in epilepsy (SUDEP) has been proposed. 
‘Sudden, unexpected, witnessed or un-witnessed, non-traumatic and non-
drowning death in patients with epilepsy, with or without evidence of a 
seizure and excluding documented status epilepticus, in which post-mortem 
examination does not reveal a toxicological or anatomical cause of death’ 
(Nashef 1997). 
Reported risk factors for SUDEP include young age, uncontrolled epilepsy 
and seizures occurring in sleep (Shorvon 1997). Death in epilepsy can occur 
because of SUDEP, due to intrinsic factors and in most witnessed cases 
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attempts of resuscitation are unsuccessful (Nouri 2011). Death can also occur 
because of unfortunate body positioning as a consequence of the seizure and 
an obstructed airway and in these cases timely assistance can prevent fatality 
(Langan et al 2000). 
The reliability of seizure detection from several commercially available alarm 
systems revealed a high incidence of false alarms, with false alarms 
demonstrating a ratio of approximately 1 positive: 10 false alarms and 
accurate seizure detection of only 17% of clinical seizures (Brotherstone 1992) 
The high incidence of false alarms was due to normal physiological events 
which is a potential source of anxiety for parents. Furthermore, parents will 
ignore an unreliable alarm system if they do not believe that the device is 
accurate. No recent systematic review of the reliability of the different types 
of seizure alarms has been evaluated in the literature. However, each 
manufacturer claims reliability of their product. 
Autonomic symptoms frequently occur during epileptic seizures and range 
from subtle to life threatening manifestations (Baumgartner et al 2001). 
Causes of SUDEP are unknown at this time, despite continued investigation 
by researchers for over one hundred years (Nashef 2000). The cause of 
SUDEP is believed to be multifactorial involving intrinsic respiratory, cardiac 
and autonomic mechanisms (Hirsch et al 2011, Nouri 2011, So et al 2000, Nei 
et al 2004).  
Central apnoea is considered to be one of the main contributing factors of 
SUDEP and is the immediate event before death. In witnessed SUDEP cases, 
seizures had stopped and in some cases the victims regained consciousness, 
before then having difficulty breathing, followed by respiratory arrest 
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(obstructive and central) and attempts of cardiopulmonary resuscitation 
were unsuccessful (Nouri et al 2011).  
Post-ictal apnea is described in a case study by So et al, 2000, where the 
patient had been monitored with electroencephalographic videotelemetry 
during a convulsive seizure that been followed by a period of central apnoea 
and then cardiac arrest. Cardio-respiratory resuscitation was successful in 
this case and there had been no evidence of obstructive apnoea. Successful 
resuscitation in patients with cental apneoa is very rare (Dashief & Dickinson 
1986). The authors proposed a SUDEP mechanism of postictal central 
apnoea.  
Central apnoea is believed to be the result of epileptic seizure activity 
directly or indirectly affecting brainstem respiratory centres via an intense 
discharge of electrical activity constituting a type of channelopathy (Nashef 
et al 1997).  In a series of witnessed cases of SUDEP, 67% of victims had 
breathing difficulties following the seizure and cyanosis Nouri et al 2011.  
In cases of obstructive apnoea from seizures, Dr Devinsky, Director of the 
Comprehensive Epilepsy Center, New York University reported by Garuchin 
from The New York Times in July, 2010 explained that most victims are 
found face down following a seizure. If someone has an obstructed airway, 
normally they would roll over but following a seizure they don’t because of 
their “reflexes are reduced.” This is why timely assistance is so important to 
prevent fatalities in these cases of obstructive apnoea.  
Hypoxia is the commonest cause of cardiac arrest in infants and children 
(Carter 1993). A theory of neuro-modulation of respiration is affected during 
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a seizure discharge altering central mechanisms of regulating phrenic 
activity (Williams 1989). 
Monitoring respiration was not included in this study as patients would have 
had to wear nasal and mouth thermistors plus two chest strain gauges (one 
monitoring chest and one monitoring abdominal respiration) in addition to a 
full set of 23 scalp electrodes and oxygen saturation and modified lead II 
ECG. Ideally respiration should have been monitored but this was not 
practical or would have been tolerated by most patients. Instead oxygen 
saturation was monitored throughout to analyse hypoxia whether it was 
resultant from central or obstructive apnoea. This was important to assess for 
the purposes of the study as to whether oximetry would be an important 
parameter to include in a seizure detection device 
Fatal cardiac arrhythmias are also believed to be another main contributing 
factor in SUDEP (Nouri 2011, Cheung et al 2000).  A ‘channelopathy’ or 
sudden excessive ion transmission triggered by neural seizure activity is 
proposed causing an ‘electrical accident’ of the myocardium, particularly on 
waking. This ‘channelopathy’ has been described as a possible cause of 
instability in cardiac rhythm, particularly during nocturnal seizures, where 
predominant vagal tone and bradycardia exists during sleep which  is 
suddenly replaced by sudden and extreme sympathetic tone and 
tachycardia, hypothetically potentially inducing a cardiac arrhythmia in pre-
disposed individuals (Nouri 2011, Ansakorpi et al 2004). At autopsy, for 
some victims of Sudden Unexplained Death in Epilepsy, evidence of 
excessive amounts of catecholamines have been found in myocardium 
suggesting massive sympathetic activity around the time of death. This 
change from vagal tone to sudden sympathetic tone is greatest in young 
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adults in their 20’s as their baseline vagal tone is higher compared to young 
children and older adults. This may explain why the incidence of SUDEP is 
highest in young adults (Nei et al 2004).  
It is with these factors in mind that I decided to analyse heart rate changes 
and alteration of oxygen saturation during different types of seizures in a 















Abstract of Thesis 
Epileptic seizures are often un-witnessed and can result in hypoxic brain 
damage or can be fatal due to injuries, status epilepticus or sudden 
unexpected death in epilepsy (SUDEP). The first aim of this thesis was to 
investigate some of the physiological parameters that accompany an epileptic 
seizure and may be useful in a seizure alarm system. The second aim was to 
investigate aspects of cardiac dysfunction during clinical and sub-clinical 
seizures that may be potential contributing factors in SUDEP. Percentage 
heart rate change and oxygen saturation were studied prospectively during 
527 epileptic seizures in 50 patients aged from one-day full term neonate to 
60 years with a variety of seizure types (absences, generalised tonic clonic 
seizures, myoclonic seizures, tonic seizures and focal seizures) and in normal 
physiological events (e.g. coughing, turning in bed). Higher percentage heart 
rate change occurred during epileptic seizures (21.8%) than during normal 
physiological events (16.4%) p<0.001. Diagnostic testing of clinically 
significant seizures i.e seizures that could potentially lead to serious 
consequences if left undetected (n=61) had a sensitivity of 91% and specificity 
of 75% when percentage heart rate change and hypoxaemia parameters were 
combined. Percentage heart rate change and oxygen saturation could be used 
as reliable indicators of a seizure when set at specific levels and distinguish 
clinically significant seizures from normal physiological events. These 
parameters can now be used to develop a reliable alarm system to detect 
epileptic seizures at night. Prolongation of QTc and increased vagal tone may 
be possible mechanisms underlying SUDEP. Corrected Q-T cardiac re-
polarisation time 5 minutes before and throughout 156 epileptic seizures 
were analysed using four corrective formulae (Bazett, Hodge, Fridericia and 
Framingham). All formulae indicated statistically significant lengthening of 
the corrected Q-T during epileptic seizures (p<0.001) compared to pre-seizure 
values. All formulae agreed that the greatest lengthening of the corrected Q-
T beyond normal limits occurred during right temporal lobe seizures in two 
patients. Reflex and tonic vagal activity utilising R-R intervals was assessed 
in 33 sub-clinical seizures occurring during stages 3 or 4 sleep and was 
compared to matched counts of R-R interval non-ictal baseline studies from 
the same stage of sleep in each patient. Altered vagal activity occurred 
during total sub-clinical seizures compared to baseline studies (p<0.001). 
Lengthening of the corrected Q-T and changes in cardiac vagal tone during 





The diagnosis of epilepsy carries an excess mortality that is 2-3 times higher 
than the general population (Cockerall et al 1994) and official statistics report 
approximately 1000 epilepsy-related deaths occur in the UK each year 
(Hanna et al 2002).  
Death in epilepsy can occur due to unfortunate circumstances at the time of 
the seizure, for example someone having a seizure while bathing and then 
drowning while unconscious. If the unfortunate circumstance of bathing at 
the time of the seizure had been avoided then death may also have been 
avoided. However, death in epilepsy can also occur due to Sudden 
Unexpected Death in Epilepsy (SUDEP) where there are no obvious 
circumstances.  The causes of SUDEP are unknown at this time but believed 
to be multi-factorial involving altered autonomic and cardio-respiratory 
control. In chronic epilepsy sudden unexpected death in epilepsy is the main 
cause of excess mortality and risk of premature death from SUDEP in 
individuals with intractable epilepsy is 1:200/year (Nashef et al 1995). 
Reported risk factors for SUDEP include young age, uncontrolled epilepsy 
and seizures occurring in sleep (Shorvon 1997).  
The aim of this thesis is to make a contribution to knowledge by firstly 
investigating whether a seizure alarm system could be reliably based on 
percentage heart rate change and oxygen saturation parameters. Secondly, 
two areas of cardiological dysfunction were investigated that may underlie 
SUDEP mechanisms.   
A reliable seizure alarm could be used to identify nocturnal seizures and 
alert family/ carers to assist in providing rescue medication during 
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prolonged seizures and allow repositioning of the body following the 
seizure. A reliable alarm system would be of benefit to those people who 
have seizures that are amenable to intervention. 
Each year several children are admitted to hospital having been found by 
their parents in the morning after convulsing for an unknown time in the 
night. Undetected prolonged nocturnal seizures can be fatal or leave the 
child brain damaged due to hypoxia (Brown et al 1991). Parents have a 
constant dread of their children having seizures in the night, which are 
undetected and they have voiced the need for a reliable alarm system. 
In an increasingly elderly population and the increased incidence of seizures 
in the elderly (Sander et al 2004), proportionally more elderly people living 
alone are at risk of having undetected seizures in the home. A seizure alarm 
system that could be worn as a wrist watch style device and could wirelessly 
alert a central care centre similar to the community alarm call system would 
be an additional improvement to what is available at the moment.  
Sections two and three of this thesis investigates two possible underlying 
cardiological mechanisms involved in SUDEP. Section two is the analysis of 
cardiac re-polarisation during seizures and whether lengthening of the 
corrected Q-T occurs which could be identified as a cardiac risk. Section three 
is the investigation of cardiac vagal tone during sub-clinical seizures where 
reduced heart rate variability may also be considered to be a separate risk 
factor contributing to sudden death in epilepsy.  
SUDEP is rare and it is difficult to determine what the causes are without 
evidence during the event. The purpose of this study is to observe and report 
two physiological findings during epileptic seizures that are considered risk 
 
 13 
factors of sudden cardiac death in other diseases and compare these findings 
to people with epilepsy. By increasing our knowledge in these areas then we 
may come a little closer to identifying possible causes of SUDEP. Research in 
lengthening of corrected QT during seizures and vagal tone during sub-
clinical seizures is new ground and no large epidemiological studies have 
been performed as yet. The findings from sections two and three in this 
study are indicative that larger studies may be important.  
In section one, XLTEK Digital 32 Channel Electroencephalography (EEG) 
Videotelemetry system with simultaneous modified lead II 
electrocardiography (ECG) and pulse oximetry were used to identify 
seizures clinically and electrographically. Fifty patients with epilepsy were 
monitored with an age range of a one-day full term neonate to 60 years and 3 
months, with a mean age of 14 years 7 months calculated for the group. 
Percentage heart rate change was analysed during 527 seizure events over 9 
second epochs with group statistical significance of p<0.001. Oxygen 
saturation changes were measured over matching epochs during 494 seizure 
events, again with group statistical significance of p<0.001. The total seizure 
group was then divided into “clinically significant” seizures (61) and 
“clinically insignificant” seizures (466). Total seizures consisited of 
generalised seizures (164), subdivided into generalised tonic-clonic seizures 
(11), tonic seizures (90), absences (35) and myoclonus (28). Complex focal 
seizures (260) consisting of frontal lobe (229) & temporal (31). Simple focal 
seizures (102) seizures could not be diagnostically tested as a separate group 
as the majority of data came from one patient but were included in the total 
data. In addition to the total seizures neonatal seizures (10) and sub-clinical 
seizure activity (83) were analysed seperately. Each category, group and sub-
divided groups of seizure type were analysed using one sample t-tests for 
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percentage heart rate change during each event. Paired t-tests were applied 
for oxygen saturation change comparing values before and during each 
event.  
A total of 496 normal physiological events were identified using the video-
telemetry system. Percentage heart rate and oxygen saturation were analysed 
using one sample t-tests and paired t-tests respectively. High statistical 
significance of p<0.001 was calculated for both parameters. Sub groups of 
arousal (190), coughing (34), crying (15), laughing (22), sneezing (10), 
stretching (36) turning over in bed (141) and yawning (48) were measured 
and statistically analysed. 
Diagnostic testing of percentage heart rate change and percentage oxygen 
saturation was used to compare changes during epileptic seizures to that of 
normal events. This type of testing was performed for total seizures, 
clinically significant seizures (sensitivity 79%, specificity 75%) clinically 
insignificant seizures (sensitivity 45%, specificity 49%) and each type of 
seizure group. Impressive diagnostic testing results are calculated for 
generalised tonic-clonic seizures with sensitivity of 88% and specificity of 
85%.  
An average oxygen saturation level of 86.9% was recorded during (49) 
clinically significant seizures compared to an average oxygen saturation level 
of 97.2% during 430 clinically insignificant seizures. When diagnostic testing 
is based on combined percentage heart rate change and oxygen saturation, 
with one/ other/ both parameters reaching their trigger levels, the sensitivity 
improves further to 91% and specificity stays the same at 75%. This result 
indicates that if a seizure alarm was triggered because of either percentage 
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heart rate change or oxygen saturation parameters triggered either 
independently or together then 91% of clinically significant seizures would 
be detected. As before, one triggered alarm in every four would be false. 
Further research development is envisaged for the future in developing a 
seizure alarm device. A scientific paper has not been submitted for this 
section of work because of the intention of further research and patency. 
In section two, one hundred and fifty nine (159) seizures were analysed for 
changes in corrected Q-T from thirty-nine (39) patients from the original 
study group before and during the seizure and analysed using Bazett, 
Hodge, Fridericia and Framingham corrective formulae. All formulae agreed 
statistically significant lengthening of the corrected Q-T (p<0.001) occurred 
during total seizures compared to pre-seizure values. Maximum changes in 
corrected Q-T occurred during generalised tonic-clonic seizures (403 
milliseconds increased to 490 milliseconds) and during focal seizures arising 
from the right temporal lobe with increases of up to 512 milliseconds 
corrected Q-T according to Bazett’s formula.  
Correcting Q-T for heart rate values are dependent on which formula is used. 
Bazett’s formula identified 21 seizures from 9 patients, Hodge’s formula 
identified 7 seizures from 4 patients, Fridericia’s formula identified 6 seizures 
from 4 patients and Framingham identified 3 seizures from 3 patients that 
lengthened the corrected Q-T beyond clinically normal limits. However, all 
formulae agreed on the identification of two patients as prolonging their 
corrected Q-T during a right temporal lobe seizure and a sub-clinical right 
temporal lobe seizure.  
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A scientific paper was reviewed, accepted and published in Epilepsia 
medical journal Epilepsia, 51(2):221–232, 2010 (doi: 10.1111/j.1528-
1167.2009.02281.x) based on section two entitled “Lengthening of corrected 
QT during epileptic seizures” (appendix). 
Section three grew from observations during section one of this research. 
Individual heart rate and oxygen saturation profile graphs were plotted for 
every patient of their seizures. It became apparent that heart rate appeared 
“stereotyped” during the tonic phase of a generalised tonic clonic seizure, 
then accelerating during the clonic phase. This compared to a gradual 
increase in heart rate during focal seizures. There appeared to be a difference 
in heart rate control during a generalised tonic clonic seizure and a focal 
seizure and this then posed the question whether heart rate variability was 
affected differently in the two types of epileptic seizures.  
My initial interest was investigating heart rate variability during clinical 
seizures but discovered that interpreting results using these measures would 
be impossible due to the physical element of the seizure directly affecting 
sympatho-vagal balance. It also became apparent that no epidemiological 
studies have been performed in people with epilepsy and therefore no 
normative data was available to compare results to. However, the 
NeuroScope offers a general range of normal values to initially compare the 
study results to. Sub-clinical seizures were identified and analysed instead of 
clinical seizures to eliminate any distortion of results due to physical effect 
on vagal tone measurements. 
In section three cardiac vagal tone/parasympathetic activity and heart rate 
variability were analysed during 33 sub-clinical seizures from 11 original 
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study group patients. Sub-clinical seizure data was compared to resting data 
with patients acting as their own controls. Strict criteria was used in selecting 
the 33 sub-clinical seizures in that they all had to occur during slow wave 
sleep so that breathing rate was constant throughout and would not 
influence results. Forty-five sub-clinical seizures were excluded from this 
study, as they did not meet the criteria of sub-clinical seizures occurring 
during slow wave sleep. 
Clear altered cardiac vagal tone/parasympathetic activity occurred during 
total sub-clinical seizures in both Cardiac Index of Parasympathetic Activity 
(CIPA) p<0.001 and 5minute Heart Rate Variability (HRV) HF% p=0.026 
compared to matched baseline data. Generalised sub-clinical seizures 
resulted in increased cardiac parasympathetic activity and low coefficient of 
variation of R-R intervals compared to a decrease in cardiac parasympathetic 
activity and high coefficient of variation of R-R intervals during temporal 
lobe seizures. Decreased heart rate variability is used as risk stratification for 
cardiac death in post-myocardial infarction patients. Decreased heart rate 
variability occurred during generalised sub-clinical seizures compared to 
focal seizures and reduced heart rate variability may be an underlying risk 
factor for SUDEP in predisposed individuals with lowered physiological 
thresholds compared to others.  
A scientific paper has been submitted and accepted for publication in 
February 2012 by Seizure medical journal based on section three entitled 
“Parasympathetic Alteration during Sub-clinical Seizures” (appendix) 
To conclude, percentage heart rate change and oxygen saturation percentage 
can be used as physiological parameters to reliably distinguish clinically 
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significant seizures especially generalised tonic-clonic seizures from normal 
events. Lengthening of the corrected Q-T, increased vagal tone and 
decreased heart rate variability may be contributing factors in the 
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Abbreviations & Units 
Abbreviations 
 
ACTH  Adrenocorticotropic Hormone. 
Bd  Bi-daily (medication dosage frequency). 
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Co.  Company. 
ECG  Electrocardiograph. 
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e.g.  For example. 
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Q-T  Q-T component parts of electrocardiographic waveform 
Q-Tc  Corrected Q-T. 
ROC  Receiver Operator Curve. 
R-R  Electrocardiographic interval. 
RyR2  Ryanodine Receptors 
SA node Sino-atrial node. 
SAO2  Oxygen saturation. 
SAO2A Actual Oxygen Saturation. 
Secs.  Seconds. 
SE Mean Standard Error of Mean. 
SPSS  Statistical Package for Social Sciences. 
SR  Sarcoplasmic Reticulum 
Std.  Standard. 
St.Deviation Standard deviation. 
SUDEP Sudden Unexplained Death in Epilepsy 
Tdp  Torsades de Pointes 
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Tdur  Time during event.(epoch). 
T wave Electrocardiographic re-polarisation waveform. 
TC  Time Constant (high pass filter). 
VideoEEG Electroencephalographic Videotelemetry  









Hz  Hertz (cycles per second) 
30 mms-1 30 millimetres per second 
kohms kilo-ohms 
kPa  kilo-pascals 
%  Percentage 
+ve  Positive electrode 
-ve  Negative electrode 
nm  nanometres. 
<  Less than. 
>  Greater than. 
  __ 
  Square root. 
uv  microvolts 
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1.1.1  Overview of Existing Seizure Alarms 
Several types of seizure alarm systems are currently commercially available. 
Nine different types of seizure alarm systems provided by various 
manufacturers or charities are considered. Systematic reviews on the 
reliability of these types of seizure alarms are not found in the literature. 
Each manufacturer advertising an epileptic seizure alarm claims reliability. 
 ‘Support Dogs’ is a registered charity, which was established in 1992 and is 
based in Sheffield. They train rescued dogs to alert their owner of an 
imminent seizure and to warn them in a positive manner, by raising a paw or 
barking twice. This allows the person to get into a safe place (Strong 1999). 
Incredibly, some dogs can sense a seizure between 20-45 minutes prior to it 
taking place and this gives people living with epilepsy the confidence to lead 
more independent lives (Stephens 1997). It is believed that the dogs sense 
chemical changes which are unique to seizure activity. They are trained to 
alert their owners of these chemical changes, which warn them that a seizure 
is about to occur. 
The cost of training a dog to detect a seizure and warn their owner of an 
imminent seizure is around £1500. The cost of this training is funded from 
donations and sponsorship and is not charged to the person who needs the 
trained dog.   
However, the charity does not provide dogs for every person with epilepsy. 
Generally, children are not included because they are not old enough to be 
responsible for the dog. The prospective owner also has to be old enough to 
work closely with the charity and the dog in residential training for a 
minimum of 170 hours (Support Dogs 1997).  
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Commercially, two devices tend to be used in detecting seizures in the home. 
The first is a baby monitor, so that parents or carers can hear a seizure 
occurring. Seizure detection then depends on the parents not sleeping 
through the seizure or the seizure not being silent. 
The second type of seizure alarm most commonly used is a bed movement 
alarm. Various manufacturers make this type of alarm e.g. Medpage Ltd, 
Emfit by Safety Systems Distribution Ltd and Sensorium providing the 
Sensalert (www.sensorium.co.uk) and the sensor can be adjusted to what the 
parents believe so it would not miss true seizures or collect unwanted false 
alarms from child restlessness. A similar type of bed movement alarm 
system called Epson alarm (no longer available) but used the same 
technology was found to have a high level of false alarms of 10:1 
(Brotherstone 1992). This type of monitor assumes that the seizure would 
cause a lot of shaking motion. This type of monitor would not be appropriate 
for someone who has restricted physical movement or has the type of 
seizures that does not result in clonus. 
 A similarly intended device measures electromyographic activity (EMG) via 
sensory electrodes placed on one arm and one leg.  The attached device then 
indicates a seizure by the increased EMG activity, particularly oscillatory 
activity. This again assumes clonic action during the seizure. It may also be 
unpleasant being wired up every night or restrictive on changing position 
during sleep. Detection of shaking (frequency 2-5Hz) using gyroscopes, 
accelerometers and computer algorithms have been developed for a mobile 
phone App called “EpDetect” can be downloaded free onto a compatible 
mobile phone. If it detects shaking of the wearer for more than 10 seconds, it 
will send a message to carer’s re-set phone numbers and give a GPS location 
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of the person who triggered the EpDetect App (www.EpDetect.com, 2012). 
Another similar device is the “SmartWatch” from SmartMonitor that detects 
abnormal movements within 7-10 seconds and alerts carers by mobile phone 
(www.Smart-Monitor.com, 2012). 
Oxygen saturation monitoring seems to be rarely used in the home, yet 
clinically our attention is often drawn to a patient having a seizure on the 
ward because of this type of monitor. 
Another type of commercially available system is the ‘wristcare’ monitor, 
which collects data for pulse, skin temperature, movement and sweat. It is 
largely used for the elderly in sheltered accommodation and detects cardiac 
events, hypothermia and epileptic seizures. When triggered it automatically 
sends a signal to a warden who can then go and assist or call for emergency 
back up. The accuracy of this device in detecting seizures will depend on 
pulse during the seizure. 
An apnoea monitor is sometimes used in detecting seizures and it will alarm 
if the person stops breathing for at least 10 seconds. False alarms can be 
problematic if the body position moves off the pressure sensor mat. In a 
previous study the apnoea monitor detected 21% of seizures and had a high 
false alarm rate of 5:1 (Brotherstone 1992).  
The remaining devices commercially available are the enuresis alarm 
supplied by Alert-it.co.uk and a pressure mat placed on the floor. The 
enuresis alarm assumes that incontinence occurs during every seizure, which 
is clearly not the case. Finally, the pressure mat is dependent on the person 
rolling out of bed during a seizure and landing conveniently on the placed 
Section One 
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mat! Alert-it monitors also supply bed movement with breathing sensor and 
bed vacation sensors. 
1.1.2 Investigation of Local Utilisation of Existing Seizure Alarms 
Methodology 
Fifty patients completed a questionnaire (appendix) prior to taking part in 
the study. For comparison, a cross section of 50 patients attending a seizure 
clinic also completed the questionnaire. 
The purpose of the questionnaire was to assess how many people were 
aware of and had tried to use a seizure alarm device and if so, how useful 
they found it. 
The questionnaire compared age range, seizure frequency, occurrence and 
clinical manifestations during seizures. The study group and non-study 
group were then compared. This then established whether the study group 
was representative of a cross section of people with epilepsy attending the 
seizure clinic. This is a relevant measure of whether the results from the 






















Very few people (10%) have tried to use a seizure alarm system (Figures 
1&2).  Additional comments on the questionnaire indicated that people 
perhaps were not aware that these devices are available. The devices that 
were used were either a baby monitor or a bed movement alarm. Those 
using the baby monitor could only use it because their child made noises 
during seizures. The accuracy of this device has been described earlier but it 
also assumes that the child will always make a noise independent of body 
and cover position. The other consideration is that of brain maturation and 
the inherent changes in seizure manifestation.  
A few people had only recently tried a bed movement device, one person 
said that it was not suitable and the others commented that they had only 
recently acquired the system and therefore could not comment on its 





















































Occurrence (Figures 5 & 6), age-range (Figure 8) and clinical manifestations 
(Figures 9 & 10) had similar distribution and therefore suggest that the study 
group is well matched with a cross section of people attending a seizure 
clinic. 
The only distribution difference is that of seizure frequency (Figures 3 & 4). 
Those in the study group had seizures either daily or weekly. The non-study 
group demonstrated a better seizure control with less than half of them 
having seizures monthly or yearly. The explanation for this difference is 
because those taking part in the study were included for two main reasons. 
Firstly, the study group patients were being ethically monitored on the ward 
primarily for clinical evaluation as their seizure control was not optimal and 
they were not being monitored solely for the purposes of research. Secondly, 
if someone is not having a seizure frequency of at least one seizure per week, 
the likelihood of capturing a seizure while being monitored 
electrographically is minimal. 
The questionnaire has highlighted that perhaps people with epilepsy or their 
families may not be aware that seizure alarm devices do exist. Perhaps this 
information is not advertised because generally, the alarm systems are not as 
reliable as professionals would like them to be. Seizure alert dogs would 
appear to be the main exception but are not generally available to everyone 
in need. The study group patients and the cross section of patients attending 
seizure clinic are similar in distribution of seizure occurrence, age range and 
clinical manifestations and so the changes seen in this study may be fairly 
representative of seizure clinic patients generally and not exclusive to this 
particular group of patients within the study. 
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Chapter 2 Investigation of Percentage Heart Rate Change & 
Oxygen Saturation during Epileptic Seizures 
ABSTRACT 
 
Objective: To calculate the percentage heart rate change and oxygen 
saturation during epileptic seizures compared to normal events and to 
determine accuracy of these parameters for application in an epileptic seizure 
detection device. Methods Fifty patients with epilepsy were monitored with 
an age range of one-day full term neonate to 60 years and 3 months adult. 
Electroencephalographic video-EEG telemetry monitoring of epileptic 
seizures with integrated simultaneous modified lead II electrocardiography 
and pulse-oximetry were used to identify and classify epileptic seizures and 
a range of normal events. Heart rate was calculated over the proceeding 9 
seconds of the event and used as a baseline. The start of each event was 
identified by clinical changes on the video and simultaneous electrographic 
changes. Averaged heart rate, percentage heart rate change and oxygen 
saturation were calculated for each consecutive 9 seconds epoch during each 
event.  The maximum percentage change in heart rate and lowest oxygen 
saturation value were recorded for each seizure and for each normal event 
and applied to one-sample Wilcoxon t-testing for percentage heart rate 
change and paired t-testing for oxygen saturation and diagnostically tested 
using receiver operator curves for each seizure group. Results: 527 seizures 
were analysed for the total seizure group compared to baseline 
measurements p<0.001. Absences (36), simple focal (102), frontal lobe seizures 
(229), generalised tonic-clonic seizures (11), myoclonus (28), temporal lobe 
seizures (31) and tonic seizures (90) were identified. A total of 496 normal 
physiological events were identified and compared to baseline 
measurements p<0.001. Arousal (190), coughing (34), crying (15), laughing 
(22), sneezing (10), stretching (36), turning over in bed (141) and yawning 
(48) were measured and statistically analysed. Impressive diagnostic testing 
results were calculated for generalised tonic-clonic seizures with sensitivity 
of 88% and specificity of 85% for percentage heart rate change at a specific 
trigger level. Clinically significant seizures gave a sensitivity of 79% and 
specificity 75%. When one/ other/ both parameters were diagnostically tested 
an improved sensitivity to 91% with specificity of 75%. Conclusion:  
Percentage heart rate change and oxygen saturation can be used as reliable 
indicators of seizures when set at specific levels and can distinguish clinically 




1.2.1  Video-Electroencephalography. 
Since 1924 when Hans Berger made the first recordings of human 
electroencephalography, it has been widely accepted that electro-
encephalographic activity is generated by postsynaptic potentials. The 
vertically orientated pyramidal neurons have apical dendrites extending 
toward the surface and then branch horizontally in the superficial layers of 
cortex. The dendrites are connected to thousands of excitatory (depolarizing) 
and inhibitory (hyperpolarizing) synaptic endings (Dinner et al, 1985).  The 
fluctuation of these postsynaptic potentials result in a flow of local currents 
and it is this electrical activity that is detected by electroencephalography at 
the scalp surface or invasively from the cortex. 
Advances in technology have seen paper electroencephalography machines 
being replaced by digital systems and now incorporate simultaneous video 
of the patient. On review, the data can be accurately correlated with what is 
happening clinically with the patient. Once the data has been recorded 
referentially, it can be reviewed on any montage selected. The digital system 
is dynamic with the ability to filter, compress or decompress data and change 
gain sensitivity retrospectively.  
1.2.2  Aims & Objectives 
Aims 
The aim of section one is to determine whether percentage changes in heart 
rate and oxygen saturation can be used as reliable indicators in identifying 
clinically significant seizures, distinct from normal physiological events or 
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clinically insignificant seizures that could be used in a seizure alarm device 
in the future. 
Objectives 
1. Record, measure and analyse changes in percentage heart rate and 
oxygen saturation during different types of seizures, identified by 
the use of electroencephalographic video EEG telemetry. 
2. Record, measure and analyse changes in percentage heart rate and 
oxygen saturation during different normal physiological events 
identified by the use of electroencephalographic video EEG 
telemetry, to enable comparison of that measured during seizures. 
3. To assess these changes in a wide range in age of patients with 
epilepsy. 
4. To analyse results in terms of sensitivity and specificity for heart 
rate percentage change and oxygen saturation for all clinically 
significant seizures & clinically insignificant seizures. 
5. To analyse results in terms of sensitivity and specificity for heart 
rate percentage change and oxygen saturation for each seizure 
classification included in the study (International League Against 
Epilepsy 2005) of epilepsy monitored in this study for focal 
seizures and generalised seizures. However, the seizures are 
further analysed in terms of “complex focal” for seizures with 
patient loss of awareness and “simple focal” seizures without 
patient awareness. This further analysis is important for 
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differentiating “clinically significant seizures” from “clinically 
insignificant seizures” for the purposes of determining trigger 
levels for a seizure alarm. 
Null Hypothesis 
No distinction can be made between epileptic seizures and normal events 
using percentage heart rate change and oxygen saturation. 
1.2.3 Methodology 
Patients were invited to take part this prospective study whom most of them  
were already familiar with having electroencephalographic studies on 
previous occasions and had agreed to receive this type of monitoring as part 
of their clinical management of their epilepsy at the Royal Hospital for Sick 
Children or Western General hospitals, Edinburgh.  
Ethical and Management Approval was given before the study commenced.  
(Ethical Approval reference number LREC/2003/6/22). 
Patient information sheets were sent prior to ward admission to give   
patients and parents an opportunity to ask questions. A junior patient 
information sheet was appropriately worded for age comprehension to 
explain the study to children aged 5-12 years (appendix) and a senior 
information sheet (appendix) was designed for an age range of 13-17 years. 




During patient preparation, 23 stick-on surface silver silver-chloride 9 mm 
electrodes (supplied by Specialised Laboratory Equipment) (Figure 11) were 
placed on the scalp using the International 10:20 system (Cooper et al) 
(Figure 13). This ensured that the potential difference recorded between pairs 
of bi-polar connections (Tables 1 & 2) were symmetrically comparable for 
each hemisphere.  This provided full coverage of all accessible scalp areas, 
including surface sphenoidals. Prior to electrode application the scalp 
electrode site was scarified by gently abrading the scalp using a cotton bud 
with ‘Nuprep’ (supplied by UniMed Electrode Supplies).  
                               
Figure 11 Stick-on 9 mm silver silver-chloride electroencephalographic 
electrodes. Supplied by Specialised Laboratory Equipment. 
 
The electrodes were attached to the scalp using collodion glue and dried 
with an air compressor. Spectra conducting saline gel were introduced via a 
disposable blunted needle (Figure 12) and syringe through the electrode 
access point. Further scarification using the disposable blunted needle was 
not usually required to achieve impedances below 10 kilo-ohms (kohms). 
The collodion glue, spectra gel and disposable blunted needles were 
supplied by Specialised Laboratory Equipment Ltd. 
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Figure 12    Disposable blunted needle.                 
              
Figure 13    Diagram of International 10:20 System (Cooper et al.2003). 
 
The electrocardiograph (ECG or EKG) is an electrographic record of the 
heart’s electrical activity or conduction, which is recorded from the skin 
surface. Voltage changes occurring in the heart can be detected at the skin 
surface because of capacitance properties of the body (Thibodeau et al, 1993) 
Modified lead II electrocardiography (ECG) was recorded from disposable 
ECG electrodes (supplied by Ambu Ltd) (Figure 14) with one electrode 
placed on the right sub-clavical position and the other electrode placed on 
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the left abdomen. All wires were tied together to minimise electrical noise 
pick up from the ward environment and to provide comfort and maximum 
mobility to the patient. Electrocardiography (ECG) was recorded 
simultaneously with Video Electroencephalography The filter settings used 
in acquiring Lead II ECG were a high frequency filter (low pass filter) 70Hz 
and low frequency filter (high pass filter) of 0.5Hz or Time Constant filter of 
1 second with a system sensitivity of 7uv/mm (uv microvolts) and a 
sampling rate of 500Hz was used in XLTEK EEG systems. High sampling 
rates of data are necessary to give high resolution and a good reproduction 
of original physiological signals. The ECG electrodes were replaced every 24 
hours so as to ensure minimum skin irritation. 
                                
Figure 14 ECG disposable sensory electrodes supplied by Ambu Ltd.  
 
1.2.4 Pulse Oximetry  
Masimo SET pulse oximetry was used in this study. The oximeter internally 
calibrates within the XLTEK EEG (Electroencephalography) video telemetry 
system and is displayed as a numeric value using adaptive filters, plotted 
from 1-100% in 0.5 percent increments every 0.4 seconds and is displayed 
simultaneously with real time EEG and ECG (Electrocardiography) data. 
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Masimo Sensor Device 
Oxygen saturation was monitored using a ‘Masimo’ forehead sensor 
(supplied by Artemis Medical), secured by an elasticated headband (Figure 
15). The sensor position was changed to either temple or mid-forehead 
regularly. This was recommended by the manufacturer to minimise any 
possible irritation from prolonged infrared to one site. In the study the sensor 
device used was a reusable ‘LNOP Forehead Sensor’. This sensor works on 
reflectance or ‘back-scatter’ of red and infra-red signal from the sensor placed 
on the forehead and held in place by a comfortable stretch band encircling 
the head. 
This sensor was well tolerated by all ages of patients. The cable was collected 
with the surface EEG electrodes and neatly tied together to minimise 
inconvenience and to maximise freedom of movement for the patient. The 
forehead sensor was preferable in case of the delay effect in detecting 
hypoxaemia due to lung / periphery circulation time when recording from 
finger sensors.  
Oxygen saturation measurement is digitally displayed every second on the 
videotelemetry polygraphy and was recorded before and during each seizure 
and normal event During the 3 second epoch, the lowest oxygen saturation 
value was selected to represent maximal de-saturation within each epoch 
measurement and entered onto the Excel spreadsheet. 
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Figure 15 Masimo Forehead Pulse Oximetry Sensor Device 
The electroencephalographic electrodes, oxygen saturation cable and the 
electrocardiographic leads were all plugged into an XLTEK Mobee 32 
channel headbox.  The Mobee headbox networked the data to a main 
computer server with simultaneous video of the patient. (Mobee 
specifications are in the appendix). The XLTEK videotelemetry system via 
the Mobee 32 headbox recorded these physiological signals continuously, 
even when disconnected from the server. When reconnected it automatically 
uploaded the data from the Mobee headbox which has a local memory 
capacity of 4 hours of disconnection (Figure 16). This allowed for patient 
disconnection from the network to go to the toilet etc. 
The recording commenced at 16:30 hrs and the patient was provided with 
meals, a variety of board games, colouring books and children’s videos / 
DVDs for their entertainment until their usual bedtime. The patient was 
observed all night by nursing staff or a parent, if they desired to stay, who 
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documented any normal events such as sneezing, coughing, yawning, 
stretching, turning over in bed and any seizures onto a diary. All parents 
were enthusiastic about their child taking part in the study, as they felt that it 
was a good opportunity for a detailed assessment of their child overnight. 
The following morning, the monitoring was ceased and the equipment was 
disconnected.  The electrodes were removed using collodion remover 
(supplied by Specialised Laboratory Equipment). The child was ready to go 
home by 10:30 am. 
The adult cohort were sometimes monitored for up to 5 days as they were 
often being clinically assessed for suitability for epilepsy surgery and 
therefore maximum data was required in those cases. Consent forms 
(appendix) were completed for wider publication and for the use of video. 
They were encouraged to bring in books and videos / DVDs of their choice 
for their stay. A daily ward service of magazines and papers was operated in 
the hospital. 
Video EEG telemetry digital data review was performed using a dedicated 
XLTEK software computer network system. The system displayed ‘raw’ 
physiological electrographic data for electroencephalography and 
electrocardiography. Pulse oximetry was displayed as a numerical value 
every second, which was time-synchronised with the data and simultaneous 
video. The videotelemetry review displayed a maximum of 32 channels of 
data depending on selected montage (Tables 1 & 2) on full screen of 12 
seconds display or 10 seconds display using a chart speed of 30mm-1. 
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F4 10uv/mm     70Hz     0.5Hz 30mms-1 
     2 F4 C4 10uv/mm     70Hz     0.5Hz       30mms-1 
     3 C4 P4 10uv/mm     70Hz     0.5Hz 30mms-1 
     4 P4 O2 10uv/mm     70Hz     0.5Hz 30mms-1 
     5 Fp1 F3 10uv/mm     70Hz     0.5Hz 30mms-1 
     6 F3 C3 10uv/mm     70Hz     0.5Hz 30mms-1 
     7 C3 P3 10uv/mm     70Hz     0.5Hz 30mms-1 
     8 P3 O1 10uv/mm     70Hz        0.5Hz 30mms-1 
     9 Fp2 F8 10uv/mm     70Hz     0.5Hz 30mms-1 
   10 F8 Sp2/T4 10uv/mm     70Hz      0.5Hz 30mms-1 
   11 Sp2/T4 T6/A2 10uv/mm     70Hz            0.5Hz 30mms-1 
   12 T6/A2 O2 10uv/mm     70Hz     0.5Hz 30mms-1 
   13 Fp1 F7 10uv/mm     70Hz        0.5Hz 30mms-1 
   14 F7 Sp1/T3 10uv/mm     70Hz 
 
    0.5Hz 30mms-1 
   15 Sp1/T3 T5/A1 10uv/mm     70Hz     0.5Hz 30mms-1 
   16 T5/A1 O1 10uv/mm     70Hz     0.5Hz 30mms-1 
   17 ECG1 ECG2 7uv/mm     70Hz     1.0Hz 30mms-1 
   18         SAO2 20%/mm      Off      Off 30mms-1 
   19    Pulse Rate 20%/mm      Off      Off 30mms-1 


















       1 F8 F4 10uv/mm     70Hz     0.5Hz 30mms-1 
       2 F4 Fz 10uv/mm     70Hz     0.5Hz 30mms-1 
       3 Fz F3 10uv/mm     70Hz     0.5Hz 30mms-1 
       4 F3 F7 10uv/mm      70Hz     0.5Hz 30mms-1 
       5 A2/Sp2 T4 10uv/mm      70Hz     0.5Hz 30mms-1 
       6 T4 C4 10uv/mm      70Hz     0.5Hz 30mms-1 
       7 C4 Cz 10uv/mm      70Hz     0.5Hz 30mms-1 
       8 Cz C3 10uv/mm      70Hz     0.5Hz 30mms-1 
       9 T3 A1/Sp1 10uv/mm      70Hz     0.5Hz 30mms-1 
     10 T6 P4 10uv/mm      70Hz     0.5Hz 30mms-1 
     11 P4 Pz 10uv/mm      70Hz     0.5Hz 30mms-1 
     12 Pz P3 10uv/mm      70Hz     0.5Hz 30mms-1 
     13 P3 T5 10uv/mm      70Hz     0.5Hz 30mms-1 
     14 F8 T4 10uv/mm      70Hz     0.5Hz 30mms-1 
     15 T4 O2 10uv/mm      70Hz     0.5Hz 30mms-1 
     16 F7 T3 10uv/mm      70Hz     0.5Hz 30mms-1 
     17 T3 T5 10uv/mm      70Hz     0.5Hz 30mms-1 
     18 ECG1 ECG2 7 uv/mm      70Hz     0.5Hz 30mms-1 
     19          SAO2 20%/mm       Off      Off 30mms-1 
     20      Pulse Rate 20%/mm      Off     Off 30mms-1 
 




Electroencephalography videotelemetry was used to identify both clinical 
seizures and sub-clinical seizures. If the electroencephalograph showed 
changes prior to the clinical onset, the start of the seizure was measured at 
the start of the electrical ictus. If the clinical manifestations appeared prior to 
the electrical discharge, then the start of the seizure was taken at the start of 
the clinical onset. Time synchronised video telemetry was necessary to be as 
accurate as possible in identifying seizure type both electrographically and 
clinically. Sub-clinical seizures are defined as “electroencephalographic ictal-
like patterns without any disturbance of motor, sensory and conscious 
functions in the wake patient and without any movemeor arousal during the 
sleep patient” (Zangaladze et al 2008). The electro-cerebral changes and 
video accompaniment of all seizures were interpreted and discussed with a 
Consultant Paediatric Neurologist or Consultant Neurologist/ 
Neurophysiologist for seizure classification. 
Electroencephalographic epileptiform activity is an interpretative term 
applied to electrographic transients of spike and sharp wave activity, 
distinguished from the background activity occurring in a proportion of 
patients with epilepsy (Dinner et al. 1985).  Seizure activity on the 
electroencephalograph is a sudden distinctive pattern of electrical change 
usually in amplitude and rhythmicity. 
The entire electroencephalographic videotelemetry study was reviewed, 
measured and analysed.  A report was then created detailing frequencies 
(Hz) and amplitudes (uv) of the awake trace, asleep trace and any seizures. 
Measurements were manually selected using XLTEK software cursors. All 
seizures were identified and annotated to the nearest second at the start of 
the seizure, whether they were electrical, clinical or both presenting 
Section One 
 62 
simultaneously.  Heart rate percentage change and oxygen saturation were 
also measured prior to the seizure. From the onset of the seizure, these 
parameters were measured 5 minutes (T-5m), 4 minutes (T-4m), 3 minutes 
(T-3m), 2 minutes (T-2m), 1 minute (T-1m) and 9 seconds (T-9s) before the 
seizure. 
1.2.5 Heart Rate Percentage Change  
The videotelemetry records the EEG/ECG/SAO2 and Video signal 
simultaneously, identifiable to the exact time of day at which it was 
originally acquired. The seizure onset was identified by 
electroencephalographic changes and clinical semiology. The data was 
annotated to the nearest second. Using dedicated software cursors 
consecutive measurements of R-R intervals were measured in milliseconds 
over consecutive 3 second epochs and entered onto a spreadsheet. The mean 
R-R intervals were calculated over each 3 second epochs and converted to 
seconds by dividing milliseconds by 1000. Heart rate was then calculated by 
dividing 60 by the converted value to calculate beats per minute. For 
example, an R-R measurement of 930 milliseconds, when divided by 1000 
becomes 0.93 seconds. When 60 is divided by 0.93, a heart rate of 64.5/min is 
calculated. Continued measurements of each R-R intervals were manually 
measured throughout each seizure and normal event. Mean heart rate was 
entered onto an excel spreadsheet and percentage change was calculated 
using subtraction of the 1st epoch (seconds 1-3) from the 3rd epoch (seconds 7-
9) of each subsequent 9 second epoch. Intra and inter-observer analyses are 
presented in chapter 1.7.1 Oxygen saturation were entered onto the same 
spreadsheet for each epoch. Continued measurements were made until the 
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event ended clinically and once the electroencephalograph had resumed the 
pre-event trace.  
The time of seizure onset was entered onto a spreadsheet and subsequent 3 
seconds epochs were identified throughout the seizure as well as analysis of 
5 minutes prior to the seizure. With this methodology, the data can be 
checked and re-measured, if necessary for any given 3 second epoch of an 
epileptic seizure or normal event for any patient measured in this study. 
Oxygen saturation measurement was digitally displayed every second. 
During each 3 second epoch, the lowest value was selected and a mean 
oxygen saturation value was calculated over each 9 second epoch and 
entered onto the spreadsheet. 
Changes in heart rate and oxygen saturation during normal events were 
necessary to compare any changes to that of seizures. Normal events e.g. 
sneezing, coughing stretching, yawning, crying, laughing, arousal and 
turning over in bed were all identified using indications on the 
electroencephalograph of electromyographic activity and movement artefact 
correlated with the video evidence and diary annotation. Arousal was 
identified by the on-going sleep trace being interrupted by the return of 
awakened activity on the electroencephalograph for at least 5 seconds. The 
trace was documented to the nearest second on the electroencephalograph.  
Using the electroencephalograph and synchronised video, each normal event 
for every patient was identified and annotated onto the 
electroencephalograph to the nearest second. A baseline measurement of 
heart rate was analysed over an epoch of 9 seconds to get a mean average 
heart rate (T-9). Heart rate was then analysed during the normal 
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physiological event over the selected 9 seconds epoch (Tdur) and the 
percentage heart rate change was calculated during subsequent 3 seconds 
epochs and calculated in the same way as for seizure heart rate methodology.  
Inter & Intra-observer Analysis 
For inter and intra-observer error analysis, a qualified Electrocardiographer / 
Electroencephalographer re measured the same raw data in one patient. A 
mean value for R-R measurements was calculated for each 3second epoch. 
Mean R-R intervals were calculated over each 3second epoch and converted 
to seconds by dividing milliseconds by 1000. Heart rate was then calculated 
by dividing 60 by the converted value to calculate beats per minute and 
entered onto an Excel spreadsheet. Percentage change in heart rate was 
calculated by subtracting heart rate of the 1st epoch (seconds 1-3) from the 3rd 
epoch (seconds (7-9) of each consecutive 9 second epoch. 
Observer 1 and Observer 2 measured the same data twice as Run 1 and Run 
2. Consistency of each observer’s measurements were analysed by 
comparing Run 1 and Run 2 for intra-observer analyses. Inter-observer 
analyses were performed by comparing results for Observer 1 and Observer 
2 with each run. 
1.2.6 Statistical Methods 
Minitab (version 14) statistical analysis software was used in analysing one 
sample t-tests for percentage change of heart rate before and during seizures 
and by the same method for normal event data.  Non-parametric Wilcoxin 
one sample t-test of percentage change is used as percentage represents 
different proportions. Percentage change of heart rate is presented instead of 
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comparing absolute heart rate “before” and “during” events to give a 
proportional change instead of an absolute change. Heart rate is very 
different depending on age whereas a proportional change from baseline is 
applicable for all ages. As the age range of patients range from a 1-day old 
infant to a 60 year old adult, I have made the assumption of independence of 
data between patients. In addition, due to high levels of intra-subject 
variation as well as inter-subject variation, I have also made the assumption 
of independence of data within the same patient. 
Paired t-tests were applied for oxygen saturation levels and compared before 
and during seizures and for normal events. Parametric paired t-tests are 
appropriate in this case as the t-tests compare the oxygen saturation before 
the seizure with the oxygen saturation during the seizure. Although there is 
a maximum ceiling of 100% oxygen saturation, the data difference produced 
is of normal distribution. Minimum oxygen saturation values during the 
seizure are presented in each seizure category for the purposes of identifying 
a useful trigger level for a seizure alarm device. 
Diagnostic testing was used to calculate sensitivity and specificity for 
grouped data for heart rate percentage change and oxygen saturation using 
Statistical Packages for the Social Sciences (SPSS) version 12.  
Diagnostic testing was used to indicate trigger levels that might be used in a 
seizure alarm if percentage heart rate and oxygen saturation were used as 
parameters. From diagnostic testing, the sensitivity gives us two results; 
firstly, it gives the ‘true positive’ (correctly identified seizure) proportion and 
the ‘false negative’ (missed seizure) proportion. 
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The specificity of each possible trigger level also gives us two results. Firstly, 
it shows the ‘true negative’ (correctly identified normal event) proportion 
and the ‘false positive’ (false alarm) proportion. 
Statistical Package for Social Sciences (SPSS) software uses these co-ordinates 
to produce a ‘Receiver Operator Curve’ (ROC). In an ideal situation, the 
curve should run closest to the top left corner of the graph. This would be 
possible if the sensitivity and specificity were close to the value of ‘1’. In 














Chapter 3: Results 
1.3.1 Study Group Characteristics 
Fifty patients were invited to take part in this prospective and ethically 
approved study (Table 3). All patients were having EEG videotelemetry 
monitoring as part of their clinical management of their epilepsy. Not all 
patients in the study had seizures captured during their monitoring. The 
patients had an age range of 1 day (full term) to 60 years and 3 months with a 
mean age of 13 years and 4 months ± 13.45 years was calculated for the 
group. The median age of 8 years 6 months indicates that most of the patients 
in the group tend towards the younger paediatric age range. The gender mix 
was 33 Males and 17 females. 
Eleven patients had structural abnormalities (not including mesial temporal 
sclerosis or sclerosis of the hippocampus); 1 patient had Rassmussen’s 
Syndrome, 3 patients had a history of stroke, 2 patients had space-occupying 
lesions, 1 patient had a double cortex (or sub-cortical band heterotopia), two 
patients had a history of an encephalitis with subsequent cortical damage, 1 
patient was microcephalic and one patient was a neonate with a severe 
ischaemic encephalopathy. 
Several different syndromes were included in the group. One patient had 
Ohtahara’s syndrome, 2 patients were Aicardi syndrome, 2 patients were 
Austistic Spectrum Disorder, 2 patients had Lennox Gastaut syndrome, 1 
patient had progressive polymorphic epilepsy of Dravet and 1 patient had 
Myoclonic Astatic Epilepsy (MAE). 
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The general seizure type of the group in this study were as follows; 21 
patients had a history mainly of complex focal seizures, 24 patients had a 
history of mainly generalised tonic-clonic seizures and 5 patients had a 
history purely of focal seizures. 
Anti-convulsant medication was used either as a monotherapy or in 
combination with other anti-convulsants in the attempt to control frequent 
seizures. In this group of patients, the most commonly used anti-convulsant 
was Sodium Valproate, which was prescribed for 17 patients (34%). The next 
most commonly used anti-convulsant was Carbamazepine, which was 
prescribed for 13 patients (26%) of the study group. Lamotrigine (9: 18%), 
Topiramate (8: 16%), Phenytoin (6: 12%) and Phenobarbitone (5:10%), were 
used less commonly. The least commonly used anti-convulsant therapies 
prescribed for the group were Nitrazepam (2: 4%), Keppra (2: 4%), 
Vigabatrin (2: 4%) and Ethosuximide (1: 2%). Rescue medication (Diazepam) 
is not included in this analysis. 
The videotelemetry provided valuable information for the clinical 
management for all patients. Based on the results, 10 (20%) patients had their 
medication changed or were commenced on anti-convulsants for the first 
time because of evidence of epilepsy. 
From the adult cohort, videotelemetry supported complex focal seizures 







Patient Age Gender Aetiology/ Epilepsy Anti-Epileptic Drugs 





2 14 years  
5 months 
F Head injury. Daily frequent 
complex focal seizures. 
Phenytoin. Carbamazepine 
3 3 years  
5 months 
M Motor developmental delay. 
Weekly complex focal seizures. 
Carbamazepine, 
Lamotrigine. 
4 3 years  
7 months 
M Mild motor delay. Weekly 




5 10 years 
10 months 






6 3 years 6 
months 
M Mild motor delay. Weekly 
complex focal seizures. 
Carbamazepine, 
Lamotrigine. 
7 14 years  
5 months 
M Rassmussen’s encephalitis. 




8 9 years 
11 months 
M Progressive polymorphic 
epilepsy of Dravet. Daily 
seizures. 
Sodium Valproate. 
9 3 years  
1 month 
M Autistic spectrum disorder. 
Weekly complex focal seizures. 
Nil. (Seizures not previously 
diagnosed). 
10 15 years 
11 months 
F Aicardi syndrome. Cerebral 
palsy with left hemiparesis. 
Weekly tonic, Generalised 
Tonic Clonic & myoclonic 
seizures. 
Phenytoin. 
11 15 years 
2 months 
M Lennox Gastaut syndrome. 
Daily absences, weekly 





12 10 years 
11 months 
M Stroke, left dystonic 
hemiplegia. Daily complex 
focal seizures. 
Topiramate. 
13 5 years  
4 months 
F Sub-cortical band heterotopia. 
Daily epileptic spasms. 
Sodium Valproate. 
14 7 years 
6 months 
M Global motor delay. Nocturnal 
seizures occurring weekly. 
Carbamazepine. 
15 6 years 
7 months 
M Lennox Gastaut syndrome. 






16 5 years  
9 months 
F Aicardi syndrome. Epileptic 
spasms daily. 
Vigabatrin, Lamotrigine. 
17 49 years 
7 months 
M Daily complex focal seizures. 
One nocturnal Generalised 
Tonic Clonic Seizure. 
Carbamazepine, 
Lamotrigine, Topiramate. 
18 5 years 
9 months 
M Normal development. 
Absences, drop attacks & 




19 60 years 
3 months 
F 3 year history of funny turns. 
Complex focal seizures. 
Nil. Commenced on AED 
after EEG Videotelemetry. 
20 20 years 
9 months 
M Epilepsy since childhood. 
Polymicrogyria. Complex focal 
seizures. 
Carbamazepine. 
21 17 years  
11 months 
F Complex focal seizures, 
occasional Generalised Tonic 
Clonic Seizures. 
Topiramate, Keppra. 
22 11 years 
3 months 
F Normal development. Recent 
weekly focal seizures. 
Carbamazepine. 
23 11 years 
5 months 
M Normal development. Weekly 
complex focal seizures with 
secondary generalisation. 
Sodium Valproate. 
24 27 years 
9 months 
F Recent focal seizures. Nil. Commenced on AED 
after EEG Videotelemetry. 
25 21 years  
3 months 
F Daily absences. Generalised 





26 4 years 
9 months 
M Mild developmental delay. 
Weekly nocturnal seizures. 
Topiramate,  
Sodium Valproate. 
27 6 years 
6 months 
F Previous viral encephalopathy. 
Cortical visual impairment & 
learning disability. Atonic 
seizures and absences. 
Phenobarbitone. 
28 6 years 
1 month 
M Magille’s syndrome. Myoclonic 
absences. 
Nil. To be commenced on 
Ethosuximide. 
29 16 years 
11 months 





30 16 years M Frequent daily episodes 
resembling torticollis & 
retrocollis. Complex focal 
seizures. 
Carbamazepine 
31 4 years 
11 months 








M Complex focal seizures Carbamazepine, 
Lamotrigine 
33 22 years 
7 months 
F Complex focal seizures Nil. Commenced on AED 
after EEG Videotelemetry 
34 41 years 
9 months 
F Myoclonic epilepsy Nil 
35 2 years 
5 months 
M Prolonged febrile convulsion. 
Nocturnal Generalised Tonic 
Clonic Seizures. 
Sodium Valproate. 
36 3 years 
9 months 





37 4 years 
3 months 
M Right temporal lesion 
extending to parahypocampal 
gyrus. Focal seizures. 
Sodium valproate, 
Carbamazepine. 
38 5 years 
11 months 
M Myoclonic Astatic Epilepsy. 
Absences, atonic, tonic, 
Generalised Tonic-Clonic 
Seizures. Periods of non-
convulsive status epilepticus. 
Phenobarbitone, 
Topiramate. 
39 12 years 
4 months 
F Normal development, 18 
month history of absences, 
single Generalised Tonic-Clonic 
Seizure. 
Carbamazepine. 
40 30 years 
11 months 
M Focal seizures (sensory 
induced by music) 
Lamotrigine 
41 5 years 
4 months 
M Microcephaly, Cerebral Palsy. 
Seizures. 
Nitrazepam. 
42 5 years 
4 months 
F Cerebral Palsy. Shunted 




43 43 years 
11 months 
M Encephalitis post typhus 
vaccination. Complex focal 
seizures with secondary 





44 22 years 
8 months 
F Complex focal seizures with 
secondary generalised 
seizures. 
To be commenced on AEDs 
45 2 years 
 
M Episodes of epilepsia partialis 
continuans involving the right 
side of face. 
Nil. To be commenced on 
Phenytoin. 
46 4 months M Non-accidental injury. Right 
hemiplegia. Left focal seizures. 
Phenytoin, Midazolam. 
47 2 days (Full 
term) 
F Focal structural lesion. Focal 
seizures. 
Nil. To be commenced on 
AEDs. 
48 34 years 
11 months 
M Nocturnal frontal lobe 
seizures. 
Carbamazepine. 
49 1 day (Full 
term) 
M Severe hypoxic ischaemic 
encephalopathy. 
Nil. To be commenced on 
phenobarbitone. 
50 10 years 
7 months 
M Learning disability. Complex 
focal seizures. 
Nil 
Table 3     Total Patient Demographics 
1.3.2 Total Seizure Group. 
527 seizures were analysed in the total seizure group. This was composed of 
36 absences (4 patients), 102 simple focal (6 patients), 229 frontal lobe 
seizures (10 patients), 11 generalised tonic-clonic seizures (6 patients), 28 
myoclonus (5 patients), 31 temporal lobe seizures (11 patients) and 90 tonic 
seizures (7 patients). In addition, 83 sub-clinical seizures (7 patients) and 10 
neonatal seizures were analysed.  
A mean difference of 21.8% in heart rate is calculated for the total seizure 
group (Table 4) during seizures compared to baseline measurements and is 
highly statistically significant (p<0.001).  Mean differences in oxygen 
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saturation are small (2.1) dropping mean oxygen saturation to 96.1, which is 





      n     Mean St.Deviation SE Mean        p< 






   494 
   494 
   494 
    
    98.2 
    96.1 
      2.1 
       
       1.9 
       5.3 
       4.9 
  
     0.1 
     0.2 
     0.2 
    0.001 
 
Table 4 Descriptive Statistics using one sample t-test for Percentage Heart 
Rate Change and Paired t-test for Oxygen Saturation for the Total Seizure 
Group. 
Overall, both the changes in heart rate and oxygen saturation for total 
seizures in the study show high statistical significance. This does not 
however explain how clinically relevant the result is or what the accuracy of 
an alarm system might be if it was to detect seizures based on heart rate 
change and oxygen saturation percentage at various trigger levels. 
It is therefore necessary to investigate the sensitivity and specificity in 
diagnostic testing of these parameters for this group. 
Diagnostic Testing for the Total Seizure Group. 
Diagnostic testing was used to compare the percentage changes in heart rate 
during seizures with percentage changes in heart rate during normal events. 
It was also used to compare oxygen saturation percentage values of seizures 
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to that of normal events. All possible trigger levels in heart rate percentage 
change and oxygen saturation that may be considered for an alarm system 
device are derived from ROC co-ordinates.  
 
























Figure   17   Receiver Operator Curve for Diagnostic Testing of Heart Rate 
Percentage Change and Oxygen Saturation During Total Seizure Group. 
 
During seizures and normal events, a wide range in percentage heart rate is 
seen (Figure 17). If a trigger level of a device is set to alarm at the smallest 
change in heart rate of 0.5% it would correctly identify 87% (sensitivity of 
0.871) of seizures (true positives).  However, it would also incur many false 
alarms (false positives). Specificity is calculated as 1-specificity from the co-
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ordinates. With a heart rate percentage change of 0.5, specificity is calculated 
as 1-0.954, which when rounded up, equates to 0.05 (5%). The level of false 
alarms is calculated as 1- specificity value, which in this case is 0.95 (95%). 
At this small alteration in heart rate percentage change, most seizures would 
be identified but there would be a very high level of false alarms. If a better 
specificity rating is considered of 0.95 (95%) with a heart rate trigger level of 
45.5%, the sensitivity value of 0.046 (5%) is very poor with 95% of seizures 
missed (false negatives). 
In this situation, the best compromise is a trigger level of 14.5%. This still 
remains poor with only 42% of seizures correctly identified (0.423 true 
positives) and a specificity of 1-0.510 (49%) true negatives (correctly 
identified normal events) with a resultant level of 51% false positives (false 
alarms). In short, an alarm system based on this trigger level has the same 
chance of the alarm being due to a normal event or a seizure, which would 
render the system pointless.  
Using an oxygen saturation trigger level of 90.5%, specificity of 1-0.045 (0.95 
or 95%) is shown. This would result in very few false alarms of 5% but the 
sensitivity of correctly identifying true seizures as true positives is poor at 
0.092 (9%). 
To conclude, the sensitivity and specificity values for the total seizure group 
compared to normal events are poor. The percentage changes in heart rate 
and oxygen saturation percentage overall, during total seizures, cannot be 
distinguished from that seen during normal events.  
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However, this result indicates a poor sensitivity and specificity because 
many epileptic seizures in the group include very brief clinically insignificant 
seizures e.g. absences and myoclonus, which perhaps do not show 
significant changes in heart rate or oxygen saturation. This has possibly 
numerically ‘devalued’ the results from changes in heart rate percentage 
change and oxygen saturation encountered during more clinically significant 
seizures. 
It is therefore important to consider sensitivity and specificity of clinically 
significant seizures and clinically insignificant seizures and compare the 
heart rate percentage changes and oxygen saturation to that of normal 
events. The logic of this is dictated by the fact that a reliable seizure alarm 
system would be more clinically useful if it identified clinically significant 
seizures like generalised tonic-clonic seizures and was not triggered because 
of an absence attack or single myoclonus.  
1.3.3 Clinically Significant Seizure Group. 
All seizures in this study were self-resolving and did not require rescue 
medication intervention to stop any prolonged seizures. However, some 
seizures were more clinically significant than others and required re-
positioning into recovery position after the seizure. The seizures that were 
categorised as being ‘clinically significant’ were seizures that were 
considered harmful to the patient and could potentially lead to serious 
consequences if left undetected and included generalised tonic-clonic 
seizures, prolonged frontal lobe seizures with clinically significant hypoxia 
and some temporal lobe seizures that caused cardiology changes e.g. 
diminished T-wave etc. Therefore seizures that posed an obvious clinical 
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threat to the patient and where an alarm system would be beneficial in 
alerting assistance to the individual having the seizure were included in this 
group. 
Sixty one clinically significant seizures were analysed from 28 patients (Table 
5) consisting of 13 frontal lobe seizures (7 patients), 2 simple focal (2 
patients), 27 temporal lobe (9 patients) 11 generalised tonic-clonic seizures (6 
patients), 9 tonic seizures (3 patients) and an acute period of epileptic spasms 





      n    Mean StDeviation SE Mean       p< 





     
      49 
      49 
      49 
   
    97.2 
    86.9 
    10.3 
    
       2.7 
     11.0 
     11.3 
    
     0.3 
     1.5 
     1.6 
   0.001 
 
Table 5   Descriptive Statistics for one sample t-test for Percentage Heart 
Rate and paired t-test for Oxygen Saturation in Clinically Significant Seizures. 
This result shows a high statistical significance of p<0.001 but again, it does 
not explain how useful these parameters would be in the use of a seizure 
alarm device. Diagnostic testing is required to discover how many seizures 





























Figure 18   Receiver Operator Curve for Diagnostic Testing of Percentage 
Heart Rate Change and Oxygen Saturation during Clinically Significant 
Seizures. 
 
Immediately, a very different trend on the Receiver Operator Curve is 
observed (Figure 18). Both traces are closer to the top left corner for the 
clinically significant seizure group compared to that seen for the total seizure 
group (Figure 17). The ROC indicates better sensitivity and specificity values 
in percentage heart rate change and oxygen saturation during clinically 
significant seizures. 
The best compromise between the best level of correctly identified seizures  
(sensitivity) and keeping false alarms to a minimum due to normal events 
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(false positives) appears to be when the trigger level is set to a percentage 
heart rate change of 25.5% (Figure 18). This level gives a sensitivity of 0.792 
(79%), which is almost 80% accurate seizure detection. This trigger level 
gives a specificity of 1-0.246 (75%), which will correctly identify heart rate 
changes due to normal events that would not trigger the alarm. This leaves a 
false alarm rate of 25%, which is possibly a little excessive, i.e. 1:4 ratios of 
false alarms.   
To minimise the proportion of false alarms, a lower sensitivity of true 
positive seizure detection would occur. If parents were given the choice they 
would probably ask for better seizure detection rate and accept that 1 alarm 
out of 4 may be a false alarm. 
1.3.4   Combined Analysis (Percentage Heart Rate Change and 
Oxygen Saturation during Clinically Significant Seizures). 
Depending on both percentage heart rate change at 25.5% and oxygen 
saturation of 85% reaching these trigger levels together lowers the sensitivity 
to 24% but improves specificity to 99%. Oxygen saturation on its own can 
only identify 38% of seizures but correctly ignores non-events to 99.5%. 
However, when the data is combined with one/ other/ both parameters 
reaching their trigger levels, the sensitivity improves further to 91% and 
specificity stays the same at 75%. This result indicates that if a seizure alarm 
was triggered because of either percentage heart rate change or oxygen 
saturation parameters triggered either independently or together then 91% of 
clinically significant seizures would be detected. As before, one triggered 




1.3.5 Clinically Insignificant Seizure Group. 
Many epileptic seizures are very brief in nature. For example, bystanders 
may not even be aware that someone has had an absence seizure. These 
types of seizures can interrupt concentration and affect school performance. 
However, in terms of a seizure alarm device it would neither be useful to the 
parent or beneficial to the patient if it triggered every time an absence seizure 
occurred. 
However, some people may have a mixture of absence seizures and 
generalised tonic-clonic seizures with their generalised seizure disorder. In 
this situation, it would be useful for an alarm system to trigger during the 
tonic-clonic seizure but not during an absence. 
It would be very useful if an alarm system could not distinguish ‘clinically 
insignificant seizures’, which include epileptic seizures like absences from 
normal events and not trigger in either situation. 
466 epileptic seizures were included in the clinically insignificant seizure 
group. This group was composed of 214 frontal lobe seizures (2 patients), 1 
atonic seizure (1 patient), 95 simple focal seizures (I patient), 16 temporal 
lobe (4 patients), 35 absences (5 patients), 27 myoclonus (5 patients) and 78 









     n Mean St.Deviation SE Mean       p< 





    430 
  
    98.4  
    97.2  
      1.2 
   
        1.7 
        2.6 
        2.1 
    
      0.1  
      0.1 
      0.1 
   0.001 
 
Table 6   Descriptive statistics for one sample t-test for percentage heart rate 
change and paired t-test for oxygen saturation for clinically insignificant 
seizures.  
Statistical significance (p<0.001) occurs in both heart rate percentage change 
and oxygen saturation (Table 6) during clinically insignificant seizures. 
Insignificant seizures have a mean heart rate change of 14.7% compared to 
baseline with a standard deviation of 16.5%. The mean oxygen saturation of 
97% and is a normal value and not clinically significant for a patient but is 
statistically significant in this group because the majority of clinically 
insignificant seizures have a slight alteration in oxygen saturation during the 
seizure of around 1%.  
Statistical significance does not equate to clinical significance in this instance 
and diagnostic testing is required to assess whether insignificant seizures can 
be distinguished from normal events using percentage heart rate and oxygen 























Diagonal segments are produced by ties.
ROC Curve
 
Figure 19 Receiver Operator Curve for Diagnostic Testing of Percentage 
Heart Rate and Oxygen Saturation during Clinically Insignificant Seizures. 
 
 
Overall, percentage heart rate change during clinically insignificant seizures, 
are not distinguishable from normal events. The best compromise seen from 
diagnostic testing (Figure 19) is a trigger level of 14.5%. This gives a 
sensitivity of 45% of identifying true positives with 55% missed seizures. A 
similar specificity is seen of 1-0.51 (49%) true negatives (correctly identified 
normal events) and a high level of false alarms at 51%. This means that when 
the alarm triggers, it could either be almost equally due to a clinically 
insignificant seizure or a normal event. This trigger level is similar to the 
mean heart rate percentage change for the group of 14.7% seen from 
statistical analysis of one sample t-tests. 
Oxygen saturation percentage for this group shows a similar result in 
diagnostic testing to heart rate percentage change and it cannot distinguish 
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clinically insignificant seizures from normal events either. The level of 
sensitivity and specificity that show the best compromise is a trigger level of 
97.5%. This results in a sensitivity of 41% true positives and a specificity of 1-
0.53 (47% true negatives). The level of false positives (false alarms) is 53%. 
Again an alarm system triggering at this level may or may not be a seizure 
with an almost equal probability. 
This is an encouraging result. An alarm system based on percentage heart 
rate change and oxygen saturation which is set at a trigger level specific in 
detecting clinically significant seizures, will be unlikely to be triggered due to 














1.3.7 Summary of Changes in Percentage Heart Rate Change and Oxygen 
Saturation during Clinically Significant and Clinically Insignificant 
Seizures. 
 
Figure 20 Maximum, Mean and Minimum % Heart Rate Change during 
Clinically and Clinically Insignificant Seizures. 
 
Figure 21 Maximum, Mean and Minimum Oxygen Saturation during   
Clinically and Clinically Insignificant Seizures. 
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Chapter 4 Results: Generalised Epilepsy. 
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     p</= 
%HR      11    53.3     24.1     7.2     0.001 
SAO2      
 
    0.018 
BEFORE       8    96.6       1.8       0.6 
DURING       8    91.2       5.2        1.8 
Difference       8      9.3       4.9       1.7 
 
Table 7 Descriptive Statistics for one sample t-test of percentage heart rate 
change and paired t-test for oxygen saturation during Generalised tonic-
clonic seizures. 
High statistical significance (p<0.001) is seen for percentage heart rate change 
during eleven generalised tonic-clonic seizures (Table 7). A mean heart rate 
change of 53.4% is calculated for the group. A standard deviation of 24.1% 
indicates that heart rate change distribution for the group can show much 
higher heart rate changes than the mean value. Despite the small sample size 
and large standard deviation, statistical significance shows that these high 
heart rate changes are unlikely to occur by chance. 
Statistical significance for oxygen saturation (p=0.018) is still considered to be 
significant measured in eight generalised tonic clonic seizures but is not as 
highly significant as that seen with heart rate change. The sample size is 
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smaller for oxygen saturation than the sample size for heart rate change. This 
may account for a difference in statistical probability calculation. 
To consider how useful an alarm device might be in detecting generalised 
tonic-clonic seizures we need to analyse the sensitivity and specificity of 
heart rate and oxygen saturation parameters during these seizures.  
























Figure 22 Receiver Operator Curve for diagnostic testing of percentage   
heart rate and oxygen saturation during Generalised Tonic-clonic Seizures. 
 
  
Diagnostic testing indicates that generalised tonic-clonic seizures can be 
distinguished from normal events by using a device based on percentage 
heart rate change (Figure 22). Oxygen saturation is not always as useful with 
a sensitivity of 50% at a trigger level of 90.5% oxygen saturation. However, 
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very few false alarms would occur (5%) with a high specificity of 1-0.046 
(95%). 
Sensitivity of detecting generalised tonic-clonic seizures, based on a trigger 
level of 32.5% heart rate change will correctly identify 88% of seizures. This 
trigger level also provides a high specificity of 1-0.148 (85%) of correctly 
identified normal events, which would be ignored by the alarm system 
providing a low false alarm rate of 15%. 
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    90 
 
 
    18.9 
 
 
      15.4 
 
 
     1.6 
 
 
  0.001 
SAO2               
 
  0.001 
BEFORE     89      98.4        1.9      0.2 
DURING     89      94.7        4.3      0.4 
Difference     89        3.7        3.8      0.4 
 
Table 8 Descriptive Statistics for one sample t-test in Percentage Heart   
Rate Change and paired t-test for Oxygen Saturation during Tonic Seizures 
Tonic seizures (n=90) produce highly significant changes in percentage heart 
rate change and oxygen saturation (n=89) of p<0.001 (Table 8). This indicates 
that these changes are very unlikely to be due to chance and they must show 
consistent or similar changes during most tonic seizures. The mean 
percentage increase in heart rate (18.9%) is not as high as that seen during 
generalised tonic-clonic seizures (53.4%). The standard deviation of 15.4% is 
also smaller than that seen during generalised tonic-clonic seizures of 24.1%. 
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The mean oxygen saturation value for the group during the seizures is 94.7%, 
which is not clinically significant. High statistical significance of p<0.001 
indicates that most tonic seizures in the group must show consistent or 
similar changes in oxygen saturation with mean values dropping by almost 
4%. To consider the accuracy of an alarm system, diagnostic testing of 
percentage heart rate change and oxygen saturation is analysed during tonic 
seizures 





















Figure 23 Receiver Operator Curve for diagnostic testing of percentage heart 
rate change and oxygen saturation during Tonic seizures. 
 
 
A percentage heart rate change trigger level of 32.5% gives the best balance 
between sensitivity and specificity proportions (Figure 23). At this level a 
sensitivity of 78% (true positives) would identify a high proportion of tonic 
seizures. A specificity of 1-0.148 (85%) would correctly identify most normal 
events with a false alarm rate of 15%. As suggested by the mean oxygen 
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saturation paired t-tests, this parameter is more limited in detecting this type 
of seizure. At a trigger level of 95.5% oxygen saturation, a sensitivity of 44% 
is poor with 56% of tonic seizures being missed. A false alarm rate of 29% 
and specificity of correctly detecting normal events is 71%. This result is not 
surprising given that 95.5% oxygen saturation is not clinically significant.  
An alarm system based on percentage heart rate alone may be sufficient in 






      n    Mean St.Deviation SE Mean     p</= 
%HR      35      3.4        7.1      1.1    0.008 
SAO2           
 
   0.378 
BEFORE      35      95.0       3.4     0.5 
DURING      35      94.8       3.5     0.5 
Difference      35        0.2       1.3     0.2 
 
Table 9 Descriptive statistics for one sample t-test of percentage heart rate 
change and paired t-test for oxygen saturation during absence seizures. 
Statistical significance is shown for percentage heart rate change during 
thirty-five absence seizures of p=0.008 (Table 9). The mean percentage change 
in heart rate is very small (3.4%) with variability of 7% standard deviation. 
Overall, heart rate changes are small during these seizures. Paired t-tests 
describe oxygen saturation changes as being insignificant. A small change in 
oxygen saturation is seen for the group. Diagnostic testing is required to 
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assess whether absence seizures can be distinguished from normal events 
using percentage heart rate and oxygen saturation in a seizure alarm. 
























Figure 24    Receiver Operator Curve for diagnostic testing of percentage 
heart rate change and oxygen saturation during absence seizures. 
 
Diagnostic testing demonstrates very poor results in distinguishing absences 
from normal events (Figure 24). The best compromise is seen at a trigger 
level of 8.5%. At this level, we have a sensitivity of 31% with many missed 
absence seizures with 69% false negatives.  A specificity of 31% of true 
negatives (1-0.69) is seen with a high level of false alarms of 69%. In short, 
less than one third of absences would be detected and over two thirds of 
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alarms would be false alarms. Therefore, an alarm system based on 
percentage heart rate change would be a poor indicator in detecting absences 
at this level. If the alarm system were set to a higher trigger level to target 
clinically significant seizures e.g. generalised tonic-clonic seizures, it would 
be less likely that the alarm would be triggered due to an absence. This is an 
encouraging result. 
Oxygen saturation optimum trigger level setting is 95.5%. At this level, 66% 
of true seizures would be detected with a similar specificity of 71% (1-0.288) 
correctly identifying normal events. A false alarm rate of 29% would occur at 
this level. 
Although oxygen saturation shows better sensitivity and specificity than that 
seen for percentage heart rate change (Figure 26), 95.5% oxygen saturation is 















      n Mean  St.Deviation SE Mean      p</= 
  %HR       28      2.2      12.3      2.3   0.359 
SAO2      
   0.001 
 
BEFORE       28      96.1       1.9      0.3 
DURING       28      93.2       4.4      0.8 
Difference       28        2.9       4.0      0.7 
Table 10 Descriptive Statistics for one sample t-test of percentage heart rate 
change and paired t-test for oxygen saturation during myoclonus 
Statistical significance is poor for percentage heart rate change during 
myoclonus (n=28) with a probability of 0.359 (Table 10). This indicates that 
there is a lot of variability in the data with a relatively high standard 
deviation of 12.3% to the mean heart rate change of 2.2%. The variability is 
nearly 6 times that of the mean heart rate change. Therefore statistically, 
there is a fairly high probability that the heart rate change could occur by 
chance. 
This is not a surprising result because myoclonus is so brief that a consistent 
change in heart rate would be unlikely. 
It is surprising that paired t-test analysis of oxygen saturation during 
myoclonus show more of a consistent change for such a brief event with 
statistical significance of p<0.001. The mean oxygen saturation percentage 
during myoclonus is 93.2%.   
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Diagnostic testing will indicate whether a seizure alarm would identify 
myoclonus and give the optimum trigger level. However, it would be more 
beneficial if an alarm system did not trigger during brief myoclonus. 
























Figure 25 Receiver Operator Curve for diagnostic testing for percentage 
heart rate change and oxygen saturation during Myoclonus. 
 
Sensitivity and specificity of percentage heart rate change is poor as 
indicated with the mean changes from the one sample t-test. The best 
compromise appears to be a trigger level of 9.5% (Figure 25). This offers a 
sensitivity of true positives of 36% with 64% of missed myoclonus (false 
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negatives). A specificity of 1- 0.664 (34%) is poor with a high level of false 
alarms in the order of 66%. 
For oxygen saturation, a trigger level of 93.5% indicated as the mean value 
from paired t-testing for the group gives a poor sensitivity of 43% with 57% 
of missed seizures. Even though the proportion of false alarms of 14% (false 
positives) is quite low, an alarm system based at this trigger level would be 
poor in detecting myoclonus. It is likely that a seizure alarm system based on 
oxygen saturation would be set at a level of clinical significance i.e 85%. At 
this level there would not be any false alarms due to myoclonus with an 
extremely poor sensitivity of 7% myoclonus detection, with 93% missed 
myoclonic episodes.  
This is an encouraging result because it is would be an advantage for a 
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   2.1 
 
 
    12.3 
 
 
    2.3 
 
 
  0.359 
Table 11 Summary of Descriptive Values of one sample t-tests for 
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      8 
 
    91.2 
 
       5.2 
 
    1.8 
 





     89 
 
    94.7 
 
       4.3 
 
    0.4 
 





     35 
 
    94.8 
 
       3.5 
 
    0.5 
 





     28 
 
    93.2 
 
       4.4 
 
     0.8 
 
   0.001 
Table 12 Summary of Descriptive Values of paired t-tests for Oxygen 
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Chapter 5   Results: Focal Seizures 
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     229 
 
     28.3 
 
     15.4 
 
     1.1 
 
    0.001 
SAO2      
    0.001 BEFORE      215      98.9       1.1      0.1 
DURING      215      97.4       4.4      0.3 
Difference      215       1.5       4.3      0.3 
 
Table 15 Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-tests for oxygen saturation during frontal lobe 
seizures. 
High statistical significance p<0.001 (Table 15) is seen in both heart rate 
percentage change (n=229) and oxygen saturation during frontal lobe 
seizures (n=215). The mean heart rate percentage change of 28.3% is lower 
than that seen during generalised tonic-clonic seizures but higher than tonic 
seizures. Many of the frontal lobe seizures have similar changes in heart rate 
because even though the sample size (229) is large, the standard error of 
mean is small (1.1).  
Oxygen saturation changes demonstrate high statistical significance but the 
mean oxygen saturation for the total frontal lobe seizure group of 97.4% is 
not clinically significant. 
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Differences in percentage heart rate and oxygen saturation during right and 
left hemisphere complex focal seizures were tested to analyse differences in 
the effect of laterality of focal seizures. Data was split into right and left 
frontal lobe seizures. One sample t-tests of heart rate percentage change and 
paired t-tests for oxygen saturation before and during seizures were 
analysed for laterality of seizure. Assumptions of independence are made 
due to intra and inter-subject variation. Therefore statistical analysis is 
analysed in terms of seizures and not patients. 
 





     n    Mean St.Deviation SE Mean      p</= 
%HR      13     53.6       39.8     11.0    0.001 
SAO2      
 
   0.005 
BEFORE     12     97.3        3.6      1.0 
DURING     12     83.6      12.1      3.5 
Difference     12     13.6      13.3      3.8 
 
Table 16   Descriptive Statistics for one sample t-test applied to percentage 
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    214 
 
 
    26.9 
 
 
      11.1 
 
 
      0.8 
 
 
   0.001 
SAO2      
 
   0.001 
BEFORE     201     99.1        0.5       0.1 
DURING     201     98.3        0.7       0.1 
Difference     201       0.7        0.8       0.1 
 
Table 17 Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Left Frontal 
Lobe Seizures. 
Interesting and major differences are seen when data is divided into right 
(n=13) and left (n=214) frontal lobe seizures in terms of percentage heart rate 
changes and oxygen saturation. Parameter changes are more marked for 
right hemisphere frontal lobe seizures (Table 16). The mean percentage heart 
rate change for the right hemisphere is twice (53.6%) the mean heart rate 
change seen from the left hemisphere (26.8%), (Table 17). 
Mean oxygen saturation percentage changes from the right hemisphere 
(n=12) are clinically significant (83.7%) compared to the mean oxygen 
saturation percentage (98.3%) from the left hemisphere (n=201). 
High statistical significance is present in all categories of frontal lobe seizure 





























Figure 28 Receiver Operator Curve for diagnostic testing of percentage heart 
rate and oxygen saturation during frontal lobe seizures. 
 
 
The optimal trigger level correctly identifying the maximum number of true 
positives and true negatives without incurring too many false positives 
during frontal lobe seizures is 30.5% (Figure 28). At this level, it is very close 
to the mean percentage heart rate change seen for the total group of frontal 
lobe seizures (28.3%), (Table 15). The specificity value is very slightly better 
(82% compared to 78%) with the chosen trigger level with slightly less false 
alarms (18% compared to 22%). With a trigger level of 30.5% a sensitivity of 
83% of true seizure detection is very high considering that the sample is 
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weighted towards left frontal lobe seizures (n=214) which do not tend to 
show as much percentage heart rate change compared to the right 
hemisphere (n=13). 
The chosen trigger level for oxygen saturation is 89.5% for the best balance in 
detecting as many frontal lobe seizures without incurring too many false 
alarms. The sensitivity of 67% is not as high as that seen with percentage 
heart rate of 83% but a very low level of false alarms would occur of only 3%. 
It is also worth bearing in mind that not all frontal lobe seizures result in 
hypoxia so the fact that the sensitivity of detecting frontal lobe seizures using 
oxygen saturation is not as high as percentage heart rate change is more 
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     p< 
 
  %HR 
       
      31 
   
    28.5 
    
     30.1 
    
    5.4 
   
   0.001 
SAO2      
 
   0.001 
BEFORE       30     96.8       2.5     0.5 
DURING       30     88.9     10.6     1.9 
Difference       30       7.9     10.4     1.9 
 
Table 18   Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Temporal 
Lobe Seizures. 
High statistical significance of p<0.001 is seen for both parameters during 
temporal lobe seizures (n=31) (Table 18). Mean percentage heart rate of 28.5% 
during temporal lobe seizures is a very similar result to that obtained from 
the total frontal lobe seizure group. A larger standard deviation of 30.1% is 
seen with the temporal lobe seizure group than that of the frontal lobe group, 
which would suggest that there is a greater range in heart rate change during 
temporal lobe seizures. Mean oxygen saturation changes for the group are 
more clinically significant with values down to 88.9% during temporal lobe 
seizures (n=30) compared to the frontal lobe seizure group mean oxygen 
saturation value of 97%. Data for temporal lobe seizures were divided into 
right and left temporal lobe seizures and statistical analysis for percentage 
































      15 
 
 
    43.5 
 
 
     22.9 
 
 
   5.9 
 
 
  0.001 
SAO2      
 
  0.072 
BEFORE      15     97.1       3.4    0.9 
DURING      15     91.8      10.9    2.8 
Difference      15       5.2      10.5    2.7 
 
Table 19   Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Right 
Temporal Lobe Seizures. 
 



















Table 20   Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Left 
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    p</= 
 
 
  %HR 
 
 
     16 
 
 
   14.4 
 
 
      29.8 
 
 
     7.4 
 
 
  0.072 
SAO2      
 
  0.001 
BEFORE      15     96.5        1.2     0.3 
DURING      15     86.1        9.8     2.5 




Very different mean percentage heart rate changes are seen when results 
from the right (n=15) (Table 19) and left hemisphere (n=16) (Table 20) are 
compared. A higher change in mean percentage heart rate (43.5%) occurs 
with right temporal lobe seizures, compared to much smaller mean 
percentage heart rate change (14.4%) seen from left temporal lobe seizures. 
High statistical significance is present in percentage heart rate change from 
both hemispheres with the right hemisphere showing a marginal higher 
statistical significance (p<0.001) compared to the left hemisphere (p<0.007). 
Sample size is equally matched in both groups. 
More clinically significant changes in mean oxygen saturation (86.1%) 
occurred in the left temporal lobe seizure (n=15) group with a high statistical 
significance of p<0.001. Mean oxygen saturation changes appear less 
clinically significant with values of 91.8% from right temporal lobe seizures 
(n=15). 
Group mean percentage heart rate changes are higher from the right 



































Figure 29 Receiver Operator Curve for diagnostic testing of percentage heart 
rate change and oxygen saturation during temporal lobe seizures. 
 
 
From diagnostic testing of percentage heart rate change, the best trigger level 
of 25.5% is determined with a sensitivity of 75% (Figure 29). At this level the 
same specificity value is met (1-0.246) at 75%, with 25% false alarm rate. 
A mean value of 28.4% was calculated by one sample t-testing for the group 
for percentage heart rate change (Table 18). If this value were selected as a 
trigger level, it would result in a lower sensitivity of 58% with more missed 
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seizures. A slightly higher specificity is encountered of 78% (1-0.218) with a 
slightly less false alarm proportion of 22%. 
A chosen trigger level for oxygen saturation in the detection of temporal lobe 
seizures is more difficult. Sensitivity falls substantially long before clinically 
significant oxygen saturation levels are reached. A reasonable trigger level 
may be 88.5%. Sensitivity is only at 29% but specificity is high (99%) with 
only 1% false alarm rate. This level may be acceptable for a seizure alarm 
system if oxygen saturation parameter is used in conjunction with 
percentage heart rate change, considering that not all temporal lobe seizures 
result in hypoxia but 29% seizures would be detected by this parameter. 
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     p</= 
%HR      102      -3.6         8.6       0.8     0.001 
SAO2           
 
   0.442 
BEFORE      98      98.3         0.9       0.1 
DURING      98      98.2         1.9       0.2 
Difference      98       0.1         1.8       0.2 
 
Table 21 Descriptive statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during simple focal 
seizures. 
 
A small mean percentage change in heart rate is seen in simple focal seizures 
with a high statistical significance p<0.001 (Table 21). Compared to other 
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seizure types this group shows similar changes to absences. Simple focal 
seizures tend to show a small decrease in percentage heart rate (-3.6%) rather 
than an increase. It is due to this consistency and small standard error 
around the mean that has lead to high statistical significance.  
Oxygen saturation is not clinically significant or statistically significant 
p=0.442 in simple focal seizures.  
Due to a small change in percentage heart rate and oxygen saturation it is 
unlikely that trigger levels on a seizure alarm device would identify simple 
focal seizures from normal physiological events. 
Diagnostic testing of simple focal seizures was not possible as 95 of the 102 
seizures were derived from one patient. This disproportion would skew 
results and even calculating descriptive statistics for this type of seizure is 
more reflective for an individual rather than a group of people. Diagnostic 
testing could also not be performed on this subset of data as only a few 
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     10 
 
    8.1 
 
     13.9 
 
   4.4 
 
   0.098 
SAO2      
   1.0 BEFORE       7     98.0         0.0     0.0 
DURING       7     98.0         0.0     0.0 
Difference       7       0.0         0.0     0.0 
 
Table 22   Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Neonatal 
Focal Seizures 
In the neonatal group (n=10), only a small change in mean percentage heart 
rate (8.1%) is seen (Table 22). Statistically, the results are also less significant 
than seen in previous seizure groups and demonstrate a poor significance of   
p= 0.098. This indicates that this small change in percentage heart rate is quite 
likely to have occurred through chance.  
No change was seen when comparing the oxygen saturation (n=7) before the 
neonatal seizure to the oxygen saturation during the neonatal seizure. This 
result is unique to this group. 
Statistical indications of mean percentage heart rate change and oxygen 
saturation during these seizures make it unlikely that useful trigger levels 




























Figure 30 Receiver Operator Curve for diagnostic testing of percentage heart 
rate change and oxygen saturation during neonatal seizures 
 
 
With a trigger level of 8.5% (representing the mean percentage heart rate 
change) gives a sensitivity of 86% true positives are shown in diagnostic 
testing (Figure 30) of neonatal seizures. However, it also gives a poor 
specificity of only 31% (1-0.693) and a resultant high false alarm rate of 69%. 
The compromise necessary in this case is a trigger level of 15.5%. This 
remains a very poor option however with sensitivity of 43% and specificity 
of 51%. This leaves a high false alarm rate of 49%, so if the alarm triggered, it 
may or may not be because of a seizure as it has equal proportions. 
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Oxygen saturation trigger level of 98% (mean value of the group) presents an 
interesting cut off for diagnostic testing. At a trigger level of 98.5%, 100% of 
seizures would be identified but with very high false alarm rates of 74%. At a 
trigger level of 97.5%, zero sensitivity is displayed with no identification of 
seizures and 53% of false positives. 
Realistically, oxygen saturation is a very poor indicator for detecting 
neonatal seizures in this group. Percentage heart rate change is also poor 
where it may or may not indicate a seizure is occurring in equal proportions. 
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      83 
 
    2.3 
 
      9.3 
 
   1.0 
 
   0.025 
SAO2      
   0.004 BEFORE      72     96.7        1.8     0.2 
DURING      72     96.3        1.9     0.2 
Difference      72       0.4        1.2     0.1 
 
Table 23   Descriptive Statistics for one sample t-test applied to percentage 
heart rate change and paired t-test for oxygen saturation during Sub-clinical 
Seizures. 
Barely statistical significance (p=0.025) for percentage changes in heart rate 
occurred during eighty three sub-clinical seizures for the group with small 
mean heart rate percentage changes of 2.3% (Table 23). The standard 
deviation of the mean percentage heart rate is proportionally large (9.3%) 
which has led to poor statistical significance. 
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Oxygen saturation (n=72) changes show more consistent values of 96.3% 
during sub-clinical seizures with very minimal variation indicated by the 
standard deviation of 1.9%. This has resulted in a high statistical significance 
of p=0.004 which does not reflect clinical significant oxygen saturation levels 
of 96% that are well within normal range. 
It would be useful to perform diagnostic testing on this group to determine 
whether a seizure alarm system would be likely to be affected by changes in 
heart rate and oxygen saturation during sub-clinical seizures. 




















Diagonal segments are produced by ties.
ROC Curve
 
Figure 31   Receiver Operator Curve for diagnostic testing of percentage 






As the receiver operator curve suggests (Figure 31), a poor sensitivity and 
specificity rating is seen in percentage heart rate change and oxygen 
saturation for sub-clinical seizures. 
A trigger level of 8.5% offers a sensitivity of 25% with 75% missed sub-
clinical seizures. The specificity of 31% (1-0.693) results in a false alarm 
proportion of 69%. Ideally however an alarm system should ignore sub-
clinical seizures and therefore a trigger level of 25.5% or higher would reduce 
sensitivity to 3%. 
The closest balance of sensitivity and specificity for oxygen saturation is a 
trigger level of 96.5%. At this level, a sensitivity of 53% is seen with 47% 
missed sub-clinical seizures. A specificity of 60% results in a false positives of 
40% . This may seem better but this level of oxygen saturation is not likely to 
be used in an alarm device, as this level is not clinically significant. 
If the trigger level was set to 86.5% oxygen saturation level, then no sub-
clinical seizures would be detected with a sensitivity of 0 and no false alarms 
would be triggered. 
This is an encouraging result as it would be preferable if sub-clinical seizures 














Seizure     
type 
 
      
     n 
 
 















    229 
 
 
  28.3 
 
 
     15.4 
 
 
  1.0 
 
 







    13 
 
 
  53.6 
 
 
     39.8 
 
 
  11.0 
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   26.9 
 
 
    11.1 
 
 
   0.8 
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  28.5 
 
 
   30.1 
 
 
   5.4 
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  43.5 
 
 
   22.9 
 
 
   5.9 
 
 






    16 
 
    14.4 
 
    29.8 
 
    7.4 
 





   102 
 
    -3.6 
 
     0.9 
 
     0.1 
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   13.9 
 
 
    4.4 
 
 







     83 
 
 
    2.3 
 
 
    9.3 
 
 
    1.0 
 
 
  0.025 
 
Table 24 Summary of Descriptive Values of One Sample t-tests for 
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     215 
 
 
    97.4 
 
 
      4.4 
 
 
    0.3 
 
 






      12 
 
 
    83.6 
 
 
     12.1 
 
 
    3.5 
 
 






    201 
 
 
    98.3 
 
 
       0.7 
 
 
     0.1 
 
 







      30 
 
 
    88.9 
 
 
     10.6 
 
 
     1.9 
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    91.8 
 
 
     10.9 
 
 
     2.8 
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    86.1 
 
 
      9.8 
 
 
     2.5 
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    98.2 
 
 
       1.9 
 
 
    0.2 
 
 





       7 
 
 
     98.0 
 
  
       0.0 
 
 
     0.0 
 
 






     72 
 
 
     96.3 
 
 
       1.9 
 
 
     0.2 
 
 
  0.004 
 
Table 25 Summary of Descriptive Values of Paired t-tests for oxygen 
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Summary of Maximum Changes in Percentage Heart Rate Change and 





Figure 32 Minimum, Mean and Maximum Values of Percentage Heart  




Figure 33 Minimum, Mean and Maximum Values for Oxygen Saturation  





Summary of Maximum Changes in Percentage Heart Rate Change and 





Figure 34 Minimum, Mean and Maximum Values of Percentage Heart  
Rates Changes during Right / Left Focal Seizures. 
 
 
Figure 35 Minimum, Mean and Maximum Values for Oxygen Saturation 
during Right / Left Focal Seizures 
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Chapter 6 Results: Normal Physiological Events. 
One sample t-tests were applied to percentage heart rate changes during the 
total normal physiological events group (n=496) and then were analysed for 
each sub-group of normal physiological event. Paired t-tests of oxygen 
saturation values were calculated for the total normal physiological events 
group (n=462) and separately for each sub-group of normal physiological 
event. 
1.6.1 Total Normal Physiological Events. 
Both percentage heart rate change and oxygen saturation changes from 
baseline to during events show high statistical significance of p<0.001. This 
indicates that the recorded changes overall are very consistent and are 







      n 
 
 















    496 
 
 
    16.5 
 
 
      14.4 
 
 
     0.6 
 
 
   0.001 
SAO2      
 
   0.001 
BEFORE     462     96.7         2.7      0.1 
DURING     462     96.4         3.1      0.1 
Difference     462       0.3         1.6      0.1 
 
Table 28   Descriptive Statistical Analysis of One Sample t-test for 
Percentage Heart Rate change and Paired t-test for Oxygen Saturation 
during Total Normal Physiological Events. 
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The mean percentage change in heart rate for the group of 16% (Table 28) is 
less than the mean percentage change in heart rate seen during the total 
seizure group of 21.8%. (Table 4) The total seizure group also demonstrates a 
much higher level of standard deviation (30%) compared to this normal data 
of 14%. The oxygen saturation change during normal events overall is only 
slight (0.3%) and mean values are not clinically significant at 96%. A small 
standard deviation (3%) during the events indicates that most of the data is 
close to the mean value. 
1.6.2    Arousal. 
The mean average heart rate percentage change of 190 arousal events is 21% 
(Table 29). This represents data from a wide age range of patients and the 
changes indicate consistency to result in a high significance of p<0.001. 
Oxygen saturation is barely significant with p=0.05 and very little change in 
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    190 
 
 
    21.0 
 
 
      13.5 
 
 
    0.9 
 
 
   0.001 
SAO2  
 





   0.049 
BEFORE 174  96.4   2.9 0.2 
DURING  174   96.2   3.2 0.2 
Difference 174    0.2   1.2 0.1 
 
Table 29 Descriptive Statistical Analysis of One Sample t-test for Percentage 




1.6.3   Coughing. 
Thirty-four events of coughing were analysed for statistical significance for 
change in percentage heart rate and oxygen saturation. A small mean change 
in percentage heart rate of 6.4% is calculated for the group (Table 30), which 
shows statistical significance of p<0.001. Oxygen Saturation change (n=33) is 
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     9.5 
   
 
    1.6 
    
 
0.001 
SAO2         
 
    0.513 
BEFORE      33     96.1       2.7    0.5 
DURING      33     96.0       2.9    0.5 
Difference      33      0.1       1.0    0.2 
 
Table 30 Descriptive Statistical Analysis of One Sample t-test for Percentage 
Heart Rate change and Paired t-test for Oxygen Saturation during Coughing. 
 
1.6.4    Crying. 
A mean percentage heart rate change of 13% is calculated for the group 
(n=15) during crying (Table 31), with high statistical significance of p<0.001.  
Oxygen saturation of 97% is not clinically significant (n=11) and 
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     15 
 
 
   13.0 
 
 
      12.5 
 
 
    3.2 
 
 
   0.001 
SAO2      
 
   0.132 
BEFORE     11     97.7        0.5     0.1 
DURING     11     97.1        1.4     0.4 
Difference     11      0.6        1.3     0.4 
Table 31 Descriptive Statistical Analysis of One Sample t-test for Heart     
Rate Percentage change and paired t-test for Oxygen Saturation during 
Crying 
1.6.5    Laughing 
A small percentage change in heart rate of 5% is calculated for the group 
(Table 32), A small variability of 4% standard deviation indicates that overall 
heart rate changes are small during laughing events (n=22). Similarly, very 
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     22 
 
 
    5.0 
 
 
     4.1 
 
 
   0.9 
 
 
    0.001 
SAO2      
 
    0.732 
BEFORE     22    97.2      1.4      0.3 
DURING     22    97.1      1.1      0.2 
Difference     22      0.1      1.2      0.3 
Table 32 Descriptive Statistical Analysis of One Sample t-tests for Heart     




1.6.6   Stretching. 
Percentage heart rate change of 14.8% is calculated for the group (n=36) 
(Table 33). This is a similar change to that seen during sneezing (15.3%) and 
crying (13%). It produces a medium change in percentage heart rate during 
normal physiological events. Statistical significance of p<0.001 for percentage 
in heart rate change occurs during stretching for the group. This high 
statistical significance indicates that there is a consistent change in heart rate 
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     36 
 
 
    14.8 
 
 
    12.2 
 
 
    2.1 
 
 
    0.001 
SAO2      
 
   0.258 
BEFORE      36      96.3     2.9     0.5 
DURING      36     96.2     3.0     0.5 
Difference      36       0.1        0.8     0.1 
 
Table 33 Descriptive Statistical Analysis of One Sample t-tests for Heart     









1.6.7    Sneezing. 
A higher mean percentage heart rate change of 15% is seen during sneezing 
(Table 34) compared to that produced by coughing (6.3%) (Table 30), crying 
(13%) (Table 31) and laughing (5%) (Table 32) but is not as high as that seen 
from arousal (21%), (Table 29). Very little oxygen saturation change occurs 
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      10 
 
 
    15.3 
 
 
     10.0 
 
 
    3.2 
 
 
    0.001 
SAO2      
 
    0.177 
BEFORE       10      96.5      3.8     1.2 
DURING       10      97.0      3.7     1.2 
Difference       10        0.5      1.1     0.3 
 
Table 34 Descriptive Statistical Analysis of One Sample t-test for Heart     
Rate change and paired t-test for Oxygen Saturation during Sneezing 
1.6.8 Turning over in bed.      
The same mean percentage change in heart rate (21%) is seen during turning 
over in bed (n=141) (Table 35) to that occurring during arousal (Table 29). 
The standard deviation indicates that this percentage change in heart rate 
during this event can increase further by 14%. Oxygen saturation effectively 
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    141 
 
 
   20.9 
 
 
   14.1 
 
 
    1.2 
 
 
   0.001 
SAO2      
 
   0.132 
BEFORE     133      96.9       2.4     0.2 
DURING     133      96.7       2.7     0.2 
Difference     133        0.2       1.9     0.2 
Table 35 Descriptive Statistical Analysis of One Sample t-tests for Heart     
Rate change and Paired t-test for Oxygen Saturation during Turning Over in 
Bed. 
1.6.9 Yawning. 
In this group, the percentage heart rate change 0.5% (n=48) and oxygen 
saturation (n=44) show a low statistical significance (Table 36). This suggests 
that the changes are so variable during yawning, that there lacks consistency 
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     48 
 
 
     0.5 
 
 
    9.9 
 
 
   1.4 
 
 
   0.728 
SAO2      
 
   0.269 
BEFORE      44    97.9      1.5     0.2 
DURING      44    97.7      1.8     0.3 
Difference      44      0.2      1.2     0.2 
Table 36 Descriptive Statistical Analysis of One Sample t-tests for Heart     

























































































































































                        





















Figure 36 Minimum, Mean and Maximum values of Percentage Heart Rates 
Changes during Normal Events. 
 
 
Figure 37 Minimum, Mean and Maximum values for Oxygen  





Chapter 7 Results 
1.7.1 Intra-observer Analysis  
F
Figure 38 Time series plot of consecutive 9 second epochs comparing Run 1 
& Run 2 (Observer 1) 



























Observer 1 Difference R-R (Run 1-Run 2) vs Average R-R (Run 1+Run 2)
F
Figure 39 Bland & Altman plot for Observer 1 R-R Measurements. Limits of 
































































































































Table 38 Descriptive statistics Observer 1 Run 1 and Run 2 (Observer 1) 
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Observer 1 Difference %change Heart Rate (Run 1-Run 2)vs Average (Run 1+ Run 2)
Figure 40 Bland & Altman plot Observer 1 Limits of Agreement on Difference 
in heart rate percentage change between Run 1 and Run 2 are 1.6% and -



















R-R Run 1 R-R Run 2
Run 1 %ge change Run 2 %ge change
Observer 1 Run 1 R-R, Run 2 R-R, %Run 1, %Run 2
 
Figure 41 Box plot comparison of observer 1 R-R interval measurements and 




















   (-3.01)    (-3.01)    0     -3.01 
Standard Error of 
Mean 
 
    5.04    5.15     0.266      5.1 
Standard Deviation 
 
     24.7    25.2    1.3    24.9 
Minimum    (-72.5)   (-76.8)   -2.4   -74.6 
Q1    (-17.9)   (-17.0)   -0.6    -17.4 
Median      4.8     4.8        0      4.8 
Q3    12.7    12.7        0    12.7 
Maximum    29.2    29.2      4.3     29.2 
Range   101.6    105.9      6.8     103.8 
 
Table 39 Descriptive statistics Observer 1 percentage change Run 1 and 
Run 2. 
A close relationship is found between Run 1 and Run 2 for observer 1 
measurements (n=146) (Table 39) with a mean difference of 0 milliseconds 
and mean percentage change difference of (-0.001) % Limits of agreement are 









































Observer 2 Difference Run 1-Run 2 vs 2Average Run 1 + Run 2
Figure 42 Bland & Altman plot Observer 2 Limits of Agreement between Run 
1 & Run 2. Limits of Agreement of difference are -10 and 10 msec.(± 2 
standard deviations). 









































Observer 2 Difference (%Run1-%Run2)vsAverage (%Run1&%Run2)
 
Figure 43 Bland & Altman plot Observer 2 Difference in heart rate percentage 
change between Run 1 and Run 2. Limits of Agreement of Difference is 
































































































































































































































































































Obs 2 R-R Run 1 Obs 2R-R Run 2
Obs 2%ge change Run 1 Obs2%ge change Run 2
Observer 2 comparison R-R Run 1, Run 2, %change Run 1,%change Run 2
 
 
Figure 44 Boxplot Observer 2 R-R Run 1, R-R Run 2, percentage changes 
Run 1 and percentage change Run 2. 
 
A close relationship is also found between Run 1 and Run 2 for Observer 2 
measurements (n=146) (Table 43) with a mean difference of (-0.1) 
milliseconds and mean percentage change difference of (-0.144) % Limits of 
agreement are very similar to Observer 1, at 10 msec and (-10) msec and 




































Obs 1 R-R Run 1*Obs 1 Run 1 %ge change Obs 2 R-R Run 1*Obs 2%ge change Run 1
Obs 1 R-R Run 2*Obs 1 Run 2 %ge change Obs 2 R-R Run 2*Obs 2%ge change Run 2
Observer 1 Run 1, Run 2, Observer 2 Run 1, Run 2
Figure 45 Scatterplot Observer 1 Runs 1 & 2 and Observer 2 Runs 1 & 2  
(R-R vs percentage heart rates change). 
 

































Run 1 Difference R-R (Obs 1) minus R-R (Obs 2) vs Average R-R (Obs1)+(R-R(Obs 2)
Figure 46 Bland & Altman plot Inter-observer difference in Run 1 R-R 














































































































































Table 42 Descriptive statistics for Inter-observer analyses. 
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Run 2 Difference R-R (Obs1) minus R-R(Obs2) vs Average R-R(Obs1)+R-R(Obs2)
 
Figure 47 Bland & Altman plot Inter-observer difference Observer 1 and 
Observer 2 in Run 2 R-R measurements. Limits of Agreement are between 2 
and (-2) msec (± 2 standard deviations). 
 
Inter-observer analysis demonstrates a close relationship with a mean 
difference of 0.3 msec between observer 1 and observer 2 for Run 1 and 0.5 
msec mean difference for Run 2 (Table 42). Narrow limits of agreement for 
Run 1 of 6 msec and (-2) msec mean 95% differences between observer 1 and 
observer 2 are within 8 msec range. 
Similarly, Run 2 shows narrow limits of agreement of 2 and (-2) msec with 





1.7.2 Proposed Device Characteristics 
 Data is stored as heart rate analysed over consecutive 3 second 
epochs.    
 Data extraction and analysis of 1st and 3rd (consecutive 3 sec. epoch) 
values are used to determine percentage change, calculated by 
subtracting the 1st epoch (1-3 sec) from the 3rd epoch (7-9 sec) during 
each 9 sec. analysis epoch, updated every 3 seconds by a moving 
window technique. 
 If the percentage change in heart rate (increase or decrease) exceeds 
25%, a trigger mechanism is activated to produce a visual, audible and 
radio page signal to a remote receiver to indicate a seizure. It would 
be beneficial if the trigger level could be adjustable to suit individual 
types of seizure detection. This proposed trigger level may need to be 
revised during clinical testing and data from larger patient 
populations. 
 An additional fixed trigger level of an absolute heart rate of 30/min 
that cannot be disabled or altered is required as a ‘safety net’ to 
indicate a life-threatening situation. 
 Two alarm trigger levels are required to indicate oxygen saturation 
levels. The first level is a trigger if oxygen saturation drops below 85% 
to indicate a seizure. The second ‘safety net’ trigger level is 60% for life 
threatening situations.     
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 For validation processes of the device all triggered events should be a 
signal-relayed to the XLTEK video-telemetry head-box to ‘flag’ events 
via a patient event socket for a clinical trial process.  
 Data stored onto an internal hard-drive capable of storing logged data 
for up to 24 hours that can be downloaded via a USB connection. This 
would be necessary to perform continual assessment of optimum 
trigger levels and validation for off-line analysis onto Excel, ‘Labview 
or ‘Matlab’ software. 
 The device would resemble a wrist watch and the pulse oximeter 
would be attached to D2 finger sensor. The device would be light 
weight and easily tolerated by all patients. 
 
1.7.3 Epileptic Seizure Alarm Epoch Analysis Method. 
Analysis is performed first of all by calculating heart rate over consecutive 3 
seconds epochs. Percentage change analysis is then performed by calculating 
heart rate change by comparing the 1st and 3rd heart rate epochs of data (this 
is data over 9 seconds from the start of the monitoring i.e. there needs to be 3 
seconds to lapse in order to calculate the first epoch). Effectively, the 
calculation analysis is performed every 6 seconds via a ‘moving window’ 






Figure 48 Schematic diagram of percentage change analysis method of data 












Figure 49 Proposed Trigger Levels in the Detection of Seizures. 
 
N.B Neonatal seizures detected using a trigger level of 15.5% still provides a 
poor sensitivity of 43% seizure detection. Sub-clinical seizures to be 
deliberately missed require a trigger level of 25.5% and will only have a 
sensitivity of 3%. 
A summary of proposed trigger levels are presented in tables in section one 








Section One Discussion and Future Studies 
1.8.1 Section One Discussion 
The diagnosis of epilepsy carries an excess mortality that is 2-3 times higher 
than the general population (Cockerall et al 1994) and official statistics report 
around 1000 deaths due to epilepsy in the UK each year. In chronic epilepsy 
sudden unexplained death in epilepsy is the main cause of excess mortality 
and risk of premature death from SUDEP in individuals with intractable 
epilepsy is 1:200/year (Nashef et al 1995). Reported risk factors for Sudden 
Unexplained Death in Epilepsy include young age, uncontrolled epilepsy 
and seizures occurring in sleep (Shorvon 1997). 
Despite these statistics, inadequate seizure alarms are commercially available 
for identifying nocturnal seizures. This remains a problem for people with 
epilepsy and their families or carers. The incidence of seizures occurring at 
night are probably under-estimated because so many attacks are un-
witnessed and the person having the seizures may not remember having 
them due to post-ictal amnesia, are unable to communicate the problem if 
they have age related communication difficulties or who may be learning 
disabled, or experience loss of consciousness following the seizure. It is well 
documented that sleep itself increases the occurrence of seizures. ‘Surveys 
suggest that in 10-45% of patients [with epilepsy] overall, have seizures that 
may occur predominantly or exclusively in sleep or in relation to sleep 
deprivation’ (Walker et al 2004). 
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Undetected prolonged nocturnal seizures can be fatal or result in significant 
morbidity due to hypoxic brain damage. This leaves an indescribable burden 
of guilt on families living with epilepsy and they have voiced the need for a 
reliable alarm system. In a professional capacity, ‘one still sees the 
catastrophe of the child who is found by his parents in the morning having 
convulsed half the night in compensated status and who is left with 
permanent hemiplegia’ (Brown et al 1991). Compensated status epilepticus is 
continual convulsive status where the body compensates to cope with 
oxygen and glucose demands metabolically by switching to anaerobic 
respiration physiological mechanisms. This usually occurs after 30 minutes 
of continual seizure activity. The brain requirements for oxygen are very 
high especially during a seizure. During convulsive status, blood flow 
increases by approximately 400% to meet oxygen and glucose demands of 
neuronal activity. Areas of brain structures most damaged by status 
epilepticus are the hippocampal regions, Purkinje cells in the cerebellum, 
thalamus and then resultant laminar necrosis of the cortex (Brown et al 1991). 
Some seizures resulting in death are accidental and death could have been 
avoided if someone was alerted to the situation and intervened with rescue 
medication and body re-positioning to prevent an obstructed airway (Langan 
et al 2000). 
Other seizures resulting in death due to SUDEP may not have been 
prevented even with intervention (Dashief et al 1986). Whether in cases of 
SUDEP or seizures amenable to intervention, if parents were given the choice 
of having an alarm system which would alert them of a seizure taking place 
or not having an alarm system, I am certain that parents and carers would 
prefer to know when a seizure was occurring. A reliable alarm system would 
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result in carers doing everything possible to prevent bodily injury, brain 
damage or even a fatality. 
The knowledge that we are dealing with two separate problems, of death in 
epilepsy namely ‘extrinsic factors’ of circumstantial compromise e.g. 
suffocation due to obstructive apnoea or drowning and ‘intrinsic factors’ of 
SUDEP, have been considered for over one hundred years. ‘Epileptologists at 
the turn of the century were well aware of the dangers from seizures and 
recognised that seizure deaths could be accidental or due to intrinsic 
mechanisms during a single seizure or serial seizures and status’ (Nashef 
2000). However, very little is understood of what exactly these ‘intrinsic‘ 
mechanisms are and much research is active in this area. 
An increased risk of SUDEP is reported in a young age group. These patients 
are most vulnerable at night when seizures are most likely to be un-
witnessed. A high percentage of nocturnal seizures occur in this age group. 
‘More nocturnal seizures recur in children, adolescents and young adults 
than daytime seizures (82%). The most likely timescale for recurrent GTCS 
are within 6 months of first seizure’ (Martinovic et al 1997). 
Another risk group for undetected nocturnal seizures are the elderly, often 
living alone with no immediate assistance during a seizure event. The 
incidence rate is 1 per 1000 of the general population but this figure is set to 
rise with the growing elderly population of recent times and is regarded as a 
significant public health issue with epilepsy being the third most common 




There is already a need to understand the physiological mechanisms 
involved during seizures and a necessity to devise a reliable alarm system. A 
reliable alarm system may not prevent true SUDEP cases but many seizures 
that are amenable to intervention, if detected, will be prevented from causing 
bodily injury, hypoxic brain damage and in some cases death. My view is 
supported by others ‘ timely assistance at the time of a seizure is likely to 
reduce the risk of death or injury’ and ‘unwitnessed seizures carry a higher 
risk of death’ (Nashef 2000) and ‘positioning of the patient or stimulation of 
respiration may prevent a fatal outcome in some cases. This raises the 
important issue of supervision’ (Langan et al 2000). 
A wide age range of patients, were recorded in this study from a 1 day old 
neonate to a 60 year old pensioner. A baseline heart rate in a neonate is 
generally much higher e.g. 210/ min compared to that of an elderly person 
with a heart rate generally of around 60/min. It is because of this age 
dependant heart rate fundamental that I have chosen to analyse heart rate 
‘percentage change’ instead of absolute heart rate. Any changes in heart rate 
before an event and during an event were calculated as a proportional 
change and can be compared for all ages.  
An alarm system based on percentage heart rate would have to show a 
significant proportional change during an epileptic seizure for all ages. In a 
neonate or young child who has a resting heart rate of 200/min, a 20% 
increase in heart rate would result in a rate of 240/min. In an adult with a 
resting heart rate of 60/min, a 20% increase in heart rate would result in a 
rate of 72/min. Both analogies show a mild proportional change in both 
patients. If we were to consider an absolute heart rate increase of 40/min of a 
neonate or young child and add that to an adult rate of 60/min, we would see 
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a significant tachycardic state of the adult at 100/min. Clearly, this would be 
a significant increase in heart rate for the adult, not a mild change. Therefore, 
absolute heart rate changes are not appropriate or offer an ideal 
measurement when considering and comparing heart rate changes during a 
wide age range of patients. 
In section one of this study, I chose to examine the changes in percentage 
heart rate and oxygen saturation during epileptic seizures, which were 
identified and clinically categorised using electroencephalographic 
videotelemetry. The rationale for choosing to examine these parameters is 
based on the general belief amongst researchers that there is a fundamental 
involvement of cardiac and respiratory changes during a seizure. These 
changes in heart rate and respiratory changes resulting in possible 
hypoxaemia may either be a centrally driven channelopathy effect or simply 
the physiological response to physical effort during the seizure with heart 
rate increase. An alarm system based on heart rate change and oxygen 
saturation could also measure vital signs and alarm if someone’s life was 
threatened.  
Percentage Heart Rate Changes and Oxygen Saturation in Seizures. 
The results of percentage heart rate changes during clinically significant 
seizures in this study are distinctly different from those of clinically 
insignificant seizures and normal events. This is an encouraging result with 
good sensitivity (79%) and specificity values (75%) when a proposed trigger 
level of percentage heart rate change of 25.5% is used. This would suggest 
that a device based on percentage heart rate and oxygen saturation would 
identify the type of seizures, which ought to attract assistance. It also 
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suggests that the alarm would have a minimal number of false alarms due to 
normal events (1:4 ratios). A factor to bear in mind with these results is that 
none of the ‘clinically significant’ seizures required medication intervention 
and were self-resolving. I would postulate that the sensitivity and specificity 
values may even be higher during more clinically prolonged seizures.  
The results for detecting generalised tonic-clonic seizures give a higher 
sensitivity of 88% and specificity of 85%. This means that most tonic-clonic 
seizures would be identified and very few false alarms would occur. A 
proposed percentage heart rate change trigger level for detecting generalised 
tonic-clonic seizures is 32.5%. In this group oxygen saturation was only 
useful in detecting 50% of this type of seizure but is a useful additional 
trigger parameter with very few false alarms (5%) when a trigger level of 
90.5% is used. 
When data is combined with one/ other/ both parameters reaching their 
trigger levels, the sensitivity improves further to 91% and specificity stays 
the same at 75%. This result indicates that if a seizure alarm was triggered 
because of either percentage heart rate change or oxygen saturation 
parameters triggered either independently or together then 91% of clinically 
significant seizures would be detected. As before, one triggered alarm in 
every four would be false. 
Changes in percentage heart rate occurring during epileptic seizures showed 
statistical significance of p<0.001 for generalised tonic-clonic seizures, tonic 
seizures, frontal lobe seizures and temporal lobe seizures. Statistical 
significance was slightly lower in absence seizures (p=0.008) and not 
significant during episodes of myoclonus (p=0.359). 
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Analysis of statistical significance for oxygen saturation was high for tonic 
seizures (p<0.001) and slightly lower for generalised tonic-clonic seizures 
(p=0.018). Absence seizures did not show statistically significant changes in 
oxygen saturation (p=0.378). 
Statistical significance does not necessarily equate to clinical significance. 
Although statistical significance of p<0.001 is also seen for percentage heart 
rate change during many types of normal events; arousal, coughing, crying, 
laughing, sneezing and turning over in bed, the maximum percentage heart 
rate changes are distinctly lower than that seen during seizures. Changes in 
oxygen saturation as a group reached high statistical significance (p<0.001) 
but generally were less statistically significant when analysed separately; 
arousal p=0.049, coughing p=0.513, crying p=0.132, laughing p=0.732, sneezing 
p=0.177, turning over in bed p=0.132 and yawning p=0.269. 
The alarm system based on these parameters would be ideally pre-set to 
trigger appropriately to the type of seizure the patient is known to have. It 
may be necessary to collect data individually for that patient to build their 
own unique range of normal values so the device could be as accurate as 
possible.  
An ideal system would analyse percentage heart rate change and oxygen 
saturation using an epoch data sampling time of 9 seconds. This would be 
necessary to average out any normal sinus arrhythmia, which can be marked 
in children. A separate safety trigger level within the device (which should 
not be altered) would act as a ‘safety-net’ to indicate life-threatening vital 
signs. This trigger would be based on minimum pulse rate and oxygen 
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saturation. If levels dropped to this level then the safety net trigger would 
indicate that life may be threatened. 
Hemisphere Lateralisation Effects on Percentage Heart Rate and Oxygen 
Saturation. 
A difference is seen when comparing percentage heart rate changes during 
seizures arising from the right hemisphere and seizures arising from the left 
hemisphere. Major differences are seen when data is divided into right and 
left frontal lobe seizures in terms of percentage heart rate changes. The mean 
percentage heart rate change for the right hemisphere is twice (53.6%) the 
mean heart rate change seen from the left hemisphere (26.8%). Similarly, 
more dramatic data of mean oxygen saturation changes are seen from 
seizures derived from the right hemisphere (83.7%) compared to the left 
hemisphere (98.3%). High statistical significance is seen (p<0.001) for heart 
rate changes occurring in frontal lobe seizures derived from either 
hemisphere. 
A similar difference is seen when percentage heart rate changes are 
examined separately for right and left temporal lobe seizures. Much higher 
changes in mean percentage change occurs from seizures arising from the 
right temporal lobe (43.5%) compared to the mean percentage heart rate 
changes from seizures arising from the left temporal lobe (14.4%). High 
statistical significance (p<0.001) is seen for heart rate change from right 
temporal lobe seizures. A marginally lower statistical significance is seen 
from heart rate changes during left temporal lobe seizures (p=0.072). 
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Reports of sinus arrest have been secondary to seizures arising from the right 
temporal region. Other reports have been cases of severe bradycardia 
secondary to seizures arising from the left temporal lobe (Vaughn et al 1997). 
A different result is obtained however when the oxygen saturation changes 
are studied for right temporal lobe seizures and left temporal lobe seizures. 
Clinically significant changes in mean oxygen saturation (86.1%) occurred 
from left temporal lobe seizures with a high statistical significance of p<0.001. 
Mean oxygen saturation changes appear less clinically significant with mean 
values of 91.8% from right temporal lobe seizures was not statistically 
significant (p=0.072). 
The general differences in heart rate change recorded when comparing 
seizures arising from the right and left hemispheres in this study are 
explained by other studies on physiological differences of innervation 
pathways.  ‘There is clinical evidence of lateralization in neurocardiac 
control’ Intra-operative stimulation of the insula and amygdala has 
demonstrated that the right cerebral hemisphere mainly modulates 
sympathetic activity (Cheung et al 2000).  
The insular cortex is the continuation of cortex between the frontal/parietal 
and temporal lobes forming the in-going C-shape on either hemisphere. 
Historically, many seizures arising from the insular cortex are mistaken for 
temporal lobe seizures as they share similarities of auras described as a 
‘rising sensation from the stomach’ (Brotherstone 2002). Chronotopic 
organization studies of the insular cortex have shown that the anterior 
portion is more likely to cause tachycardia compared to any other cortical 
area (Opherk et al 2002).  Lateralisation of effect on heart rate is documented. 
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‘Stimulation of the left anterior insula causes a bradycardia whereas 
stimulation of the right insular cortex induces tachycardia’ (Nouri et al 2004). 
Accuracy of oxygen saturation technology.  
In 1989, Diab and Kiani at Masimo Corporation invented signal extraction 
pulse oximetry. They used adaptive filters to separate the arterial signal from 
the non-arterial ‘noise’ or venous blood movement during patient motion. 
Previous technology had problems because it was not possible to distinguish 
between arterial and venous blood at these times resulting in error. Masimo 
adaptive filters isolate the venous signal and then ‘cancel’ it. This allows 
continuous data of true arterial oxygen saturation only. Masimo has been 
scientifically and clinically proven to be accurate during patient motion and 
during low perfusion. Validation of Masimo’s technology has been 
performed in over 50 independent clinical studies with impressive results of 
accuracy with Sensitivity of 99% and Specificity of 97% (Barker SJ. in Radical 
“SatShare” White Paper). This technology has been commercially available 
since 1998 and to date more than 60% of the world’s manufacturers have 
licensed Masimo SET technology to make signal extraction pulse oximetry. 
Masimo uses Discrete Saturation Transform (DST) algorithim. This system 
comprises of a ‘Reference Signal Generator’, an ‘Adaptive Filter’ and a ‘Peak 
Picker’ (appendix). The Reference Signal Generator builds a ‘noise reference’ 
from the incoming red and infra-red signals for each percent gauged from 1-
100.  This data (S-Signal and N-Noise) is then passed through the Adaptive 
Filter, which cancels the correlated frequencies between the Reference Signal 
and the incoming infra-red signal. Arterial blood has the highest oxygen 
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saturation and the Peak Picker algorithim displays the highest oxygen 
saturation monitored. 
Masimo disposable finger probes were not used as these are less well 
tolerated and restrictive for the patient’s normal use of their hand. The 
forehead sensor was preferable in case of the delay effect in detecting 
hypoxaemia due to lung / periphery circulation time when recording from 
finger sensors. In a study by Hamber et al a delay of 51 seconds was reported 
when comparing detection time of hypoxaemia at the finger compared to 
detection of hypoxaemia at the ear. 
Seizures with associated hypoxia. 
Hypoxia occurs during some seizures and not others. In the study, hypoxia 
occurred with clinically significant levels of 71%.  A wide range of seizure 
types of focal and generalised seizures, were associated with hypoxia. A 
focal seizure involving the right frontal lobe resulted in oxygen saturation 
levels down to 71%. Hypoxia was also recorded during a left temporal lobe 
seizure with oxygen saturation levels down to 75%. Several generalised 
seizures were associated with hypoxia. One period of hypoxia was recorded 
during a series of epileptic spasms with oxygen saturation recorded down to 
81%. Another generalised epileptic myoclonic drop attack resulted in oxygen 
saturation level of 84%. 
One group that did not show any change in oxygen saturation at all in this 
study group, were the neonates demonstrating focal seizures. A possible 
explanation for this is that the neonate has a very high concentration of red 
blood cells. In the womb, the baby depends on oxygen supply via the 
umbilical cord, which provides comparatively lower oxygen than that 
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obtained during spontaneous respiration. The high concentration of red 
blood cells maximise the absorption of all available oxygen molecules. 
Therefore, the neonatal haemoglobin copes better with low oxygen 
availability compared to the older infant, child and adult. During a neonatal 
seizure, the baby may have a suppressed respiratory effort but it would take 
much longer for oxygen saturation levels to drop significantly. In animal 
studies, ‘immature animals appear to tolerate hypoglycaemia and anoxia 
better than the more mature’ Young animals have a ‘higher energy reserve’ 
and a ‘lower metabolic rate’ (Mayman 1971). 
Accidental death during seizures can result from suffocation. The prevalence 
figures of this cause is somewhat disputed but various reports indicate that 
suffocation has either occurred due to unfortunate body position and 
obstructive apnoea or simply the possibility that after a seizure in an 
unconscious state, the person has suffocated because they have been unable 
to turn over or move their face to breathe and have consequently suffocated. 
This is distinctive from death during seizures (SUDEP) where the person has 
happened to be in a prone position during a sudden ‘electrical accident’ and 
that respiratory failure was secondary to another main cause of death. 
Several reports describe people being ‘found face down onto his pillow’ the 
following morning (Martin 2005). Clearly, there may be several factors 
involved in determining the fundamental cause or combinations of factors 
why death can occur during seizures. However, anti-suffocation ventilated 
pillows may prevent suffocation in some instances and are advertised on the 
‘The National Society for Epilepsy’ website. An alarm system based on 




A more common reason for respiratory problems during seizures appears to 
be an ‘intrinsic’ one. ‘ There is strong evidence in favour of hypoventilation 
being a common occurrence in epileptic seizures and this is likely to be a 
significant mechanism in SUDEP’ with ‘ central apnoea observed commonly 
during seizures, including complex partial seizures’ (Nashef 2000). 
Mechanically many seizures cause a change in breathing pattern particularly 
during generalised tonic-clonic or tonic seizures where not just the limbs are 
involved in tetanic contraction but the intercostal respiratory muscles are 
also contracted which leads to cyanosis (James 1991). In this study most of 
the patients having apparent generalised tonic-clonic seizures had a 
reduction of oxygen saturation down to 85.5%. 
Apnoea and hypoxia during seizures are described during many types of 
seizures by several authors (Brown & Hussain 1991, James et al 1991, Jallon 
1997, Langan et al 2000, Nashef et al 1997 and Opherk et al 2002). Seizures 
may cause a physical restriction to the respiratory muscles by tetanic 
contraction but others appear to be caused by an‘intrinsic’ mechanism. 
Langan et al 2000 reports, ‘hypoventilation, which was primarily central in 
nature, occurred in the context of both generalised and partial seizures.’  
Animal studies may give some insight as to possible mechanisms of seizure 
related apnoea and hypoventilation. A study by Williams et al 1989, 
concentrated on stimulation of sites within the fastigial nucleus of 
anaesthetised cats. Stimulation rates of 20Hz, 50Hz and 200Hz caused 
respiratory inhibition and apnoea. They found that the higher the frequency 
of stimulation the longer the period of apnoea occurred. 
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Electroencephalographic high frequency spike activity is recorded from 
surface electrodes during the tonic phase of clinical seizures in humans and 
animals. The recordable band-width of frequencies we use routinely in 
Neurophysiology nationally is 0.5Hz-70Hz. This has been continued from the 
filter settings used on conventional paper machines that were unable to cope 
with frequencies higher than this due to the friction/striction characteristics 
of pen writers and paper collection with speeds of 30mm/second. 
Theoretically with the common use of digital machines it is now possible to 
increase the bandwidth to record higher frequencies during seizures. This 
would only be of interest on research grounds as the traditional bandwidth is 
adequate for investigative and diagnostic purposes.  
The use of depth electrodes reveals higher frequencies and amplitude of 
signal than compared to scalp recordings. The frequencies of spike activity 
recorded during electrocorticography appear faster than scalp recordings 
due to the fact that signals are not reduced by having to travel through 
meninges and skull. Theoretically, an epileptic seizure especially during the 
tonic phase produces high frequency discharges at the cortex. This discharge 
could travel to brainstem respiratory centres and as seen with the study of 
the anaesthetised cats (Williams et al 1989) demonstrating that high 
frequency discharges can cause apnoea. This hypothetically is an intrinsic 
channelopathy. 
The effect of repeated seizures on cardiac muscle and the response to 
hypoxia have been indicated as further risk factors of SUDEP. Opherk 
suggests that repeated autonomic stimulation because of frequent seizures 
could structurally damage the heart leaving it more susceptible to 
arrhythmias or ischaemia. A study in piglets showed an attenuated 
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hyperventilatory response to hypoxia following regular periods of hypoxia 
(Moss 2002). Maturation in the response to hypoxia may be a factor.  
Pathological effect on neural networks is also a consideration. ‘The most 
common abnormalities found on computerised tomography are 
hippocampal sclerosis, malformations of cortical development, vascular 
malformations, tumors and acquired cortical damage’ (Duncan 2004). For 
example, atrophy of the hippocampus and amygdala and other mesial 
temporal areas which are susceptible to tissue shrinkage due to neuronal loss 
subsequent to damage from temporal lobe seizures may be a participant to 
channelopathies during seizures as ‘evidence exists that seizures involving 
the amygdala and its adjacent areas may result in serious cardiac 
arrhythmias’ (Ansakorpi et al 2004). 
It has been suggested that SUDEP includes a ‘heterogenous group of 
patients’ which are more susceptible to lethal cardiac arrhythmias compared 
to people who demonstrate cerebral dysrhythmias leading to nonlethal 
cardiac arrhythmias (Dasheiff et al 1986).  
1.8.2 Further Studies 
A UK patent on method has been submitted by NHS Lothian for a seizure 
alarm device based on this study 2011. No other seizure alarm device has 
been found through patent searches that use percentage heart rate change 
and oxygen saturation. 
The next stage in this research is to apply for research funding to build a 




1.8.3 Section One Conclusions 
Undetected prolonged nocturnal seizures can result in hypoxic brain damage 
or death. The cases of death during these seizures are believed to be either 
due to extrinsic factors of obstructive apnoea and suffocation or intrinsic 
factors due to sudden excessive discharges affecting autonomic pathways 
resulting in central apnoea or lethal cardiac arrhythmias. This means that 
some seizures are amenable to intervention and some are not. The prevalence 
of nocturnal seizures is probably higher than estimated due to many seizures 
being undetected. This figure is set to rise due to the aging population and 
increased risks of undetection with more people living on their own. The 
emphasis is on detecting seizures and calling for assistance ‘studies also need 
to focus on avoidable mortality’ (Nashef 1997).  The majority of cases of 
SUDEP occur during sleep with evidence of marked increases in sympathetic 
tone and surges of catecholamines and autonomic instability (Nei et al 2004). 
The need for seizure detection is clear and the results of this study indicate 
that an alarm system based on percentage heart rate change and oxygen 
saturation can distinguish many seizures from normal events. Experts in this 
specialty believe that ‘timely assistance by positioning of the patient or 
stimulation of respiration may prevent a fatal outcome in some cases’ 
(Langan et al 2000). 
In this study, I have analysed percentage heart rate change and oxygen 
saturation before and during 527 epileptic seizures and 496 normal events. 
Diagnostic testing of this data gives a sensitivity of 79% and specificity of 
75% of distinguishing epileptic events from normal events with a trigger 
level of 25.5% percentage heart rate change. The same trigger level is 
optimum for the detection of temporal lobe seizures with a sensitivity of 75% 
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and specificity of 75%. Frontal lobe seizure detection trigger level is optimum 
at 30.5% percentage heart rate change to give a sensitivity of 83% and 
specificity of 82%. For the detection of generalised tonic clonic seizures, the 
trigger level is 32.5% percentage heart rate change. Diagnostic testing 
suggests a sensitivity of 88% and specificity of 85%. 
The results for oxygen saturation during seizures are less sensitive but a 
useful addition to the percentage heart rate trigger. For the group as a whole 
a trigger level of 90.5%, gives a sensitivity of 49% and specificity of 54%. This 
result would indicate that an alarm triggered at this level may or may not 
actually be a seizure. A similar sensitivity of 50% with the same trigger level 
of 90.5% oxygen saturation is seen with generalised tonic clonic seizures 
however the specificity is higher at 95%, which would indicate very few false 
alarms. Diagnostic testing of oxygen saturation of frontal lobe seizures has a 
higher sensitivity of 67% and specificity of 97% with a trigger level of 89.5%. 
Oxygen saturation is least sensitive in the detection of temporal lobe seizures 
with a sensitivity of 29% and specificity of 99% with a trigger level of 88.5% 
oxygen saturation. 
An alarm system based on these parameters can be set to trigger for 
individual seizure types depending on the patient’s habitual seizures. A 
second trigger level is proposed which is not adjustable and would indicate a 
life threatening status of the patient if pulse is lost and oxygen saturation 
drops to severe hypoxic levels. Abnormal pulse and reduced pulse oximetry 
are listed as part of the identified risk factors for cardiac arrest (Hodgetts et al 
2002). This second trigger level would act as a ‘safety net’ and both types of 
alarms would alert parents or carers via an audible alarm and/or a radio 
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Objective: To measure the corrected Q-T cardiac re-polarisation time before 
and during epileptic seizures. Methods Thirty-nine video-EEG/ECG/SAO2 
telemetry patients were included in this prospective study. Epileptic seizures 
were identified both clinically and electrographically.  R-R intervals and 
associated Q-T intervals were measured 5 minutes prior to the onset of the 
identified seizure. Consecutive R-R and associated Q-T intervals were then 
measured from the seizure onset until the seizure had ended and the 
electroencephalograph had resumed its pre-seizure trace. Averaged R-R and 
Q-T intervals over 9 consecutive beats were applied to Bazett’s, Hodge’s, 
Frederica’s and Framingham’s Formulae to compare the corrected Q-T 
values before and during the seizures. Results A total of 156 seizures had 
corrected Q-T analysis performed. 9 generalised tonic-clonic seizures (5 
patients), 34 absences (6 patients), 12 tonic seizures (6 patients), 27 temporal 
lobe seizures (14 patients), 58 frontal lobe seizures (4 patients) and 16 sub-
clinical seizures (4 patients). All formulae reported a statistically significant 
difference in corrected Q-T (p<0.001) during total seizure data compared to 
total pre-seizure data. According to Bazett’s formula, 21 seizures (9 patients) 
transiently increased their corrected Q-T beyond normal limits with 
maximum corrected Q-T of 512 milliseconds during a right temporal lobe 
seizure. Conclusion Significant lengthening of corrected Q-T cardiac re-
polarisation time occurred during some epileptic seizures in this study. 
Prolonged corrected Q-T may have a possible role in Sudden Unexplained 




















2.1.1 Sudden Unexpected Death in Epilepsy and Corrected Q-T. 
SUDEP has been recognised for over one hundred years but there still 
remains little evidence to explain what mechanisms are involved (Nashef 
2000). Several hypotheses have been postulated mainly concerning 
respiratory, cardiac and genetic involvement (Nashef et al 2007). 
SUDEP has been defined as ‘sudden, unexpected, witnessed or un-
witnessed, non-traumatic and non-drowning death in patients with epilepsy, 
with or without evidence of a seizure and excluding documented status 
epilepticus, where post-mortem examination does not reveal a toxicological 
or anatomical cause of death’ (Nashef 1997).  
Cardiac arrhythmia is considered to have a possible role in SUDEP (Soonhak 
et al 2003, Tavernor 1996). Prolonged corrected Q-T re-polarisation time can 
lead to fatal cardiac arrhythmias (Morganroth and Pyper 2001, Tavernor et 
al, 1996). The Q-T interval by definition represents the time required for 
depolarization and re-polarization of the ventricular musculature (Yu et al 
1950). Autonomic symptoms frequently occur during epileptic seizures and 
range from subtle to life threatening manifestations (Baumgarter et al 2001). 
An increase in re-polarisation time can lead to cardiac arrhythmias with any 
combination of a slow heart rate, atrial fibrillation, hypokalemia, 
hypomagnesemia, hypoxia, congestive heart failure or ischaemia resulting in 
an induced polymorphic ventricular tachycardia (Morganroth 2001). Some 
seizures are associated with various levels of hypoxia and ischemic changes, 
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potentially contributing to a prolonged corrected Q-T, cardiac arrhythmia 
and sudden death.  
A study of patients with severe epilepsy and learning disabilities showed 
that 60% had abnormalities on the electrocardiogram raising the question 
whether underlying cardiac rhythm disturbance increases the risk of SUDEP 
(Jeffrey 2006). Measurements of the corrected Q-T during inter-ictal 
electroencephalographic discharges indicated that the corrected Q-T (QTc) 
increased during inter-ictal epileptic discharges and it was proposed that a 
prolonged QTc could be a possible risk factor of SUDEP in patients with 
epilepsy (Tavernor et al 1996). One previous study by Nei et al (2006) 
examined the corrected Q-T during epileptic seizures. This study however 
only considered using a total mean average for group data and did not 
analyse individual seizures in each subject. They reported that no corrected 
Q-T lengthening occurred during seizures based on a grouped mean average. 
When total data is averaged for all patients in this study a normal mean 
value of 427 milliseconds is calculated. However, when the data is analysed 
for individual seizures for each subject, lengthening of the corrected Q-T 
does occur during some epileptic seizures, and I hypothesize that this may be 
one of the possible intrinsic mechanisms involved in SUDEP.  
The Q-T interval represents the time period of ventricular depolarisation and 
re-polarisation from the beginning of the QRS complex and ending where the 
T-wave returns to an iso-electric baseline. An increase in re-polarisation time 
can lead to cardiac arrhythmias, notably Torsades de Pointes but other types 
of arrhythmias are also known to occur. Torsades de Pointes is recognised on 
the electro-cardiograph as a continuous twisting of the vector around the 
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baseline. An increase in Q-T interval is measured in the supraventricular beat 
preceding Torsades de Pointes and this can either spontaneously recover or 
degenerate into ventricular fibrillation (Figure 1) and lead to sudden death 
(Dept. of Health & Human Services 2004). Syncope in adults and children is 
described in patients with catecholaminergic polymorphic ventricular 
tachycardia (CPVT) who demonstrate a normal resting Q-T interval and no 
identified heart disease but collapse, often with clonic movements following 
exercise or emotion. In some of these cases, epilepsy has been given as a 
misdiagnosis and care must be taken in clearly identifying CPVT treatable 
with Beta-blockers. Sudden death can occur in 50% of these cases before the 
age of 20 years (Leite et al 2001). Circulating adrenaline can produce 
lengthening of the corrected Q-T by a direct effect on the myocardium (Lee et 
al 2003). During epileptic seizures increased adrenaline occurs and may 
produce a combined effect with a sudden and sustained increase in heart 
rate, hysteresis and changes in ionic flux during hypokalaemia, 
hypomagnesemia physiological conditions that may be compounded by 
hypoxia, congestive heart failure and active ischemia leading to increased 
risk factors of producing cardiac arrhythmias in some individuals. 
Evidence of excessive sympathetic activity around the time of seizures are 
noted from autopsy reports of SUDEP victims, which describe ‘post-mortem 
examination may show neurogenic pulmonary oedema, oedema of various 
organs and scattered microscopic injury of the heart, possibly due to 
increased levels of catecholamines, reflecting excessive sympathetic function 
but the primary cause of SUDEP is unknown’ (Ansakorpi et al 2004). 
Excessive levels of catecholamines at autopsy would suggest Beta-adrenergic 
activity around the time of death. Heart rate changes during seizures are 
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common and can be dramatic. Hypothetically, the effects of sudden arousal 
from sleep compounded with the effect of a seizure may result in excessive 
cardiological demands resulting in lengthening of the corrected Q-T and 
possible fatal arrhythmias.   
 
 
Figure 1 Catecholaminergic Polymorphic Ventricular Tachycardia. An 
important diagnosis in children with syncope and normal heart  
(Leite et al 2001). 
Over the last ten years, the identification of ion channel mutations causing a 
wide variety of inherited disorders has been discovered in clinical Neurology 
and Cardiology. It is anticipated that many new target channels will emerge 
in the next few years (Kullmann 2002). As yet no single mutation of either 
voltage-gated or ligand-gated ion channelopathies has been identified that 
singularly affects neuronal activity and the cardiac myocyte. So far, however, 
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two closely related potassium channels KCNQ2 and KCNQ3 which are 
associated with benign familial neonatal convulsions are homologous with 
KCNQ1 channel which is known to cause mutations of two inherited cardiac 
arrhythmias; autosomal dominant long QT syndrome and Jervell and Lange-
Nielsen syndrome-autosomal recessive long QT syndrome associated with 
bilateral deafness.   
QTc prolongation exceeding 60 milliseconds from baseline is considered to 
be a possible risk factor of a patient developing a fatal arrhythmia (European 
Agency for the Evaluation of Medicinal Products 2005, Fenichel et al 2004, 
Morganroth and Pyper 2001, Pater 2005). Some seizures are associated with 
various levels of hypoxia and ischemic changes, which could theoretically 
contribute to a prolonged QTc and potentially cardiac arrhythmia and 
sudden death. 
Tavernor et al (1996) measured the corrected Q-T during inter-ictal 
electroencephalographic discharges and indicated that the corrected Q-T 
increased during some epileptic discharges and proposed that prolonged 
corrected Q-T could be a possible risk factor of SUDEP in patients with 
epilepsy.  
It was with this hypothesis in mind that I decided to measure the corrected 
Q-T before and during many different types of epileptic seizures and in a 





2.1.2  Aim and Objectives. 
Aim 
The aim of this study is to calculate and analyse the corrected Q-T during 
different seizure types. This is to determine whether any lengthening of the 
corrected Q-T occurs during seizures and if there are some seizure types 
resulting in more Q-T lengthening than others indicating a higher risk of 
cardiac arrhythmia and possible involvement in SUDEP. 
Objectives 
 To analyse the corrected Q-T before and during epileptic seizures. 
 Compare results using the following formulae: 
1. Bazett’s Q-T correction formula. 
2. Hodge’s Q-T correction formula 
3. Fridericia’s Q-T correction formula 
4. Framingham’s Q-T correction formula. 
 Analyse Q-T data using linear regression plots on selected data. 
 Apply statistical analysis to results. 
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2.1.3 Null Hypotheses 
 No lengthening of the corrected Q-T occurs during seizures according 
to Bazett’s corrective formula. 
 No lengthening of the corrected Q-T occurs during seizures according 
to Hodge’s corrective formula. 
 No lengthening of the corrected Q-T occurs during seizures according 
to Fridericia’s corrective formula. 
 No lengthening of the corrected Q-T occurs during seizures according 
to Framingham’s corrective formula. 
 Seizure-derived laterality does not effect lengthening of the corrected 
Q-T. 
 There is no difference in lengthening of the corrected Q-T in focal 
seizures or generalised seizures. 
 The results are the same for each corrective formula in terms of 
sensitivity and specificity using normal values dependent on heart 
rate according to Luo et al. 
 No lengthening of the corrected Q-T occurs during sub-clinical 
seizures. 




Chapter 10: Methodology. 
2.2.1. Methodology of corrected Q-T analysis. 
Thirty-nine patients from the original study group took part in this ethically 
approved prospective study LREC/2003/6/22. Patients diagnosed with any 
seizure type were accepted as part of the inclusion criterion. No restrictions 
on data inclusion were made due to patient pharmacology. All patients were 
in sinus rhythm and none demonstrated a conductance disturbance during 
the pre-event resting trace. The study was inclusive for all ages except for 
neonates. The predicted observer error of Q-T measurement was considered 
to be too high to reliably measure the corrected Q-T in this group due to high 
heart rates in neonatal tachycardia. Paediatric age in this study is defined as 
3 months to 16 years Data resulted in excessive electromyographic (EMG) 
artefact and obscuring the electrocardiographic (ECG) signal with 371 
seizures being excluded from the study.  
Lead II ECG (Tavernor et al 1996, Benatar et al 2001, Pater 2005) was 
recorded from disposable ECG electrodes (Ambu Ltd). Twenty three silver 
silver-chloride electroencephalographic electrodes where applied using 
collodion glue, saline conducting gel with impedances below 10 kilo ohms in 
accordance to the International 10:20 system (Cooper et al 1980). All wires 
were tied together to minimise electrical noise pick-up from the ward 
environment and to provide comfort and mobility to the patient. The 
electroencephalographic, electrocardiographic and oxygen saturation leads 
were connected to an XLTEK Mobee 32 channel headbox. Continuously 
integrated Masimo oxygen saturation monitoring was recorded via a 
Masimo forehead transducer and all signals were networked via a Mobee 
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Headbox to a main computer server with simultaneous integrated video of 
the patient. Electrographic physiological signals were sampled at 500Hz 
(Rijinbeek et al 2001) and displayed on review using a maximum of 32 
channels depending on selected montage on full screen of 12 seconds display 
using a chart speed of 30mms-1. 
The electroencephalograph with simultaneous video was used to identify all 
epileptic events, both clinical seizure events and sub-clinical seizure activity. 
If the electroencephalograph showed changes prior to the clinical onset, the 
start of the event was measured at the start of the electro-graphic change. If 
the clinical manifestations appeared prior to the electrical event, then the 
start of the event was taken at the start of the clinical onset. The data was 
annotated to the nearest second. Q-T intervals were measured manually 
(Morganroth et al 2001, Benatar et al 2001, Pater 2005, Fossa et al 2005, Malik 
2004) from modified lead II ECG. Consecutive measurements of Q-T 
intervals and their preceding R-R intervals were measured over a 9 seconds 
epoch (Tavernor et al 1996, Benatar et al 2001, Luo et al 2004). The QT 
interval was measured at the start of the QRS complex, to the end of the T-
wave, defined as the intersection of iso-electric line and the tangent of 
maximal downward limb of the T-wave (Lepeschken et al 1952, Surawicz et 
al 1998, Benatar et al 2001) and entered onto a Microsoft Excel spreadsheet. 
Careful measurement of the T-wave did not include the U wave as the final 
Q-T measurement (Lepeschken et al 1952, Surawicz et al 1998, Bazett 1920). 
The mean average values of 9 consecutive R-R and Q-T intervals were 
calculated over a 9 seconds epoch to average out the effect of normal sinus 
arrhythmia (Benatar et al 2001, Luo et al 2004, Malik 2004). During the 
seizure, the 9 seconds epoch with the longest QTc was chosen to compare 
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with pre-seizure values. Clinically significant hypoxia was considered to be 
below 85% oxygen saturation in this study. Corrective formulae were 
applied to each consecutive 9 seconds epoch from Excel formulae 
computation. Effectively every heartbeat was manually measured during 
every event until the event ended clinically and once the 
electroencephalograph had resumed its pre-event trace. Data were also 
measured and analysed prior to the seizure event. From the onset of the 
seizure, data was measured 5 minutes (T-5m), 4 minutes (T-4m), 3 minutes 
(T-3m), 2 minutes (T-2m), 1 minute (T-1m) and 9 seconds (T-9s) before the 
event. During the seizure, the 9 seconds epoch with the longest QTc was 
chosen to compare with the pre-seizure QTc value calculated 9 seconds prior 
to the seizure (T-9).  
2.2.2 Intra & inter-observer analysis 
A qualified Electrocardiographer / Electroencephalographer was asked to 
independently re-measure the same raw data that had been previously 
measured in three different patients in order to analyse the inter-observer 
error. The Q-T interval was corrected for rate using Bazett’s Formula. 
Consecutive Q-T and R-R measurements over a 9 second epoch were listed 
onto an excel spreadsheet. Mean values for the Q-T and R-R measurements 
were calculated for consecutive 9 seconds epochs. The mean values were 
then applied to Bazett’s Formula to calculate the Corrected Q-T. The mean Q-
T and R-R measurements are recommended in cardiology literature to 
minimise the effect of normal sinus rhythm. In children in particular, normal 
sinus rhythm can show marked variation. On inspiration, the heart rate 
Section Two 
 180 
speeds up with a shortened Q-T. On expiration, the heart rate slows down 
resulting in a longer Q-T.  
Inter-observer analysis is important particularly in this calculation as 
measurements exceeding 450 milliseconds are considered to be clinically 
significant in paediatric patients and in adult males with a heart rate less 
than 60/min. Therefore if measurements are consistently over estimated then 
this may lead to an unrealistically long Q-T. Conversely, if measurements are 
consistently under estimated a genuinely long Q-T measurement could 
appear to be normal. 
2.2.3 Multivariate analysis of effects of Anti-Epileptic Drugs on 
QTc 
Multivariant analysis was performed on QTc, according to Bazett’s formula 
derived from patients receiving different anti-epileptic medication, 
monotherapy, polytherapy and those patients not receiving any anti-
epileptic drug (AED). Analysis was performed using One-way Analysis of 
Variation (ANOVA) for comparisons of QTc means in each AED, nil AED, 
monotherapy, polytherapy and analysed in terms of age, gender and seizure 







2.2.5 Q-T Correction Formulae  
 
Four commonly used correction formulae were applied to all data: 
Two nonlinear formulae:- 
                                                               __________ 
Bazett (Bazett HC 1920) QTc=QT/2 RR interval. 
 
                                                                           ___________ 
Fridericia (Fridericia LS 1920) QTc=QT/ 3 RR interval 
 
Two linear formulae:- 
 
Hodges (Hodges M 1997, Hodges et al 1983) QTc=QT+1.75(heart rate –60) 
Framingham (Sagie et al 1992) QTc=QT+0.154(1-RR) 
Statistical analysis was performed using Minitab version 14 paired student t-
tests comparing the maximum corrected Q-T value prior to the epileptic 
seizure with the maximum corrected Q-T value during the epileptic seizure. 
Paired t-testing was considered appropriate for the analysis method to 
compare the corrected Q-T prior to the seizure with the corrected Q-T during 
the seizure. Linear regression is applied to a few cases for comparison to 
results from corrective formulae. Cross tabulation of data comparing all 
formulae were analysed to give sensitivity and specificity values for each 
formula. Bazett’s formula was used as the ‘gold standard’ to enable 
uniformity and comparison to other studies (Yu et al 1950, Morganroth et al 
2001, Pater 2005, Fossa et al 2005). The Pearson Chi-Square (Chernoff et al 
1954) was applied to determine statistical significance in the comparison of 
the corrected Q-T during generalised seizures, right hemisphere focal 
seizures and left hemisphere focal seizures. Fishers Exact Test was applied to 
the number of patients in each of the aforementioned categories. Normal 
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limits of corrected Q-T during a seizure were considered to be comparable to 
corrected QT values during exercise. In children the normal limit of corrected 
QT during exercise is 440 milliseconds (Rijnbeek et al 2001, Benatar et al 
2001). Adult male and adult female corrected QT limit is dependent on 
formulae upper normal limits for all heart rate summarised in Table 1 (Luo et 
al, 2004), which are heart rate and gender specific.  Increases in corrected QT 
from the baseline exceeding 60 milliseconds are considered to present a small 
risk of a fatal arrhythmia (European Agency for the Evaluation of Medicinal 
Products 2005, Fenichel et al 2004, Morganroth and Pyper 2001, Pater 2005). 
Patients in this study were also investigated for corrected Q-T increases 
exceeding 60 milliseconds during epileptic seizures and categorised into 
seizure types. 
_________________Upper normal limits (98% in ms)___________           
 
Gender                          HR        QTcB  QTcFri QTcFra QTcH 
 Both (10,303)             All HR 483 460 457 457 
   HR<60 454 459 459 466 
   HR 60 to 99 483 461 458 456 
   HR >99 492 445 436 451 
 Male (5,420)  All HR 480 457 454 454 
   HR<60 450 455 455 465 
   HR 60 to 99 480 457 454 452 
   HR>99 490 445 436 450 
 Female (4,883) All HR 486 463 461 460 
   HR<60 460 463 463 470 
   HR 60 to 99 486 465 462 459 
   HR>99 492 448 434 452 
__________________________________________________________ 
Table 1 Upper limit of normal values for corrected Q-T in adult males and 
adult females using Bazett’s (QTcB), Hodge’s (QTcH), Fridericia’s (QTcFri) 
and Framingham’s Formulae (QTc Fra) Luo et al 2004. 
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Chapter 11 : Results 
2.3.1 Study group characteristics 
The subject gender mix was 25 males and 14 females. The age range was 2 
years 5 months to 60 years 3 months. The mean age was 17 years 2 months 
with a median age 11 years 5 months. The patients included in corrected Q-T 
analysis are from the original patient group analysed in the percentage heart 






Age Gender Aetiology/Epilepsy Anti-Epileptic Drugs 
3 1 3 years5 
months 
M Motor developmental 




4 2 3 years  
7 months 
M Mild motor delay. Weekly 




6 3 3 years 6 
months 
M Mild motor delay. Weekly 
complex focal seizures. 
Carbamazepine, 
Lamotrigine. 
9 4 3 years 1 
month 
M Autistic spectrum disorder. 
Weekly complex focal 
seizures. 
Nil. (Seizures not 
previously diagnosed). 
10 5 15 years 
11 
months 
F Aicardi syndrome. Cerebral 
palsy with left hemiparesis. 
Weekly tonic, Generalised 
Tonic Clonic & myoclonic 
seizures. 
Phenytoin. 
11 6 15 years 2 
months 
M Lennox Gastaut syndrome. 
Daily absences, weekly 








13 7 5 years 4 
months 
F Sub-cortical band 
heterotopia. Daily epileptic 
spasms. 
Sodium Valproate. 
14 8 7 years 6 
months 




15 9 6 years 7 
months 
M Lennox Gastaut syndrome. 





16 10 5 years 9 
months 




17 11 49 years 7 
months 
M Daily complex focal 
seizures. One nocturnal 





18 12 5 years 9 
months 
M Normal development. 
Absences, drop attacks & 
nocturnal Generalised 
Tonic Clonic Seizures. 
Sodium Valproate, 
Clobazam. 
19 13 60 years 3 
months 
F 3 year history of funny 
turns. Complex focal 
seizures. 
Nil. Commenced on 
AED after EEG 
Videotelemetry. 
20 14 20 years 9 
months 




21 15 17 years 
11 
months 
F Complex focal seizures, 
occasional Generalised 
Tonic Clonic Seizures. 
Topiramate, Keppra. 
22 16 11 years 3 
months 
F Normal development. 
Recent weekly focal 
seizures. 
Carbamazepine. 
23 17 11 years 5 
months 
M Normal development. 
Weekly complex focal 





24 18 27 years 9 
months 
F Recent focal seizures. Nil. Commenced on 
AED after EEG 
Videotelemetry. 
25 19 21 years 3 
months 
F Daily absences. 
Generalised Tonic Clonic 




26 20 4 years 9 
months 
M Mild developmental delay. 
Weekly nocturnal seizures. 
Topiramate,  
Sodium Valproate. 
27 21 6 years 6 
months 
F Previous viral 
encephalopathy. Cortical 
visual impairment & 
22learning disability. 
Atonic seizures and 
absences. 
Phenobarbitone. 
28 22 6 years 1 
month 
M Magille’s syndrome. 
Myoclonic absences. 
Nil. To be commenced 
on Ethosuximide. 
29 23 16 years 
11 
months 
M Normal development. Daily 
absences. 
Sodium Valproate. 
30 24 16 years M Frequent daily episodes 
resembling torticollis & 
retrocollis. Complex focal 
seizures. 
Carbamazepine 
31 25 4 years 11 
months 




32 26 4 years 7 
months 
M Complex focal seizures Carbamazepine, 
Lamotrigine 
33 27 22 years 7 
months 
F Complex focal seizures Nil. Commenced on 
AED after EEG 
Videotelemetry 
34 28 41 years 9 
months 
F Myoclonic epilepsy Nil 
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35 29 2 years 5 
months 
M Prolonged febrile 
convulsion. Nocturnal 
Generalised Tonic Clonic 
Seizures. 
Sodium Valproate. 
36 30 3 years 9 
months 






37 31 4 years 3 
months 






38 32 5 years 11 
months 
M Myoclonic Astatic Epilepsy. 
Absences, atonic, tonic, 
Generalised Tonic-Clonic 





39 33 12 years 4 
months 
F Normal development, 18 




40 34 30 years 
11 
months 
M Focal seizures (sensory 
induced by music) 
Lamotrigine 
41 35 5 years 4 
months 
M Microcephaly, Cerebral 
Palsy. Seizures. 
Nitrazepam. 
42 36 5 years 4 
months 







43 37 43 years 
11 
months 
M Encephalitis post typhus 
vaccination. Complex focal 






44 38 22 years 8 
months 
F Complex focal seizures 
with secondary generalised 
seizures. 
To be commenced on 
AEDs 
45 39 2 years 
 
M Episodes of epilepsia 
partialis continuans 
involving the right side of 
face. 
Nil. To be commenced 
on Phenytoin. 






























Results According to Bazett’s corrective formulae 
Introduction 
Henry Cuthbert Bazett was born in Gravesend, England. He 
was educated at Oxford (B.A., 1908; M.B., 1911; B.Ch., 1911; 
M.S., 1913; and M.D., 1919). After service as a medical officer 
in the British Army during World War I, he accepted a 
professorship in physiology at the University of Pennsylvania 
in 1921. Bazett’s formula QTc= QT/2 R-R interval is used to compare 
Hodge’s, Fridericia’s and Framingham’s formulae to in this study as Bazett’s 
formula is considered to be the ‘gold standard’ for comparison to other 
studies. Bazett’s formula is found in most cardiology equipment software in 
the UK (Yu et al 1950, Morganroth et al 2001, Pater 2005, Fossa et al 2005). 
Bazett’s study was based on 39 subjects.  
















































































Bazett's QTc During Grouped Seizures n=156
 Figure 2. Boxplot of Bazett’s corrected Q-T values during grouped seizures.  
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The subject gender mix was 25 males and 14 females (Table 2). The age range 
was 2 years 5 months to 60 years 3 months. The mean age was 17 years 2 
months with a median age 11 years 5 months. A total of 156 seizures had 
corrected Q-T analysis performed (370 seizures had to be excluded from the 
study due to EMG artefact obscuring the ECG trace) The 156 analysed 
seizures were composed of: 9 generalised tonic-clonic seizures (5 patients), 34 
absences (6 patients), 12 tonic seizures (6 patients), 27 temporal lobe seizures 
(14 patients), 58 frontal lobe seizures (4 patients) and 16 sub-clinical seizures 
(4 patients) were clinically and electrographically identified.  
According to Bazett’s formula, nine patients were identified as prolonging 
their corrected Q-T during seizures, representing 23% (9/39) of the total study 
group. The longest QTc value from a 9 seconds epoch was selected to 
compare re-polarisation values prior to the seizure and during the seizure. 
Of these nine patients 21 seizures when analysed prolonged their corrected 
Q-T beyond normal values (Luo et al, 2004) according to Bazett’s formula. 
The 21 seizures identified were: 
 5 right temporal lobe sub-clinical seizures (1 paediatric patient).  
 1 left temporal lobe sub-clinical seizure (1 paediatric patient). 
 11 right temporal lobe seizures (3 patients). 
 2 left temporal lobe seizures (2 patients). 
 1 generalised tonic-clonic seizure (1 paediatric patient). 
 1 myoclonic absence seizure (1 paediatric patient). 
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The proportion of seizures identified by Bazett’s formula as resulting in a 
prolongation of the corrected Q-T of total seizures in the study is 13% (21/156 
seizures). The number of patients identified as prolonging their corrected Q-
T during seizures is 23% (9/39), (Table 3, Figure 3). 
 
Figure 3 Bar chart of total patients & total seizures with applied Bazett’s 



























9M(paediatric) 119.5      441     492      51 Right  
Sub-clinical 
Temporal 
9M(paediatric) 111.9     444     474     30 Right 
Sub-clinical 
Temporal 





9M(paediatric) 120     376     493    117 Right  
Sub-clinical 
Temporal 
9M(paediatric) 140.5     445     472     27 Right  
Sub-clinical 
Temporal 
22F(paediatric) 72.2     425     454     29 Left  
Sub-clinical 
Temporal 
20M 66.7     396     495     99 Right 
Temporal 
20M 119.5     412     501     89 Right 
Temporal 
20M 100.6     410     494     84 Right 
Temporal 
20M 100.8     421     493     72 Right 
Temporal 
20M 88.4     401     490     89 Right 
Temporal 
20M 102     411     502     91 Right 
Temporal 
20M 100.3     436     494     58 Right 
Temporal 
20M 110     390     512    122 Right 
Temporal 
20M 102     410     492     82 Right 
Temporal 
21F 101     413     494     81 Right 
Temporal 
24F 110.1     420     505     85 Right 
Temporal 




17M 76.8     433     491     58 Left 
Temporal 
18M(paediatric) 148.1     403     490     87 Generalised 
Tonic-clonic 
28M(paediatric) 117.6     440     462     22 Myoclonic 
Absence 
 
Table 3 Summary of Bazett’s corrected Q-T values for patients during 
seizures exceeding normal limits (according to Luo et al 2004). 
Paired t-testing using minitab version 14 was performed on the total seizure 
group n=156 data according to Bazett’s formula and shows a statistically 
significant difference (p<0.001) between the corrected Q-T value prior to the 
seizure and during the seizure. The mean corrected Q-T value for the group 
is within normal limits of 427 milliseconds. When the data is divided into 
seizure types, high statistical significance is seen in frontal lobe seizures, 
generalised tonic-clonic seizures and temporal lobe seizures. Tonic seizures 
show a moderate statistical significance and absence seizures present a poor 
statistical significance when analysing changes in corrected Q-T before the 



















During 427.6   34.0   2.7   
Before 399.9   35.2   2.8   






During 414.5  18.4   3.2   
Before 417.9  19.0   3.3   








During 411.2  25.0   3.3   
Before 379.5  31.4   4.1   





During 417.8  42.1  14.0   
Before 365.6  58.5  19.5   






During 463.0  34.6    6.7   
Before 408.9  20.8    4.0   







During 481.4  28.5    7.6   
Before 405.0  21.4    5.7   







During 444.5  32.4    9.8   
Before 412.7  21.9    6.6   





During 429.2 19.3   5.4   
Before 414.6  34.5    9.6   






During 467.5  18.2    4.5   
Before 435.6  23.1    5.8   
Difference  31.9  30.2    7.5 15.8, 48.0 <0.001 
 
Table 4 Paired T-testing Statistical Analysis for Bazett’s Corrected Q-T 






2.3.3 Generalised seizures 
Generalised tonic clonic seizures 
Changes in the corrected Q-T were analysed before and during nine 
generalised tonic clonic seizures (p<0.001). One seizure resulted in corrected 
Q-T beyond normal limits with a maximum increase of 87 milliseconds from 
403 to 490 milliseconds (Table 3). Three generalised tonic clonic seizures 
(33%) from 2 patients increased corrected Q-T values exceeding 60 
milliseconds during the seizure. Two of these seizures (2 patients) although 
they demonstrated an increase in corrected Q-T exceeding 60 milliseconds, 
remained within normal QTc limits for age and gender (Table 7). This seizure 
type represents one of the highest proportions (33%) of increased corrected 
Q-T exceeding 60 milliseconds compared to other seizure types in this study 
(Table 8). Patient 43M became hypoxic during a seizure with oxygen 
saturation dropping to 67% during the de-saturation period of 87 seconds 
and total seizure duration 165 seconds. This seizure was a secondary 
generalised left temporal lobe seizure. The corrected Q-T increased by 130 
milliseconds but stayed within normal limits (Table 5).  None of the remaining 
six patients in the study who had generalised tonic clonic seizures became hypoxic 
This seizure group was the smallest group in the study n=9 but shows high 
statistical significance (p<0.001) because the standard deviation is relatively 
large at 34.9 milliseconds indicating one of the largest change in corrected Q-
T than any other seizure group. The mean corrected Q-T during generalised 
tonic-clonic seizures is however still within normal range for this group at 
417 milliseconds (Table 4). 
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An interesting observation is seen in the standard deviation before the 
seizures being much higher at 58.5 milliseconds compared to 42.0 
milliseconds during the generalised tonic clonic seizure group of seizures. 
This suggests that the corrected Q-T values stay much closer to the mean 
during the seizure than they did before the seizure indicating a more 
stereotyped heart rate, re-polarisation time or some characteristic difference 
autonomically during the seizure compared to before the seizure. This 
reduction in standard deviation during the event is dramatically different in 
this seizure type compared to any others. 
Absence seizures 
Seventy four percent (26/35) of absence seizures either showed no increase in 
corrected Q-T or slightly shortened the corrected Q-T and as a group did not 
reach statistical significance (p=0.329), (Table 4). One myoclonic absence 
without hypoxia demonstrated corrected Q-T lengthening by a small amount 
of 20 milliseconds resulting in corrected Q-T prolongation of 460 
milliseconds in a child (Table 3, Figure 3). The remaining 8 events only 
increased the corrected Q-T by 10 milliseconds.  
Corrected Q-T during absences shows the least statistical significance of 
p=0.329 compared to other seizure groups, with the least amount of change (-
3 milliseconds) measured in the corrected Q-T for the group n=34. The 
corrected Q-T during absences collectively is well within normal limits of 414 
milliseconds with one of the tightest standard deviation of 19.3 milliseconds 




Tonic seizures  
Small increases in corrected Q-T from 10 up to 50 milliseconds occurred 
during fifty eight percent (7/12) of tonic seizures with maximum values of 
440 milliseconds (p=0.06), (Table 4). According to Bazett’s formula none of 
the tonic seizure events increased the corrected Q-T values beyond normal 
limits. Oxygen saturation dropped to 86% in one patient 15M but remained within 
clinically normal range. 
Corrected Q-T changes seen during tonic seizures n=12 in this study hardly 
scrape statistical significance at p=0.06. The mean corrected Q-T for this 
group is within normal limits at 429 milliseconds with a standard deviation 
difference of 25.3 milliseconds slightly larger to that seen in absences and 
frontal lobe seizures indicating a less tight variation about the mean. The 95% 
confidence interval seen during tonic seizures is small at (–0.7), 29.9 
milliseconds which is slightly wider than that seen during absences at (-10.1), 
3.5 milliseconds (Table 4). 
2.3.4 Complex focal seizures. 
Frontal lobe seizures 
Fifty-eight frontal lobe seizures were analysed (2 derived from the right 
hemisphere and 56 derived from the left hemisphere). Generally, slight 
increases in corrected Q-T lengthening were observed in sixty four percent 
(37/58) of frontal lobe seizures resulting in high significance (p<0.001), (Table 
4). However, the QTc lengthening was not clinically lengthened with values 
remaining within normal limits. Three left frontal lobe seizures resulted in 
corrected Q-T lengthening exceeding 60 milliseconds during the seizure but 
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again remained well within normal limits Table 8. Overall, this result 
represents a small proportion of five percent (3/58) of total frontal lobe 
seizures demonstrating this increase (Table 9). 
The frontal lobe seizure group n=58 was the largest grouped seizure type 
data. Changes in corrected Q-T in this group was statistically significant 
(p<0.001) however, this is surprising given that the mean corrected Q-T 
during seizures is shorter (411 milliseconds) than that of absences (414 
milliseconds). The standard deviation is smaller at 17.6 milliseconds 
compared to of absences at 19.3 milliseconds. Both standard deviation values 
for frontal lobe seizures and absences are smaller than that seen in temporal 
lobe seizures and generalised tonic-clonic seizures. No hypoxia occurred during 
frontal lobe seizures in this study. 
Temporal lobe seizures  
Seventy percent (19/27) of temporal lobe seizures measured an increase in 
corrected Q-T during the seizures (p<0.001), (Table 3). Bazett’s formula 
indicated forty eight percent (13/27) of these seizures exceeded normal limits 
(Table 3, Figure 3) with the most dramatic corrected Q-T lengthening 
occurring from 390 milliseconds to 512 milliseconds during a right temporal 
lobe seizure lasting 1 minute 27 seconds.   
Of the twenty-seven temporal lobe seizures recorded, 13 seizures measured 
an increase in corrected Q-T beyond normal limits according to Bazett’s 
formula. Eleven of the temporal lobe seizures that showed this increase in 
corrected Q-T were derived from the right temporal lobe compared to only 
two left temporal lobe seizures.  
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Temporal lobe seizures n=27 demonstrate high statistical significance 
(p<0.001) comparing the corrected Q-T value before the seizure and during 
the seizure. This group gives the longest corrected Q-T mean value for the 
group at 462 milliseconds during the seizure compared to other seizure 
types. When this group is sub-divided into right temporal lobe seizures n=17 
and left temporal lobe seizures n=10 more interesting statistics emerge. The 
right temporal lobe seizure group is more highly statistically significant 
(p<0.001) compared to the left temporal lobe seizure group (p=0.016). 
Additionally, the mean corrected Q-T during right temporal lobe seizures is 
481 milliseconds compared to 444 milliseconds for the left temporal lobe 
seizure group. The 95% confidence interval for the right temporal lobe 
seizure group is the largest compared to any other groups at 62.9, 89.9 
milliseconds indicating that 95% of data in this group has the largest range in 
corrected Q-T compared to other groups (Table 3). Four patients (8 seizures) 
became hypoxic during their temporal lobe seizures. During two right 
temporal lobe seizures (1 patient) oxygen saturation dropped to 71% during 
the de-saturation period lasting up to 81 seconds but the corrected Q-T 
remained within normal limits. During one of the left temporal lobe seizure, 
oxygen saturation dropped to 75% during the de-saturation period lasting 78 
seconds. The corrected Q-T lengthened to 494 milliseconds, with an increase 






2.3.5 Sub-clinical seizures. 
Sixteen sub-clinical temporal lobe seizures were recorded and QTc analysed 
from 4 patients (6 derived from the right hemisphere and 10 derived from 
the left hemisphere) compared to baseline measurements (p<0.001). Six sub-
clinical temporal lobe seizures from 2 patients were found to lengthen the 
corrected Q-T beyond normal limits according to Bazett’s formula, with a 
maximum increase of 117 milliseconds during one sub-clinical seizure from 
376 milliseconds to 493 milliseconds. Five of these sub-clinical seizures (1 
patient) were derived from the right temporal lobe compared to one sub-
clinical seizure from the left temporal lobe (1 patient).  
The standard deviation of 30.2 milliseconds is the third largest calculation 
after temporal lobe seizures (36.9) and generalised tonic clonic seizures (34.9) 
milliseconds. A long mean corrected Q-T during sub-clinical seizures for the 
group is 467 milliseconds which is longer than that seen during generalised 
tonic clonic seizures (417 milliseconds) and comparable to that seen during 
temporal lobe seizures (462 milliseconds). The 95% confidence interval of 
15.7, 47.9 milliseconds calculate a difference of 32.1 milliseconds, which is 






2.3.6 Seizures associated with hypoxia. 
Figure 4   Seizures associated with hypoxia. 
Hypoxia occurred in 8 seizures (4 patients). 
 2 right temporal lobe seizures (1 paediatric patient). 
 5 left temporal lobe seizures (3 patients). 
 1 generalised tonic-clonic seizure. 
During the right temporal lobe seizures, oxygen saturation decreased to 71%, 
with a hypoxic duration of up to 81 seconds. The seizure lasted 255 seconds 
and was the longest seizure in the study. However the corrected Q-T 




One of the left temporal lobe seizures (patient 43M) had the longest period of 
hypoxia lasting 132 seconds with oxygen saturation down to 72% with no 
change in corrected Q-T. Patient 19F became hypoxic lasting 78 seconds 
during a left temporal lobe seizure lasting 111 seconds. This patient increased 
the corrected Q-T by 98 milliseconds to a prolonged 494 milliseconds during 
the seizure. The T-wave also diminished at the start of the electrical 
discharge, slowly returning during the second half of the seizure. 
The single secondary generalised seizure, originating from the left temporal 
lobe (43M) increased the corrected Q-T by 130 milliseconds during hypoxia 
of 67%, lasting 87 seconds and seizure duration of 165 seconds but the QTc 
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2.3.7 Right and Left Hemisphere Focal Seizure Comparison 
Patients who had temporal lobe seizures or sub-clinical seizures derived 
from the right hemisphere that produced a prolongation in corrected Q-T 
demonstrated a tendency to have multiple seizures compared to those 
patients experiencing left hemisphere seizures. 
A total of twenty-seven temporal lobe seizures (14 patients) were recorded 
and analysed (17 right temporal lobe seizures (7 patients) and 10 left 
temporal lobe seizures (7 patients)). Thirteen temporal lobe seizures were 
found to lengthen the corrected Q-T beyond normal limits according to 
Bazett’s formula. Eleven of these events (11/13) from 3 patients were derived 
from the right temporal lobe compared to two events (2/13) from 2 patients 
from the left temporal lobe. Sixteen sub-clinical temporal lobe seizures (4 
patients) were recorded and analysed (six derived from the right hemisphere 
(2 patients) and ten derived from the left hemisphere (2 patients)). Six sub-
clinical temporal lobe seizures were found to lengthen the corrected Q-T 
beyond normal limits according to Bazett’s formula. Five of these seizures (1 
patient) were derived from the right temporal lobe compared to one seizure 
from the left temporal lobe (1 patient).  
Although it appears that lengthening of the corrected Q-T occurs more often 
from seizures derived from the right hemisphere there is no statistical 
significance when comparing right and left hemisphere seizures when the 
analysis is performed in terms of number of patients. 
Lengthening of the corrected Q-T exceeding 60 milliseconds occurred in 
nineteen seizures of different seizure types (ten right temporal lobe seizures, 
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one left temporal lobe seizure, three generalised tonic-clonic seizures, three 
left frontal lobe seizures and two right temporal sub-clinical seizures). Ten 
(10/19) were derived from the right temporal lobe compared to one (1/19) 
derived from the left temporal lobe. Two (2/19) right temporal lobe sub-
clinical seizures were identified compared to no seizures from left temporal 
sub-clinical seizures (Table 8). 
Analysis of Effects of Laterality both in terms of Number of Seizures and in 
terms of Number of Patients 
When the data is analysed in terms of number of seizures, a bias is 
introduced because of multiple seizures occurring from a few patients, 
giving the impression that there is a statistically significant difference in the 
lengthening of the corrected Q-T from seizures derived from the right 
hemisphere compared to the left hemisphere. When the data is analysed in 
terms of number of patients, there is no statistical difference in data derived 
from right and left hemisphere seizures. 
Analysis of Laterality effect in terms of Number of Seizures 
Corrected Q-T data using Bazett’s formula was grouped into three seizure 
categories: generalised seizure, right hemisphere seizures and left 
hemisphere seizures and tested using Pearson Chi-Square analysis (Chernoff 
et al 1954) which makes the assumption that ‘all things are equal.’ The 
Pearson Chi-Square displays a strong statistical significance (p< 0.001) of 
prolonged QTc during right hemisphere seizures compared to both left 














































Pearson Chi-Square = 68.925, DF = 2,  
P-Value < 0.001 
 
Likelihood Ratio Chi-Square = 50.172, DF = 2,  
P-Value < 0.001 
 
Table 6   Pearson Chi-Square analysis comparing Bazett’s corrected Q-T 
grouped data derived from generalised, right hemisphere and left hemisphere 
seizures.  
Analysis of Laterality effect in terms of Number of Patients 
However, when the data is analysed in terms of number of patients instead 
of number of seizures, the bias is eliminated. Again, corrected Q-T data using 
Bazett’s formula was grouped into three seizure categories: generalised 
seizure, right hemisphere seizures and left hemisphere seizures but the 
number of patients were substituted instead of seizures and tested using 
Pearson Chi-Square analysis. Although patients with seizures arising from 
the right hemisphere showed more frequent lengthening of the corrected Q-T 
there is no statistical significance when comparing right and left hemisphere 
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seizures when the analysis is performed in terms of number of patients. 
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        12 
     85.71 
         2  
     14.29 
      14 




        7 
     63.64 
        4 
     36.36 
      11 




       11 
    78.57 
        3 
     21.43 
      14 
     100% 
           
      All 
       30 
    76.92 
         9 
     23.08 
      39 
     100% 
Pearson Chi Square=1.725, DF=2,P-Value=0.422 
Likelihood Ratio Chi-Square=1.684, DF=2, 
P-Value=0.431 
 
Table 7 Pearson Chi-Square analysis comparing Bazett’s corrected Q-T data 
for number of patients derived from generalised, right hemisphere and left 



















2.3.8 Corrected Q-T prolongation exceeding 60 milliseconds. 
It is considered that when the corrected Q-T lengthens by more than 60 
milliseconds there is a small risk of a fatal arrhythmia. (European Agency for 
the Evaluation of Medicinal Products 2005, Fenichel et al 2004, Morganroth 
and Pyper 2001, Pater 2005). In this study, nineteen (19) seizures 
demonstrated an increase in corrected Q-T lengthening exceeding 60 
milliseconds. Ten (10) seizures (3 patients) demonstrating this increase were 
right temporal lobe seizures, representing 59% (10/17) of all right temporal 
lobe seizures in the study. This compares to only one left temporal lobe 
seizure increasing the corrected Q-T exceeding 60 milliseconds during the 
seizure from a total of ten (1/10) left temporal lobe seizures. The patient (19F) 
who had the left temporal lobe seizure increased the corrected Q-T by 98 
milliseconds to a prolonged measurement of 494 milliseconds and was 
hypoxic with an oxygen saturation of 75%.  
Sixteen sub-clinical temporal lobe seizures were recorded and analysed. In 
two of these sub-clinical seizures ((1 patient) the corrected Q-T lengthened by 
more than 60 milliseconds. Both of these seizures were right temporal sub-


































9M(paediatric) 109.1     390     471        81 Right  
Sub-clinical 
Temporal 
9M(paediatric) 120     376     493     117 Right 
Sub-clinical 
Temporal 
20M 119.5     412     501       89 Right 
Temporal 
20M 100.6     410     494       84 Right 
Temporal 
20M 100.8     421     493       72 Right 
Temporal 
20M 88.4     401     490       89 Right 
Temporal 
20M 102     411     502       91 Right 
Temporal 
20M 110     390     512     122 Right 
Temporal 
20M 102     410     492       82 Right 
Temporal 
20M 66.7     396     495       99 Right 
Temporal 
21F 101     413     494       81 Right 
Temporal 
24F 110.1     420     505       85 Right 
Temporal 
19F 109     396     494       98 Left 
Temporal 
30M 98.1     336     417       81 Left Frontal 
30M 105.2     333     413       80 Left Frontal 
30M 90.9     330     401       71 Left Frontal 
18M(paediatric) 148.1     403     490       87 Generalised 
Tonic-clonic 
18M(paediatric) 123.9     351     421       70 Generalised 
Tonic-clonic 




Table 8.(above) Summary of patients demonstrating an increase in corrected 
QT exceeding 60 milliseconds during a seizure according to Bazett’s 
Formula. 
Of these 19 seizures, 5 seizures identified as having an increase from baseline 
by 60 milliseconds were still within normal QTc limits of which 2 where 
generalised tonic clonic seizures and 3 were left frontal lobe seizures. The 
types of seizures resulting in maximum increases in corrected Q-T 
lengthening occurred in a generalised tonic clonic seizure (130 milliseconds), 
right temporal lobe seizure (122 milliseconds) and right temporal sub-clinical 
seizure (117 milliseconds). This result is consistent with the grouped analysis 
of seizure types that demonstrated maximum increases of corrected Q-T 
exceeding 60 milliseconds in this study of 3/9 generalised tonic clonic 
seizures (33%) from 2/5 patients, 10/17 right temporal lobe seizures (59%) 
from 3/7 patients and 2/6 right temporal sub-clinical seizures (33%) from 1/2 
patients compared 10% (1/10) of left temporal lobe seizures from 1/7 patients 




















QTc > 60 
milliseconds. 
% Seizures with 
Bazett’s QTc  > 
60 milliseconds. 
 
Right Temporal 17 10 59 
Left Temporal 10 1 10 
Right Temporal 
Sub- clinical 
6 2 33 
Left Temporal 
Sub-clinical 
10 0 0 
Right Frontal 4 0 0 
Left Frontal 54 3 5 
GTCS 9 3 33 
Tonic 12 0 0 
Absences 34 0 0 
 
Table 9.Percentage of corrected Q-T lengthening exceeding 60 milliseconds 





Figure 5 Total seizures and percentage of each seizure type increasing 




Nine patients (23%) of the study group were identified as prolonging their 
corrected Q-T during seizures. Twenty-one seizures (13% of total seizures) 
prolonged their corrected Q-T during 5 right sub-clinical temporal lobe 
seizures (1 patient), 1 left temporal lobe seizure (1 patient), 11 right temporal 
lobe seizures (3 patients), 2 left temporal lobe seizures (2 patients), 1 
generalised tonic clonic seizure and 1 myoclonic absence seizure.  
Bazett’s formula shows a statistically significant difference (p<0.001) between 
the corrected Q-T value prior to the seizure and during the seizure for the 
total seizure group. When the data is divided into seizure types, high 
statistical significance is seen in frontal lobe seizures, generalised tonic-clonic 
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seizures, temporal lobe seizures and sub-clinical seizures. Tonic seizures 
show a moderate statistical significance and absence seizures present a poor 
statistical significance when analysing changes in corrected Q-T before the 
seizure with during the seizure. 
A right temporal lobe seizure resulted in the most prolonged corrected Q-T 
of 512 milliseconds. No distinction is found when comparing corrected Q-T 
lengthening during right temporal lobe seizures with left temporal lobe 
seizures when analysed in terms of number of patients. Nineteen seizures 
demonstrated an increase in corrected Q-T lengthening exceeding 60 
milliseconds. Ten (10) seizures demonstrating this increase were right 
temporal lobe seizures, representing 59% (10/17) of all right temporal lobe 
seizures in the study. This compares to only one left temporal lobe seizure 
increasing the corrected Q-T exceeding 60 milliseconds during the seizure 
from a total of ten (1/10) left temporal lobe seizures. 
Three patients (4 seizures) became hypoxic during their seizures with oxygen 
saturation dropping to 67% during a generalised tonic-clonic seizure 
whereupon the corrected Q-T lengthened by 130 milliseconds but stayed 
within normal limits. Patient 19F prolonged the corrected Q-T beyond 







Chapter 12: Results: According to Hodge’s corrective formula 
Introduction:  
Dr Morrison Hodges, Minneapolis introduced a relatively new heart rate 
correction formula in 1983 (Hodge et al 1983). QTc=QT+1.75(heart rate –60).  
Luo et al 2004 recommends Hodge's Formula instead of Bazett's when 





















































































Hodge's QTc During Epileptic Seizures n=156
 







2.4.1 Total seizure group 
The subject gender mix was 25 males and 14 females. The age range was 2 
years 5 months to 60 years 3 months (Table 2). The mean age was 17 years 2 
months with a median age 11 years 5 months. A total of 156 seizures had 
corrected Q-T analysis performed (370 seizures had to be excluded from the 
study due to EMG artefact obscuring the ECG trace) The 156 analysed 
seizures were composed of: generalised tonic-clonic seizures (9), absences 
(34), tonic seizures (12), temporal lobe seizures (27), frontal lobe seizures (58) 
and 16 sub-clinical seizure events were clinically and electrographically 
identified.  
Fewer seizures resulting in lengthening of the corrected Q-T according to 
Luo et al were identified using Hodge’s formula compared to Bazett’s 
results. Seven seizures were derived from four patients. 
 2 Tonic seizures (1 paediatric patient).  
 1 Generalised tonic-clonic seizure (1 paediatric patient)  
 1 right temporal lobe seizure (1 patient). 
 3 right temporal lobe sub-clinical seizures (1 paediatric patient)  
When Hodge’s formula is applied to the data, 10% of total patients (4/39) 
were identified as prolonging their corrected Q-T during seizures. The 
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proportion of seizures demonstrating this increase is 4% (7/156) of the total 
seizure group (Figure 7, Table 10). 
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Table 10 Summary of Hodges corrected Q-T values for patients during 
seizures exceeding normal limits according to Luo et al 2004. 
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Figure 7 Bar chart of total patients & total seizures exceeding Hodge’s 
corrected Q-T normal limits (according to Luo et al 2004). 
Paired t-testing using minitab version 14 was performed on the total seizure 
group n=156 data according to Hodge’s formula and shows a statistically 
significant difference (p>0.001) between the corrected Q-T value prior to the 
seizure and during the seizure. The mean corrected Q-T value for the group 
is within normal limits of 409 milliseconds. This mean average is 16 
milliseconds shorter than that presented using Bazett’s formula. 
According to Hodge’s corrective formula the total seizure group shows a 
highly statistically significant change in corrected Q-T during seizures 
(p<0.001). Frontal lobe seizures and temporal lobe seizures show significance 
values of p<0.001 (Table 9). Hodge’s formula attaches equally high statistical 
significance (p<0.001) to temporal lobe seizures when sub-divided into right 
temporal lobe seizures and left temporal lobe seizures. This compares to 
Bazett’s formula which gave less significance to left temporal lobe seizures 
(p=0.016). Hodge’s formula also indicates tonic seizures as having a higher 
statistical significance (p=0.002) compared to that of Bazett’s formula (p=0.06). 
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Absence seizures still rank poorest with statistically significance in corrected 
Q-T with a value of p=0.191 Sub-clinical seizures have a slightly less 
significant result of p=0.006 from Hodge’s formula compared to Bazett’s 
formula of p<0.001. 
 
















During 409.9 26.9   2.1   
Before 388.4 29.0   2.3   






During 399.8 14.7   2.5   
Before 402.3 15.1   2.6   








During 397.6 19.8   2.7   
Before 372.0 20.8   2.8   
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Before 358.8 44.3  14.8   
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Before 401.7 23.6    4.5   






During 437.8 26.6    7.1   
Before 405.0 23.8    6.3   








During 424.5 23.0    6.9   
Before 390.9 22.1    6.7   





During 411.8 28.6    8.3   
Before 388.6 20.0    5.8   






During 442.2 14.7    3.7   
Before 426.6 19.5    4.9   
Difference  15.6 19.6    4.9  5.1,  26.1 =0.006 
Table 11 Statistical analysis of Corrected Q-T Data from Epileptic Seizures 
according to Hodge’s Formula. 
2.4.2 Generalised seizures 
Generalised Tonic-Clonic Seizures. 
The generalised tonic-clonic seizures group (n=9) is the smallest group in the 
study. Hodge’s formula differs slightly in statistical significance of p=0.002 
compared to Bazett’s formula (p<0.001). The mean corrected Q-T remains 
within normal range at 422 milliseconds, which is actually longer than that 
using Bazett’s formula at 417 milliseconds. According to Hodge’s formula, 
the generalised tonic-clonic seizure group has the largest standard deviation 
at 41.6 milliseconds compared to all other groups. Bazett’s formula by 
comparison calculated the longest standard deviation of 36.9 milliseconds to 
temporal lobe seizures. 
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The 95% confidence interval of Hodge’s formula is wider for generalised 
tonic clonic seizures at 32.1, 96.1 compared to that seen using Bazett’s 
formula of 25.4, 79.1 milliseconds. Therefore, 95% of generalised tonic-clonic 
seizure data according to Hodge’s formula fell over a wider range of 
measurement i.e. 64.0 (96.1-32.0) milliseconds compared to Bazett’s results of 
53.7 (79.1-25.4) milliseconds. This result explains why in this instance, 
Hodges formula calculates a longer mean corrected Q-T value of 421 
milliseconds than Bazett’s formula of 417 milliseconds for this seizure group 
(Table 11). 
An interesting observation is that the standard deviation of the before seizure 
data is larger at 44.3 milliseconds than the during seizure data of 32.2 
milliseconds which indicates that the data stays closer to the mean value 
during the seizure than before the seizure. It is the only seizure type that this 
occurs suggesting that during generalised tonic clonic seizures heart rate 
becomes more stereotyped, less variable re-polarisation time or 
autonomically different during this type of seizure group compared to any 
other seizure types. This is the same finding as seen using Bazett’s formula. 
Absence Seizures 
The mean corrected Q-T for the absences group is one of the shortest values 
of 399 milliseconds during the seizure. Hodge’s formula attaches slightly 
more statistical significance (p=0.191) to changes in corrected Q-T during 
absence seizures (n=34) than Bazett’s formula (p=0.329), (Table 10). This 
indicates that the results have a large probability of ‘chance’ and not 
particularly related to any single event. Absences show the smallest standard 
deviation from the mean in the group of 11.0 milliseconds compared to all 
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other groups. The 95% confidence interval is also very small with 95% of data 
between (-6.4), 1.3 milliseconds. 
Tonic Seizures 
Hodge’s formula considers tonic seizures to indicate a higher statistical 
significance of p=0.002 than Bazett’s (p=0.06) when comparing changes in 
corrected Q-T before tonic seizures with during tonic seizures. The mean 
corrected Q-T using Hodge’s formula during the seizure is shorter at 412 
milliseconds than that seen using Bazett’s formula at 429 milliseconds. The 
difference in standard deviation of Hodge’s calculation is smaller at 20.3 
milliseconds compared to Bazett’s difference in standard deviation in 
corrected Q-T at 25.4 milliseconds. The 95% confidence interval difference is 
smaller 25.8 (36.2-10.3) milliseconds for Hodge’s results compared to Bazett’s 
results of 30.7 ((-0.7), 29.9-(-0.7)) milliseconds. 
2.4.3 Complex Focal Seizures. 
Frontal Lobe Seizures 
It remains surprising that frontal lobe seizures show high statistical 
significance (p<0.001) as was the case using Bazett’s formula. The mean 
corrected Q-T for the group (n=58) was similar (397 milliseconds) to that seen 
during absence seizures (399 milliseconds) but the standard deviation is 
slightly larger at 15.1 milliseconds and a narrow 95% confidence interval of 
21.5, 29.7 milliseconds. The mean corrected Q-T for frontal lobe seizures 
according to Hodge’s formula 397 milliseconds is only slightly shorter than 
that determined by Bazett’s formula at 411 milliseconds. 
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Temporal Lobe Seizures 
High statistical significance (p<0.001) occurred in the changes of corrected Q-
T during temporal lobe seizures (n-27) and in the sub-divided groups of right 
temporal lobe seizures (n=17), (p<0.001) and left temporal lobe seizures 
(n=10), (p<0.001), (Table 11). Hodge’s formula attaches a higher statistical 
significance to left temporal lobe seizures than Bazett’s formula of p=0.016. 
The mean corrected Q-T value during temporal lobe seizures is calculated to 
be 432 milliseconds which is within normal range and compares to Bazett’s 
mean corrected Q-T of 462 milliseconds. Although the left temporal lobe 
seizure group show high statistical significance (p<0.001) using Hodge’s 
formula, they still show the shorter mean corrected Q-T value of 424 
milliseconds compared to right temporal lobe seizures at 437 milliseconds. 
Temporal lobe seizures have a much smaller standard deviation of 17.6 
milliseconds compared to generalised tonic clonic seizures (41.6 
milliseconds). This also compares quite markedly with Bazett’s standard 
deviation of 36.9 milliseconds. 
2.4.4 Sub-clinical seizures. 
A total of 16 sub-clinical seizures recorded and analysed (p=0.006), (6 derived 
from the right hemisphere and 10 derived from the left hemisphere), three 
right temporal sub-clinical seizures showed an increase beyond normal QTc 
limits defined by Luo et al 2004 when Hodge’s formula is applied with no 
left temporal sub-clinical seizures identified (Figure 7, Table 10).  
A mean corrected Q-T for the group is 442 milliseconds compared to Bazett’s mean 
value of 467 milliseconds. A narrower 95% confidence interval is seen from Hodge’s 
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formula for the sub-clinical group (5.1, 26.1) with a range of 21 milliseconds 
compared to Bazett’s formula (15.8, 48.0) with a range of 32.2 milliseconds.  
2.4.5 Right and Left Hemisphere Focal Seizure Comparison. 
Three right sub-clinical temporal lobe seizures and one right temporal lobe 
seizure are identified using Hodges corrective formula as prolonging the 
corrected Q-T during the seizure according to normal limits (Luo et al 2004). 
This compares to no seizures identified from the left hemisphere as 
prolonging the corrected Q-T. Surprisingly, Hodge’s formula attaches 
equally high statistical significance (p<0.001) to temporal lobe seizures when 
sub-divided into right temporal lobe seizures and left temporal lobe seizures 
(Table 11). 
2.4.6 Corrected Q-T prolongation exceeding 60 milliseconds 
A total of five seizures where identified from five patients as increasing the 
corrected Q-T during seizures according to Hodge’s formula. Only one 
seizure exceeded normal corrected Q-T limits (Luo et al 2004) of 470 
milliseconds during a right sub-clinical temporal lobe seizure. Three 
generalised tonic clonic seizures exceeded the corrected Q-T by 60 
milliseconds. One generalised tonic clonic seizure in particular increased QTc 
values by 130 milliseconds but stayed within normal corrected Q-T limits. 
This seizure was identified by Bazett’s formula as exceeding 60 milliseconds. 
Bazett’s formula also identified all of Hodge’s seizures exceeding 60 
milliseconds except patient 35M who demonstrated an increase of 70 





































































































Table12. Summary of patients demonstrating an increase in corrected QT 
exceeding 60 milliseconds during a seizure according to Hodge’s Formula. 
2.4.7 Summary 
When Hodge’s formula is applied to all seizure data, seven seizures derived 
from four patients exceeded corrected Q-T normal limits according to Luo et 
al 2004 (Table 11, Figure 8). Hodge’s formula identified 2 tonic seizures, 1 
generalised tonic-clonic seizure, 1 right temporal lobe seizure and 3 right 
temporal lobe sub-clinical seizures. 
Five patients demonstrated an increase in corrected Q-T exceeding 60 
milliseconds during seizures with a right sub-clinical seizure resulting in 
QTc prolongation of 475 milliseconds. A generalised tonic clonic seizure 
increased the corrected Q-T by 130 milliseconds but remained within normal 
limits of 400 milliseconds. 
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Hodge’s formula shows a statistically significant difference (p<0.001) when 
comparing the corrected Q-T value prior to the seizure and during the 
seizure. Frontal lobe seizures and temporal lobe seizures both show 
significance values of p<0.001. Hodge’s formula attaches equally high 
statistical significance (p<0.001) to temporal lobe seizures when sub-divided 
into right temporal lobe seizures and left temporal lobe seizures. This 
compares to Bazett’s formula giving less significance to left temporal lobe 
seizures (p=0.016). High statistical values are still seen in generalised tonic 
clonic seizures (p=0.002), tonic seizures (p=0.002) and sub-clinical seizures 

























Chapter 13: Results: According to Fridericia’s Formula 
Introduction:  
Dr L.S Fridericia was professor of medicine and physiology in Copenhagen, 
Denmark (Moss 2003) in the early 1900s and published his paper on the 
duration of electrical systole in 1920. His formula was based on the data of 50 
patients. Despite the technological difficulties described in his paper 
(translation 2003) of using aluminium string galvanometers and 
photographic plates, his results are impressively accurate measuring very 
similar corrected Q-T values that we use today.  In drug trials, Fridericia’s 
formula is considered to have a more accurate correction factor than other 
traditional correction formulae in subjects with tachycardia (Pater 2005). 
Fridericia’s paper was published the same year as Bazett’s paper. However, 
although both corrective formulae have been used widely, Bazett’s has 
always been the most commonly used formula and both formulae have been 
debated over the last 80 years. 
                                                                                __________ 


















































































































Fridericia's QTc During Epileptic Seizures n=156
 
Figure 8 Boxplot of Fridericia’s corrected Q-T values during grouped 
seizures. 
The subject gender mix was 25 males and 14 females (Table 2). The age range 
was 2 years 5 months to 60 years 3 months. The mean age was 17 years 2 
months with a median age 11 years 5 months. A total of 156 seizures had 
corrected Q-T analysis performed (370 seizures had to be excluded from the 
study due to EMG artefact obscuring the ECG trace) The 156 analysed 
seizures were composed of:- generalised tonic-clonic seizures (9), absences 
(34), tonic seizures (12), temporal lobe seizures (27), frontal lobe seizures (58) 





From a total of 156 epileptic seizures analysed in this study according to 
Fridericia’s corrective formula, 6 seizure events were identified as 
lengthening the corrected Q-T values beyond normal limits of QTc during 
exercise (Luo et al 2004). The seizures identified were: 
 1 right sub-clinical temporal lobe seizure (1 paediatric patient). 
 1 generalised tonic clonic seizure (1 paediatric patient).  
 1 left temporal lobe seizure (1 patient). 
 3 right temporal lobe seizures (1 patient)   
These results represent 4 patients (10%) from the total of 39 patients in the 
study. Fridericia’s formula identified 6 seizures as prolonging the corrected 
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Table13. Summary of Fridericia’s corrected Q-T values for patients during 
seizures exceeding normal limits according to Luo et al 2004. 
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Figure 9 Bar chart of total patients & total seizures exceeding Fridericia’s 
corrected Q-T normal limits (according to Luo et al 2004). 
Paired t-testing using minitab version 14 was performed on the total seizure 
group n=156 data according to Fridericia’s formula and shows a statistically 
significant difference (p<0.001) between the corrected Q-T value prior to the 
seizure and during the seizure (Table 13). The mean corrected Q-T value for 
the group is within normal limits of 399 milliseconds. This mean average is 
28 (427-399) milliseconds shorter than that presented using Bazett’s formula 
and 10 (409-399) milliseconds shorter than Hodge’s formula. 
Fridericia’s corrective formula results in highly statistically significance 
(p<0.001) in corrected Q-T changes the during total seizure group. The 
formula also agrees with Bazett’s and Hodge’s formulae in high statistical 
significance (p<0.001) during frontal lobe seizures, temporal lobe seizures 
and right temporal lobe seizures. It disagrees with Bazett’s (p<0.001) and 
Hodge’s (p=0.002) for generalised tonic clonic seizures of high statistical 
significance and instead calculates a lower statistical significance of p=0.07. 
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Fridericia gives a lower statistical significance to tonic seizures (p=0.846) 
compared to Bazett’s formula (p=0.06) and Hodge’s formula (p=0.002). Sub-
clinical seizures are statistically significant when using Fridericia’s formula 
(p=0.002), similar to Bazett’s (p<0.001) and Hodge’s (p=0.006). Fridericia’s 
formula results agrees generally with Bazett’s (p=0.329) and Hodge’s 
(p=0.191) that absence seizures have a lower statistically significance in 
corrected Q-T during seizures (p=0.856). Fridericia’s formula agrees with 
Bazett’s formula (p=0.016) in attaching a slightly lower statistical significance 


















During 399.4 29.5    2.4   
Before 386.3 30.0    2.4   






During 391.8 16.2    2.8   
Before 392.1 15.7    2.7   






During 385.9 17.8    2.3   
Before 371.0 23.9    3.1   




During 378.9 39.2  13.1   
Before 356.7 47.7  15.9   
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During 434.3 26.8    7.2   
Before 411.4 24.1    6.4   






During 423.7 26.9    8.1   
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During 383.1 18.0   5.0   
Before 384.6 27.0   7.5   






During 444.2 15.7   3.9   
Before 425.6 22.8   5.7   
Difference 18.6 20.4   5.1 7.7, 29.5 =0.002 









2.5.2 Generalised seizures 
Generalised Tonic-Clonic Seizures 
According to Fridericia’s corrective formula, the generalised tonic clonic 
seizure group (n=9) shows less statistical significance (p=0.07) than that 
determined by Bazett’s (p=0.002) and Hodge’s (p=0.002) corrective formulae.  
The reduction in statistical significance may reflect that some of the 9 
seizures did not all show the same trend in changes in corrected Q-T during 
seizures. Fridericia’s corrective formulae is said to underestimate corrected 
Q-T at fast heart rates and this may have some bearing on the statistical 
results emphasized by a small data group (Table 14). 
The mean corrected Q-T is 378 milliseconds which is well within normal 
range and has the shortest mean value compared to any other seizure group. 
As seen with previous formulae analysis, the standard deviation of the 
corrective Q-T value is larger before the seizures (47.7 milliseconds) than that 
seen during the seizures (39.2 milliseconds) indicating a much tighter range 
of corrected Q-T values during generalised tonic clonic seizures.  
 The 95% confidence interval is one of the largest compared to other seizure 
groups (-2.3, 46.8 milliseconds) with a difference of 49.1 milliseconds 
compared to that of frontal lobe seizures (10.1, 19.5 milliseconds) of 9.4 






According to Fridericia’s formula absences (n=34) have the poorest statistical 
significance of p=0.856 compared to all other groups. This result indicates a 
high probability that the corrected Q-T measurements occurring before and 
during absence seizures are not distinctly different from chance (Table 14).  
The mean corrected Q-T 391 milliseconds is shorter than the total mean of 
399 milliseconds and is within normal range. Absences have the smallest 95% 
confidence interval of (-3.6), 3.0 compared to any other seizure group, with a 
difference of 6.6 milliseconds.  
Tonic Seizures 
Fridericia’s formula calculates the lowest statistical significance of Q-T 
changes during tonic seizures (p=0.846) compared to Bazett’s formula 
(p=0.06) and Hodge’s formula (p=0.002). There is very little difference 
between mean corrected Q-T before the seizures (384.6 milliseconds) and 
during the seizures (383.1 milliseconds). The 95% confidence interval (-
18.4,15.3 milliseconds) appears to have a reasonable range of 33.8 
milliseconds however it also indicates almost equal proportions of values 
decreasing as well as increasing, resulting in a lower statistical significance 
(Table 14).  
2.5.3 Complex Focal Seizures. 
Frontal Lobe Seizures 
Frontal lobe seizures (n=58) produce highly statistical results (p<0.001) using 
Fridericia’s corrective formula for corrected Q-T change during this seizure 
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group as with all formulae (Table 14). The mean corrected Q-T during the 
seizures is 385 milliseconds, which is well within normal limits and is shorter 
to the mean corrected Q-T for this group using Bazett’s (411 milliseconds) 
and Hodge’s (397 milliseconds). The difference in mean corrected Q-T before 
the seizures and during the seizures is small at 14.8 milliseconds compared 
to other seizure groups. Fridericia’s formula calculates frontal lobe seizures 
as having the same level of statistical significance as Bazett’s and Hodge’s 
formulae. The 95% confidence interval is narrow at 10.1, 19.5 milliseconds 
with a difference of 9.4 milliseconds and therefore in order for this group of 
data to show highly statistical results most events would have to show 
consistent changes albeit small changes during the seizure to distinguish the 
results from chance. The other weighting factor is that this group has the 
largest set of data, which strengthens statistical significance if consistent 
changes are seen even if the amount of change is minimal. 
Temporal Lobe Seizures 
Temporal lobe seizures (n=27) as a group show high statistical significance 
(p<0.001) in corrected Q-T changes during seizures. When this group is sub-
divided into right temporal lobe seizures n=17 and left temporal lobe 
seizures n=10, the results are similar to Bazett’s formula results. Left 
temporal lobe seizure corrected Q-T changes become less statistically 
significant (p=0.008) compared to right temporal lobe seizures (p<0.001), 
(Table 14). 
The mean corrected Q-T difference in left temporal seizures is the largest in 
any seizure group according to Fridericia of 31.8 milliseconds but the lowest 
statistical significance for this group suggests that not all left temporal lobe 
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seizures measure an increase in corrected Q-T during seizures and an 
element of chance is considered. There are also fewer cases of left temporal 
lobe seizures (n=10) to use in the analysis compared to right temporal lobe 
seizures (n=17).  
The 95% confidence intervals using Fridericia’s formula for temporal lobe 
seizures (16.7, 36.9 milliseconds) has a larger difference of 20.2 milliseconds 
than frontal lobe seizures (10.1, 19.5 milliseconds) of 9.4 milliseconds. 
Interestingly, temporal lobe seizures have a smaller 95% confidence interval 
than sub-clinical seizures (7.7, 29.5 milliseconds) with a difference of 21.8 
milliseconds. 
2.5.4 Sub-clinical seizures. 
16 sub-clinical seizures were recorded and analysed (p=0.002), (6 derived 
from the right hemisphere and 10 derived from the left hemisphere), one 
right temporal sub-clinical seizures showed an increase beyond normal QTc 
limits defined by Luo et al (2004) when Fridericia’s formula is applied with 
no left temporal sub-clinical seizures identified (Table 13, Figure 9).  
A mean corrected Q-T of 444 milliseconds was calculated for the group using 
Fridericia’s formula, compared to Bazett’s formula (467 milliseconds) and 
Hodge’s formula (442 milliseconds).  The group shows a smaller standard 
deviation of 30.2 compared to temporal lobe seizures of 36.9 milliseconds but 
sub-clinical seizures show a slightly larger 95% confidence interval of 7.7, 
29.5 milliseconds with a difference of 21.8 milliseconds compared to 
temporal lobe seizures 16.7, 36.9 milliseconds with a difference of 20.2 
milliseconds. This analysis added to the group size difference of sub-clinical 
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seizures (n=16) and temporal lobe seizures (n=27) has lead to a slight 
reduction in statistical significance (p=0.002) for sub-clinical seizures 
compared to temporal lobe seizures (p<0.001). 
2.5.5 Right and Left Hemisphere Focal Seizure Comparison. 
Three right temporal lobe seizures (1 patient) and one right sub-clinical 
temporal lobe seizure were identified as prolonging the corrected Q-T 
beyond normal limits compared to one left temporal lobe seizure when 
Fridericia’s formula is applied. Right temporal lobe seizures show a slightly 
higher statistical significant corrected Q-T change during seizures (p<0.001) 
compared to left temporal lobe seizures (p=0.008). 
In contrast to results from Bazett’s and Hodge’s formulae, more left temporal 
lobe seizures increase the corrected Q-T exceeding 60 milliseconds when 
applying Fridericia’s corrective formula.. Three left temporal lobe seizures 
derived from two patients are identified by Fridericia’s formulae compared 
to one right sub-clinical temporal lobe seizure. 
2.5.6 Corrected Q-T prolongation exceeding 60 milliseconds 
Four seizures resulting in the corrected Q-T exceeding 60 milliseconds, 
according to Fridericia’s formula were derived from three patients (Table 15).  
The maximum increase in corrected Q-T during seizures was 74 milliseconds 
occurring during a left temporal lobe seizure and 84 milliseconds during a 
right sub-clinical temporal lobe seizure. However, none of the increases in 
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Table15. Summary of patients demonstrating an increase in corrected QT 
exceeding 60 milliseconds during a seizure according to Fridericia’s Formula 
 
2.5.7 Summary 
Four patients (10%) from the total of 39 patients in the study were identified 
as prolonging the corrected Q-T during 6 seizures (3%) by applying 
Fridericia’s formula. The 6 seizures were 1 sub-clinical right temporal lobe 
seizure, 1 generalised tonic clonic seizure, 1 left temporal lobe seizure and 3 
right temporal lobe seizures. The three right temporal lobe seizures were 
from one patient.   
Fridericia’s formula shows a statistically significant difference (p<0.001) 
between the corrected Q-T value prior to the seizure and during the seizure 
for the total group. Fridericia’s formula also agrees with Bazett’s and 
Hodge’s formulae in high statistical significance (p<0.001) during frontal lobe 
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seizures, temporal lobe seizures and right temporal lobe seizures. It disagrees 
with Bazett’s and Hodge’s formulae for generalised tonic clonic seizures of a 
high statistical significance (p=0.002) and instead calculates a lower statistical 
significance of p=0.07.  
Four seizures resulting in the corrected Q-T exceeding 60 milliseconds 
according to Fridericia’s formula were derived from three patients but all 
data remained within normal limits. Unlike Bazett’s and Hodge’s formulae, 
Fridericia identified more left temporal lobe seizures than right temporal 
lobe seizures increasing the corrected Q-T by more than 60 milliseconds. 
However, this formula does identify three right temporal lobe seizures 













Chapter 14: Results: According to Framingham’s Formula 
 
Introduction: The ‘Framingham Heart Study’ (Sagie et 
al 1992) is a large epidemiological study of 5,018 patients analysed to test this 
correction formula and because of the large cohort could additionally sub-
divide data for age and gender. Framingham’s formula QTc=QT+154(1-R-R). 
Although this formula was derived from a large amount of data, the study 
limitations were that fast heart rates were not tested. Framingham is a 
neighbourhood in Massachusetts whose population was targeted in 1948 
when the Framingham Heart Study was launched. This study is a landmark 
in history for linking high blood pressure and cholesterol levels with 
cardiovascular disease and revolutionised preventative medicine. The 
Framingham Heart Study continues today researching many cardiological 














































































































Framingham's QTc During Epileptic Seizures n=156
 
Figure 10 Boxplot of Framingham’s corrected Q-T values during grouped 
seizures. 
The subject gender mix was 25 males and 14 females (Table 2). The age range 
was 2 years 5 months to 60 years 3 months. The mean age was 17 years 2 
months with a median age 11 years 5 months. A total of 156 seizures had 
corrected Q-T analysis performed (370 seizures had to be excluded from the 
study due to EMG artefact obscuring the ECG trace) The 156 analysed 
seizures were composed of: generalised tonic-clonic seizures (9), absences 
(34), tonic seizures (12), temporal lobe seizures (27), frontal lobe seizures (58) 






From a total of 156 seizure events recorded and analysed, only 3 seizures 
were identified as demonstrating lengthening of the corrected Q-T during 
the seizure. The three identified seizures were  
 1 right sub-clinical temporal lobe seizure (paediatric). 
 1 left temporal lobe seizure   
 1 right temporal lobe seizure.  
This result represents 2% (3/156) of total seizures from 8% patients (3/39) 
identified as having lengthened the corrected Q-T beyond normal limits 
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Table 16 Summary of Framingham’s corrected Q-T values for patients during 





Figure 11 Bar chart of total patients & total seizures exceeding Framingham’s 
corrected Q-T normal limits (according to Luo et al 2004). 
Total Group Testing 
Paired t-testing using minitab version 14 was performed on the total seizure 
group (n=156) data according to Framingham’s formula and shows a 
statistically significant difference (p>0.001) between the corrected Q-T value 
prior to the seizure and during the seizure (Table 17). The mean corrected Q-
T value for the group is within normal limits of 398 milliseconds. A mean 
average of 29 (427-398) milliseconds shorter than that presented using 
Bazett’s formula, 11 (409-398) milliseconds shorter than Hodge’s formula and 
is very similar to Fridericia’s mean corrected Q-T for total group with very 
little difference of 1 (399-398) milliseconds. 
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Framingham’s corrective formula agrees with all other formulae that the 
total seizure group shows a high statistical significance of p<0.001. It also 
agrees that frontal lobe seizures and total temporal lobe seizures show a high 
statistical significance (p<0.001) and that absence seizures do not demonstrate 
high statistical significance (p=0.861). Framingham’s formula agrees with 
Bazett’s and Fridericia’s formulae that left temporal lobe seizures (p=0.009) 
are not as statistically significant as the temporal lobe seizure group (p<0.001) 
as a whole. During generalised tonic clonic seizures Framingham (p=0.284) 
and Fridericia’s (p=0.07) formulae do not reach the same degree of high 
statistical significance as that determined by Bazett’s (p=0.002) and Hodge’s 
(p=0.002) formulae. Tonic seizures show similar low statistical significance 
using Framingham’s (p=0.612) and Fridericia’s (p=0.846) formulae but 
disagree with Hodge’s formula (p=0.002) of more statistically significant 
results for this group. Interestingly, Bazett’s formula is more moderate in 
calculation of corrected Q-T change during tonic seizures (p=0.06). 
 
 















During 398.3 26.9  2.1   
Before 386.8 28.3  2.3   
Difference  11.4 20.2  1.6 8.2,14.6 <0.001 
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During 421.8 26.3  7.9   
Before 394.5 17.5  5.3   




During 380.0 16.8  4.7   
Before 383.8 21.8   6.0   





During 441.7 14.5   3.6   
Before 423.2 23.9   5.9   
Difference   18.5 19.4   4.9 8.14,28.9 =0.002 





2.6.2 Generalised seizures 
Generalised Tonic-Clonic Seizures. 
According to Framingham’s corrective formula, changes in corrected Q-T 
during generalised tonic-clonic seizures are not statistically significant 
(p=0.284). This contrasts with Bazett’s and Hodge’s formulae results for this 
group of high statistical significance (p=0.002). Fridericia’s result for this 
group (p=0.07) shows a statistical significance that comes somewhere in-
between results of Bazett’s or Hodges and those of Framingham’s formulae 
calculations. 
The mean corrected Q-T for this group is 375 milliseconds according to 
Framingham’s formula compared to 417 milliseconds according to Bazett’s 
formula, 422 milliseconds according to Hodge’s formula and 378 
milliseconds according to Fridericia’s formula. The discrepancy of high 
statistical significance from Bazett’s formula and Hodge’s formula compared 
to lower statistical significance from Fridericia’s formula and Framingham’s 
formula probably lies with the well recognised fact that Bazett’s and Hodge’s 
formulae tend to over-estimate corrected Q-T at fast heart rates that occur 
during tonic-clonic seizures and that Fridericia and Framingham’s formulae 
tend to under-estimate corrected Q-T at fast heart rates. The types of seizure 
groups most likely to be prone to these influencing factors are likely to be 
generalised tonic-clonic seizures and right temporal lobe seizures due to 
induced fast heart rates.  
Another factor in this interpretation is the 95% confidence interval (-12.3, 36.8 
milliseconds) with a difference of 49.1 milliseconds. This is the largest range 
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in confidence interval when using this formula however it also has the 
largest standard deviation of 31.9 milliseconds. The combination of these big 
changes with few seizures (n=9) brings in the probability of chance lowering 
the significance value. 
Absence Seizures. 
Framingham’s corrective formula agrees generally Bazett’s formula 
(p=0.329), Hodge’s formula (p=0.191) and Fridericia’s formula (p=0.856) that 
a lower statistical significance (p=0.861) in changes in corrected Q-T is 
calculated for absence seizures (n=34) and agrees very closely with 
Fridericia’s statistical results for this group of seizures. Framingham’s 95% 
confidence interval (-3.7, 3.1 milliseconds) is also similar to Fridericia’s 95% 
confidence interval (-3.6, 2.9 milliseconds) with very small ranges of 6.5 
milliseconds for Framingham’s formula results and 6.5 milliseconds for 
Fridericia’s formula. 
Mean corrected Q-T from Framingham’s formula is 391 milliseconds and is 
shorter than the mean for the total group of seizures (399 milliseconds). 
Fridericia has the same mean average during absence seizures of 391 
milliseconds compared to Hodges (399 milliseconds) and Bazett’s (414 
milliseconds). 
Tonic Seizures. 
According to Framingham’s formula tonic seizures do not show statistical 
significance (p=0.612). Similarly Fridericia has a low significance of p=0.846. 
Borderline significance is seen using Bazett’s formula (p=0.06) during tonic 
seizures. Surprisingly Hodge’s formula does show a high statistical 
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significance for this group of p=0.002. Framingham’s formula 95% confidence 
interval results span zero (-19.9, 12.2) milliseconds. This compares to the 95% 
confidence interval of Hodge for this group (10.3, 36.2 milliseconds).  
The mean corrected Q-T using Framingham’s formula results during tonic 
seizures is 380 milliseconds which is much shorter than that seen using 
Bazett’s  (429 milliseconds), Hodge’s (411 milliseconds) but similar to  
Fridericia’s (383 milliseconds). 
2.6.3 Complex Focal Seizures. 
Frontal Lobe Seizures. 
High statistical significance (p<0.001) is calculated in corrected Q-T changes 
during frontal lobe seizures (n=58) using Framingham’s corrective formula 
(Table 15). The 95% confidence interval becomes increasingly narrower from 
Bazett’s formula (27.1, 36.4 milliseconds), Hodge’s formula (21.5, 29.7 
milliseconds), Fridericia’s formula (10.1, 19.5 milliseconds) and 
Framingham’s formula (11.6, 20.5 milliseconds). Despite a shortening range, 
high statistical significance remains for frontal lobe seizures from all 
corrective formulae. This low probability of chance suggests that even 
though the measurements are small, consistent increases in corrected Q-T 
occur during frontal lobe seizures.  
The mean corrected Q-T during frontal lobe seizures from Framingham’s 
data is 386 milliseconds. This is almost identical to that seen using 
Fridericia’s formula of 385 milliseconds. Hodge’s mean value is longer at 397 
milliseconds but Bazett’s is the longest at 411 milliseconds. 
Section Two 
 248 
Statistical significance however does not necessarily equate to clinical 
significance and although all formulae agree a high significance (p<0.001) in 
corrected Q-T change during frontal lobe seizures- no frontal lobe seizures 
demonstrated corrected Q-T prolongation during seizures in this group of 
patients. 
Temporal lobe seizures 
Framingham’s formula agrees with all other corrective formulae that 
temporal lobe seizures (n=27) have a high statistical significant change in 
corrected Q-T during seizures (p<0.001). However, when this group is sub-
divided into right temporal lobe seizures (n=17) and left temporal lobe 
seizures (n=10), both groups lose some statistical significance of p=0.002 and 
p=0.009 respectively. Framingham’s formula is the only formula which does 
not attach a value of p<0.001 to right temporal lobe seizures, although p=0.002 
is still highly statistically significant (Table 17). 
Framingham’s mean corrected Q-T (422 milliseconds) for temporal lobe 
seizures is the second longest compared to other seizure groups. All other 
formulae give longer mean values with Bazett’s (462 miliseconds), Hodge’s 
(432 milliseconds) and Fridericia’s (429 milliseconds). 
95% confidence intervals are greatest for temporal lobe seizures according to 
Framingham’s formula (10.3, 26.7 milliseconds) with a difference of 16.4 
milliseconds. Left temporal lobe seizures give the largest 95% confidence 
interval of 8.5, 46.1 milliseconds with a difference of 37.6 milliseconds which 
is much wider than that seen from right temporal lobe seizures (5.9, 19.8 
milliseconds) with a difference of 13.9 milliseconds. This may reflect that 
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Framingham’s formula tends to under-correct at fast heart rates and over-
corrects at slow heart rates. Right temporal lobe seizures generally tend to 
lead to increased fast heart rates compared to left temporal lobe seizures. 
2.6.4 Sub-clinical seizures. 
16 sub-clinical seizures recorded and analysed (p=0.002), (6 derived from the 
right hemisphere and 10 derived from the left hemisphere), one right 
temporal sub-clinical seizures showed an increase beyond normal QTc limits 
defined by Luo et al (2004) when Framingham’s formula is applied with no 
left temporal sub-clinical seizures identified (Figure 11, Table 16).  
High statistical significance is agreed by all corrective formulae for sub-
clinical seizures with Bazett’s (p<0.001), Hodge’s (p=0.006), Fridericia’s 
(p=0.002) and Framingham’s (p=0.002).  
Mean Q-T values for sub-clinical seizures when calculating from data 
derived from Framingham’s formula give the longest values compared to 
any seizure group of 441 milliseconds compared to generalised tonic clonic 
seizures (375 milliseconds), temporal lobe seizures (426 milliseconds), frontal 
lobe seizures (386 milliseconds) and tonic seizures (380 milliseconds). 
It is interesting that sub-clinical seizures demonstrate the longest mean value 
compared to other seizure types in that there is no physical exertion 





2.6.5 Right and Left Hemisphere Focal Seizure Comparison. 
One right temporal lobe seizure and one right sub-clinical temporal lobe 
seizure were identified as prolonging the corrected Q-T according to Luo et 
al (2004) during seizures when Framingham’s formula was applied, 
compared to one left temporal lobe seizure. 
One right temporal lobe seizure and one left temporal lobe seizure are 
identified as increasing the corrected Q-T beyond 60 milliseconds (Table 18). 
2.6.6 Corrected Q-T prolongation exceeding 60 milliseconds 
Three seizures comprising 1 generalised tonic-clonic seizure, 1 left temporal 
lobe seizure and 1 right sub-clinical temporal lobe seizure, derived from 
three patients were identified as increasing the corrected Q-T by more than 
60 milliseconds according to Framingham’s formula but all remained within 
normal limits. The maximum increase of 82 milliseconds in corrected Q-T 
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Table18. Summary of patients demonstrating an increase in corrected QT 
exceeding 60 milliseconds during a seizure according to Framingham’s 
Formula 
2.6.7 Summary 
Three seizures (2% total seizures) derived from three patients (8% total 
patients) were identified as prolonging the corrected Q-T according to Luo et 
al (2004) when Framingham’s formula is applied to all data. The three 
seizures were 1 right sub-clinical temporal lobe seizure, 1 left temporal lobe 
seizure and 1 right temporal lobe seizure. Framingham’s formula and shows 
a statistically significant difference (p<0.001) between the corrected Q-T value 
prior to the seizure and during the seizure for the total group. Frontal lobe 
seizures and total temporal lobe seizures show a high statistical significance 
(p<0.001).When the temporal lobe group is sub-divided into right temporal 
lobe seizures (n=17) and left temporal lobe seizures (n=10), both groups lose 
some statistical significance of p=0.002 and p=0.009 respectively. 
Framingham’s formula is the only formula which does not attach a value of 
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p<0.001 to right temporal lobe seizures, although p=0.002 is still highly 
statistically significant but is only slightly lower. 
According to Framingham (p=0.284) and Fridericia’s (p=0.07) formulae, 
generalised tonic-clonic seizures do not reach the same degree of high 
statistical significance as that determined by Bazett’s (p=0.002) and Hodge’s 
(p=0.002) formulae.  
Three seizures (1 generalised tonic clonic seizure, 1 left temporal lobe seizure 
and 1 right sub-clinical temporal lobe seizure) from three patients were 
identified as increasing the corrected Q-T by more than 60 milliseconds 













2.7.1 Inter and Intra-observer Analyses 
The inter and intra-observer analysis shows a maximum difference of 0.01 
seconds which represents 0.02% of possible error in measuring 0.425 seconds. 
The numerical values of the cursors with a 500Hz sampling rate changes 
with increments of 0.005 seconds, which gives an error margin of 1 increment 
for inter observer analysis. When considering factors of observer judgement 
and precision of actually placing the cursors, the error margin is very small. 
This result is comparable to those accepted within guidelines agreed in drug 
trial regulations of inter and intra-observer variability of +/- 10 msec. (Pater 
2005). 
2.7.2 Kappa  
The Kappa statistic was used to check the “precision” between two 
independent observers in the measurement of the corrected Q-T. The data 
measurements were compared to assess the level of agreement of prolonged 
Q-T results with normal Q-T results and the “expected agreement” because 
of the chance measurement agreement.  “Accuracy” analysis for this type of 
data is not possible as there is not a “correct value” to compare the measured 
values to. 
The Kappa calculation is based on the difference between how much 
agreement is actually present i.e the “observed agreement” compared to how 




Table 19 Number of observed agreement of normal QTc and prolonged QTc 
from two independent reviewers. 
(a) Calculation of Observed Agreement. 
Percentage of all agreement / total observations = 15+4 / 21=19/21=0.90 (90%) 
(b) Difference of the observed agreement from the expected agreement  
P e =    (16/21) x (16/21) + (5/21) x (5/21) 
     =     0.579 + 0.056 
     =     0.635 
(c) Kappa statistic 
(Observed agreement minus expected agreement) / (1-expected agreement) 
= (0.9 – 0.635) /  (1-0.635) 
= 0.265 / 0.365 
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A Kappa statistic of 0.726 constitutes a substantial agreement between the 
two observers even with the expected chance measurements.  Perfect 
agreement of Kappa is “1” and chance agreement is “0” (Viera & Garrett 
2005). 
Chapter 16 Comparison of results according to Bazett’s, Hodge’s, 
Fridericia’s and Framingham’s Formulae. 
2.8.1 Total Seizure Group. 
The subject gender mix was 25 males and 14 females (Table 2). The age range 
was 2 years 5 months to 60 years 3 months. The mean age was 17 years 2 
months with a median age 11 years 5 months. A total of 156 seizures had 
corrected Q-T analysis performed (370 seizures had to be excluded from the 
study due to EMG artefact obscuring the ECG trace) The 156 analysed 
seizures were composed of: generalised tonic-clonic seizures (9), absences 
(34), tonic seizures (12), temporal lobe seizures (27), frontal lobe seizures (58) 
and 16 sub-clinical seizure events were clinically and electrographically 
identified.  
All formulae agreed a statistically significant increase in the corrected Q-T for 
the total group (p<0.001) when comparing values prior to the seizure with 




























































































Total QTc Before & During Seizures n=156
 
Figure 12 Box plot of corrected Q-T data derived from total seizures before 
and during seizure events calculated by Bazett’s, Hodge’s, Fridericia’s and 
Framingham’s formulae.  
Figure 13 Total seizures and patients with corrected QT exceeding normal 
limits (Luo et al 2004) derived from Bazett’s, Hodge’s, Fridericia’s & 
Framingham’s applied Formulae.  
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Figure 13 shows a wide range of results seen using the same data for each 
formula. Bazett’s identified 9 patients with prolonged Q-T occurring in 21 
seizures, Hodge’s identified 4 patients with prolonged corrected Q-T 
occurring in 7 seizures, Fridericia identified 4 patients with prolonged 
corrected Q-T occurring 6 seizures and Framingham identified 3 patients 
with prolonged corrected Q-T occurring in 3 seizures.  
2.8.2 Formulae Identified Corrected Q-T Prolongation Seizure 
types and Patients  
A general shortening trend in the mean corrected Q-T is seen for each 
formula when comparing the before and during seizure corrected Q-T 
values. Bazett’s formula shows a difference for the grouped data at 27.7 
milliseconds, Hodge’s formula gives a difference of 21.5 milliseconds, 
Fridericia’s formula then gives a difference for the group of 13.0 milliseconds 
and Framingham’s give a difference for the grouped data at 11.4 
milliseconds. 
Bazett’s 95% confidence interval is the largest with 95% of data measuring 
between 22.6, 32.8 milliseconds (difference of 10.2 milliseconds) compared to 
a fairly similar but shorter data window using Hodge’s formula of 17.7, 25.4 
milliseconds (difference of 7.7 milliseconds). Both Fridericia and 
Framingham’s formula appear similar and squeeze data into narrower data 
windows with Fridericia’s 95% confidence interval being 9.6, 16.4 
milliseconds (difference of 6.8 milliseconds) and Framingham’s 95% 




Bazett’s formula identified 21 seizures as prolonging the corrected Q-T. Of 
these 21 seizures there were 5 right sub-clinical temporal lobe seizures, 1 left 
sub-clinical temporal lobe seizure, 11 right temporal lobe seizures, 2 left 
temporal lobe seizures, 1 generalised tonic-clonic seizure and one myoclonic 
absence. 
Hodge’s formula identified 7 seizures prolonging the corrected Q-T beyond 
normal values, which were 3 right sub-clinical seizures, 1 right temporal lobe 
seizure, 1 generalised tonic-clonic seizure and 2 tonic seizures. 
Fridericia’s corrective formula identified 6 seizures resulting in a prolonged 
corrected Q-T of which there were 1 right sub-clinical seizure, 3 right 
temporal lobe seizures, 1 left temporal lobe seizure and 1 generalised tonic-
clonic seizure. 
Framingham’s formula identified only 3 seizures that prolonged the 
corrected Q-T beyond normal limits of which there were 1 right sub-clinical 
temporal lobe seizure, 1 right temporal lobe seizure and 1 left temporal lobe 
seizure. 
The only two seizure types consistently identified by all corrective formulae 
were right sub-clinical temporal lobe seizures and right temporal lobe 
seizures. Of the right sub-clinical temporal lobe seizures, Bazett’s identified 5 
of these sub-clinical seizures, Hodge’s formula identified 3 seizures but 
Fridericia and Framingham equally only identified 1 sub-clinical seizure. Of 
the right temporal seizures identified as prolonging the corrected Q-T 
beyond normal limits, Bazett’s identified 11 of these seizures, Hodge’s 
formula identified 1 seizure, Fridericia’s formula identified 3 of these 
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temporal lobe seizures and Framingham’s formula identified only 1 right 
temporal lobe seizure. 
Bazett’s, Fridericia’s and Framingham’s formulae agreed that a left temporal 
lobe seizure prolonged the corrected Q-T beyond normal limits but Hodge’s 
formula did not identify this seizure as prolonged. Three formulae identified 
a generalised tonic-clonic seizure as prolonging the corrected Q-T beyond 
normal limits but Framingham’s formula did not identify this seizure. Only 
Hodge’s corrective formula identified 2 tonic seizures as prolonging the 
corrected Q-T but this was not agreed with Bazett’s, Fridericia’s or 
Framingham’s formula results. Bazett’s formula identified 1 left sub-clinical 
temporal lobe seizure and 1 myoclonic absence but was not agreed by 
Hodge’s, Fridericia’s and Framingham’s formulae. 
There were only two patients who were identified by all four corrective 
formulae as having prolongation of the corrected Q-T during epileptic 
seizures. The corrected Q-T prolongation occurred as the seizure progressed 
and as the heart rate changed each formulae demonstrated prolongation 
during different epochs within the same seizure The first patient (9M) was a 
2 years old male during a right sub-clinical seizure with prolonged QTc  
(Bazett’s 492 milliseconds (heart rate 119.5/min), Hodge’s 475 milliseconds 
(heart rate 127.3/min), Fridericia’s 454 milliseconds (heart rate 92.8/min) and 
Framingham’s 451 milliseconds (heart rate 88.8/min). The second patient 
(20M) was a 21 years old male during a right temporal lobe seizure with 
prolonged QTc (Bazett’s 495 milliseconds (heart rate 66.7/min), Hodge’s 479 
milliseconds (heart rate 66.7/min), Fridericia’s 463 milliseconds (heart rate 
65.9/min) and Framingham’s 462 milliseconds (heart rate 65.9/min). 
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Patient 20M had right temporal lobe seizures. Patient 9M proved to have 
drug resistant focal seizures and sub-clinical seizures. He later underwent 
neurosurgery in the attempt to control his intractable seizures and had an 
antero-temporal lobectomy. Since the surgery he has become seizure free and 
doing well. Patient 20M still has seizures although he is having fewer 
seizures than at the time of this study controlled therapeutically by anti-
epileptic medication. 
 
Comparison of Formulae Results QTc increasing by more than 60 
milliseconds. 
 
Figure 14   Total seizures and patients with corrected QT increasing >60 
milliseconds derived from Bazett’s, Hodge’s, Fridericia’s & Framingham’s 
applied Formulae   
 
Bazett’s formula identified 19 seizures (8 patients) that increased the 
corrected Q-T by more than 60 milliseconds. 
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 2 right temporal sub-clinical seizures (1 paediatric patient). 
 10 right temporal lobe seizures (3 patients). 
 4 left temporal lobe seizures (2 patients). 
 3 Generalised tonic-clonic seizures (1 adult, 1 paediatric patient). 
Hodge’s formula identified 5 seizures (5 patients) that increased the 
corrected Q-T by more than 60 milliseconds. 
 1 right temporal sub-clinical seizures (paediatric patient). 
 1 left temporal lobe seizure. 
 3 generalised tonic-clonic seizures (1 paediatric patient, 2 adult 
patients). 
Fridericia’s formula identified 4 seizures (3 patients) that increased the 
corrected Q-T by more than 60 milliseconds. 
 1 right temporal sub-clinical seizures (paediatric patient). 
 3 left temporal lobe seizures (2 patients). 
Framingham’s formula identified 3 seizures (3 patients) that increased the 
corrected Q-T by more than 60 milliseconds. 
 1 right temporal sub-clinical seizures (paediatric patient). 
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 1 left temporal lobe seizure. 
 1 generalised tonic-clonic seizure. 
All formula identified and agreed that 1 right temporal sub-clinical seizure 
and left temporal lobe seizure increased the corrected Q-T by more than 60 
milliseconds. Three formulae identified a generalised tonic-clonic seizure 
that increased the corrected Q-T beyond 60 milliseconds but Fridericia did 
not agree. 
Comparison of Results for Paediatric Patients, Exceeding Normal Values 
according to all Corrective Formulae. 
 
Figure 15 Total Paediatric seizures and patients with corrected QT exceeding 
normal limits according to Benetar et al, 2001 derived from Bazett’s, Hodge’s, 




Bazett’s formula identified 8 seizures (4 paediatric patients) that lengthened 
the corrected Q-T beyond normal limits with QTc values up to 493 
milliseconds. 
 5 right temporal sub-clinical seizures (1 patient). 
 1 left temporal lobe seizure  
 1 generalised tonic-clonic seizure. 
 1 myoclonic absence 
Hodge’s formula identified 6 seizures (3 paediatric patients) that lengthened 
the corrected Q-T beyond normal limits with QTc values up to 471 
milliseconds. 
 3 right temporal sub-clinical seizures (1 patient). 
 1 generalised tonic-clonic seizure. 
 2 tonic seizures (1 patient). 
Fridericia’s formula identified 2 seizures (2 paediatric patients) that 
lengthened the corrected Q-T beyond normal limits with QTc values up to 
464 milliseconds. 
 1 right temporal sub-clinical seizure. 
 1 generalised tonic-clonic seizure. 
Framingham’s formula identified 1 seizure (1 paediatric patient) that 
lengthened the corrected Q-T beyond normal limits with QTc value up to 451 
milliseconds. 
 1 right temporal sub-clinical seizure. 
All formulae agreed to the identification of 1 paediatric patient who had a 
right temporal sub-clinical seizure as lengthening the corrected Q-T beyond 
normal values. All formulae except Framingham’s identified a paediatric 
patient having a generalised tonic-clonic seizure who lengthened the 
corrected Q-T beyond normal limits. 
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2.8.3 Characteristic Similarities and Differences in the Corrective 
Formulae Results. 
Similarities of QTc results are found using Bazett’s and Hodge’s corrective 
formulae and also with Fridericia and Framingham’s formulae. If we 
examine a scatterplot of total QTc data used for each formula there is a 
general emphasis of ‘shortened’ QTc to the left of the graph of data points 
belonging to Fridericia’s and Framingham’s corrective formula results in 
contrast to ‘lengthened’ QTc to the right of the graph of data points 




























Figure 16   Scatterplot of corrected QT data and heart rate according to 





This similarity of formulae results is clarified further by separating data for 
each formula in adjacent scatterplots demonstrated in Figure 17. The 
distribution of Bazett’s QTc data shows a similar pattern to that seen using 
Hodge’s formula. The distribution of QTc data of Fridericia’s formula 
appears to have a similar distribution as Framingham’s data. Identical 























Bazetts QTc During Hodges QTc During
Fridericia QTc During Framingham QTc During
 
Figure 17 Scatterplots of QTc data calculated by Bazett’s, Hodge’s, 
Fridericia’s and Framingham’s corrective formulae. 
Bazett’s formula has been the most commonly used corrected formula for 
over 80 years and continues to be the formula used in clinical practice. Most 
cardiology equipment calculates the QTc using Bazett’s formula in adult and 
paediatric services. Unfortunately, although Bazett’s formula is the most 
commonly used corrective formula it is also the most criticised. This is 
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because Bazett’s formula over-corrects and therefore over-estimates QTc at 
fast heart rates resulting in a tendency towards falsely prolonged corrected 
Q-T values and under-corrects and under-estimates QTc at slow heart rates 
resulting in a tendency towards falsely shortened corrected Q-T values (Sagie 






















Figure 18    Scatterplot of corrected Q-T data according to Bazett’s formula. 
On further examination of the corrected Q-T data using Bazett’s formula, the 
mean lies offset above the zero Figure 18. This indicates the tendency for 
Bazett’s formula to over-emphasize the QTc values and lead to falsely 




2.8.4 Sensitivity and Specificity of Hodge’s, Fridericia’s and 
Framingham’s formulae in comparison to Bazett’s Formula 
Cross tabulation was performed using Minitab ‘version 14’ to calculate the 
sensitivity and specificity of Hodges (Hodges 1997, 1983), Fridericia 
(Fridericia 1920) and Framingham’s formulae (Sagie et al 1992) with Bazett’s 
formula (Bazett 1920) used as the gold standard (Yu et al 1950). All formulae 
gave good specificity values with Framingham’s giving the highest 
specificity of 100% of correlation with Bazett’s formula in identifying normal 
values (Table 22) with Hodge’s specificity slightly lower at 98.5% (Table 20). 
Sensitivity of identifying positive events in agreement with Bazett’s formula 
was poor from all comparative formulae with Hodge’s (Table 20) and 
Fridericia’s formula at 35.7% (Table 21) and Framingham’s 21% (Table 22).  
Cross Tabulation for sensitivity & specificity  
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Table 21 Sensitivity & Specificity of Fridericia’s Formula compared to Bazett’s 
Formula 
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Specificity= proportion 
of –ve correctly 
identified QTc:- 
Specificity=142/142 
                 = 100% 
 
Table 22 Sensitivity & Specificity of Framingham’s Formula compared to 
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The results of identified cases of lengthening of the corrected Q-T are 
dependent on which formula is used. Data derived from Bazett’s Formula is 
significantly different (p<0.001) from all comparative formula data   
2.8.5 Summary 
The results of identified cases of lengthening of the corrected Q-T are 
dependent on which formula is used. Bazett’s formula identified a total of 21 
seizures (9 patients), Hodge’s formula identified 7 seizures (4 patients), 
Fridericia identified 6 seizures (4 patients) and Framingham’s formula 
identified 3 seizures (3 patients). However, all formulae agreed on the 
identification of two patients as having a prolonged corrected Q-T during 
their seizures. The seizure types of these patients were a right sub-clinical 
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      p<0.001 
Heart Rate (HR) 
Max. QTc msec 
 
     110 (HR) 
     512 (M) 
      66.7(HR) 
      479 (F) 
       103.2(HR) 
       464 (F) 
     65.9(HR)        










































      p=0.002 
Heart Rate 
Max. QTc msec 
 
    120(HR) 
    493 (P) 
127.3(HR) 
  475 (P) 
92.8(HR) 
         454 (P) 
88.8(HR) 











































      p<0.001 
Heart Rate 
Max. QTc msec 
     117.9(HR) 
     462 (M) 
      117.9(HR) 
      437 (M) 
      117.9(HR) 
      423 (M) 
      117.9(HR) 
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     p=0.284 
Heart Rate 
Max.QTc msec 
     148.1(HR) 
     490 (P) 
       148.1(HR) 
       466 (P) 
       131.8(HR) 
         464 (P) 
       131.8(HR) 












































     p=0.612 
Heart Rate 
Max. QTc msec 
     124.2(HR) 
     465 (M) 
      124.2(HR) 
      463 (M) 
     121.9(HR) 
      421 (M) 
     121.9(HR) 
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CI (-3.5, 2.9) 






Max. QTc msec 
     117.6(HR) 
     462 (P) 
     117.6(HR) 
      432 (P) 
        90.1(HR) 
       434 (F) 
         90.1(HR) 






















(P)=Paediatric. (M)=Male. (F)=Female. HR=Heart Rate. CI=95% Confidence 
Interval. 
 
Table 23 Summary of QTc Results During Epileptic Seizures according to 





































Table 24   Corrected Q-T values for Patients 9M and 20M according to all 
Corrective formulae demonstrating QTc lengthening. 
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Chapter 17: Linear Regression Plots 
Introduction 
An alternative method for calculating Q-T interval rate correction that is less 
directly influenced by heart rate is described by Davey (1999). He obtained 
QT intervals from subjects at rest and during exercise. A Q-T / heart rate plot 
was created with each point on the graph representing the mean of eight 
measurements of the Q-T interval at that heart rate. A linear regression curve 
was then fitted to the rest and exercise Q-T intervals and the curve 
extrapolated back to obtain values of the Q-T interval at 60/min. 
This method of calculating the Q-T interval for the standard heart rate of 
60/min was tested on data derived from the two subjects whom all formulae 
agreed an increase in corrected Q-T in this study. A similar method was used 
in this analysis as Davey except that the mean of nine measurements of the 
Q-T interval is used for each data point instead of eight measurements. 
Minitab version 14 was used to create the scatterplot with linear regression 


























Scatterplot of QT Interval vs Heart Rate Patient 20 Total Events
 
Figure 19 Scatterplot of QT Interval vs Heart Rate with Linear Regression 
Curve for Total Data during Right Temporal Lobe Seizures. 
 
 
Regression Analysis: QT Interval versus Heart Rate  
 
The regression equation is 
 
QT Interval = 529 - 1.74 Heart Rate 
QT Interval = 529 – 1.74 x 60 
                   = 529 – 104.4 
                   = 424.6 milliseconds 
R-Sq = 83.8% 
Table 25 Calculation of Q-T Interval for Linear Regression Curve during Total 
Right Temporal Lobe Seizures 
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The total QT and heart rate data was plotted with a linear regression curve 
fitted for total right temporal lobe seizures derived from patient 20 (Figure 
19). Minitab version 14 shows a ‘best fit’ linear regression line through the 
data points and gives a Q-T value of 424.6 milliseconds at a heart rate of 
60/min. A high square root value (R-Sq) of 83.8% indicates a high correlation 
of Q-T ‘fit’ with heart rate. The Q-T value derived using this method is 
normal at 424.6 milliseconds (Table 25). However, visual inspection of the 
linear regression line shows that the line is weighted evenly at fast heart rates 
but is not weighted evenly at slower heart rates with the majority of points 



















Scatterplot of QT Interval vs Heart Rate Pt 20 Event 1
 
Figure 20 Scatterplot of QT Interval vs Heart Rate with Linear Regression 





Regression Analysis: QT Interval versus Heart 
Rate  
The regression equation is 
QT Interval = 528 - 1.25 Heart Rate 
QT Interval = 528 – 1.25 x 60 
                   = 528 – 75 
                   = 453 milliseconds 
R-Sq = 34.2% 
 
Table 26 Calculation of Q-T Interval for Linear Regression Curve during Right 
Temporal Lobe Seizure 
The QT and heart rate data was plotted with a linear regression curve fitted 
for a single right temporal lobe seizure derived from patient 20 (Figure 20). 
The linear regression line through the data points calculated a Q-T value of 
453 milliseconds at a heart rate of 60/min. A low square root value (R-Sq) of 
34.2% indicates a poor correlation of Q-T ‘fit’ with heart rate (Table 26). This 
poor correlation may be a product of fewer data points or it may indicate that 
the Q-T values are not closely associated with heart rate and there is some 
other factor involved. The Q-T value derived when analysing a single seizure 
gives different results of a prolonged Q-T (453 milliseconds) compared to Q-

























Scatterplot of QT Interval vs Heart Rate Patient 9 Total
 
Figure 21 Scatterplot of QT Interval vs Heart Rate with Linear Regression 














Table 27 Calculation of Q-T Interval for Linear Regression Curve during Total 
Right Sub-clinical Temporal Lobe Seizures 
 
 
Regression Analysis: QT Interval versus Heart Rate  
 
The regression equation is 
QT Interval = 414 - 0.650 Heart Rate 
QT Interval = 414 – 0.650 x 60 
                   = 414 – 39 
                   = 375 msec. 
R-Sq = 17.2% 
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The total QT and heart rate data was plotted with a linear regression curve 
fitted for total right temporal lobe sub clinical seizures derived from patient 9 
(Figure 21). Minitab version 14 shows a ‘best fit’ linear regression line 
through the data points and gives a Q-T value of 375 milliseconds at a heart 
rate of 60/min. A high square root value (R-Sq) of 17.2% indicates a poor 
correlation of Q-T ‘fit’ with heart rate (Table 27). The Q-T value derived 
using this method is normal at 375 milliseconds. Patient 9 is a male aged 3 
years and it could be argued that his resting heart rate is not likely to be 
60/min. There is only one data point on the scatter plot at 60/min, which has 
been fundamental in the calculation for placing the linear regression line. If 
that one point did not exist, then the regression line could easily take a 
different position especially if the two points at around 140/min were not 
included. The wide distribution of points for any given heart rate in this 























Scatterplot of QT Interval vs Heart Rate Patient 9 Event 4
 
Figure 22 Scatterplot of QT Interval vs Heart Rate with Linear Regression 
Curve during a Right Temporal Lobe Sub-Clinical Seizure. 
 
 
Regression Analysis: QT Interval versus Heart 
Rate  
 
The regression equation is 
QT Interval = 487 - 1.30 Heart Rate 
QT Interval = 487 – 1.30 x 60 
                   = 487 – 78 
                   = 409 
R-Sq=35.3% 
 
Table 28 Calculation of Q-T Interval for Linear Regression Curve during a 




The QT and heart rate data was plotted with a linear regression curve fitted 
for a single right temporal lobe sub-clinical seizure derived from patient 9 
(Figure 22). The linear regression line through the data points calculated a Q-
T value of 409 milliseconds at a heart rate of 60/min. A low square root value 
(R-Sq) of 35.3% indicates a poor correlation of Q-T ‘fit’ with heart rate (Table 
28). This poor correlation may be a product of fewer data points or it may 
indicate that the Q-T values are not closely associated with heart rate and 
there is some other factor involved. The Q-T value derived when analysing a 
single sub clinical seizure gives longer Q-T results (409 milliseconds) 
compared to Q-T results when analysed in a larger group (375 milliseconds).  
2.9.3 Limitations 
Scatter plots with few data points when analysing individual seizures and 
applying linear regression techniques are perhaps inappropriate as each 
point can dramatically change the course of the ‘best fit’ line. Conversely, 
lengthening of the corrected Q-T is sometimes not recognised if the data is 
















Chapter 18  
 
Multivariate Analysis on Corrected Q-T and Anti-Epileptic Drugs in 
Relation to Age, Gender & Seizure Duration. 
 
2.10.1 Results for Total Patients  
Thirty-nine patients (25 males and 14 females), (Table 2) with an age range of 
2 years 5 months to 60 years 3 months (mean age 17 years, 2 months) had a 
total of 156 epileptic seizures. Of the 156 seizures, there were 9 generalised 
tonic clonic seizures (5 patients), 34 absences (6 patients), 12 tonic seizures (6 
patients), 27 temporal lobe seizures (14 patients), 58 frontal lobe seizures (4 
patients) and 16 sub-clinical seizures (4 patients). Ten anti-epileptic drugs 
(AEDs) were included in this analysis; carbamazepine (7 patients), 
lamotrigine (8 patients), sodium valproate (14 patients), Phenytoin (3 
patients), clobazam (5 patients), topiramate (6 patients), vigabatrin (1 
patient), levetiracetam 3 patients), Nitrazepam (2 patients) and 
Phenobarbitone (3 patients). Nine patients in the QTc analysis were not being 
treated on any AEDs, 13 patients had montherapy treatment and 17 patients 
had polytherapy. Descriptive statistics of mean QTc (Table 29) demonstrate a 
normal range of mean QTc values for all patients regardless of anti-epileptic 




































Vigabatrin 1 471 28.9 4.63 353 475 511 
Nitrazepam 2 380 27.1 4.34 330 380 430 
Phenobarbitone 3 412 27.6 3.11 370 400 481 
Levetiracetam 3 392 34.3 2.43 260 390 494 
Topiramate 6 432 31.1 1.73 350 487 528 
Carbamazepine 7 430 39.4 1.77 420 433 512 
Clobazam 5 402 34.9 1.93 310 399 528 
Phenytoin 3 382 23.1 2.51 330 390 440 
Sodium 
Valproate 
14 398 35.4 1.25 310 400 535 
Lamotrigine 8 410 50.3 2.47 330 400 511 
 
Table 29 Descriptive statistics of QTc for patients on anti-epileptic drugs 
Analysis of QTc and AEDs 
In this study group of patients, one patient receiving Vigabatrin 
demonstrated the longest mean QTc of 471 msec (still within normal limits 
for all heart rate according to Bazett’s formula). However, patients treated on 
Sodium Valproate have the maximum QTc of 535 msec as monotherapy 
treatment and this is prolonged. Prolonged maximum QTc values are also 
present in patients receiving Vigabatrin, Levetiracetam, Topiramate, 
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Carbamazepine, Clobazam and Lamotrigine. However, patients receiving no 
anti-epileptic medication, although they have a normal mean QTc also 
demonstrate prolonged maximum QTc of 510 msec. This is slightly shorter 
compared to those patients on monotherapy of 535 msec and polytherapy of 
528 msec. Pooled standard deviation for the group is 38.06 msec. The patients 
exhibiting the smallest standard deviation were being treated with Phenytoin 
(23.1 msec), Nitrazepam (27.1 msec), Phenobarbitone (27.6 msec) and 
Vigabatrin (28.9 msec). However, the number of QTc observations is smaller 
in these groups and the small standard deviation may simply be the result of 


































































95% CI for the Mean
Nil AED, Monotherapy, Polytherapy Baseline & Seiizure Mean QTc (n=39 pts)
 
Figure 23 Mean Baseline and Seizure QTc for patients with nil, monotherapy 




One way Analysis of Variation (ANOVA), (Table 30) demonstrates that mean 
QTc increases the most from baseline QTc in patients who are not on any 
AEDs during the seizure (441 msec), (n=9)) compared to those patients on 
monotherapy (424 msec), (n=13) or polytherapy (412 msec), (n=17) 












9 399.0 27.0 441.8 44.9 
Monotherapy 13 417.8 40.9 424.2 41.9 




















14(F) 420.8 38.4 432.8 37.6 
25(M) 405.5 29.6 417.9 44.9 
Gender 
Nil AED 
5 (F) 403.8 9.39 447.8 21.5 
4 (M) 393.0 41.7 434.2 68.1 
Gender  
Monotherapy 
5(F) 438.4 46.1 420.2 44.5 
8(M) 405.0 34.2 426.8 43.2 
Gender 
Polytherapy 
4(F) 420.0 49.3 429.8 47.1 































Table 30 ANOVA for QTc in patients with Nil, Monotherapy and Polytherapy 
Anti-Epileptic Drugs in relation to Age, Gender and Seizure Duration. 
2.10.2  Monotherapy and Polytherapy and QTc  
Anti-Epileptic Drug (AED) effect on QTc in relation to age shows that young 
adults (aged 21 years) have longer mean QTc (505 msec) compared to 
children and older adults for those patients receiving monotherapy. 
However, mean QTc increases in young children from 354 msec 
monotherapy and to 400 msec in patients receiving polytherapy AEDs. 
2.10.3 Anti-Epileptic Drug Effect on QTc in relation to Seizure 
Duration. 
ANOVA of QTc and seizure duration show that patients who are not on any 
AEDs have a shorter baseline QTc (420 msec), (n=9) than those patients on 
monotherapy (502 msec), (n=13) and polytherapy (480 msec), (n=17). For 
patients not on any AEDs, the longest mean QTc occurs at 490msec with 
seizure duration of 45 seconds. This compares to a longer QTc of 505msec 
occurring during a seizure lasting 190 seconds in patients receiving 
monotherapy and 490msec QTc at 120 seconds seizure duration in patients 
receiving polytherapy. A general uniform distribution of QTc is noted with 
all seizure durations with patients not on any AEDs. Patients on 





2.10.4 Anti-Epileptic Drug on QTc in relation to Gender. 
The effects of QTc and gender show that QTc is consistently longer in 
females (432 msec), (n=14) compared to males (417 msec), (n=25) during 
seizures. Baseline QTc is also longer in females (420 msec) compared to males 
(405 msec). This difference remains similar for patients on no AED, 
monotherapy and polytherapy. The largest difference in QTc in relation to 
gender is in those female patients on polytherapy with mean QTc 429 msec 
compared to males mean QTc 407 msec during seizures. 
Chapter 19 Section Two Discussion and Future Studies 
2.10.1 Discussion 
Impulses from higher brain regions in the cerebral cortex, limbic system and 
hypothalamus affect the cardio-vascular centre (Torora and Grabowski 1992). 
During cases of SUDEP it has been hypothesized that an intrinsic 
‘channelopathy’ may occur with sudden and intense impulses directed from 
cortical areas; driven by a seizure source, which over-stimulate either the 
cardio-inhibitory centre causing asystole or cause massive adrenergic effect 
on the sympathetic pathways resulting in tachycardia (Wannamaker 1985, 
Lathers et al 1987, Cheung and Hachinski 2000, Ansakorpi et al 2004) At 
autopsy, raised catecholamine detection has been identified on occasions, 
indicating massive Beta-adrenergic catecholamine effect (Nei et al 2004). It is 
considered that this physiological mechanism may not be amenable to 
intervention (Dashieff and Dickinson 1986). Soonhak et al (2003) comments 
that cardiac arrhythmia may be one of the major causes of sudden 
unexpected death in children with epilepsy. However, hypoxia is described 
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as the initial cause preceeding cardiac arrest in children (Carter 1993). 
Malfunction in ion channels resulting from mutations in the genes encoding 
channel proteins could be inter-related and part of the same disease 
spectrum.  
Even though it has been recognised since the turn of the last century that 
seizure deaths could either be accidental or have intrinsic mechanisms 
(Nashef 2000), very little is really understood of what exactly these intrinsic 
mechanisms are, although several hypotheses have been postulated mainly 
concerning respiratory, cardiac and genetic involvement (Nashef et al 2007). 
Accidental death from suffocation or bodily injury during seizures can occur 
because of unfortunate body position if no one is alerted to the seizure, 
particularly during nocturnal seizures or if someone is living alone with 
epilepsy. ‘Positioning of the patient or stimulation of respiration may prevent 
a fatal outcome in some cases. This raises the important issue of supervision’ 
(Langan et al 2000). Accidental death during seizures may be prevented and 
hypoxic brain damage could be minimised by the administration of 
prescribed anti-epileptic medication in order to stop prolonged seizures. It is 
the true SUDEP cases which may not be preventable due to sudden 
physiological intrinsic mechanisms.  
Channelopathies. 
Over the last ten years increasing knowledge and interest has been gained in 
channelopathies and their pathophysiological basis in cardiac arrhythmias 
and epilepsy. The most understood type of channelopathy at this time is the 
voltage-gated sodium channelopathy group. Mutations of the voltage-gated 
sodium channel gene SCN4A affects peripheral neurones and causes 7 
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different disorders of muscle control including a myasthenic syndrome. In 
cardiac channelopathies, genetic mutations of the sodium channel SCN5A 
have been identified in 7 different syndromes including congenital long Q-T 
syndrome (Romano Ward), Idiopathic ventricular fibrillation (Brugada 
syndrome) and sudden infant death syndrome. In neuronal sodium 
channelopathies, genetic defects of sodium channels SCN1A, SCN2A and 
SCN1B have been identified in generalised epilepsy and febrile seizures, 
severe myoclonic epilepsy (Dravet syndrome), Intractable childhood 
epilepsy and benign familial neonatal infantile seizures. Sodium channel 
mutations are expressed in the mRNA of neurones found in the limbic 
regions and produce abnormal depolarisation and lower the seizure 
threshold. 
A single channelopathy mutation that affects the myocardium causing a 
cardiac arrhythmia because of neuronal seizure activity has not been 
identified to date. However, highly homologous potassium channel mutation 
has been identified KCNQ2 and KCNQ3, which cause familial neonatal 
seizures and is homologous with KCNQ1 channelopathy causing mutations 
of two inherited cardiological conditions ie Long QT syndrome and Jervell 
and Lange-Nielson syndrome. In the neurone, including hippocampal 
pyramidal neurones, the potassium channel influences the M current 
(muscarinic current), which controls membrane excitability. Mutations that 
cause disruption of the M current of KCNQ2 and KCNQ3 result in a decrease 
in inhibitory electrical activity, resulting in seizures (Tripathi & Jain 2002). 
Experts (George 1985, Kullmann 2002) suggest that many other 
channelopathies will be discovered in the near future. However, the 
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mechanisms of these channelopathies will take much longer before they are 
fully understood. 
Cardiac-pacemaker Intervention? 
Implantable loop recorders identified potentially fatal cardiac abnormalities 
in three out of nineteen patients with focal epilepsy over a period of 24 
months monitoring in a study by Rugg-Gunn et al (2004). They suggested 
that the incidence of bradycardia and asystole have been under reported in 
patients with epilepsy. They believe that asystole underlies SUDEP and 
could be prevented by cardiac-pacemaker insertion. Four patients were 
identified as having bradycardia or periods of asystole had cardiac 
pacemaker insertion.  
Identifying patients with epilepsy who have a cardiac abnormality that could 
potentially develop into the risk of sudden death and being offered 
protection by having an implanted pacemaker may prevent some fatalities.  
The National Institute for Clinical Excellence (NICE) guidelines. 
The requirement guidelines issued by the National Institute for Clinical 
Excellence (NICE) to medical staff is that “Individuals with epilepsy and 
their families/and or carers should be given and have access to information 
on SUDEP” (www.nice.org.uk, accessed 2009). The guidelines recommend to 
practitioners that all patients visiting a Neurology clinic who have the 
diagnosis of epilepsy are also to be told of the small risk of SUDEP. A 
national audit in 2006 by Morton et al highlighted the general reluctance of 
British Neurologists to implement these guidelines. Only 5% of UK 
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Neurologists discussed SUDEP with all patients because of the expected 
disproportionate amount of anxiety this knowledge would give to patients. 
The commonest reasons for SUDEP to actually be discussed were if the 
patients themselves asked about it and/or the Neurologist considered that 
the patients presented with considered risk factors for SUDEP.  
Many clinical practitioners debate that imparting this knowledge to everyone 
is unjustifiable because of the level of anxiety caused to some individuals 
being so great that their lifestyle and outlook on life is devastated because of 
the worry to themselves and to their family of possible death during their 
habitual seizures. In a review by Beran et al (2004) of this legal obligation of 
informing the patient they ask the question “What will be gained by warning 
of that which cannot be prevented and knowledge of which may seriously 
deteriorate quality of life?” and consider the patient’s right ‘not to know.’ 
I view this approach as negligent and believe that all patients with epilepsy 
have the right to know about the small risk of SUDEP. If the risk is explained 
in the context of a comparative risk for example, deaths from road traffic 
accidents, people are then more able to understand the likelihood of the risk 
of SUDEP happening to them as being very small. The national statistics for 
road traffic fatalities was 3,201 in 2005 and this figure has remained similar 
over the last 10 years. In terms of road traffic fatalities per proportion of the 
general population it is estimated at 5.6/100,000 (www.statistics.gov.uk). If 
the number of deaths from seizures is compared proportionally to the 
number of deaths from road traffic accidents in the UK each year, less than 
1/3 of people die from seizures at 1000 deaths per year which proportionally 
is 1.7/100,000 compared to 5.6/100,000 road traffic fatalities. In terms of the 
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relative proportion of SUDEP cases based on 600 deaths each year, to road 
traffic fatalities it calculates to be 1/100,000 of the general population, 
suggesting that someone could be statistically nearly six times less likely to die 
from SUDEP than from a road traffic accident. If people can relate the risk of 
SUDEP to the risk of a daily activity, I think this helps everyone put the level 
of risk into perspective. I believe that it is also extremely important however 
that patients and their families do have the knowledge that SUDEP can 
happen and this knowledge helps to minimise some of the anger in cases 
where SUDEP does occur because the families have had time to understand 
and acknowledge that there had been a risk from the start.  
If some patients with epilepsy are identified as having a cardiac abnormality 
and are considered to have an increased risk of SUDEP because of this, then 
by offering an implanted cardiac pacemaker, intervention has been made 
possible on the basis of prevention and therefore a reduced risk of SUDEP 
would be anticipated. Therefore, the argument against the NICE guidelines 
of “What will be gained by warning of that which cannot be prevented and 
knowledge of which may seriously deteriorate quality of life?” is no longer 
quite true. However, some truth in this question does remain because the 
causes of all SUDEP cases are unknown at this time and until this evidence is 
found, the risk of SUDEP prevails. 
Electro-cardiological Effects During Seizures and Possible Mechanisms. 
In a study by Jeffrey (2006), 60% of patients who had severe epilepsy and 
learning disabilities had abnormalities on their electrocardiograms. Patients 
who have epilepsy with severe on-going symptoms accompanied by learning 
disabilities are considered to be in a high risk category of SUDEP and Jeffrey 
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raises the possibility of neuro-cardiac channelopathies as an underlying 
mechanism in this group. 
The question however, still remains of what these intrinsic mechanisms are, 
what happens physiologically and what can be done to prevent this intrinsic 
mechanism from happening? 
The data in this study has identified that transient lengthening of the 
corrected Q-T beyond normal limits according to Bazett’s Formula occurs in 
a high proportion of right temporal lobe seizures (11/17) representing the 
most common seizure type to lengthen the corrected Q-T overall of (11/21) 
and right sub-clinical temporal lobe seizures with 5 events (5/21) compared 
to left temporal lobe seizures (2/21) and left temporal sub-clinical seizures 
(1/21) However, when data is analysed in terms of number of patients rather 
than the number of seizures, no statistical difference is seen. 
 It is considered that when the corrected Q-T lengthens by more than 60 
milliseconds there is a small risk of a fatal arrhythmia (Nei et al 2000, Pater et 
al 2005, Morganroth 2001). In this study, right temporal lobe seizures (59%) 
right temporal sub-clinical seizures (33%) and generalised tonic clonic 
seizures (33%) demonstrated the highest proportions of increased corrected 
Q-T exceeding 60 milliseconds compared to other seizure types (Tables 7 & 
8). Lengthening of the corrected Q-T during sub-clinical seizures from the 
right temporal lobe seen in this study, which have a cardiological effect of 
stimulating adrenergic pathways strengthens the possibility that Q-T 
lengthening could be involved in SUDEP where no evidence of a seizure has 
clinically taken place but an intrinsic cardiac effect may have resulted from 
sub-clinical seizure activity. Epileptic seizures are frequently associated with 
Section Two 
 292 
alteration of cardiac activity causing tachycardia or bradycardia. Persson et al 
(2003) proposes the mechanism for these changes being the spread of seizure 
discharges to autonomic centres in the cortical, limbic and hypothalamic 
structures. Animal models of epilepsy suggest even inter-ictal epileptogenic 
activity may induce changes in the autonomic nervous system which could 
result in cardiac arrhythmia and risk of sudden death. 
It is sometimes reported that generalised tonic clonic seizures are responsible 
for seizure-related deaths (Opherk et al 2002, Tavernor et al 1996).  In this 
study, lengthening of the corrected Q-T beyond normal limits occurred 
during this type of seizure in one child.  Two further generalised tonic clonic 
were found to cause a large increase of corrected Q-T of 130 milliseconds 
during one seizure in an adult male and 70 milliseconds during a seizure in a 
child but both remained within normal QTc limits during exercise according 
to Bazett’s formula (Table 7). Even though values remain within normal 
limits, these increases in corrected Q-T may be a possible contributing factor 
in triggering cardiac arrhythmias in some individuals and additionally could 
be further compounded by cases of associated hypoxia. 
Nocturnal Seizures and SUDEP 
Sudden and extreme changes in heart rate can occur during nocturnal 
seizures. ‘This increased instability during seizures arising from sleep may be 
a key factor in SUDEP’ and ‘seizures from sleep could cause sudden and 
extreme fluctuations in autonomic tone which might precipitate lethal 
cardiac arrhythmias’ (Nei et al 2004). Nei et al reported 14/21 people died 
from SUDEP in sleep and studying seizure EEG/ECG data of these patients 
retrospectively discovered that much higher increases in heart rate occurred 
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during seizures arising from sleep than from wakefulness in the SUDEP 
group compared to the non-SUDEP group. Additionally, ‘Ictal cardiac 
repolarization and rhythm abnormalities occurred in 56% of SUDEP.’ Forced 
awakening occurs during nocturnal seizures and the effects of sudden 
waking with associated increase in heart rate is compounded by the seizure 
itself at a time of suspected autonomic instability and therefore could leave 
some individuals more vulnerable to an induced cardiac arrhythmia during 
early waking hours. 
Marked changes in T-wave morphology, signalling an alteration in 
ventricular re-polarisation was demonstrated when subjects were 
unexpectedly woken from deep sleep (Dweck et al 2006) and ‘sudden arousal 
has been associated with sudden cardiac death in individuals with ischaemic 
heart disease, cardiac arrhythmias and the congenital long Q-T syndrome’ 
are described. Increased autonomic instability is described during early 
waking hours corresponding to a reported period of increased vulnerability 
to ventricular tachycardia and sudden death (Pater 2005). Cardiological 
effects during seizures can be the result of autonomic instability because of a 
nocturnal seizure presenting when vagal tone is high or an undiscovered 
channelopathy triggered by the seizure, directly affecting the heart (Lathers 
et al 1987, Wannamaker 1985, Cheung et al 2000, Ansakorpi et al 2004). 
Another consideration is that some susceptible individuals may develop an 
intracellular ionic flux disturbance in the myocyte because of changes in ionic 
environment due to the physiological demands of the seizure. This 
disturbance in ionic flux may deteriorate over time in cases of undetected 
prolonged nocturnal seizures and this could also be a contributing factor in 
some cases of SUDEP.  
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Myocardium Cellular Mechanisms and Physiological Effects during Seizures. 
In the cardiac myocyte, release of Ca2+ from the sarcoplasmic reticulum is the 
key event linking membrane depolarisation and mechanical activity during 
excitation-contraction coupling. Intracellular calcium handling in ventricular 
cardiac myocytes may play an important role in the occurrence of cardiac 
arrhythmias in the failing heart. Diastolic calcium leak from the sarcoplasmic 
reticulum (SR) via ryanodine receptors (RyR2) may initiate delay in re-
polarisation time that could lead to ventricular fibrillation or other 
arrhythmias (Wehrens et al 2005). Patients with inherited arrhythmia 
syndromes such as catecholaminergic polymorphic ventricular tachycardia 
(CPVT) demonstrate SR Ca2+ leak through mutant RyR2 triggered activity 
during exercise. During diastole, Ca+ is effluxed. If a cell did not have Ca+ 
extrusion mechanisms, Ca+ would rapidly load the cell. During rest, there is 
Ca+ leak from the SR lumen to the cytoplasm. Ca+ in the cytoplasm is then 
extruded from the cell via the Na/Ca exchanger or the sarcolemmal Ca-
pump. This leak followed by Ca+ extrusion is called ‘rest decay’. In CPVT 
patients, RyR2 are slow in Ca+ extrusion, thereby causing slow de-
polarisation (Bers 2001). 
The cardiac Na+ channel, skeletal muscle and brain neurone are highly 
homologous. Some agents e.g. quinidine (anti-arrhythmic agent) binds to the 
S6 region of domain 1V of the membrane. This produces cumulative block of 
Na current at high frequency; blocking Na current during tachycardia and in 
depolarised tissues can be pro-arrhythmic. Na channels characteristically 
snap open and shut very quickly to generate a large and brief inward Na 
current and cause the rapid upstroke of the action potential. Hypoxia often 
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occurs during seizures that could cause persistent Na channel openings even 
at very negative membrane potentials. 
Human congenital mutation (deletion of the 3rd amino acid) in the cardiac 
Na channel in the region of III-IV loop, results in the long Q-T syndrome. 
This is characterised by long ventricular action potential depolarisations and 
may pre-dispose these individuals to arrhythmias. The mutation does not 
greatly alter the Na current but late openings occur at the single channel 
level, which cause the action potential depolarisation prolongation. 
Sympathetic stimulation of the heart results in catecholamine release 
(isoprenaline) and produces inotropic (force) and chronotropic (rate) effect 
on cardiac-contraction coupling. Sympathetic nerve endings and Beta-
adrenergic receptor agonists are found widely throughout the heart. 
Isoprotenolol, which is a B-adrenergic agonist, produces large increases in 
cardiac contraction. Although the intra-cellular Ca+ load increases, B-
adrenergic agonists also increase cardiac K-conductance, which shortens the 
action potential. Another positive chronotropic effect of B-adrenergic 
agonists is that they alter the resting membrane potential of the pacemaker 
potential to a more de-polarised potential resulting in a faster depolarisation 
of the pacemaker. However, metabolic demands are high during sustained 
tachycardia and oxygen consumption increases dramatically. In the failing 
heart B-adrenergic receptors are ‘down-regulated’ during chronic activation.  
This negative inotropic effect is then complicated further by hypoxia and 
ischaemia. Hypoxia is sometimes part of the physiological effect during 
seizures. Acidosis is an early consequence of hypoxia due to metabolism 
changing to glycolysis and lactic acid production. Acidosis decreases 
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myofilament Ca+ sensitivity and reduces force. Respiratory acidosis produces 
an even faster decline in pH than metabolic acidosis, which adds to this 
negative inotropic effect because low pH inhibits the Na/Ca exchange   
pumps and the cell is unable to extrude Ca+. In ischaemia, arrhythmias can 
occur after reperfusion when pH is restored. This is because a large outward 
H+ gradient causes rapid Na+ gain due to the Na/H exchanger, which in turn 
causes an inward flux of Ca+ via the Na/Ca exchanger. Therefore this 
situation can also result in Ca+ overload and potential arrhythmias. Re-
oxygenation following hypoxia during a seizure may also result in Ca+ 
overload of the cell due to oxygen free radical production. (Bers 2001) 
Ionic flux in the heart is finely tuned and there are many situations that can 
affect the cardiac cell to produce arrhythmias. During seizures sudden 
changes in heart rate occur often when vagal tone is high during sleep. 
Sustained tachycardia could result in acidosis, acidosis results in decreased 
contractility and Ca+ overload. Hypoxia exacerbates this negative inotropic 
effect and reperfusion ironically can result in arrhythmias. 
Q-T Hysteresis 
Another important aspect is cardiological physiological Q-T dynamics of Q-T 
hysteresis. In an ideal situation, when the heart rate increases and the R-R 
interval shortens, the Q-T interval should correspondingly also shorten. 
However, physiologically during a rapid onset of tachycardia when the R-R 
interval immediately shortens, there is a delay or ‘lag effect’ in the 
corresponding shortening of the Q-T interval. This effect has been described 
in studies (Lauer et al 2005) during exercise, which is similarly applicable 
during physical exertion during seizure activity. During nocturnal seizures 
Section Two 
 297 
when vagal tone is high during sleep, sudden changes in heart rate could 
theoretically leave the heart vulnerable because of Q-T hysteresis. Q-T 
hysteresis is defined as the recovery Q-T peak interval subtracted from the 
exercise Q-T peak interval. (Chauhan et al 2002).  Hysteresis loops 
demonstrating ‘Q-T lag’ associated with sudden changes in heart rate during 
epileptic seizures has not yet been studied and it is my intention to 
investigate the effects of Q-T hysteresis during different seizure types at 
some stage in the future. If there is a significant lag time relationship between 
the R-R interval and Q-T associated with a sudden tachycardia during a 
seizure then this phenomenon could theoretically lengthen the corrected Q-T 
and increase the risk of cardiac arrhythmia.  
Suggested formula is available to ‘correct’ this cardiological ‘lag effect’ but 
the fact that hysteresis occurs during sudden heart rate increase is worth 
measuring in an uncorrected manner in order to ascertain what the actual 
ventricular re-polarisation time is during a seizure. If cardiac hysteresis 
contributes to a prolonged corrected Q-T then this may partially explain why 
the Q-T is prolonged. This may be the very key as to why sudden 
unexplained death in epilepsy occurs in some cases. 
Proposed Imbalance of Autonomic Activity Resulting in SUDEP. 
In recent years, researchers have tried to identify risk for sudden cardiac 
death and have mainly focussed on patients with poor left ventricular 
function. Although patients with poor left ventricular function have higher 
risks of sudden cardiac death, it does not explain why patients who do have 
good left ventricular function can also die from ventricular arrhythmias or 
fibrillation. Cain (2006) reports on findings of an imbalance of sympathetic 
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activity and vagal tone leads to increased vulnerability to ventricular 
arrhythmias in patients with ischaemic heart disease. Algra et al (1993) 
considers that in addition to an imbalance of sympathetic activity and vagal 
tone there is also an imbalance between the left and right sympathetic 
nervous systems and hypothesizes that this imbalance is related to sudden 
unexplained death. This finding hypothetically links with possible intrinsic 
mechanisms triggered during seizures that may suddenly induce cardiac 
arrhythmias because of an imbalance of autonomic activity resulting from 
seizure discharge activity leading to some SUDEP cases.  
Hypertrophic Cardiomyopathy, Ischaemic Changes and Epilepsy. 
Of course there are a group of patients with undiagnosed hypertrophic 
cardiomyopathy who experience episodes of exercise-induced ischaemia 
during intensive training that can result in myocardial cell death and fibrosis 
that over time can lead to triggered electrical instability and ventricular 
fibrillation (Gold 2006).The incidence of sudden cardiac death in apparently 
healthy young adults and athletes aged 12-35 years is reported to be 
2.3/100,000 in the United States compared to 1/100,000 non-athletes. There 
may be some patients with epilepsy who have hypertrophic cardiomyopathy 
who with repeated seizures render their heart vulnerable to electrical 
instability and ventricular fibrillation because of increased myocardial cell 
death and fibrosis.  
During a left temporal lobe seizure, of a 60 year-old female patient (patient 
19F) in this study, evidence of ischaemic changes on the ECG with 
diminution of the T-wave occurred in the absence of physical exercise. The 
patient became apnoeic during this seizure resulting in clinically significant 
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hypoxia with oxygen saturations dropping to 75%.  Her body position 
remained unchanged except for some subtle right hand automatisms and 
chewing movements of her mouth. On return of the T-wave, the corrected Q-
T measurements according to Bazett’s formula had increased from 396 
milliseconds prior to the event to 494 milliseconds during the peak of the 
electroencephalographic seizure demonstrating marked spike wave activity 
over the left temporal lobe. This seizure occurred from sleep and at the onset 
of the seizure, the patient opened her eyes, her heart rate increased from 
78/min to 90/min. Peak heart rate increased transiently to 120/min within the 
first 6 seconds of the seizure. T-wave diminution occurred for 18 seconds 
during an average heart rate of 110/min. Corrected Q-T prolongation did not 
occur until after 1 minute of the seizure onset and the T-wave morphology 
had been restored for some 30 seconds with an average heart rate of 100/min. 
At this time the electroencephalograph showed some spread of the spike 
wave activity to the left parietal region. At the end of the seizure, the patient 
simply closed her eyes and went back to sleep again with no memory of the 
event. Clearly, this patient is at risk of developing a serious cardiac 
arrhythmia given the ischaemic changes occurring electro-cardiologically, 
clinically significant hypoxia down to 75% with a hypoxic period of 78 
seconds and with no obvious physical evidence of a seizure occurring to alert 
carers or a family member in case of need of resuscitation or rescue 
medication. Repeated seizures could result in myocardial cell death and 






Although according to Bazett’s formula, twenty-one seizure seizures in the 
study showed a transient increase in corrected Q-T, none of the nine patients 
had died of SUDEP at the time of this publication. The duration of QTc 
prolongation was typically brief with maximum seizure duration of 4 
minutes 15 seconds and all seizures were self-resolving without the 
requirement of rescue medication. However, prolonged un-witnessed 
nocturnal seizures could lead to more marked and sustained cardiological 
effect of corrected Q-T lengthening and therefore place some individuals at 
risk of cardiac arrhythmia. Transient QTc prolongation (Kandler et al 2005) 
occurred in 7/30 paediatric patients during a post-convulsive period of two 
hours following generalised seizures. 
Effects of Anti-epileptic Medication on Corrected Q-T. 
The longest mean QTc was derived from one patient receiving Vigabatrin 
and from fewer observations than most other categories of AEDs. The QTc is 
still within normal range and may reflect more on the patient’s own 
cardiological ability to re-polarise compared to others, regardless of 
medication. Vigabatrin inhibits the catabolism of gamma-aminobutyric acid 
(GABA) by irreversibly inhibiting GABA transaminase effectively preventing 
the breakdown to GABA after the neurone has depolarised and this results in 
increased amounts of GABA transmitter at the receptor sites maintaining the 
neurone in an inhibited state. However, GABA action is confined to brain 
neurotransmitters and is not a neurotransmitter in cardiac contraction and 
re-polarisation. Vigabatrin is not known to have any cardiological side 
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effects. It has restricted use in clinical practice because of cases of visual field 
loss. 
Several different anti-epileptic medications were being used therapeutically 
in this study (Carbamazepine, Topiramate, Levetiracetam, Phenobarbitone, 
Sodium Valproate, Lamotrigine Clobazam and Vigabatrin) by patients that 
demonstrate transient maximal prolonged QTc. There were no correlations 
between the type of pharmacological action of the AED and transient 
prolonged QTc. Some AEDs like Carbamazepine act by stabilizing the 
inactivated state of the sodium channel once the neurone has depolarised, 
others like Topiramate and Sodium Valproate block voltage dependent 
sodium channels to increase GABA and Clobazam acts on the 
benzodiazepine receptors, enhacing binding of GABA and increasing the 
effectiveness of this neuroinhibitor, making the neurones less excitable.  
In the study, two patients had prolonged QTc that was agreed by all 
corrective formulae (Bazett, Hodge, Fridericia and Framingham) during the 
seizure compared to baseline measurements. One patient was receiving 
carbamazepine and the other was not being treated by AEDs at that time. 
However, six other patients were also receiving carbamazepine in this study 
but did not indicate prolonged QTc according to all formulae. 
Cardiac sodium channels play a key role in ventricular re-polarization. It is 
described by Waseem et al (2010) that the cardiovascular sodium channels 
were only “minimally effected” when therapeutic dosages of Carbamazepine 
were given. These authors describe that over dosage of Carbamazepine can 
produce sodium channel blockade and this can be pro-arrhythmic.  
Section Two 
 302 
A case controlled study of 100 patients by Amin et al (2010) found that there 
was no association between carbamazepine as monotherapy and prolonged 
QTc interval. However, the authors do consider that carbamazepine may 
contribute to prolonged Q-T in situations of electrolyte disturbance and 
polytherapies. In this study, 17 patients were receiving polytherapy (4 
patients with carbamazepine and other AED’s). However, the mean baseline 
and seizure QTc is shorter (412 msec) in these patients than those patients 
receiving monotherapy (417 msec baseline, 424 msec seizure) and indeed 
shorter than the patients not on any AED’s during a seizure (441msec).  
If hypoxia occurs during a seizure, acidosis can result from metabolism 
altering glycolysis and lactic acid production. Low pH inhibits the Na/Ca 
exchange pumps and the myocyte is unable to extrude Ca+ leading to 
increased risk of cardiac arrhythmia. Characteristically, Na+ channels snap 
open and shut very quickly to generate a large brief inward current and 
cause the rapid upstroke of the action potential. Hypoxia causes persistent 
Na+ channel openings that can lead to cumulative block, especially during 
tachycardia where this combination can be pro-arrhythmic (Bers 2001).  
In this study, four patients (one child, 3 adults) had hypoxia associated with 
their seizures. The level of hypoxia ranged between 67% and 75% with a 
duration between 33 seconds and 132 seconds (Table 5). The mean duration 
of seizure lasted 169.5 seconds with the longest seizure lasting 252 seconds. 
Rescue medication had not been required for any of these patients for their 
seizures as they were not prolonged i.e more than 5 minutes. However, there 
are many cases of patients having prolonged unwitnessed seizures where 
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hypoxia and tachycardia could theoretically result in cardiac arrhythmia due 
to cumulative block of sodium channels and Ca+ overload.  
In this study, patients not receiving any AEDs lengthen to a maximum QTc 
quickly at a mean duration of 45 seconds. Patients receiving monotherapy 
and polytherapy take longer to reach the maximum QTc at 190msec and 120 
msec respectively. This result may indicate that the types of seizures the 
patients have who are on AEDs have longer seizures, more difficult to 
control and there is always the compounding factors of hypoxia with longer 
seizures and the effects of these factors on cardiac repolarisation A previous 
study
 
reported that there was no evidence of QTc prolongation detected in patients 
receiving anti-convulsant monotherapy or polytherapy in a paediatric group 
(Soonhak 2003). 
The government Medicine & Healthcare Products Regulatory Agency (2008) 
Public Assessment Report includes several warnings of effects from 
carbamazepine. Plasma levels of concomitant agents can have reduced 
efficacy as carbamazepine increases liver metabolism and reduces the 
effectiveness of these medications. Phenytoin levels can be difficult to 
manage alongside carbamazepine. Warnings of neurotoxic reactions due to 
carbamazepine’s structural relationship to tri-cyclic anti-depressants and the 
increased side effects of anti-depressants occasionally give rise to suicidal 
thoughts. Risk of Stevens-Johnson Syndrome in Asian patients. 
Teratogenecity of congenital abnormalities of spina bifida, craniofacial 
defects, cardiovascular malformations can be associated with carbamazepine 
if taken during the first trimester of pregnancy. In the long list of side effects 
of carbamazepine, cardiac conduction disturbances are stated as ‘rare’ and 
bradycardia and arrhythmias are described as ‘very rare.’ Carbamazepine 
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was the commonest drug used as a monotherapy in this study. The longest 
mean QTc occurred late into the mean seizure duration for the monotherapy 
group. Accumulative myocardiological changes are difficult to determine but 
there may be some association of carbamazepine, duration of seizure, 
hypoxia and lengthened QTc in some cases. 
In cases of SUDEP, the cause is as yet unknown but believed to be 
multifactorial. Cardiac arrhythmia is one of the most suspected causes with 
the other being central apnoea. The contributing factors of what has led to 
cardiac arrhythmia in SUDEP cases are harder to assess. Increased circulating 
catecholamines are often found in the victim at autopsy, indicating sustained 
tachycardia during the seizure. Any factors of cumulative block of Na+  
channels, severe hypoxia and the effects of acidosis and what part a drug like 
carbamazepine would have had are difficult or impossible to find evidence. 
SUDEP is rare and people who are pre-disposed to the physiological 
demands of the seizure are relatively few compared to others with seizures, 
who are also taking anti-epileptic medication. The combined effects of all 
contributing factors may disguise how anti-epileptic medication may also be 
one of these contributing factors in a pre-disposed individual. 
Rugg-Gunn et al (2004) report no clear correlation between cardiac events 
and specific epileptic drugs but use one of the risk criteria for SUDEP as the 
treatment of more than two antiepileptic drugs. This is expanded upon by 
Beran et al (2004) who explained that although there is no evidence that any 
particular anti-epileptic medication influences the risk of SUDEP, poly-
therapy was found to be a significant risk factor, confirming the refractory 
nature of the epilepsy. Only anecdotal reports of brady-arrhythmia and 
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asystole have been associated with carbamazepine. However, carbamazepine 
is used to control simple focal and complex focal epilepsy and it is this type 
of epilepsy that has been reported in this study and in many others of 
causing marked changes in heart rate, respiration and autonomic control 
during seizures. At this time, there is no conclusive evidence of AEDs 
contributing to the risk of SUDEP and most researchers believe that 
cardiological changes occurring in focal or complex focal seizures are 
perhaps due to the nature of the seizure and not the medication. 
Which Corrective Formula? 
Bazett’s formula is the commonest corrective formula and has been used 
widely for over 80 years (Bazett 1920, Yu et al 1950). For consistency of data 
collection in this study and to allow a comparison to other studies Bazett’s 
has been the main formula used to compare other formulae results to. 
However, it is important to note that Bazett’s formula over-corrects and 
therefore over-estimates QTc at fast heart rates resulting in a tendency 
towards falsely prolonged corrected Q-T values and under-corrects and 
under-estimates QTc at slow heart rates resulting in a tendency towards 
falsely shortened corrected Q-T values (Hodges 1997, Sagie 1992, Pater 2005, 
Sredniawa et al 2005). 
Conversely, Framingham’s formula can lead to falsely shortened corrected 
Q-T values at fast heart rates and falsely lengthened QTc values at slow heart 
rates (Sagie et al 1992). No single mathematical transformation can adjust for 
the rapidly changing non-linear dynamics of the QT/RR interval relationship 
(Fossa 2005).  
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Heart rate correction of the Q-T interval using scatterplots with linear 
regression curves (Davey 1999) were investigated in this study in the two 
subjects whom all corrective formulae had identified as showing an increase 
in corrected Q-T during seizures. Q-T values at 60/min were calculated by 
minitab version 14. Grouped data for each patient indicated normal values. 
However individual seizure data plots showed either a prolonged Q-T or a 
much longer Q-T than that calculated for each total group in both subjects. 
There are limitations in using this technique when there are only a few data 
points derived during a seizure as a single data point can dramatically 
influence the gradient of the linear regression curve. Conversely, important 
Q-T values can be lost in grouped scatter plot data if the linear regression 
curve is more strongly positioned in one area of the data points eg at fast 
heart rates compared to another area at slower heart rates.  
Individual correction formulae have been proposed by Malik et al (2004). 
These authors describe the relationship between the Q-T interval and heart 
rate as highly individual and using a parabolic heart rate correction formula 
(QTc= QT/RR) demonstrated a large variability of the  exponent in healthy 
individuals and concluded that the correction of QT interval by heart rate 
may be misleading with any formula. However, creating individual 
correction formula in practice would be excessively time consuming. Luo et 
al 2004, Pater 2005, Fossa 2005 and Toivonen 2002 argues that there is no 
evidence that using an individual correction method would help to improve 
discrimination of diseases such as hereditary long Q-T syndrome. Walker et 
al (2005) accept that Bazett’s formula may overcorrect at fast heart rates and 
can lose accuracy during sudden changes in heart rate but believe that 
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Bazett’s formula is still the best predictor of Long Q-T syndrome carrier 
status. 
All researchers and cardiologists in the field of corrected Q-T analysis 
describe the Q-T becoming ‘over-corrected’ leading to a falsely prolonged 
corrected Q-T and vice versa of an ‘under-corrected’ Q-T leading to a falsely 
shortened corrected Q-T value. I find the semantics of the use of the word 
‘corrects’ to mean the opposite i.e if something is ‘over-corrected’ its value 
becomes shortened. However, the use of ‘over-correction’ in this field 
appears to apply ‘numerically’ to a prolonged value. Therefore, despite my 
reluctance of the use of the word ‘corrects’ to describe a numerical value 
instead of a description of function I recognise uniformity of describing 
results in this way for comparison with data to that researched by other 
authors. 
Artificially Prolonged QTc due to Rapidly Accelerated Heart Rate? 
Some authors warn of artificially prolonged QTc calculated from rapidly 
accelerating heart rate disproportionately affecting QTc measurements (Yu et 
al 1950, Malik 2004). This potential error was objectively assessed in this 
study and it was found that corrected Q-T lengthening occurred during some 
seizures whether heart rate increased or decreased. Also during some sub-
clinical seizures where there is no element of physical exertion, again 
measurements of Q-T prolongation occurred whether heart rate increased or 
decreased. During a left temporal sub-clinical seizure heart rate decreased 
from 80-70/min and the corrected Q-T increased from 425-454 milliseconds. 
Therefore, although there is a strong heart rate correlation with corrected Q-
T calculations when using a linear formula like Bazett’s, we have found that 
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during seizures corrected Q-T prolongation is not simply the result of the 
previous R-R history. Magnano et al (2002) demonstrated that autonomic 
conditions effect the ventricular myocardium and cause differences in Q-T 
that are independent of heart rate.  
Measuring corrected Q-T during exercise is used as a clinical method for 
distinguishing and identifying patients with latent long Q-T syndrome from 
healthy subjects who all have normal Q-T at rest. Bazett’s formula is used 
widely in clinical practice as remains the best predictor of carrier status 
compared to other formulae (Walker 2005). Catecholaminergic polymorphic 
ventricular tachycardia is rare but can occur in apparently healthy children. 
Exercise testing of the ECG dynamics is necessary in this group as the 
corrected Q-T is normal at rest. Delayed after de-polarisation potentials are 
considered to be the probable electrophysiological mechanism responsible 
for this cardiac arrhythmia induced by exercise or sudden emotion that can 
then result in syncope and sudden cardiac death (Leite et al 2001). 
Some epileptic seizures cause more rapid acceleration or deceleration than 
others and this is highly variable both between individuals and within the 
same individual. Nocturnal seizures causing forced arousal compounds 
heart rate acceleration than simple arousal itself. There may be an element of 
‘artificial prolongation’ effect in some cases where heart rate increases 
dramatically and short epochs are used. Many researchers only average 3 
beats and apply these values to corrective formulae. In fact a minimum of 3 
or 4 beats is recommended in drug trials. However, since ‘artificial 
prolongation’ of the corrected Q-T is possible in accelerated heart rates when 
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analysing the effects during seizures, I used a longer epoch of 9 seconds to 
average out this effect. 
Formula Comparison of Identified Patients and Seizure types with Prolonged 
QTc. 
Twenty three percent  (9 patients) were identified as having transiently 
lengthened the corrected Q-T during epileptic seizures using Bazett’s 
Formula compared to 10 percent (4 patients) identified by Hodges and 
Fridericia’s and only eight percent (3 patients) identified by Framingham’s 
formula. Only two patients (2/39) were identified consistently by all four 
formulae as having QTc prolongation during epileptic seizures. This 
represents 5% of the total patients in the study. Only two types of seizures 
were consistently agreed by all four formulae as having a prolonged 
corrected Q-T during the seizure and those were right sub-clinical temporal 
lobe seizures and right temporal lobe seizures. One generalised tonic-clonic 
seizure was identified by three corrective formulae as prolonging the 
corrected Q-T beyond normal limits but this was not agreed with 
Framingham’s formulae. Three formulae identified a left temporal lobe 
seizure as having a prolonged corrected Q-T but Hodge’s formula did not 
identify this seizure.  
A large study by Luo et al (2004) analysing 10,303 normal ECG’s testing the 
effect of heart rate using all four formulae concluded that Hodge’s formula 
fitted the database globally better than the other formulae. They also 
comment on the results from using Bazett’s formula suggested that 30% of 
apparently normal ECGs had abnormal intervals compared to 2% identified 
by other formulae. 
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In a study by Benatar et al (2001), at peak exercise in healthy children, 
Hodge’s and Bazett’s correction formulae resulted in prolongation of the 
corrected Q-T whereas Fridericia’s and Framingham’s formulae resulted in a 
shortening of the corrected Q-T. They concluded that none of the four 
formulae provided an optimum QT interval correction.  
A previous study analysed corrected Q-T during epileptic seizures and 
reported that all mean QTc values using Bazett’s formula, were normal for 
total grouped data (Nei et al 2000). Unfortunately transient QTc increases or 
individual patients demonstrating an increase in corrected Q-T are lost if 
calculated as a mean average of total patient grouped ‘pre-seizure’ and 
‘during seizure’ event data.  Differing epoch lengths were used to calculate 
the pre seizure data with the seizure data, lead I was measured instead of 
lead II and there was no explanation as to whether different normal limits 
were applied to gender and age differences by these authors. By comparison, 
this study used a standard epoch length of 9 seconds to measure 9 
consecutive beats in order to calculate the corrected Q-T prior to the seizure  
and throughout the seizure as described in the methodology. Lead II is also 
generally recommended instead of lead 1 so that the U wave is not included 
in the Q-T measurement. 
The ‘Lockstep Phenomenon’ and SUDEP. 
In this study, sub-clinical seizures demonstrated marked corrected Q-T 
lengthening particularly with seizures arising from the right hemisphere. A 
mechanism called the ‘lockstep phenomenon’ is described in a study by 
Lathers et al (1987) of anaesthetised cats where ‘the sympathetic discharge 
was synchronised with epileptogenic activity and associated with changes in 
Section Two 
 311 
the electrocardiogram.’ The changes during an epileptiform discharge were 
shown to alter the sympathetic activity and caused an alteration of peripheral 
efferent discharge to the heart. Lathers postulated that the lockstep 
phenomenon maybe a factor of SUDEP where there has been no evidence of 
a clinical seizure around the time of death. Increases in corrected Q-T during 
sub-clinical seizures are not related to exercise as no physical exertion takes 
place and therefore must have an intrinsic basis. Hypothetically, a sudden 
and intense electrical discharge caused by a sub-clinical seizure could 
directly alter the peripheral efferent discharge to the heart causing 
lengthening of the corrected Q-T and lead to a cardiac arrhythmia.  
The Effects of Hemisphere Laterality of Seizure Activity. 
The results of corrected Q-T differences relating to hemisphere laterality may 
be due to physiological differences of innervation pathways. Cheung (2000) 
describes ‘There is clinical evidence of lateralization in neurocardiac control.’  
Intra-operative stimulation of the insula and amygdala has demonstrated 
that the right cerebral hemisphere mainly modulates sympathetic activity. 
Nouri supports this finding ‘ stimulation of the left anterior insula cause a 
bradycardia whereas stimulation of the right insular cortex induces 
tachycardia’ Rugg-Gunn et al (2004), reported that there was no effect of 
seizure lateralisation on heart rate but continue to explain that their study 
was not large enough to allow detailed analysis of this. 
Study Limitations 
Studies of larger sample sizes with controlled drug monotherapy and 
polytherapy analyses may be useful in the investigation of any contributing 
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effect on lengthening of the corrected Q-T. However, a previous study 
reported that there was no evidence of QTc prolongation detected in patients 
receiving anti-epileptic drug monotherapy or polytherapy in a paediatric 
group (Soonhak et al 2003). 
Effects of diurnal variation, effects of winter months on adult male subjects 
and stages of sleep were not quantified in this study.  
2.10.2 Future Studies 
Continued research analysing corrected Q-T in larger populations of people 
with epilepsy may provide risk stratification of SUDEP for different seizure 
types. 
2.10.3 Conclusion  
One of the main aims of this study was to determine if there was any 
lengthening of the corrected Q-T during epileptic seizures. This study has 
indicated that significant lengthening of the corrected Q-T beyond normal 
limits in children and adults transiently occurs during some epileptic 
seizures. Prolonged corrected Q-T is associated with an increased risk of 
cardiac arrhythmia and this study supports the possibility that this 
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Introduction. To measure reflex and tonic vagal activity using the 
NeuroScope and BioSignal software during sub-clinical seizures. Methods 
Video-EEG/ECG/SAO2 telemetry patients were included in the prospective 
study. Sub-clinical seizures were identified electrographically during stage 3 
or 4 sleep. R-R intervals were measured one minute prior to the onset of the 
sub-clinical seizure and until the sub-clinical seizure had ended. A matched 
R-R baseline was selected from non-sub-clinical seizure trace during stage 3 
or 4 sleep. R-R interval data were analysed by the NeuroScope for cardiac 
index of parasympathetic activity (CIPA). Short-term Heart Rate Variability 
(HRV) was then analysed with the selected section of R-R intervals 
embedded within 5minute period of baseline data and sub-clinical seizure 
data.    Results A total of 33 sub-clinical seizures from eleven patients were 
analysed. 19 generalised sub-clinical seizures (two patients), 9 right temporal 
lobe sub-clinical seizures (five patients) and 5 left temporal lobe sub-clinical 
seizures (four patients) were compared to matched baseline studies. Clear 
altered parasympathetic activity occurs during total sub-clinical seizures in 
both CIPA (p<0.001) and 5minute HRV HF% (p=0.026) compared to matched 
baseline data. Generalised sub-clinical seizures resulted in increased cardiac 
parasympathetic activity and low coefficient of variation of R-R intervals 
compared to a decrease in cardiac parasympathetic activity and high 
coefficient of variation of R-R intervals during temporal lobe seizures. 
Conclusion This study favours the view that generalised seizures could 
result in autonomic instability and may be one of the contributing factors in 





















The evidence of mechanisms involved in Sudden Unexpected Death in 
Epilepsy is yet to be proven (SUDEP). A proposed definition by Nashef & 
Shorvon (1997) is a “sudden, unexpected, witnessed or un-witnessed, non-
traumatic and non-drowning death in patients with epilepsy, with or 
without evidence of a seizure and excluding documented status epilepticus, 
where post-mortem examination does not reveal any toxicological or 
anatomical cause of death” Alterations in autonomic control during seizures 
are well documented e.g. alterations in heart rate and respiration, cardiac 
dysrhythmias and respiratory arrest, sweating, pallor, urinary and bowel 
incontinence.  
A measure of autonomic changes during different types of seizures may give 
some insight as to a possible mechanism involved during sudden 
unexpected death in epilepsy. A study by Al-Aweel et al (1999) investigated 
post-ictal heart rate oscillations in partial/ focal epilepsy. They reported a 
type of ‘ringing’ oscillation pattern following focal seizures distinct from the 
increase in sympathetic activity and vagal withdrawal. Their conclusions 




Beat to beat variation of heart rate is partly due to influences of the 
autonomic nervous system innervating the sinus node. Loss of this variation 
is widely considered to be a measure of risk for sudden death in myocardial 
infarction patients (Bigger et al 1984, Kleiger et al 1987, Malpas 2002, Miller et 
al 2004). Cardiac vagal tone is a measurement of parasympathetic activity 
and is analysed in this study using the NeuroScope measuring baroreflex 
cardiac vagal tone and BioSignal HRV measuring tonic vagal activity. 
Measurements of cardiac index of parasympathetic activity (CIPA) and heart 
rate variability analyses during clinical seizures are impossible to interpret 
due to influencing factors including alteration in body position and physical 
movement and increased cardiologic demand, changes in conscious level, 
alteration in temperature etc. However, it is possible to measure cardiac 
vagal tone during sub-clinical seizures where no perceived alteration occurs 
in conscious level during non-REM sleep where there is no physical activity 
or change in body position to alter blood pressure and heart rate. Sub-clinical 
seizures have been defined as “electroencephalographic ictal-like patterns 
without any disturbance of motor, sensory and conscious functions in the 
wake patient and without any movement or arousal during sleep” 
(Zangaladze et al 2008). 
Sometimes in cases of sudden unexpected death in epilepsy (SUDEP) there is 
no evidence of the victim having had a seizure and no evidence of any 
anatomical or toxicological cause of death (Nashef 1997). Many researchers 
believe that death must be the result from a fatal cardiac arrhythmia or 
respiratory arrest mediated by a seizure source (Ansakorpi 2000, Healy et al 
1995, Novak et al 1999). Alteration of autonomic activity driven by seizures 
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and sub-clinical seizures may lead to cardiac or respiratory instability and 
may be the underlying cause of SUDEP in some cases. 
Autonomic manifestations during seizures are common. The aim of this 
study is to measure cardiac vagal tone and heart rate variability during sub-
clinical seizures where there is no perceived alteration in body position 
(orthostatic stress), conscious level and where sleep state remains unchanged 
and no physical activity occurs. The data will be collected from the same 
cohort of patients from the original study group of whom some have been 
included in corrected Q-T analysis in the previous thesis section.  
3.1.2 The NeuroScope. 
A method for physiological measurement of neuro-cardiological control. 
Cardiac vagal tone is a measure of medullary cardio-inhibition. Medullary 
cardio-inhibition has its motor nucleus in the Nucleus Ambiguus (NA) of the 
medulla oblongata, its efferent pathway is entirely in the vagus. It is the only 
parasympathetic activity of the heart. During ventricular systole, brief 
elevation of blood pressure stretches arterial smooth muscle and stimulates 
baroreceptors in the vessel lining. This causes a reflex response (240msec in 
humans) of the baroreceptor to sino-atrial node via the vagal nerve, directly 
modulating the firing rate of the sino-atrial node, gradually slowing the heart 
and increasing the R-R intervals on a beat-by-beat basis (Little et al 1999, 
Murray et al 2001). This increase in R-R interval slowing the heart is 
proportional to the concentration of acetylcholine at the sino-atrial node 
accumulated by the release from vagal stimulation of synaptic vesicles but 
also remaining acetylcholine neurotransmitter from the previous beat that 
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has not been degraded by acetylcholinesterase. Sympathetic control of the 
heart is slower in effect and is activated by peripheral resistance. 
The NeuroScope is described as the first brainstem monitor to be produced 
commercially, invented by Dr Peter Julu (Pontoppidan, Copenhagen, 
Denmark) and is based on a theoretical model by Katona (1970). The 
NeuroScope measures cardiac vagal tone by predicting R-R interval 
measurements based on incoming QRS signal compared to a previously 
acquired QRS template generated at the initial stage of the recording. The 
NeuroScope measures the delay in the next cardiac cycle induced by 
baroreceptor stimulation, which is proportional to baroreceptor strength and 
duration (Little et al 1999). The physiological ECG signal is sampled at a very 
high sampling rate of 5KHz to ensure precise identification of the peak of the 
‘R’ wave and accurate R-R intervals. Ectoptic beats and electromyographic 
artefact must not be included in data for analysis. 
The NeuroScope generates a QRS template and compares this to incoming 
QRS signals. Using high pass and low pass filters and integrators the High 
Frequency oscillation signal amplitude is extracted, so that the vagal signal is 
isolated and changes in heart beat variation are converted to a linear scale 
called the Cardiac Index of Parasympathetic Activity (CIPA) and has been 
shown to be a sensitive and specific measure of vagal activity (Julu 1992, 
Little et al 1999). The NeuroScope detects pulse-synchronised delays in the 
onset of successive cardiac cycles as phase-shifts and quantifies these delays 
in milliseconds independently from respiration and heart rate (Julu 1992, 
Little et al 1999). CIPA is defined as “the increase in pulse interval per unit 
increase in systolic pressure” (Smeets et al 2006) and measured on an 
arbitrary scale of 1-10 based on studies of supine resting healthy volunteers 
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in response to atropine and uses a zero reference point. An output 
measurement 1-4 units represents low cardiac vagal tone and 5-10 units 
represents the normal range of Cardiac Index of Parasympathetic Activity 
(CIPA), (Murray et al 2001). However, in a review article by McKechnie et al 
(2002) they suggested that the upper limit of normal should be extended.  
Since the NeuroScope quantifies the effects of the baroreflex on the pulse 
intervals on a beat-by-beat basis, it can output the CIPA results on this basis 
and can therefore give real-time measurements of cardiac vagal tone. 
3.1.3 BioSignal Heart Rate Variability 
The Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology (1996) produced 
standards of measurements, physiological interpretation and clinical use 
made the following statement:- 
‘The last two decades have witnessed the recognition of a significant 
relationship between the autonomic nervous system and cardiovascular 
mortality, including sudden cardiac death. Experimental evidence for an 
association between the propensity for lethal arrhythmias and signs of either 
increased sympathetic or reduced vagal activity has spurred efforts for the 
development of quantitative markers of autonomic activity. Heart Rate 
Variability represents one of the most promising such markers.’  
Many factors have to be considered when using this type of measurement. 
Body position should be recumbent or semi-recumbent with no physical 
movement to produce any visceral changes to the passive autonomic balance 
of the sympathetic and parasympathetic nervous system at rest. Regular 
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respiration, normal resting body temperature and consistency in recordings 
should all be made either nocturnally or in daylight hours due to circadian 
cycle influences on vagal tone. 
BioSignal Heart Rate Variability Software. 
Heart Rate Variability is the comparison of sequential R-R intervals from 
ECG recordings. The changes in time domain R-R interval can be plotted on 
a Tachogram and ranges of heart rate for a selected period can be quantified. 
Several measurements can be made from the time domain R-R interval 
including the mean and the standard deviation (SDNN). The standard 
deviation measures the overall variation in the R-R interval (or Normal to 
Normal beat interval). The root mean square of the differences of consecutive 
R-R intervals is known as RMSSD. The NN50 gives the number of 
consecutive intervals that increase by more than 50 milliseconds and the 
pNN50 is the percentage value of NN50 intervals.   
The Time Domain R-R interval tachogram is interpolated using a cubic 
interpolation at a default ratio of 4Hz prior to spectrum estimation. 
Frequency Domain is displayed separately for Welch’s Periodogram Fast 
Fourier Transform (FFT) and an autoregressive modelling based spectrum 
(AR). Frequency oscillations are quantified and displayed as a power spectral 
density once any leakage current frequencies are removed using a Hamming 
window filter. The power spectral density is calculated by BioSignal software 
producing powers and peak frequencies for different frequency bands. The 
frequency bands are very low frequency (VLF, 0-0.04Hz), low frequency (LF, 
0.04-0.15Hz) and high frequency (HF, 0.15-0.4Hz). In this study, only HF will 
be considered, as it is believed to be a measure confined to parasympathetic 
vagal activity. Heart Rate Variability functional indices are based on 
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generalisations of cardiac sympathetic and parasympathetic activity.  Low 
frequency (LF) HRV is believed to be a mixture of both sympathetic and 
parasympathetic activity and Very Low Frequency (VLF) signal reflects 
rennin-angiotensin-aldosterone hormonal interplay of the autonomic 
nervous system. 
The use of HRV in the clinical setting has not been evaluated in each disease 
to know what the expected measurement should be in different disease 
processes.  Shifts in spectral density of LF and HF signal can be quantified 
during events but there are no pre-determined normal values and only 
general description of the changes can be described at this stage until 
comparisons to other disease processes are made in the future. In this study, 
HRV will be analysed using advanced HRV BioSignal software which was 
developed by Juha-Pekka Niskanen, Mika P. Tarvainen, Perttu O. Ranta-aho 
and Pasi A. Karjalainen, University of Kuopio, Department of Applied 
Physics, Finland in conjunction with the Kuopio university Hospital and the 
Brain@Work –Laboratory of the Finnish Institute of Occupational Health 
using a Matlab platform for event-related BioSignal analysis (2002).  
3.1.4 Aims and Limitations 
 To measure and analyse counted R-R intervals during 
electroencephalographic sub-clinical seizures from the original study 
group of patients and compare this to non sub-clinical seizure baseline 
counted R-R intervals taken from the same stage of sleep from the 
same patients’ recordings using the NeuroScope to determine cardiac 
index of parasympathetic activity (CIPA). In effect, the patients act as 
their own controls. 
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 To analyse the same counted R-R interval data collected for the 
NeuroScope (CIPA) and directly compare results with BioSignal 
software. 
 To measure and analyse R-R intervals using traditional 5 minute 
epochs encapsulating the electroencephalographic sub-clinical seizure 
and compare this to a baseline 5 minute epoch taken from the same 
stage of sleep and processed using BioSignal Heart Rate Variability. 
 To quantify and compare the high frequency (HF) component 
produced by the BioSignal Heart Rate Variability software between 
counted epochs and 5 minute epochs. 
 To assess sub-clinical seizure laterality for CIPA and HF Heart Rate 
Variability. 
 To group data and compare differences for adult and paediatric CIPA 
and HF Heart Rate Variability.  
 To compare results from NeuroScope CIPA and BioSignal HRV 
software using R-R intervals, CIPA and High Frequency (HF) data.  
 To assess effects of anti-epileptic medication monotherapy and 





Exclusions and limitations of Data comparisons 
 It is recognised that it is inappropriate to compare different lengths of 
time domain data and “counted” BioSignal Heart Rate Variability 
should not be directly compared with the 5 minute BioSignal Heart 
Rate Variability analysis. However, for the purposes of this study, 
deliberate comparisons will be made of NeuroScope, “counted” and 5 
minute HRV HF to determine whether shorter epochs can provide 
similar results when investigating changes in parasympathetic control 
during brief sub-clinical seizures which may be lost over longer 
epochs. 
 Clinical seizures cannot be investigated for changes in vagal tone due 
to alterations in autonomic control related to changes in conscious 
levels e.g. from sleep to wakefulness, body position, voluntary muscle 
activity and catecholamine release and temperature change. These all 
alter autonomic balance and would therefore make interpretation of 
CIPA or Heart Rate Variability impossible.  
 Limitations of number of original study patients with sub-clinical 
seizures arising from the same stage of sleep meant that only a few 
could be included in the analysis of cardiac vagal tone. Ideally, many 
more patients would have to be included for this study to be age and 
sex matched if the study had been designed to analyse sub-clinical 
seizures from the outset. In this study it was only possible to group 
adults and paediatric data instead of age-matched data. 
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 Manual measurements are extremely time consuming but are 
necessary for importing R-R intervals via Excel and then transformed 
to MSDOS for BioSignal analysis. In this study, a total of twenty-seven 
thousand, one hundred and fifty one R-R interval measurements were 
manually measured for 5 minutes data analysis. Clearly, this is a time-
limiting factor and a larger study would require a reliable method of 
automated peak detection software. Automated peak detection 
software other than the NeuroScope was investigated but the software 
was very inaccurate. Manual measurement of the R-R interval was 
preferred to ensure reliable data. 
3.1.5 Null Hypotheses 
 There are no differences in CIPA or Heart Rate Variability parameters 
when comparing baseline measurements with sub-clinical seizure 
measurements whether “counted” or during 5 minutes epochs. 
 There are no differences when comparing CIPA or Heart Rate 
Variability parameters for laterality of sub-clinical seizures or 
generalised sub-clinical seizures. 
 There is no difference when comparing paediatric and adult CIPA or 
Heart Rate Variability HF%  
 There is no difference in “scatter” or co-efficient of variation 
comparing baseline data with sub-clinical data for total, lateralised or 






3.2.1 Video-EEG/ECG/SAO2 telemetry. 
Sub-clinical electroencephalographic seizures were captured and identified 
on XLTEK videotelemetry equipment from the original study group data 
(Ethical approval LREC/2003/6/22). Video enhancement was used to ensure 
that there were no clinical manifestations accompanying the sub-clinical 
seizures and all patients were lying in a recumbent position. Twenty-three 
silver silver-chloride electrodes including surface sphenoidal were applied to 
the patient’s scalp in accordance to the international 10:20 electrode 
placement system. Conductive gel filled each electrode with skin impedance 
below 10 kilo-ohms. Modified lead II ECG, oxygen saturation and integrated 
video were recorded simultaneously with the electrographic signals. XLTEK 
sampling rate for ECG signal was 500Hz with a digital chart speed of 
30mm/sec. High frequency filter (low pass) was 150Hz and low frequency 
filter (high pass/time constant) was 0.5Hz. This bandwidth exceeds the 
minimum requirements set out by the American Heart Association’s 
recommendations for recording physiological electrocardiographic data 
(Bailey et al 1990). 
3.2.2  NeuroScope and “Counted” BioSignal HRV analysis. 
The start of the sample was taken 1 minute prior to the sub-clinical 
electrographic change to ensure that any cardiac vagal tone changes just 
prior to sub-clinical seizure onset were not omitted. The end of the sample 
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was where the sub-clinical seizure ended electrographically and the resting 
trace was resumed.  R-R intervals were counted manually for each sub-
clinical seizure duration and a matched baseline count was selected from the 
same stage 3 or 4 slow wave sleep (Rechtschaffen & Kales 1968, Carskadon & 
Rechtschaffen 1994) or “N3 or N4” stage as defined by the American 
Academy of Sleep Medicine (2007) in which the sub-clinical seizure had 
occurred, for baseline measurements. The baseline matched R-R intervals 
were compared to data derived to R-R intervals during the sub-clinical 
seizures. Manual selection of R-R interval sections ensured that the trace was 
artefact free, void of waking or movement or change in sleep stage and any 
ectoptic beats could be excluded. All patients were in sinus rhythm 
throughout. No patients were known to have diabetes or coronary heart 
disease. 
HRV measurements cannot be compared to files of different lengths and 
therefore individual patients cannot be compared to another. However, the 
baseline and sub-clinical files per patient can be compared to each other as 
they are heartbeat matched and act as their own control. Total patient 
baseline and sub-clinical files can also be compared, as they are summated 
matched data for baseline compared to sub-clinical data. 
The data used for the CIPA analysis was then converted from Excel 
spreadsheets into Text (MSDOS) files and then imported into BioSignal 
Analysis software. Identical R-R data used in the CIPA analysis was 
therefore used in the counted HRV analysis. Categories of High Frequency 
(HF, representing the parasympathetic component of heart rate variability 
analysis) and R-R interval analysis compared total sub-clinical data with total 
baseline data using Minitab version 14. Skewed distribution of total data 
Section Three 
 342 
meant that nonparametric analysis was required using Wilcoxon two sample 
testing. Comparisons of baseline and sub-clinical data were also analysed in 
terms of hemisphere laterality and generalised sub-clinical seizures.  
Coefficient of variation was calculated for grouped data to determine scatter 
of HF data. HF% data was interpreted from the BioSignal software and 
displayed with limits of agreement calculated using Bland & Altman plots 
(Bland & Altman 1983, 1986). 
The High Frequency (HF%) band of heart rate variability frequency domain 
analysis is considered to represent cardiac vagal tone. This is the closest 
equivalent to CIPA in measuring vagal tone. Like CIPA, a decrease in HF% 
indicates a reduction of cardiac vagal tone resulting in an increase in heart 
rate and vice versa.  
3.2.3 BioSignal 5 minute HRV Analysis 
R-R intervals of sub-clinical seizures analysed for ‘counted’ HRV and CIPA 
analysis were embedded within a 5 minute epoch of R-R intervals for 
BioSignal analysis. Matched 5 minute R-R interval baseline studies for each 
patient were again selected within the same stage of sleep as the sub-clinical 
seizure for each patient and imported into BioSignal software for comparison 
to sub-clinical R-R intervals. R-R intervals were manually measured for all 5 
minute sub-clinical and baseline studies and entered onto Excel 
spreadsheets. The spreadsheets were then converted to Text (MSDOS) files 
and imported into Bio-Signal analysis software.  
R-R interval, High Frequency (HF, parasympathetic component) data were 
analysed for individual and grouped data. Wilcoxon two sample testing was 
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performed on data with a tailed distribution. Data is displayed and limits of 
agreement calculated using Bland & Altman plots (Bland & Altman 1983, 
1986). Coefficient of Variation was performed to indicate scatter on grouped 
data. Data is displayed at ± 2 standard deviations. 
3.2.4 Multivariate analysis on the effects of Anti-Epileptic Drugs 
on CIPA 
Multivariant analysis on the effects of Anti-Epileptic Drugs was performed 
on CIPA data derived from patients and analysed in terms of monotherapy, 
polytherapy and those patients not receiving any anti-epileptic drug (AED). 
Analysis was performed using One-way ANOVA for comparisons of means 
in each category, Minitab version 14  
3.2.5 Inter & Intra-observer analysis.  
Consecutive R-R intervals (n=369) over a selected 5 minutes period were 
manually measured in a blind controlled trial by a qualified cardiographer 
(Observer 1) and compared to values measured by myself (Observer 2) from 
the same selected 5 minutes period. Low Frequency Filter (1.0Hz) and High 
Frequency Filter (70Hz) settings were the same and the gain sensitivity was 
50uv/mm and the Notch Filter was off on the XLTEK 
electroencephalographic / electrocardiographic display. 
The R-R intervals were listed onto an Excel spreadsheet and matched and 
unmatched R-R intervals identified and counted. The data was imported into 
Minitab version 14 and descriptive statistics were performed. The data was 
also imported into BioSignal software and HRV was analysed from each 
observer sample and statistical analysis compared.  
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Bland Altman plots (Bland & Altman 1983, 1986) are plotted to show 
distribution of differences in observer analysis. Histograms were created to 
show distribution curves and differences between observer measurements. 
Boxplots were used to demonstrate distribution of R-R interval 
measurements for each observer with whisker outlier limits. Paired t testing 
was appropriate for this data with normal distribution. A Kappa statistic 
could not be used in this analysis as R-R intervals are continuous data and 
there is no ‘normal’ value to test against for observer agreement. 
3.2.6 Statistical analysis. 
Statistical analyses compared total sub-clinical CIPA with total baseline CIPA 
data using Minitab version 14. Tailed distribution of total data meant that 
nonparametric analysis was required using Wilcoxon paired sample testing. 
Comparisons of data were also analysed in terms of hemisphere laterality of 
sub-clinical seizures and generalised sub-clinical seizures. Mean CIPA were 
calculated for each group to allow for data comparison with BioSignal HF% 
HRV. Bland & Altman plots (Bland & Altman 1983, 1986) are used to display 
limits of agreement to give a range of results in each area of analysis. Data is 
described to ± 2 standard deviations. One-way ANOVA is applied to test 
variance of data within individuals and between individuals. Bonferroni 
correction is applied for multiple measurements of repeated sub-clinical 






Chapter 21: Results 
3.3.1 Patient Demographics 
Patient 
ID 

















































































Nil Nil. Commenced 






























































Table 1 Section 3 Patient Demographics 
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3.3.2 Results: R-R interval Analysis prior to NeuroScope 
Conversion 
Thirty-three R-R counted (R-R n=8583) sub-clinical seizures and matched R-R 
counted (R-R n=8583) baseline measurements were analysed from 11 original 
study group patients (Table 1) with an age range of 3 years 1 month to 60 
years 3 months (mean age 23.1 ± 18.7 years). Six patients were adults (3 male 
and 3 female, mean age of 35.8 ± 16.0 years) and 5 patients were paediatric (4 
male and 1 female, mean age of 7.8 ± 4.8 years). Nine sub-clinical seizures 
(Sub-clinical R-R intervals n=2688 & Baseline R-R intervals n=2688) were 
derived from the right temporal lobe (5 patients: 3 adults; 3 seizures & 2 
paediatrics; 6 seizures) and five sub-clinical seizures (Sub-clinical R-R 
intervals n=1307 & Baseline R-R intervals n=1307) were derived from the left 
temporal lobe (4 patients: 3 adults; 3 seizures & 1 paediatric; 2 seizures). 
Nineteen generalised sub-clinical seizures (Sub-clinical R-R intervals n=4588 
& Baseline R-R intervals n=4588) were analysed from two paediatric patients. 









R-R interval analysis of raw input data prior to analysis using the 
NeuroScope or BioSignal software. 
 



























Right Counted R-R Baseline vs Right Counted R-R Subclinical n=5376 (Baseline 2688, Subclinical 2688)
Figure 1 Scatterplot of R-R intervals during right temporal lobe sub-clinical 
seizures versus matched baseline R-R intervals 


















































Right Counted R-R Diff B-S vs Right Counted R-R Ave B+S  n=5376  (2688 Baseline 2688 subclinical)
Figure 2 Bland & Altman scatterplot of the difference (Baseline minus sub-
clinical) versus average of R-R intervals during right temporal sub-clinical 
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Right Counted R-R Baseline
Right Counted R-R Subclinical
Normal 
Right Counted R-R Baseline, Right Counted R-R Subclinical
 
Figure 3 Histogram of Baseline R-R intervals & Sub-clinical R-R intervals 
during right temporal lobe sub-clinical seizures. 
 
Analysis of R-R intervals during right temporal seizures compared to 
baseline show a decrease in interval (Figure 3) and therefore indicates an 
overall increase in heart rate (p<0.001). The limits of agreement (–83 and 432) 
























Table 2 Baseline & sub-clinical R-R intervals for patients with right temporal 
lobe sub-clinical seizures. 
During right temporal sub-clinical seizures, R-R intervals show an average 
shortening from 917.1 to 742.5 milliseconds (p<0.001) indicating an increase 
in heart rate (65.4/min to 80.8/min). A mean difference of 175 ± 257 
milliseconds increase with limits of agreement (-83) and 432 milliseconds 





      
 
   n 
     Right Temporal Counted R-R  
Difference 
  Median 
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       Baseline      Sub-clinical  










132 1084     7.8 840    17.4      247 0.158 
 
Patient 2 
257 920     5.2 750     6.6      159    0.449 
 
Patient 2 
327 925     5.1 758     6.3      164    0.293 
 
Patient 2 
408 924     5.2 724     6.4      196 0.308 
 
Patient 2 
363 927     5.2 729     5.9      184 0.652 
 
Patient 2 
373 923     5.2 696     3.8      224 0.601 
Total  
Patient 2 
1728 923     5.2 764     6.7      231 0.109 
 
Patient 3 
359 904     8.4 578    29.2      300 0.003 
 
Patient 4 
123 1236    11.6 1140    14.5      106 0.705 
 
Patient 5 













      18.1 
 































Left Counted R-R Subclinical vs Left Counted R-R Baseline  n=2614 (Basleine 1307, Subclinical 1307)
Figure 4 Scatterplot of R-R intervals during left temporal lobe sub-clinical 
seizures versus matched baseline R-R intervals 
















































Left Counted R-R Diff B-S vs Left Counted R-R Ave B+S n=2614 (Baseline 1307, Subclinical 1307)
Figure 5 Bland & Altman scatterplot of the difference (Baseline minus sub-
clinical) versus average of R-R intervals during right temporal sub-clinical 






























Left Counted R-R Baseline , Left Counted R-R Subclinical
 
Figure 6 Histogram of Baseline R-R intervals & Sub-clinical R-R intervals 
during left temporal lobe sub-clinical seizures 
 
The analysis of R-R interval data during left temporal lobe data compared to 
baseline shows an overall shortening of R-R intervals (Figure 6), (p<0.001). 
The limits of agreement (–242 and 493) give a range of 735 milliseconds (95% 








Table 3 Baseline & sub-clinical R-R intervals for patients with left temporal 
lobe sub-clinical seizures. 
 
 
A shortening occurs on average during left temporal sub-clinical seizures 
from 899.0 to 773.3 milliseconds (p<0.001) again indicating an increase in 
heart rate (66.7/min to 77.6/min). A mean difference of 126 ± 367 milliseconds 
with limits of agreement (-242) and 493 milliseconds occur during left 
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Gen Counted R-R Baseline vs Gen Counted R-R Subclinical  n=9176 (Baseline 4588, Subclinical 4588)
Figure 7 Scatterplot of R-R intervals during generalised sub-clinical seizures 
versus matched baseline R-R intervals 















































Gen Counted R-R Diff B-S vs Gen Counted R-R Ave B+S n=9176 (Baseline 4588, Subclinical 4588)
Figure 8 Bland & Altman scatterplot of the difference (Baseline minus sub- 
clinical) versus average of R-R intervals during generalised sub-clinical 































Generalised R-R Baseline, Generalised R-R Subclinical
 
Figure 9 Histogram of Baseline R-R intervals & Sub-clinical R-R intervals 
during generalised sub-clinical seizures 
The analysis of R-R interval data of generalised sub-clinical data compared to 
baseline shows an overall increase in R-R interval data (Figure 9), (p<0.001). 
The limits of agreement (–196 and 80) give a range of 276 milliseconds (95% 
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Table 4 (above) Baseline & sub-clinical R-R intervals for patients with 
generalised sub-clinical seizures 
In contrast with R-R intervals derived during right and left temporal sub-
clinical seizures, generalised sub-clinical seizures show a mean increase in R-
R interval 628.9 to 687.0 milliseconds (p<0.001), indicating a decrease in heart 
rate (95.4/min to 87.3/min). A mean difference of (–58) ± 138 milliseconds 
with limits of agreement (-196) and 80msec occurred during generalised sub-
clinical seizures (Figure 8, Table 2). 
Counted R-R Interval 
Descriptive Data 
n Baseline  
R-R 
n Sub-clinical  
R-R 









    742.5 





















Right Temporal  









Left Temporal  


















































Table 5 Descriptive statistics for Baseline and Sub-clinical R-R during right 




R-R interval analysis shows a statistically significant difference between 
baseline and sub-clinical data (p<0.001), (Figures 3, 6 & 9). Generalised sub-
clinical seizures demonstrate a much tighter co-efficient of variation of R-R 
interval data despite having a much larger pool of data (n=9176) compared to 
right temporal data (n=5376) and left temporal data (n=2614), (Table 2). The 
co-efficient of data reflects the amount of “scatter” of data and generalised 
baseline data has coefficient of data (6.9) which is half or less than half of that 
seen during right temporal baseline data (12.8) and left temporal baseline 
data (15.1). All data shows an overall increase in coefficient of variation 
during sub-clinical seizures compared to baseline measurement but 
generalised data still remains much tighter with an average value of 12.9 
compared to right temporal sub-clinical seizures (18.1) and left temporal sub-





















3.3.3 NeuroScope Results: Total Sub-clinical Seizures 
Patient 
ID 
          Baseline CIPA 
 










   p</= 















Pt 1 132 14.6 14.6 55.7 132 7.8 8.0 71.2 146 0.032 
Pt 2 257 10.4 10.4 65.8 257 8.5 8.6 80.2 259 0.074 
Pt 2 327 10.7 10.9 65.3 327 9.7 9.2 79.0 232 0.094 
Pt 2 408 10.8 10.8 65.2 408 8.7 8.5 82.1 202 0.001 
Pt 2 363 10.9 10.9 65.2 363 9.0 8.9 81.4 253 0.926 
Pt 2 373 10.7 10.7 65.1 373 4.7 4.6 86.3 317 0.017 
Pt 3 359 12.0 12.0 67.4 359 4.4 2.3 100.5 269 0.019 
Pt 4 123 28.3 24.6 50.0 123 21.2 22.4 55.4 261 0.949 
Pt 5 346 17.1 15.8 80.8 346 15.2 16.6 86.8 139 0.002 
Pt 6 52 17.7 17.6 56.6 52 15.1 15.9 62.7 313 0.420 
Pt7 404 17.8 17.6 75.6 404 12.9 13.2 79.7 159 0.604 
Pt 7 306 18.0 17.8 76.0 306 16.9 17.0 76.4 149 0.296 
Pt 8 211 16.4 14.8 56.3 211 6.7 6.1 62.6 161 0.152 
Pt 9 334 4.9 4.6 61.6 334 1.3 0.9 98.6 218 0.485 
Pt 10 322 3.5 3.6 97.7 322 4.0 3.4 97.0 154 0.008 
Pt 10 264 3.3 3.5 99.1 264 4.1 3.8 96.0 109 0.235 
Pt 10 272 3.3 3.5 98.9 272 4.0 3.7 97.1 108 0.280 
Pt 10 241 3.3 3.5 99.3 241 4.9 4.3 95.4 98 0.004 
Pt 10 347 3.4 3.6 98.0 347 3.3 2.7 93.8 104 0.000 
Pt 10 340 3.4 3.6 98.1 340 4.3 3.4 91.6 93 0.013 
Pt 10 345 3.4 3.6 98.0 345 4.1 4.0 93.0 114 0.190 
Pt 10 431 3.6 3.7 97.4 431 3.0 2.2 91.1 103 0.000 
Pt 10 270 3.3 3.5 99.0 270 4.0 3.4 90.8 199 0.629 
Pt 10 374 3.5 3.6 97.8 374 3.2 2.6 92.5 234 0.000 
Pt 10 317 3.4 3.6 98.4 317 3.9 3.4 91.2 168 0.256 
Pt 11 189 4.5 3.7 88.1 189 8.1 7.7 74.2 157 0.482 
Pt 11 136 4.7 3.6 87.4 136 9.0 8.9 75.1 225 0.971 
Pt 11 131 4.8 3.7 87.3 131 8.8 7.9 72.8 223 0.424 
Pt 11 120 4.9 4.0 87.2 120 7.8 6.5 72.4 224 0.721 
Pt 11 123 4.9 3.9 87.2 123 6.4 6.5 71.1 340 0.052 
Pt 11 111 5.1 4.1 87.1 111 8.8 7.8 71.5 179 0.660 
Pt 11 133 4.8 3.7 87.3 133 9.5 9.6 71.2 243 0.376 
Pt 11 122 5.0 3.9 87.2 122 7.2 6.3 70.1 209 0.548 
Total Pts 
(mean) 
260 8.2 8.0 81.4 260.1 6.9 7.3 82.2 193 0.001 
Table 6 Total Baseline & sub-clinical Cardiac index parasympathetic activity 





A decrease in CIPA indicates reduced vagal tone and tends to result in an 
increase in heart rate and vice versa. CIPA alters during sub-clinical seizures 
compared to baseline data (p<0.001) with baseline (n=8583) CIPA 8.2 ± 6.3 























































































Right Temporal, Left Temporal & Generalised CIPA
 
Figure 10 Boxplot of Mean CIPA baseline & sub-clinical for right temporal, left 

































Right CIPA B-S Diff vs Right CIPA B+S Ave  n=5376 (Baseline 2688, Subclinical 2688)
Figure 11 Bland & Altman scatterplot of the difference (Baseline minus          
sub-clinical) versus average of CIPA during right temporal sub-clinical 
seizures. 
Limits of Agreement are (–7.00) and 14.3 




























Left B-S CIPA Diff vs Left B-S CIPA Ave  n=2614 (Baseline 1307, Subclinical 1307)
Figure 12 Bland & Altman scatterplot of the difference (Baseline minus               
sub-clinical) versus average of CIPA during left temporal sub-clinical 
seizures. Limits of Agreement are (–7.8) and 16.6. 
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Generalised CIPA B-S Diff vs Ave B+S  n=9176 (Baseline 4588, Subclinical 4588)
 
Figure 13 Bland & Altman scatterplot of the difference (Baseline minus               
sub-clinical) versus average of CIPA during generalised sub-clinical seizures 
Limits of Agreement are (–6.8) and 4.6.  
 
Sub-clinical seizures arising from the right temporal lobe have a mean 
difference of 3.64 ± 10.72 with limits of agreement (-7), 14.3 (range of 21.3). 
(Figure 11).This is fairly similar to left temporal lobe data mean difference 
4.39 ± 12.22 with limits of agreement (-7.8), 16.6 (range 24.4), (Figure 12). 
Generalised data shows a mean difference of (-1.11) ± 5.76 with limits of 





















Mean St. Dev Coef 
Var% 
Mean St Dev Coef 
Var% 
Pt 1 132 14.7 2.2 15.0 7.8 2.7 33.8 
Pt 2 257 10.4 2.1 20.6 8.5 1.8 20.7 
Pt 2 327 10.8 2.1 19.4 9.7 2.7 27.9 
Pt 2 408 10.8 2.1 19.0 8.7 2.8 31.7 
Pt 2 363 10.9 2.3 20.7 9.0 2.3 25.5 
Pt 2 373 10.7 2.2 20.5 4.7 1.2 26.1 
Pt 3 359 12.0 2.7 22.7 4.4 5.1 115.6 
Pt 4 123 28.3 8.8 31.0 21.2 5.7 27.1 
Pt 5 346 17.1 6.0 34.9 15.2 4.8 31.7 
Pt 6 52 17.7 2.5 14.2 15.2 4.7 31.3 
Pt7 404 17.8 3.2 18.2 12.9 2.9 22.9 
Pt 7 306 18.0 3.0 16.9 16.9 5.4 32.0 
Pt 8 211 16.4 7.2 44.0 6.7 3.5 51.2 
Pt 9 334 4.9 2.5 51.8 1.3 1.1 86.6 
Pt 10 322 3.5 0.8 23.3 4.0 2.2 55.8 
Pt 10 264 3.3 1.0 29.0 4.2 1.5 35.4 
Pt 10 272 3.3 0.9 28.6 4.0 1.3 32.7 
Pt 10 241 3.3 1.0 30.0 4.9 2.1 43.4 
Pt 10 347 3.4 0.9 25.6 3.3 1.6 47.5 
Pt 10 340 3.4 0.9 25.8 4.3 2.5 57.9 
Pt 10 345 3.4 0.9 25.6 4.1 1.7 40.6 
Pt 10 431 3.6 0.9 24.9 3.0 2.1 69.3 
Pt 10 270 3.3 1.0 28.7 4.0 2.4 59.6 
Pt 10 374 3.5 0.9 25.2 3.2 1.6 51.0 
Pt 10 317 3.4 0.9 26.6 4.0 2.2 55.4 
Pt 11 169 4.5 2.1 47.7 8.1 2.4 29.8 
Pt 11 136 4.7 2.5 52.2 9.0 2.0 21.8 
Pt 11 131 4.8 2.5 51.9 8.8 2.5 28.9 
Pt 11 120 4.9 2.5 51.1 7.8 2.6 33.9 
Pt 11 123 4.9 2.5 51.4 6.4 0.9 14.6 
Pt 11 111 5.1 2.6 50.4 8.8 3.1 35.4 
Pt 11 133 4.8 2.5 52.0 9.5 1.5 15.6 
Pt 11 122 5.0 2.8 56.0 7.2 2.7 37.5 
Total pts 
(mean) 
259.5 8.4 2.4 32.0 7.6 2.6 40.3 
Table 7 Descriptive statistics for baseline & sub-clinical mean CIPA for total 
sub-clinical seizures and patients. 
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Mean differences in data are analysed using Bland & Altman plots The Y-
axis determines the mean difference, limits of agreement within ± 2 standard 
deviations (95% confidence intervals) of baseline minus sub-clinical data. 
 
































Total Mean Baseline CIPA vs Total Mean Subclinical CIPA
Figure 14 Scatterplot of total mean baseline CIPA versus total mean sub-
clinical CIPA 
 


































Total Mean CIPA Diff B-S vs Total Mean CIPA Ave B+S
Figure 15 Bland & Altman scatterplot of the difference (Baseline minus               
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sub-clinical) versus average of Mean CIPA during right temporal1, left 
temporal2 and generalised sub-clinical seizures3. 


































Total log CIPA Difference B-S vs Total log CIPA Average B+S
 
Figure 16 Bland & Altman scatterplot of the difference (Baseline minus               
sub-clinical) versus average of Mean log CIPA during right temporal, left 
temporal and generalised sub-clinical seizures. 
 
Limits of agreement of log values are (-0.7) and 1.0 from this Bland & Altman 
plot. The antilog of these values are 0.5 and 2.7 which indicates that the limits 
of agreement for 95% data are between 0.5 and 2.7 change in CIPA from 
mean baseline to mean sub-clinical data for the total group.  
Looking at the mean difference for right temporal sub-clinical seizures CIPA 
difference is 3.7 ± 6.1 with limits of agreement 1.0 and 9.8 (p=0.032). Figure 19 
is similar to left temporal sub-clinical seizures CIPA difference 4.4 ± 6.5 with 
limits of agreement 1.1 and 9.7 (p=0.855), (Figure 23, Table 8).  
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Bland & Altman analysis of differences between baseline CIPA 
measurements and CIPA derived during right temporal sub-clinical seizures 
show the limits of agreement of log values 0.1 and 1.0 (Figure 16). The antilog 
of these values are 1.1 and 2.7 indicating that the limits of agreement for 95% 
data are between 1.1 and 2.7 change in CIPA from mean baseline to mean 
sub-clinical data for right temporal sub-clinical seizures. The scatter 
relationship shows all values are above zero and show a general change in 
CIPA from baseline to sub-clinical. Generally there is a marked increase in 
heart rate and a resultant decrease in CIPA as vagal tone withdraws during 
right temporal sub-clinical seizures.  
Bland & Altman analysis of differences between baseline CIPA 
measurements and CIPA derived during left temporal sub-clinical seizures 
show the limits of agreement of log values 0.1 and 1.3 (Figure 16).The antilog 
of these values are 1.1 and 3.8 indicating that the limits of agreement for 95% 
data are between 1.1 and 3.8 change in CIPA from mean baseline to mean 
sub-clinical data for left temporal sub-clinical seizures. The distribution of 
values on the plot shows a general change in CIPA from baseline to sub-
clinical. Generally there is an increase in heart rate and a correlated decrease 
in CIPA as vagal tone decreases during some left temporal sub-clinical 
seizures.  
Bland & Altman analysis of differences between baseline CIPA 
measurements and CIPA derived during generalised sub-clinical seizures 
show the limits of agreement of log values (-0.7) and 0.2 (Figure 16). The 
antilog of these values are 0.5 and 1.2 indicating that the limits of agreement 
for 95% data are between 0.5 and 1.2 change in CIPA from mean baseline to 
mean sub-clinical data for generalised sub-clinical data. The plot distribution 
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shows two distinct areas relating to each of the two patients. Both clusters are 
mainly below zero indicating that there is a consistent change in CIPA 
related to generalised sub-clinical seizures. Generally there is a small 
decrease in heart rate and a relative increase in CIPA as vagal tone increases 
during generalised sub-clinical seizures.  
Statistically, the left temporal sub-clinical data mean difference is not 
significant because of small data volume but the range of limits of agreement 
are similar to that of the right temporal sub-clinical data. Generalised mean 
data has a mean difference of (-1.6) ± 3.5 with limits of agreement are (-7.8) 











All nine sub-clinical seizures arising from the right temporal lobe indicate a 





Figure 18 Bar chart of baseline & sub-clinical CIPA for left temporal sub-
clinical seizures. 
 
All five sub-clinical seizures arising from the left temporal lobe indicate a 







Figure 19 Bar chart of baseline & sub-clinical CIPA for generalised sub-
clinical seizures. 
 
Eighty-four percent (16/19) of generalised sub-clinical seizures indicate an 
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  0.001 
 
Table 8 Bland & Altman lower and upper limits of agreement for Total and 
Mean CIPA & Mean log CIPA for right temporal, left temporal and 























































































































Table 9 Total & sub-total baseline CIPA & total & sub-total sub-clinical CIPA 




Sub-clinical seizures arising from the right temporal lobe show a decrease in 
CIPA (p<0.001) from 12.7 ± 5.3 baseline (n=2688) to 9.1 ± 5.4 sub-clinical 
(n=2688).  Similarly, sub-clinical seizures arising from the left temporal lobe 
also decreased CIPA (p<0.001) from baseline 14.3 ± 6.8 (n=1307) to sub-clinical 
10.0 ± 6.9 (n=1307).  Conversely, generalised sub-clinical seizures indicate 
increased CIPA (p<0.001) from 3.7 ± 1.5 baseline (n=4588) to 4.8 ± 2.8 sub-
clinical (n=4588), (Table 9). An increase in CIPA reflects increased vagal tone 
during generalised sub-clinical seizure electroencephalographic activity and 
results in decreased heart rate. This result is consistent with that shown in 
the R-R analysis (Tables 2, 3 & 4). 
 












Standard Deviation for Total, Right, Left & Generalised CIPA Difference B-S
 
Figure 20 Boxplot of standard deviation of CIPA for total, right temporal, left 
temporal and generalised sub-clinical seizures. 
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Total Mean StDev Baseline CIPA vs Total Mean StDev Subclinical CIPA
Figure 21 Scatterplot of baseline mean CIPA standard deviation versus mean 
sub-clinical CIPA standard deviation for right temporal, left temporal and 
generalised sub-clinical seizures. 
 













































Total Mean Counted StDev.log CIPA Diff B-S vs Total Mean Counted StDev. log CIPA Ave B+S
 
Figure 22 Bland & Altman scatterplot of mean CIPA standard deviation 
difference (baseline minus sub-clinical) versus average for right temporal, left 
temporal and generalised sub-clinical seizures. 
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Limits of agreement of log values for total data are 0.8 and 1.0 from the Bland 
& Altman plot. The antilog of these values are 0.4 and 2.3 indicating that the 
limits of agreement for 95% data are between 0.4 and 2.3 change in CIPA 
standard deviation from mean baseline to mean sub-clinical data for total 
seizures. Limits of agreement of log values are (-0.6) and 0.6 from CIPA data 
derived during right temporal sub-clinical seizures. The antilog is 0.5 and 1.8 
(range 1.3). Limits of agreement of log values are (-0.6) and 0.8 from CIPA 
derived during left temporal sub-clinical seizures. The antilog of these values 
are 0.5 and 2 (range is 1.5) Limits of agreement of log values are (–1.048) and 
0.507 from CIPA derived during generalised sub-clinical seizures. The 
antilogs of these values are 0.4 and 1.7 (range 1.3).  
The largest standard deviation difference between baseline and sub-clinical 
seizures is found in left temporal sub-clinical seizures of 1.726 compared to 
right temporal sub-clinical seizures standard deviation of 1.261 and 
generalised sub-clinical seizures standard deviation of 1.31. A possible 
reason for this could be that standard deviation generally decreases or 









3.3.5 Right Temporal Sub-clinical Seizures 
 
 
Table 10 Total & sub-total median baseline minus sub-clinical CIPA for right 








      n   Right Temporal Median CIPA  
Difference 
  Median 





  p</= 




132          14.5           8.0       5.9     0.032 
 
Patient 2 
257          10.4           8.6      1.5     0.074 
 
Patient 2 
327          10.9           9.2      1.5     0.094 
 
Patient 2 
408          10.8           8.5       2.8      0.001 
 
Patient 2 
363          10.9           8.9      1.9      0.926 
 
Patient 2 
373          10.7           4.6       5.7      0.017 
Total  
Patient 2 
1728           
         10.7 
           
          8.0 
     
      2.9 
 
 
    0.036 
 
Patient 3 
359          12.0           2.3       8.8     0.019 
 
Patient 4 
123          24.6          22.4       7.1     0.949 
 
Patient 5 











































Right Heart Rate B-S Difference vs B+S Average  n=2688
Figure 23 Bland & Altman scatterplot for heart rate difference (baseline minus 
sub-clinical) versus average for right temporal lobe seizures. 
























Scatterplot of Right Temporal Sub-clinical HR vs Baseline HR
Figure 24 Scatterplot of baseline heart rate versus sub-clinical heart rate 












Boxplot of Right Temporal Baseline Heart Rate, Sub-clinical Heart Rate (Bpm)
 
Figure 25 Boxplot of baseline heart rate and sub-clinical heart rate for right 
sub-clinical seizures. 
 
An overall increase in heart rate is seen during sub-clinical seizures arising 
from the right temporal lobe compared to matched baseline studies (Figure 
25). A mean difference in heart rate of 16.9/minute is found using Bland & 




















              Baseline CIPA          Sub-clinical CIPA 













































































































































 Table 11 Descriptive statistics for right temporal CIPA baseline & right  















Boxplot of Mean CIPA Right Baseline & Mean CIPA Right Subclinical
Figure 26 Boxplot of mean CIPA right temporal baseline, mean CIPA right 
temporal sub-clinical  
 





















Right Temporal Mean CIPA Baseline v's Right Temporal Mean CIPA Sub-clinical
Figure 27 Scatterplot with connect lines from baseline to sub-clinical data for 







































































































































Table 12 Descriptive statistics for mean CIPA differences for right temporal,    




Data is then analysed as mean values for total events to be able to compare 
CIPA results with BioSignal results. When mean data is analysed, statistical 
significance is lost for total data (p=0.743), (Table 19) but statistical significant 
changes in CIPA are still seen for right temporal (p=0.032) and generalised 
data (p=0.024) but not for left temporal (p=0.855), (Tables 12 & 19, Figures 17, 
18 & 19). For right temporal lobe sub-clinical seizures (n=9), (p=0.032), left 
temporal lobe sub-clinical seizures (n=5), (p=0.855) and generalised sub-
clinical seizures (n=19), (p=0.024) when comparing baseline data with sub-
clinical data (Table 8). 
 














Left Temporal Baseline Heart Rate, Left Temporal Subclinical Heart Rate (Bpm)  Matched n=1307
 

































Left Temporal Heart Rate Difference B-S vs Left Temporal Heart Rate Average B+S
Figure 29 Bland & Altman plot scatterplot for heart rate difference (baseline 
minus sub-clinical) versus average for left temporal lobe seizures. 
Limits of agreement of Difference are (-23.2) and 48.1 








































Left Temporal Subclinical Heart Rate vs Left Temporal Baseline Heart Rate (n=1308)
 
Figure 30 Scatterplot of baseline heart rate versus sub-clinical heart rate 




An overall increase in heart rate is seen during sub-clinical seizures arising 
from the left temporal lobe (Figure 28). A mean difference in heart rate is 
12.1/minute derived by using Bland & Altman scatterplot (Figure 29). 
 
 
Table 13 Total & sub-total median baseline minus sub-clinical CIPA for left 
temporal sub-clinical seizures 
 
Median CIPA gives poorer statistical significance for left temporal sub-
clinical data (p=0.249), (Table 13) compared to right temporal sub-clinical 
data (p<0.001), (Table 10). The median differences in CIPA overall are similar 
for both right temporal (3.4) compared to left temporal (4.0). However the 
standard deviation of data (6.9) is wider from data derived the left temporal 
(Table 14) with fewer observations (n=1307) compared to the standard 
deviation (5.3) derived from the right temporal n=2688 (Table 11). 
Patient ID       n Left Temporal Median CIPA  
Difference 
  Median 

































































































              Baseline CIPA          Sub-clinical CIPA 













































































































































  Table 14 Descriptive statistics for CIPA baseline & CIPA sub-clinical for left  
   temporal lobe. 
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Mean CIPA Left Temporal Baseline, Mean CIPA Left Temporal Sub-clinical
 
Figure 31 Boxplot of mean CIPA left temporal baseline, mean CIPA left 






















Left Temporal Mean CIPA Baseline & Left Temporal Mean CIPA Sub-clinical
 
Figure 32 Scatterplot with connect lines from baseline to sub-clinical data for 




Figure 32 scatterplot shows an individual plot of each seizure for CIPA 
during baseline measurements and left temporal lobe sub-clinical seizures 




3.3.7 Generalised Sub-clinical Seizures 
 





























Generalised HR Differences B-S vs Generalised HR B+S Average  n=4588
 
 
Figure 33 Bland & Altman plot scatterplot for heart rate difference (baseline 
minus sub-clinical) versus average for generalised sub-clinical seizures 

















Boxplot of Baseline Generalised Heart Rate, Subclinical Generalised Heart Rate (Bpm)
 
Figure 34 Boxplot generalised baseline heart rate, generalised sub-clinical 
heart rate. 
 
Figure 34 boxplots indicate that there is a general decrease in heart rate 
during sub-clinical seizures compared to matched baseline studies.  The 
mean decrease in heart rate calculated from Bland & Altman scatterplot is (–
7.2) /minute. 
The difference of mean heart rate from baseline to sub-clinical for right 
temporal sub-clinical data is 16.9 ± 29.4 with limits of agreement 12.4 and 
46.1 (n=2688), (Figure 23). Left temporal sub-clinical seizures have a mean 
heart rate difference of 12.1 ± 36.2 with a wider range in limits of agreement 
of (-23.2) and 48.1 (Figure 29). Generalised sub-clinical seizures have a mean 
heart rate difference of (-7.2) ± 16.1, limits of agreement (-23.2) and 8.9 
(Figure 33). This indicates that there is mean increase in heart rate for right 
and left temporal sub-clinical seizures but a mean decrease in heart rate 
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difference from generalised baseline to sub-clinical data. Patient defined 
heart rate scatterplots for right and left temporal lobe baseline data versus 
matched sub-clinical data are presented in Figures 24 & 30. A scatterplot for 
generalised data could not be created due to the quantity of data exceeding 
Minitab limits of 10,000 values. However, the patients’ defined heart rate 
graphs, show that individual data clusters with a little overlap but are 
generally distinct. Therefore a much larger study would be required to 
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Sample Test  
       p</= 
 
 
   Baseline CIPA 
 











































































































































































































































































Table 15 (above) Total & sub-total median baseline minus sub-clinical CIPA 
for generalised sub-clinical seizures 
         
 
 
              Baseline CIPA          Sub-clinical CIPA 















































































































































Table 16 Descriptive statistics for generalised baseline CIPA & sub-clinical 
CIPA  















Boxplot of Mean CIPA Generalised Baseline, Mean CIPA Generalised Subclinical





































Generalised Mean CIPA Baseline and Generalised Mean CIPA Sub-clinical
Figure 36 Scatterplot with connect lines from baseline to sub-clinical data for 




3.3.8 Total Sub-clinical Seizures and Results Interpretation of 
CIPA 
 
              Baseline CIPA          Sub-clinical CIPA 
   Total 
Count 










































































































































































Histogram of Baseline CIPA, Subclinical CIPA
Normal 













95% CI for the Mean
Interval Plot of Baseline Mean CIPA, Subclinical Mean CIPA



































Total Mean CIPA Baseline & Total Mean CIPA Subclinical
 
Figure 39 Scatterplot baseline mean CIPA and sub-clinical mean CIPA with 
connect lines for total patients 
 
An overall decrease in CIPA occurs during total sub-clinical seizures (Figures 
38 & 39). Baseline mean CIPA reduces from 8.3 to 7.6 (Figure 37) with 












































































































95% CI for the Mean
Rt Base CIPA, Rt sub CIPA, Lt Base CIPA, Lt sub CIPA, Gen Base CIPA, Gen sub CIPA Coef.Var.%
 
Figure 40 Interval plot of coefficient of variation for CIPA in Right baseline, 
subclinical (n=2688) Left baseline , Left sub-clinical n=1307) and Generalised 
baseline ,sub-clinical n=4588). 
The co-efficient of variation is a normalised measure of dispersion or scatter 
of data. The co-efficient of variation of CIPA data show an average increase 
in scatter of total data from baseline 32 to sub-clinical 40.3 (Table 7). 
Sub-clinical seizures arising from the right temporal lobe have a co-efficient 
of variation of 37.8% (C.I 15.4, 60.3) increasing from baseline measurements 
22.1% (C.I 17.2, 26.9), (Figure 40). An increase in coefficient of variation is 
also seen from sub-clinical seizures arising from the left temporal lobe of 
44.4% (C.I 12.7, 76.0) increasing from baseline measurements 29.4% (C.I 7.8, 
50.9) Figure 4 Conversely, the co-efficient of variation difference from 
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generalised sub-clinical seizures decreases during sub-clinical seizures 27.3% 
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Table 18 Descriptive statistics for total mean CIPA difference (Baseline 












Table 19 CIPA difference (baseline minus sub-clinical) for total & mean CIPA 
for total, right temporal, left temporal and generalised data. 
 
N.B When CIPA is analysed using total CIPA data per patient, significant 
differences are seen comparing baseline CIPA with Sub-clinical CIPA. If 
mean CIPA data is used to compare baseline CIPA with Sub-clinical CIPA, 








   Wilcoxon 
Two Sample 






   Wilcoxon 
Two Sample 
































































3.3.10 Comparison of Adult CIPA and Paediatric CIPA 
This pilot study included 5 paediatric patients (2 patients with generalised 
sub-clinical seizures, 2 patients with right temporal and 1 patient with left 
temporal lobe sub-clinical seizures) and 6 adult patients (3 patients with right 
temporal lobe and 3 patients with left temporal lobe sub-clinical seizures). 
No generalised sub-clinical seizures were recorded from the adult patients to 
compare to the CIPA results from two paediatric patients who had a total of 




Total CIPA measurements for paediatric baseline and sub-clinical is 14,744 
and therefore exceeds the maximum of 10,000 values for Minitab to produce 






Table 20 Total paediatric baseline, sub-clinical & difference in CIPA 
A decrease in CIPA occurred in three paediatric patients having focal sub-
clinical seizures. For two patients with right temporal lobe sub-clinical 
seizures mean CIPA decreased from 11.8 to 9.2, (p=0.006). In the patient with 




















   p</= 
Pt 10 
Generalised 
3523 3.4 3.8 -0.4 -4.7, 3.9 <0.001 
Pt 11 
Generalised 
1065 4.8 8.2 -3.4 -10.7,3.9 0.454 
Total 
Generalised 





1728 10.7 8.1 2.6 -4.28, 9.6 0.036 
Pt 5  
Right 
Temporal 


















































Total Paediatric Generalised CIPA Diff B-S vs Total Ave CIPA B+S (19 seizures)  n=4588
Figure 41 Bland & Altman scatterplot for total (paediatric) CIPA difference 
(baseline minus sub-clinical) versus average for generalised data 
Limits of agreement are 4.7 and (–6.9). Mean CIPA p<0.001 
 






























Total Right Paediatric CIPA Diff B-S vs Total Right Ave B+S (6 seizures)  n=2074
Figure 42 Bland & Altman scatterplot for total CIPA difference (baseline 
minus sub-clinical) versus average for paediatric right temporal lobe data. 





































Total Paediatrics Left CIPA Diff B-S vs Total Left CIPA Ave B+S (2 seizures)  n=710
Figure 43 Bland & Altman scatterplot for total CIPA difference (baseline 
minus sub-clinical) versus average for paediatric left temporal lobe data. 
Limits of agreement are 14.6 and (–8).  p=0.682   
 


































Paeds Mean CIPA Diff (B-S) vs Paeds Mean CIPA Average (B+S)
Figure 44 Bland & Altman scatterplot for total CIPA difference (baseline 
minus sub-clinical) versus average for paediatric data. 




































































334 4.9 1.3 3.6 (-0.6), 6.3 0.485 
Total Left 
Temporal 
597 10.1 4.4 5.7 (-5.6), 18.1 0.014 
Total 
Adults 
1211 13.0 6.5 6.5 (-6), 19.1 0.001 
 




Similar to the paediatric group, a decrease in CIPA occurred in all focal 
seizures in the adult group. Mean CIPA decreased from 15.8 to 8.5 in three 
adult patients with right temporal lobe sub-clinical seizures (p=0.010). 
Similarly mean CIPA decreased from 10.1 to 4.4 in three adult patients with 
left temporal sub-clinical seizures, (p=0.014).  
Changes in baseline CIPA to sub-clinical CIPA are more statistically marked 
in adults (n=1211), (p<0.001), (Table 21) than in paediatrics (n=7372), (p=0.203) 
(Table 20). This statistical difference between paediatrics and adults is 
possibly due to the combined effect of generalised data with lateralised data 
for paediatrics that is not comparable for adults. Generalised sub-clinical 
seizures tend to result in an increase in CIPA from baseline to sub-clinical 
(baseline minus sub-clinical calculates as a negative value, Table 20). This 
contrasts generally for CIPA changes from baseline to sub-clinical for right 
and left temporal lobe sub-clinical seizures which tend to show a decrease in 
CIPA from baseline to sub-clinical (baseline minus sub-clinical calculates as a 
positive, Tables 20 & 21). In the case of paediatrics, combining generalised 





































Total Right Adults CIPA Difference B-S vs Right CIPA Average B+S (3 seizures)  n=614
Figure 45 Bland & Altman scatterplot for CIPA difference (baseline minus 
sub-clinical) versus average for adult total right temporal lobe data 
Limits of agreement are 19.6 and (–5). p=0.01 
 
 






























Total Left Adults CIPA Difference B-S vs Total Left CIPA Average B+S (3 seizures)  n=597
Figure 46 Bland & Altman scatterplot for CIPA difference (baseline minus 
sub-clinical) versus average for adult total left temporal lobe data 
Limits of agreement are 18.1 and (–5.6). p=0.014.   
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Total Adult CIPA Difference B-S vs Total Adult CIPA Average B+S n=1211
 
Figure 47 Bland & Altman scatterplot for CIPA difference (baseline minus 
sub-clinical) versus average for total adult data 
Limits of agreement are 19.1 and (–6.0). p<0.001  
 
CIPA differences in right temporal lobe data in adults (n=614) is 7.3 ± 12.4 
with limits of agreement (-5) and 19.6 (p=0.01), (Figure 45) compared to 
paediatrics (n=2074) of CIPA difference 2.5 ± 9.1.with limits of agreement      
(-6.5) and 11.4 (p=0.006), (Figure 42). In left temporal sub-clinical seizures a 
CIPA difference of 5.7 ± 12.7 is seen in adults (n=597) with limits of 
agreement (-5.6) and 18.1 (p=0.014), (Figure 46) compared to a CIPA 
difference of 3.3 ± 11.3 in paediatrics (n=710) with limits of agreement (-8) 
and 14.6 (p=0.682), (Figure 43). No generalised sub-clinical seizures were 
recorded in adults and therefore a comparison cannot be made between 





































 Adult Mean CIPA Difference (B-S)vs Adult Mean CIPA Average (B+S)
 
Figure 48 Bland & Altman scatterplot for mean CIPA difference (baseline 
minus sub-clinical) versus average for total adult data 
Limits of agreement are 1.95 and 9.67. p=0.191 
 
For mean data (n=33), a lower statistical significance is seen compared to 
total CIPA values with adults mean CIPA (n=7) difference 5.8 ± 7 (limits of 
agreement 1.9 and 9.7) range 7.8, (p=0.191), (Figure 48). Paediatric mean 
values (n=26) have a mean CIPA difference of (-0.3) ± 5.2 (limits of agreement 
(-4.8) and 2.1) range 6.9, (p=0.772), (Figure 44). Again, poorer statistical 
significance in the paediatric group occurs compared to the adult group as 
the same influence of the inclusion of generalised data is again reflected in 














                           Individual 95% CIs For Mean Based on Pooled 
                           StDev 
Pt ID   N     Mean  StDev     -+---------+---------+---------+-------- 
 1      1   -5.470      *               (--*--)A 
 2      5   -0.890  0.896                       (-*)P 
 3      1   -6.950      *             (--*--)A 
 4      1    4.890      *                              (--*--)A 
 5      1    8.450      *                                   (--*--)P 
 6      1  -12.650      *     (--*--)A 
 7      2   -4.990  1.400                 (-*-)P 
 8      1   -6.530      *              (--*--)A 
 9      1   -7.390      *            (--*--)A 
10     11   -0.435  0.841                        (*)P 
11      8   -0.304  1.216                         (*)P 
                              -+---------+---------+---------+-------- 
                           -14.0      -7.0       0.0       7.0 
 
 
Figure 49 One-way ANOVA CIPA difference versus patient ID co-efficient of 
variation. (Key A=Adult, P=Paediatric). 
 
One-way analysis of variation (ANOVA) was used to identify if there were 
any systematic differences between paediatric and adult CIPA co-efficient of 
variation. ANOVA compares variation in data within each patient and also 
between each patient. Figure 49 shows a scattered distribution for both adult 
(A) and paediatrics (P) data. This would suggest that any differences in 
coefficient of variation in CIPA are not due to any inherent differences 
between adults and paediatrics. 
3.3.11 Multivariate Anaysis of Anti-epileptic Drugs and 
Cardiac Vagal Tone 
 
Cardiac vagal tone was measured by the NeuroScope device producing an 
output of Cardiac Index of Paraympathetic Activity (CIPA) from eleven 
patients who took part in the study previously described. The CIPA data for 
matched baseline ‘counted’ vagal tone (but not the sub-clinical data), selected 
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from the same stage of sleep, was then analysed in terms of CIPA derived 
from patients receiving anti-epileptic medication and further categorised as 
monotherapy, polytherapy and those patients not receiving any anti-
epileptic drug (AED). Analysis was performed using One-way ANOVA for 


























































95% CI for the Mean
Interval Plot of Anti-Epileptic Drugs & Cardiac Index Parasympathetic Activity
 
 
Figure 50 Interval plot of Cardiac Index of Parasympathetic Activity (CIPA) 
from baseline measurements for anti-epileptic drugs. 
 
In this pilot study, eleven patients (mean age 23.09 ± 18.73 years) were 7 
males and 4 females. Six patients were adults (3 male and 3 female, mean age 
of 35.8 ± 16.0 years) and 5 patients were children (4 male and 1 female, mean 
age of 7.8 ± 4.8 years). Thirty-three sub-clinical seizures (mean duration 191.1 
± 136.4 seconds of which 9 were derived and confined to the right temporal 
lobe, 5 were derived from and confined to the left temporal lobe and 19 sub-
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clinical attacks were generalized. Matched ‘counted’ baseline measurements 
selected from the same stage of sleep were analysed in terms of AED’s. Five 
anti-epileptic drugs (AEDs) were included in this analysis; carbamazepine (5 
patients), sodium valproate (2 patients), clobazam (2 patients), topiramate (1 
patient), phenobarbitone (1 patient). Four patients were not receiving any 
anti-epileptic medication, four patients were being treated with monotherapy 
and three patients were receiving polytherapy.  Figure 50 shows that CIPA 
analysed from the patient receiving topiramate and phenobarbitone is very 
low. All other results would be considered to be in the normal range for 






























































































Table 22 Descriptive statistics of Cardiac Index of Parasympathetic Activity 




The NeuroScope uses an arbitrary scale of 1-4 is considered to be low cardiac 
vagal tone. The lowest mean CIPA (3.5) is from one patient receiving 
polytherapy of topiramate and phenobarbitone. All other mean CIPA data is 
in normal range. However, patients receiving carbamazepine have the 
highest resting CIPA (16.2) indicating a slow heart rate. The maximum CIPA 
form patients receiving carbamazepine is much higher than any other group 
of 50.3. Low minimum CIPA are observed in all categories of AED’s except 
those patients on carbamazepine. 
Analysis of one-way ANOVA, where the pooled standard deviation (5.255) is 
compared to data for each AED category, is in normal range. Low CIPA is 
found in data derived from a patient being treated by topiramate and 
































































95% CI for the Mean
Cardiac Vagal Tone (Baseline . Subclinical Seizure) & Anti-Epileptic Drugs
 
Figure 51 Baseline & Subclinical CIPA for patients with nil Anti-Epiletic 
Drugs, Monotherapy & Polytherapy. 
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Patients receiving polytherapy AEDs have the lowest baseline CIPA 
compared to those patients on monotherapy or nil AED (Table 23). Mean 
CIPA is within normal range but minimum values for patients in the nil AED 
group during the sub-clinical seizure and for the polytherapy group are low, 
indicating high heart rates. 
Cardiac Vagal Tone 













Nil AED 4 11.6 6.3 10.9 6.5 
Monotherapy 4 18.6 6.8 12.0 5.7 
Polytherapy 3 6.1 3.8 6.6 2.5 
Gender 
Total 
4(F) 13.1 6.2 10.3 6.4 
7(M) 13.6 8.6 9.8 5.2 
Gender 
Nil AED 
3(F) 11.5 6.4 8.8 6.9 
1(M) 17.1 0.0 15.1 0.0 
Gender 
Monotherapy 
1(F) 18.0 0.0 14.8 0.0 
3(M) 19.9 7.5 11.1 6.7 
 
Table 23 Cardiac Vagal Tone in relation to Nil Anti-Epileptic Drugs, 
Monotherapy, Polytherapy and Gender. 
N.B. Too few observations are available to perform ANOVA for polytherapy 
and gender. Also, ANOVA was not possible to investigate any relationship 
between CIPA and seizure duration. 
CIPA is within normal ranges for all patients whether receiving nil AED, 
monotherapy or polytherapy. The standard deviation indicates that CIPA 
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can be low for polytherapy patients during sub-clinical seizures. This 
however is due to one patient with intractable generalised epilepsy. 
CIPA in relation to gender is similar for total comparison for the group but 
also for those receiving monotherapy. One male had a higher CIPA 













Chapter 22   BioSignal Heart Rate Variability 
3.4.1 Inter and Intra Observer Analysis 














Total count (R-R 
intervals) 
 
     369 
 
 
     369 
 
 
      0.0 
 
 






   817.57 
 
 
   817.63 
 
 
     0.06 
 
 
    817.6 
 
 
Standard Error of 
Mean 
 
    0.734 
 
    0.737 
 
     0.003 
 




    14.09 
 
    14.15 
 
    0.06 
 
    13.96 
 
Variance   198.59   200.20     1.61    194.78 
Coefficient of Variance 
 
    1.72 
 
    1.73 
 
     0.01 
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     784 
 
      0.0 
 




     816 
 
     816 
 
      0.0 
 




     848 
 
     848 
 
      0.0 
 
    848.0 
 
Range       64       64       0.0      64.0 
MSSD     92.54     87.41      5.13     83.91 






       0.0 
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Histogram of Observer 1 (Thea) & Observer 2 (Ruth)
Figure 52 Histogram of Inter-observer analyses 
With normal distribution, a paired t test was performed comparing observer 



















Scatterplot of Inter-observer analysis (R-R Difference vs R-R Average)  n=369
Figure 53 Bland & Altman scatterplot of Inter-observer difference (baseline 
minus sub-clinical) versus average in R-R  
















Boxplot of Observer 1 (Thea) & Observer 2  (Ruth)
 
Figure 54 Boxplot R-R intervals for observer 1, observer 2 
 
Observer 1 has a mean R-R measurement of 817.57 compared to observer 2 
mean measurement of 817.63 with a difference of (0.06 milliseconds). Both 
observers measured identical minimum and maximum measurements but 
the standard deviation and variance are slightly different at 0.06 and 1.61 





































Vagal tone is represented by the High Frequency (HF) band and is calculated 
and displayed by BioSignal software. Only slight differences in HF power % 
are produced by the Inter-observer measurements of Observer 1 (45.7%), 
(Figure 55) and Observer 2 (46.3%), (Figure 56). 
Inter-observer agreement of identical R-R measurements was 280/369=75.9%. 
Unmatched R-R intervals are still close in measurement with mean (817.6) 
and Median (816) values being identical (Table 24).  This is also represented 
by a very tight standard deviation of 14.09 (observer 1) and 14.15 (observer 2) 
with no statistically significant difference between observers (p=0.809), 
(Figure 52). Mean difference between observers is (-0.05) ± 8.59 with limits of 
agreement (-8) and 8 (Figure 53). 
3.4.3 Intra-observer Analysis 
The same methods were employed as for the inter-observer analysis except 
that the same 5 minutes sample of data (n=369) was re-measured by 
Observer 2 (blind to the first run measurements) and then entered the data 




























Total count (R-R 
intervals) 
 
    369 
 
     369 
 
      0.0 
 




   817.63 
 
    817.63 
 
      0.0 
 
  817.63 
 
Standard Error of 
Mean 
 
    0.735 
 
    0.733 
 
    0.002 
 




    14.13 
 
    14.09 
 
    0.04 
 




   199.58 
 
   198.41 
 
     1.17 
 
   195.96 
 
Coefficient of Variance 
 
 
     1.73 
 
 
     1.72 
 
 
     0.01 
 





     784 
 
 
      784 
 
 
      0.0 
 
 






     816 
 
 
      816 
 
 
      0.0 
 
 
      828 
 
 
Maximum      848       848       0.0       848 
Range 
 
     64.00 
 
    64.00 
 
      0.0 
 





     85.73     90.80 
 
 
     5.07 
 
 
    84.99 
 
 
Q1 808.00 808.00 0.0 808 


























Histogram of Intra observer Analysis Run 1, Run 2
Figure 57 Histogram of Intra-observer 2 analyses. 
With normal distribution, a paired t test was performed comparing Run 1 




















Scatterplot of Intra-observer analysis (R-R interval Difference vs R-R Average)  n=369
Figure 58 Bland & Altman scatterplot of Intra-observer 2 difference (baseline 
minus sub-clinical) versus average in R-R. 
















Boxplot of Intra-observer Analysis Run 1, Run 2
 




Observer 2 made two measurement studies of the same data. Mean R-R 
measurement of 817.63 with no difference between Run 1 and Run 2. Both 
Run 1 and Run 2 measured identical minimum and maximum measurements 
but the standard deviation and variance are slightly different at 0.04 and 1.17 
milliseconds respectively. Run 1 and Run 2 measurements are closer for 


























Figure 61 BioSignal HRV Intra-observer 2 Run 2 R-R analyses 
 
 
Vagal tone is represented by the High Frequency (HF) band and is calculated 
and displayed by the BioSignal software. HF% is closely matched comparing 







Intra-observer agreement of identical R-R measurements was 300/369=81.3%. 
Unmatched R-R intervals are close in measurement with mean (817.6) and 
median (816) values being identical (Table 25). This is again represented by a 
very tight standard deviation of 14.13 (Run 1) and 14.09 (Run 2), with no 
statistically significant difference between runs of observations (p=0.976), 
(Figure 57). Mean difference between run 1 and run 2 is (-0.01) ± 6.97 with 
limits of agreement (-4) and 2 (Figure 58). 
Inter-observer analysis shows a close measurement outcome of R-R intervals 
comparing observer 1 and observer 2. Intra-observer analysis shows an even 






















Chapter 23 BioSignal Heart Rate Variability: Counted Data. 
 
3.5.1 BioSignal Analysis of Counted beats and Matched 
Baselines for Total Sub-clinical Seizures 
Thirty-three sub-clinical seizures (R-R intervals n=8583) and matched R-R 
counted baseline studies (n=8583) were analysed from 11 patients, mean age 
23.1 ± 18.7 years. Nine sub-clinical seizures (R-R interval n=2688) were 
derived from the right temporal lobe (5 patients) and five sub-clinical 
seizures (R-R intervals n=1307) were derived from the left temporal lobe (4 
patients). Nineteen generalised sub-clinical seizures (R-R intervals n=4588) 
were analysed from two patients. 
Only one mean value is produced to represent the entire baseline or sub-
clinical epoch using the BioSignal HRV software. Thus although total data 
for right temporal lobe derived data was imported (from identical data used 
for CIPA) n=2688 baseline and n=2688 sub-clinical, 9 mean data values are 
given for both baseline and sub-clinical HF%. Left temporal lobe derived 
data was imported into BioSignal software n=1307 baseline and n= 1307 sub-
clinical, 5 mean data values are produced for both baseline and sub-clinical 
HF%. Generalised data n=4588 was imported into BioSignal and 19 mean 












   (ms) 
SDNN      




   (%) 
RMSSD 
   (ms) 
SDNN 




  (%) 
Pt 1 69.2 0.080 73 55.7 47.2 0.108 20 15.3 146 
Pt 2 48.2 0.045 77 30.1 40.3 0.037 49 19.1 259 
Pt 2 48.8 0.044 107 32.8 48.9 0.045 89 27.3 232 
Pt 2 49.8 0.045 138 33.9 48.0 0.043 89 21.9 202 
Pt 2 50.0 0.045 124 34.3 44.5 0.039 93 25.7 253 
Pt 2 50.0 0.045 127 34.2 22.1 0.023 11 3.0 317 
Pt 3 57.4 0.067 148 41.5 86.5 0.093 48 13.4 269 
Pt 4 146.3 0.139 85 69.7 112.4 0.103 70 57.4 261 
Pt 5 89.7 0.090 170 49.3 76.2 0.073 153 44.3 139 
Pt 6 80.4 0.078 31 60.8 88.1 0.099 22 43.1 313 
Pt 7 81.7 0.072 256 63.5 64.2 0.064 145 36.0 159 
Pt 7 82.5 0.073 196 64.3 88.8 0.087 152 49.8 149 
Pt 8 95.6 0.067 117 55.7 36.3 0.078 32 15.3 161 
Pt 9 23.2 0.045 13 3.9 8.1 0.039 0 0.0 218 
Pt 10 16.2 0.017 0 0.0 26.9 0.029 10 3.1 154 
Pt 10 15.3 0.016 0 0.0 21.8 0.025 6 2.3 109 
Pt 10 15.4 0.017 0 0.0 21.2 0.032 9 3.3 108 
Pt 10 15.3 0.016 0 0.0 27.4 0.032 17 7.1 98 
Pt 10 15.9 0.017 0 0.0 18.0 0.021 5 1.4 104 
Pt 10 15.9 0.017 0 0.0 26.4 0.029 17 5.0 93 
Pt 10 15.8 0.017 0 0.0 22.0 0.027 14 4.1 114 
Pt 10 16.6 0.017 0 0.0 18.3 0.020 9 2.1 103 
Pt 10 15.4 0.016 0 0.0 24.2 0.027 9 3.3 199 
Pt 10 16.3 0.017 0 0.0 17.7 0.024 8 2.1 234 
Pt 10 15.6 0.017 0 0.0 22.8 0.028 13 4.1 168 
Pt 11 22.1 0.028 7 3.7 38.6 0.040 33 17.6 157 
Pt 11 23.5 0.031 7 5.2 52.1 0.065 31 23.0 225 
Pt 11 23.8 0.031 7 5.4 46.4 0.052 26 20 223 
Pt 11 24.5 0.032 7 5.9 56.5 0.060 19 16 224 
Pt 11 24.3 0.032 7 5.7 31.4 0.029 11 9.0 340 
Pt 11 25.2 0.033 7 6.4 48.1 0.044 17 15.5 179 
Pt 11 23.7 0.031 7 5.3 51.9 0.061 36 27.3 243 





























18.5 0.024 56 1.4 31.0 0.034 302 6.9 172.8 
Mean 
Total 
40.54 0.041 52.1 20.4 43.22 0.049 38.64 16.6 192.8 
 
Table 26 (above) Total patient & group data for baseline & sub-clinical Heart 




3.5.2 NN50 and pNN50 for Counted HRV 
NN50 and pNN50 data approximately halve during right temporal sub-
clinical (NN50 1064 to 626, pNN50 39.7 to 23.3) and left temporal sub-clinical 
(NN50 615 to 356, pNN50 47.2 to 27.3) but generalised sub-clinical seizures 
increase (NN50 64 to 315, pNN50 1.4 to 6.9), (Table 26).  The NN50 is the 
number of intervals of successive NN intervals increased more than 50msec. 
pNN50 is the proportion derived by dividing NN50 by the total NN 
intervals. Generalised sub-clinical seizures again are characteristically 
different compared to sub-clinical seizures derived from either the right or 
left temporal lobes. NN50 and pNN50 data approximately halve during right 
temporal sub-clinical (NN50 1064 to 626, pNN50 39.7 to 23.3) and left 
temporal sub-clinical (NN50 615 to 356, pNN50 47.2 to 27.3) but generalised 
sub-clinical seizures have a low baseline and show an increase NN50 during 
sub-clinical seizures (NN50 64 to 315, pNN50 1.4 to 6.9), (Table 26). Bland & 
Altman plots show that SDNN derived from data during right temporal lobe 
activity has the largest limits of agreement and range (0.7 to 2.0, range 1.2) 
compared to SDNN derived from data during left temporal lobe activity (0.5 
and 1.2, range 0.7), and then generalised data for SDNN (0.5 to 0.8, range 
0.4), (Figure 67, Table 30). This result would indicate that during generalised 
sub-clinical seizures, heart rate variability reduces compared to baseline. 
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3.5.3 High Frequency HRV: Total Sub-clinical Seizures 
 
Pt. ID Baseline HRV HF 
(counted beats) 
Sub-clinical HRV  
HF(counted beats) 
Difference HRV HF  































Pt 1 45.5 1692 50.1 1.5 87 12.0   <44 <160
5 <38.1 
Pt 2 53.1 393 42.2 58.6 287 62.6 >5.5 <106 
>20.4 
Pt 2 60.5 465 50.3 44.8 307 54.5 <15.7 <158 
>4.2 
Pt 2 63.3 512 53.1 60.5 652 66.3   <2.8 >140 
>13.2 
Pt 2 61.7 488 50.7 56.9 380 58.5   <4.8 <108 
>7.8 
Pt 2 61.9 503 52.6 42.0 99 39.8 <19.9 <404 
<12.8 
Pt 3 45.5 657 31.3 27.5 1187 29.3 <18.0 >530 
>2 
Pt 4 36.8 2654 30.4 57.8 3973 59.1 >21.0 >131
9 >28.7 
Pt 5 40.8 1170 28.9 33.0 645 25.8  <7.8 <525 
<3.1 
Pt 6 27.8 1203 91.7 23.0 888 21.8  <4.8 <315 
<69.9 
Pt 7 81.1 1843 73.8 53.5 1039 47.5 <27.6 <804 
<26.3 
Pt 7 79.5 1882 73.0 52.5 2042 60.8 <27 >160 
<12.2 
Pt 8 59.8 906 45.3 1.5 59 77.8 <58.3 <847 
>32.5 
Pt 9 6.0 54 98.9 0.3 2 2.4 <5.7 <52 
<96.5 
Pt 10 58.2 69 56.3 57.8 235 59.8 <0.4 >166 
>3.5 
Pt 10 52.5 57 54.6 45.3 133 48.5 <7.2 >76 
<6.1 
Pt 10 50.6 59 54.0 22.3 109 21.3 <28.3 >50 
<32.7 
Pt 10 51.7 58 54.1 53.8 270 48.7 >2.1 >212 
<5.4 
Pt 10 54.7 68 55.6 37.7 73 34.8 <17 >5 
<20.8 
Pt 10 53.3 65 54.8 46.2 207 43.1 <7.1 >142 
<11.7 
Pt 10 54.2 66 55.4 43.8 145 78.2 <10.4 >79 
>22.8 
Pt 10 58.6 77 59.3 40.4 78 40.2 <18.2 >1 
<19.1 
Pt 10 52.7 59 55.6 39.0 134 36.7 <13.7 >75 
<18.9 
Pt 10 57.0 74 58.4 21.3 55 58.3 <35.7 <19 
<0.1 
Pt 10 52.6 64 56.3 32.7 116 60.2 <19.9 >52 
>3.9 
Pt 11 27.8 89 36.9 38.3 267 73.6 >10.5 >178 
>36.7 
Pt 11 22.5 88 29.8 21.4 565 19.2 <1.1 >477 
<10.6 
Pt 11 22.7 90 28.7 25.5 254 20.6 >2.8 >164 
<8.1 
Pt 11 21.7 92 26.8 26.9 757 21.5 >5.2 >665 
<5.3 
Pt 11 22.7 95 28.2 56.3 230 51.1 >33.6 >135 
>22.9 




Pt 11 22.3 88 29.0 19.5 248 15.3 <2.8 >160 
<13.7 


















45.55 481 49.11 36.82 485 42.73 <8.73 <4 
<6.38 
 
Table 27 (above).Total patient & group data for baseline, sub-clinical & 




Statistically significant changes in HF% occurred comparing baseline and 
sub-clinical values. Baseline HF% 45.6 ± 18.3 for total sub-clinical seizures 
alters to sub-clinical HF% 36.8 ± 16.9 (Table 27) showing a definite alteration 
in HF% (p=0.049), (n=33). Right baseline HF% 52.1 ± 10.2 alters to sub-clinical 
HF% 42.5 ± 19.4, (p=0.151), (n=9). Left baseline HF% 50.8 ± 33.0 alters more 
dramatically to sub-clinical HF% 26.2 ± 26.1 (p=0.065), (n=5). Generalised 
baseline HF% 41.0 ± 16.0 alters to sub-clinical HF% 36.9 ± 12.0, (p=0.291), 







Figure 62 Bar chart baseline & sub-clinical HF% HRV for right hemisphere 
counted data. 
Figure 62 shows counted HF% derived from sub-clinical seizure from the 
right temporal lobe. 7/9 seizures resulted in a decrease in HF% (77%) 
compared to baseline measurements, indicating that most sub-clinical 
seizures derived from the right temporal lobe results in a decrease in 






Figure 63 Bar chart baseline & sub-clinical HF% HRV for left hemisphere 
counted data. 
Figure 63 presents counted HF% derived from sub-clinical seizures from the 
left temporal lobe. All sub-clinical seizures from the left temporal lobe 
resulted in a decrease in HF% suggesting an increase in heart rate.  
 
 





Figure 64 presents HF% from two patients who had generalised sub-clinical 
seizures. There is a general split in results with one patient (sub-clinical 
seizures 1 to 11) having 10/11 decreased HF% during sub-clinical seizures 
compared to baseline. The second patient (sub-clinical seizures 12 to 19) 


































Estimation of Short term HRV components 
Root Mean Square of Successive Differences (RMSSD)  
Counted beats: matched baseline & sub-clinical 
 




































Total Counted RMSSD Baseline vs Total Counted RMSSD Subclinical
Figure 65 Scatterplot baselines RMSSD versus sub-clinical RMSSD for total 
mean counted HRV data. 









































Total Mean Counted log RMSSD Diff B-S vs Total Mean Counted log RMSSD Ave B+S
Figure 66 Bland & Altman scatterplot log RMSSD difference (baseline minus 
sub-clinical) versus average for total mean counted HRV data. 
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RMSSD is the square root of the mean squared differences of successive NN 
intervals and is an estimate of short term HRV. Generalised total baseline 
RMSSD (18.5) is much lower than right RMSSD (66.3) and left RMSSD (75.7) 
baseline studies (Table 26). During generalised sub-clinical seizures, RMSSD 
increases (31.0) whereas, right temporal sub-clinical RMSSD (60.1) and left 
temporal sub-clinical RMSSD ((60.7) show reduced short term HRV 
compared to baseline. Generalised sub-clinical seizures again are 
characteristically different compared to sub-clinical seizures derived from 
either the right or left temporal lobes. 
Bland & Altman analysis of log RMSSD difference between HRV derived 
during total baseline and total sub-clinical seizures show limits of agreement 
of log values are (-0.8) and 0.8 with antilog values of 0.4 and 2.3. Limits of 
agreement of log RMSSD derived during baseline and right temporal sub-
clinical seizures are -0.4 and 0.8 with antilog values of 0.7 and 2.3 (Range of 
1.6 seconds). Limits of agreement of log RMSSD derived during baseline and 
left sub-clinical seizures are (-0.1) and 1.1 with antilog values of 0.9 and 3.0 
(Range of 2 seconds). Limits of agreement of log RMSSD derived during 
baseline and generalised sub-clinical seizures are (-0.8 and –0.1) with antilog 
values of 0.4 and 0.9 (Range of 0.5 seconds), (Figure 66, Table 30). Results 
indicate that there is less short term variability during generalised sub-
clinical seizures and baseline measurements compared to HRV data derived 









Standard Deviation of Normal-to-Normal Beat variation (SDNN) 
 
The SDNN is the standard deviation of the NN intervals, which is the square 
root of variance and is an overall estimate of HRV. It is possible to compare 
counted baseline studies and matched counted sub-clinical studies as they 
are of equal number of NN intervals. It is inappropriate to compare 
individual patient studies as each event is of a different duration. 
Using Bland & Altman plots to analyse the difference versus the average for 
matched counted baseline R-R studies and counted sub-clinical R-R studies, 
the smallest range in limits of agreement for SDNN is seen with generalised 
sub-clinical seizures (0.5 and 0.8), (Figure 68) indicating the smallest heart 
rate variability compared to right (0.7, 2.0) and left (0.5, 1.2) temporal sub-









































Total Counted SDNN Subclinical vs Total Counted SDNN Baseline
Figure 67 Scatterplot baselines SDNN versus sub-clinical SDNN for total 
mean counted HRV data. 








































Total Mean Counted log SDNN Diff B-S vs Total Mean Counted log SDNN Ave B+S
Figure 68 Bland & Altman scatterplot log SDNN difference (baseline minus 




Limits of agreement of log values for total sub-clinical seizures are (–0.8) and 
0.3 from the Bland & Altman plot with antilog values of 0.5 and 1.3. Limits of 
agreement of log values for SDNN derived during right sub-clinical seizures 
compared to baseline measurements are (–0.3) and 0.7 with antilog values are 
0.7 and 2.0 (Range of 1.2 seconds). Limits of agreement of log values for 
SDNN derived during left temporal sub-clinical seizures compared to 
baseline measurements are (–0.8) and 0.1 with antilog values of 0.5 and 1.2 
(Range of 0.7 seconds). Limits of agreement of log values for SDNN derived 
during generalised sub-clinical seizures compared to baseline measurements 
are (–0.740 and –0.162) with antilog values of 0.5 and 0.8 (Range of 0.4 
seconds). This result indicates that overall estimation of HRV is smallest 
during generalised sub-clinical seizures compared to HRV derived during 
right or left sub-clinical seizures (Figure 68, Table 30). 
 
Standard Deviation of Heart Rate  











































Total Counted StDev Subclinical Heart Rate vs Total Counted StDev Baseline Heart Rate
Figure 69 Scatterplot baselines standard deviation of heart rate versus sub-
clinical standard deviation of heart rate for total mean counted HRV data. 
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Total Mean Counted log St Dev.HR Diff B-S vs Total Mean Counted log St Dev.HR Ave B+S
Figure 70 Bland & Altman scatterplot log standard deviation of heart rate 
difference (B-S) versus average for total mean counted HRV data.  
 
Limits of agreement of log values for total standard deviation of heart rate 
during total sub-clinical seizures are (-0.6) and 0.2 with antilog values 0.5 and 
1.2. Limits of agreement of log values for standard deviation of Heart Rate 
during right temporal lobe seizures are (-0.8) and 0.2 with antilog values of 
0.4 and 1.2 (Range of 0.7 beats per minute). Limits of agreement of log values 
for standard deviation of heart rate during left temporal lobe seizures are (-
0.6) and 0.1 with antilog values are 0.5 and 1.0.  (Range of 0.5 beats per 
minute). Limits of agreement of log values for standard deviation of heart 
rate during generalised sub-clinical seizures are (-0.6) and 0.1 with antilog 
values of 0.5 and 1.1 (Range of 0.7/min).  This result shows that changes in 
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Total Counted HFms Subclinical vs Total Counted HFms Baseline
Figure 71 Scatterplot baselines HFms2 versus sub-clinical HFms2 for total 
mean counted HRV data. 









































Total Mean Counted log ln HFms Diff B-S vs Total Counted log ln HFms Ave B+S
Figure 72. Bland & Altman scatterplot log lnHFms2 difference (baseline minus 




Limits of agreement of log ln values for HRV HFms2 for total sub-clinical 
seizures are (–0.4) and 0.5 with ln (natural log) of 0.7 and 1.7 power.  Limits 
of agreement of log ln for HRV HFms2 for right temporal sub-clinical 
seizures are (–0.1) and 0.3 with ln (natural log) of 0.9 and 1.4. (Range of 0.4 
mean counted HRV HFms2 power). Limits of agreement of log ln for HRV 
HFms2 for left temporal sub-clinical seizures are (–0.1) and 1.8 with ln 
(natural log) of 1.0 and 2.8. (Range of 1.8 mean ‘counted’ HRV HFms2 
power). Limits of agreement of log ln for HRV HFms2 for generalised sub-
clinical seizures are (–0.383) and 0.017 with ln (natural log) of 0.7 and 1.0. 
(Range of 0.3 mean ‘counted’ HRV HFms2 power), (Figure 72). 
  
 





















































































Right Temporal, Left Temporal & Generalised Counted HRV HF%
 
Figure 73 Boxplot right, left & generalised baseline & sub-clinical mean 





































Total Counted Subclinical HF% vs Total Counted Baseline HF%
Figure 74 Scatterplot baselines HF% versus sub-clinical HF% for total 
counted HRV data. 
 

































Total Counted Mean HF% Diff B-S vs Total Counted Mean HF% Ave B+S
Figure 75 Bland & Altman scatterplot of HF% difference (baseline minus sub-
clinical) versus HF% average for total mean counted data. 
Group key 1=right 2=left 3=generalised HF% 
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Limits of agreement are 44.0 and (–21) for counted HF% during total sub-
clinical seizures compared to baseline measurements. Limits of agreement 
are 44 and (–21) for counted HF% derived during right temporal lobe sub-
clinical seizures. (Range of 65%) Limits of agreement are 58.3 and 4.8 for 
counted HF% derived during left temporal lobe sub-clinical seizures. (Range 
of 53.5%) Limits of agreement are 35.7 and (–15) for counted HF% derived 
during generalised sub-clinical seizures (range of 50.7%). This result shows a 
fairly similar spread of HRV HF% for all groups. The smallest HRV HF% is 
found marginally in generalised sub-clinical seizures compared to baseline 
measurements (Figure 75, Table 30). 
Many researchers measure HFms2 as the main parasympathetic component 
of HRV. ln HFms2 gives the widest limits of agreement and range during left 
temporal lobe activity (1.0 to 5.8, range 4.8). The ln HFms2 is much less (0.9 to 
1.4, range 0.5). The smallest limits of agreement and range are from 
generalised data (0.7 to 1.0, range 0.3). When all baseline ln HFms2 data is 
compared to sub-clinical ln HFms2 data, poor statistical significance (p=0.980) 
is found (Figure 77). Poor correlations are found between HFms2 and CIPA 
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(2688) 
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(8583) 













Table 28 Total & Sub-Total Baseline HRV HF%, Total & Sub-Total Sub-
clinical HRV HF% for counted data (Wilcoxon Two Sample Test). 
 
Sub-clinical seizures derived from the right or left temporal lobes 
demonstrate a decrease in HF% indicating a decrease in vagal tone and 
resulting in an increase in heart rate, similar to CIPA results. Generalised 
data shows a mixture of an increase and decrease in HF% but overall shows 
an increase in HF% indicating an increase in vagal tone resulting in a 
































Total Baseline Counted HF, Total Subclinical Counted HF%
Figure 76 Histogram of HF% baseline, HF% sub-clinical total counted HRV 
























Histogram of HFms Counted Baseline, HFms Counted Subclinical
Normal 
Figure 77 Histogram of HFms2 baseline, HFms2 sub-clinical total counted 




























Right Baseline HRV HF%
Right Subclinical HRV HF%
Normal 
Right Counted Baseline HRV HF% , Right Counted Subclinical HRV HF%




























Left Baseline HRV HF%
Left Subclinical HRV HF%
Normal 
Left Counted Baseline HRV HF% , Left Counted Subclinical HRV HF%






























Gen Baseline HRV HF%
Gen Subclinical HRV HF%
Normal 
Gen Counted Baseline HRV HF% , Gen Counted Subclinical HRV HF%
Figure 80 Histogram of generalised counted HRV HF%, generalised counted 
sub-clinical HRV HF% 
 
 

































Counted Mean lnHF% Diff B-S vs Counted Mean lnHF% Ave B+S
Figure 81 Bland & Altman scatterplot lnHF% difference (baseline minus sub-




Limits of agreement from Bland & Altman analysis of Counted lnHF% 
derived during total sub-clinical seizures compared to baseline are (-0.9) and 
1.0 with anti-log values of 0.4 and 2.7. Limits of agreement for Counted HRV 
lnHF% derived during right temporal sub-clinical seizures are (-0.4) and 2.5 
with anti-log values of 0.6 and 32.0. Range in lnHF% of 32.6 % HF power). 
Limits of agreement for Counted HRV lnHF% derived during left temporal 
sub-clinical seizures are 0.2 and 3.7 with anti-log values of 1.2 and 39.9. 
(Range in lnHF% of 38.7 % HF power). Limits of agreement for Counted 
HRV lnHF% derived from generalised sub-clinical seizures are (-0.5) and 1.0 
with antilog values of 0.6 and 2.7. (Range in lnHF% of 2.1%). This indicates 
that lower parasympathetic activity is present during generalised sub-clinical 
seizures compared to right and left temporal sub-clinical seizures (Figure 81, 
Table 30). 










































Total Mean Counted log ln HF% Diff B-S vs Total Mean Counted log ln HF% Ave B+S
Figure 82 Bland & Altman scatterplot log lnHF% difference (baseline minus 




Limits of agreement of Bland & Altman analysis for Counted HRV log 
lnHF% for total sub-clinical seizures compared to baseline are (–0.9) and 1.7 
with antilog 0.4 and 5.6. Limits of agreement analysis for HRV log ln HF% 
for right sub-clinical seizures compared to baeline are (–0.9) and 0.2 with 
antilog 0.4 and 1.2. (Range 0.8 log ln HF% power). Limits of agreement 
analysis for HRV log In HF% for left sub-clinical seizures compared to 
baseline are 0.1 and 2.3 with antilog 1.1 and 10.1. (Range of 9.0 log ln HF% 
power). Limits of agreement analysis for HRV log ln HF% for generalised 
sub-clinical seizures are (–0.2) and 0.3 with antilog 0.9 and 1.3 (range of 0.5 



































Descriptive Statistics: Total CIPA & HF Difference (Counted R-R) 
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Table 29 Descriptive statistics of CIPA, log CIPA, HF%, lnHF% & log lnHF% 
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Table 30 Bland & Altman limits of agreement for log RMSSD, log SDNN, 
HF%, lnHF% & log lnHF% in total, right, left and generalised difference 



























































































Boxplot of Counted HF% Right, Left & Generalised Coef.of Variation
 
Figure 83 Boxplot of co-efficient of variation for right, left and generalised 
baseline & sub-clinical data. 
 
Coefficient of variation for counted HF% shows an increase for all sub-
clinical seizures although generalised sub-clinical seizures has lower mean 
coefficient of variation (Baseline 4.7%, Sub-clinical 5.5%) compared to mean 
coefficient of variation for right subclinical seizures Baseline (7.4%, Sub-
clinical 11.4%) and left sub-clinical seizures (Baseline 8.1%, Sub-clinical 













































Total Counted Coef.Var.HRV Baseline VS Total Counted Coef.Var.HRV Subclinical
 
Figure 84 Scatterplot of coefficient of variation baseline versus sub-clinical 
HRV for total mean counted data. 
 
 
Bland & Altman plot of coefficient of variation for counted HF% HRV shows 
data derived during generalised sub-clinical seizures has the least variation 









3.5.5 Comparison of Adult HF% and Paediatric HF% (Counted). 
 
















































Total Adult Counted Mean HF% Diff B-S vs Total Adult Counted Mean HF% Ave B+S
Figure 85 Bland & Altman scatterplot HF% difference (baseline minus sub-
clinical) versus average HF% for total mean counted adult HRV data 
Limits of agreement are 44 and (–77.8).  Wilcoxon p=0.917       














































Total Paediatric Mean Counted HF% Diff B-S vs Total Paediatric Mean Counted HF% Ave B+S
Figure 86 Bland & Altman scatterplot HF% difference (baseline minus sub-
clinical) versus average HF% for total mean counted paediatric HRV data 




3.5.6 Adult HF% and Paediatric HF%:Counted.HRV 
Mean HF% differences are calculated for total paediatric (p=0.648) and total 
adult (p=0.917) data. Mean HF% Bland & Altman difference for paediatric 
data (n=27) is 6.5 ± 31.1 with limits of agreement (-15) and 35.7 (Figure 86). 
Mean HF% Bland & Altman difference for adult data (n=6) is (-4.4) ± 83.4 
with limits of agreement (-77.8) and 44 (Figure 85). Neither group reach 
statistical significance. Standard deviations are larger for the adult group 
with the total being much smaller with a range of 121.80 compared to 



















Chapter 24 Relationship of NeuroScope CIPA data and BioSignal 
HF% from Matched Counted R-R 
3.6.1 Total Sub-clinical Seizures 






































Total Counted Mean Baseline CIPA vs Total Counted Mean Subclinical CIPA
Figure 87 Scatterplot of baseline CIPA versus sub-clinical CIPA for total 
mean counted data 




































Total Counted Mean Baseline HF% vs Total Counted Mean Subclinical HF%








































Total Counted Mean Baseline lnHF% vs Total Counted Mean Subclinical lnHF%
Figure 89 Scatterplot of baseline lnHF% versus sub-clinical lnHF% for total 












Counted Difference for CIPA, HF, lnHF, log lnHF% & ln CIPA
Figure 90 Boxplot of differences (baseline minus sub-clinical) in CIPA, HF%, 















Interval Plot of log CIPA Diff, InHF Diff, log ln HF Diff
95% CI for the Mean
Figure 91 Interval plot of differences (baseline minus sub-clinical) in lnCIPA, 
lnHF% & log lnHF% 
 







































Counted HF% Diff -Counted CIPA Diff vs Counted HF% Ave + Counted CIPA Ave
Figure 92 Bland & Altman scatterplot of difference (HF% difference minus 
CIPA difference) versus CIPA & HF% average for total mean counted data. 




HF% difference (baseline minus sub-clinical) minus CIPA difference 
(baseline minus sub-clinical) versus HF% & CIPA average lets us look at 
what the difference is between the data represented by BioSignal and the 
NeuroScope. The mean difference is 8.0 ± 34.6 with limits of agreement (-
12.3) and 37.2 (range 49.4), (Figure 92). Clinically, this is difficult to interpret, 
as it is the wrong scale for HF%. In order to look at the scale closer to CIPA, 
the natural log of HF% is analysed. 
 
 









































Counted CIPA Diff - Counted lnHF% Diff vs Counted CIPA Ave + Counted ln HF% Ave
 
Figure 93 Bland & Altman scatterplot of difference (CIPA difference minus 
lnHF% difference versus CIPA & lnHF% average for total mean counted 
data. Limits of agreement are (–4.914) and 5.984. Range is10.89. 
CIPA difference (baseline minus sub-clinical) minus lnHF% difference 
(baseline minus sub-clinical) versus CIPA & lnHF% average again let us look 
at the difference between data represented by the NeuroScope and BioSignal 
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but on a more comparable scale. The mean difference between data from the 
NeuroScope and BioSignal for CIPA and lnHF% is 0.4 ± 6.4 with limits of 
agreement (-4.9) and 6.0 (range 10.9), (Figure 93). 
 


















































Counted lnHF Diff - Counted log CIPA Diff vs Counted ln HF Ave + log CIPA Ave
 
Figure 94 Bland & Altman scatterplot of difference (lnHF% difference minus 
lnCIPA difference versus lnHF% & lnCIPA average for total mean counted 
data. Limits of agreement are (–0.743) and 1.664. Antilog of these values are 0.475 
and 5.280. Range is 4.805. 
The mean difference between lnHF% and log CIPA is 0.4 ± 1.6 with antilog 

























































Counted log lnHF Diff-Counted logCIPA Diff vs Counted log lnHF Ave + Counted logCIPA Ave
 
Figure 95. Bland & Altman scatterplot of difference (log lnHF% difference 
minus lnCIPA difference versus log lnHF% & lnCIPA average for total mean 
counted data. Limits of agreement are (-1.026) and 1.420. Antilog values are 
0.358 and 4.137. Range is 3.779. 
 
A further reduction between the difference between the NeuroScope and 
BioSignal is seen using log lnHF and log CIPA with a mean difference of 0.02 

















































































































































3.6.2  Scale Relationship of HF% & CIPA for Counted Data 
In clinical practice, a new device should be compared to an accepted 
technology before it can be used confidently. BioSignal is a traditionally 
accepted method for quatifying HRV. The NeuroScope is a novel device and 
is compared to BioSignal results in this pilot study for a limited comparison. 
HF% mean difference of baseline minus sub-clinical (n=33) is 8.7 (with limits 
of agreement (-21) to 44, range 65), (Figure 75, Table 30), (p=0.049) is on a 
larger scale compared to CIPA. Mean CIPA difference (n=33) is 0.8 ± 3.6 (with 
limits of agreement (–4.8) to 6.8, range 11.6), (Figure 15, Table 8), (p=0.233). 
By using natural log HF%, the HF% data is scaled down to a closer 
relationship to CIPA but is smaller with a mean difference (n=33) of 0.4 ± 1.0 
(limits of agreement 0.4 to 2.7, range 2.3), (Figure 81, Table 29), (p=0.076). 
The closest scale difference between NeuroScope CIPA and BioSignal HF% is 
log CIPA and log lnHF% mean difference 0.02 ± 1.0 (limits of agreement are 
0.5 to 2.7, range 2.2), (Figure 16, Table 29). This would indicate that at this 
scale comparison, there would be a 2% difference in the results between the 
systems for shorter ‘counted’ epochs, less than 5 minutes HRV. 
Mean data per epoch of data is limiting and can only be useful for trend 
interpretation for CIPA and HF. There are obvious scale differences between 
CIPA, log CIPA, HF%, lnHF% and log lnHF% data and direct comparisons 
are limited. However, similar representation of vagal measurements are 
found in data distribution for baseline, sub-clinical and visually proportional 
differences are present between baseline and sub-clinical values for 
NeuroScope CIPA and BioSignal HF% data. 
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In summary, counted data comparison of CIPA and lnHF% shows similar 
results on a different scale with lnHF% approximately half that of CIPA. The 
closest scale comparisons for mean values are log CIPA and log lnHF% for 
counted data. With limited mean data to test this comparison only very 
general observations can be made. 
Chapter 25. Heart Rate Variability (5 minutes) 
 
3.7.1 Results of R-R Interval Analysis prior to 5 minute BioSignal 
Analysis. 
From data derived from the original study group of patients, twenty-seven 
thousand, one hundred and fifty-one (27,151) R-R intervals were manually 
measured from thirty-three (33) sub-clinical seizures and time matched 
baseline studies. The sub-clinical seizures were encapsulated within 5minute 
epochs and R-R intervals (n= 13,229) measured and analysed. Matched 5 
minute baseline studies were manually measured (n= 13,922) and analysed 
from 11 patients mean age 23.1 ± 18.7 years. Nine sub-clinical seizures were 
derived from the right temporal lobe (5 patients) (R-R intervals n= 3330 sub-
clinical, n=3110 baseline) and five sub-clinical seizures were derived from the 
left temporal lobe (4 patients), (R-R intervals n=1780 sub-clinical, n=1757 
baseline). Nineteen generalised sub-clinical seizures (R-R intervals n=8119 
sub-clinical, 9055 baseline) were analysed from two patients. 
Twenty-seven thousand, one hundred and fifty-one (27,151) R-R intervals 






























Right 5min R-R Baseline (n=3110) vs Right 5min R-R Subclinical (n=3330)  n=6440
Figure 96 Scatterplot of R-R intervals during right temporal lobe sub-clinical 
seizures versus matched 5minute baseline R-R intervals 
 








































Right 5min R-R Difference B-S vs Right 5min R-R Average B+S  n=6440
Figure 97 Bland & Altman scatterplot difference (baseline minus sub-clinical) 
R-R interval versus average (B-S) for right hemisphere 5minute data Limits 


























Right 5min R-R Baseline, Right 5min R-R Subclinical
Figure 98 Histogram of 5minute R-R baseline, 5minute R-R sub-clinical 
during right temporal lobe data. Wilcoxon Two Sample p<0.001. Mean baseline 
heart rate is 68.11/min, mean sub-clinical heart rate is 72.89/min,  
 
Similar to ‘counted’ R-R interval analysis, 5 minute R-R interval also shows a 
difference when comparing baseline R-R with sub-clinical R-R interval data 
but to a lesser extent. R-R intervals shorten from right temporal baseline 
(n=3,110) 880.9 ± 121.3 milliseconds to right temporal sub-clinical (n=3,330) 
823.1 (72.89/min) ± 165.4 milliseconds (p<0.001), (Figure 98, Table 32). This 
indicates an overall increase in heart rate and has a mean difference of 77 ± 
329 milliseconds and limits of agreement (-250) and 405.9 milliseconds 
(Figure 97). A smaller increase in mean heart rate (4.62/min) is seen 
comparing 5 minute epochs to ‘counted’ epochs of mean heart rate increase 
(10.5/min) due to the longer epoch diminishing the sub-clinical data with non 




























Left 5min R-R Baseline (n=1757) vs Left 5min Subclinical (n=1780)  n=3537
Figure 99 Scatterplot of R-R intervals during left temporal lobe sub-clinical 
seizures versus matched 5minute baseline R-R intervals 






































Left 5min R-R Difference B-S vs Left 5min R-R Average B+S  n=3537
Figure 100 Bland & Altman scatterplot difference (baseline minus sub-
clinical) R-R interval versus average (baseline & sub-clinical) for left 


























Left 5min R-R Baseline, Left 5min R-R Subclinical
Figure 101 Histogram of 5minute R-R baseline, 5minute R-R sub-clinical 
during left temporal lobe data. Wilcoxon Two Sample p<0.001 Mean baseline 
heart rate is 68.57/minute mean sub-clinical heart rate is 74.85/min. 
 
The results for left temporal and generalised data give a similar trend as seen 
with counted R-R interval epochs but again are less marked for the same 
reason of diminution. Left baseline (n=1757) 875.0 (68.6) ± 135.7milliseconds 
shortens during left temporal sub-clinical (n=1780) 801.6 (74.8/min) ± 
188.5msec (p<0.001). This again indicates an overall increase in heart rate and 
has a mean difference of 70 ± 495msec and limits of agreement (-424) and 565 
milliseconds (Figures 100 & 101). The mean difference 70 ± 495milliseconds is 
only slightly less than that seen from counted data 126 ± 367msec  
 
Generalised 5min limits of agreement are (–231) and 112. Unable to combine 

























Generalised 5min Baseline R-R






















Generalised 5min Subclinical R-R
Figure 103 Histogram 5minute R-R interval for generalised sub-clinical data. 
Baseline heart rate is 92.9/min and the sub-clinical heart rate is 84.85/min. 
Generalised data indicates a lengthening of R-R interval from baseline 
(n=9055) 645.5 (92.95/min) ± 44.4 milliseconds to sub-clinical (n=8119) 707.1 
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(84.84/min) ± 98.1 milliseconds as seen with counted data (Figures 102 & 103). 
A mean difference between baseline and sub-clinical R-R data is (-61.6) and 
limits of agreement (-231) and 112 milliseconds. The mean difference of R-R 
intervals baseline minus sub-clinical are similar to that seen for 5 minute (-
61.6 milliseconds) counted R-R interval difference (-58 milliseconds) 
5min R-R Interval 
Descriptive Data 
n Baseline  
R-R 
n Sub-clinical  
R-R 
 

































































































Co-efficient of variation of R-R intervals from 5 minute epochs show the 
same trends as seen with counted data for right, left and generalised baseline 
and sub-clinical data but have a slightly wider scatter. Generalised data 
again has the tightest coefficient of variation baseline 5% and sub-clinical 
4.3% (Table 32). R-R interval data for right temporal lobe baseline data is 
7.3% and right temporal lobe sub-clinical data 10.66% (Table 32). The left 
temporal baseline data is 8.6% and left temporal sub-clinical data 15.8% 
(Table 32). There is an expected wider scatter because of a greater number of 
R-R intervals analysed and the inherent increased chance of variation 
captured. However, despite generalised data having the greatest number of 
R-R intervals, generalised sub-clinical seizures have the smallest co-efficient 




Standard Deviation Heart Rate 5minutes HRV 



































Total 5min StDev.HR Subclinical vs Total 5min StDev. HR Baseline
Figure 104 Scatterplot baseline heart rate standard deviation versus sub-
clinical heart rate standard deviation for total mean 5minute data 




































Total 5min log StDev.HR Diff B-S vs Total 5min log StDev.HR Ave B+S
Figure 105 Bland & Altman scatterplot of difference (B-S) log heart rate 
standard deviation versus average log heart rate standard deviation for total 




Limits of agreement for 5 min HRV standard deviation of heart rate during 
total sub-clinical seizures compared to baseline data (Figure 105) are (–0.5) 
and 0.3 with antilog of 0.6 and 1.3. Limits of agreement for 5 min HRV 
standard deviation of heart rate derived during right temporal sub-clinical 
seizures are (–0.5 and -0.0) with antilog of  0.6 and 1.0 (range 0.4). Limits of 
agreement for 5 min HRV standard deviation of heart rate derived during 
left temporal sub-clinical seizures are (–0.8 and –0.3) with antilog of 0.4 and 
0.7  (range 0.3). Limits of agreement for 5 min HRV standard deviation of 
heart rate derived during generalised sub-clinical seizures are (–0.5) and 0.4 




























3.7.2  BioSignal Analysis of 5 minutes HRV for Total Sub-clinical 
Seizures & Baseline Data. 
 
As with imported counted R-R data, only mean values can be measured per 
event with the BioSignal HRV software. 5 minute R-R interval epochs of 
baseline and sub-clinical data for each event were imported into the 
BioSignal software for analysis. A total of 27,151 R-R intervals (13,922 
baseline & 13,229 sub-clinical) were imported comprising of 6,440 R-R 
intervals for the right temporal lobe (3,110 baseline, 3,330 sub-clinical), 3,537 
R-R intervals for the left temporal lobe (1,757 baseline, 1,780 sub-clinical) and 
17,174 R-R intervals for generalised data (9,055 baseline, 8,119 sub-clinical). 
After software conversion of this data, mean values were produced resulting 
in one mean total per baseline study and one mean total per sub-clinical 
seizure study. A total mean of 33 baseline studies and matched sub-clinical 
comprising of right temporal lobe (9 baseline, 9 sub-clinical) left temporal 
lobe (5 baseline, 5 sub-clinical) and generalised (19 baseline, 19 sub-clinical). 
This data encapsulated the same data analysed for counted R-R data but 
















Pt. ID Baseline HRV (5 minutes) Sub-clinical HRV (5 minutes) 
RMSSD 
   (ms) 
SDNN 




  (%) 
RMSSD 
  (ms) 
SDNN 






Pt 1 74.6 0.091 145 51.4 66.5 0.111 116 33.2 
Pt 2 50.1 0.046 106 32.1 50.8 0.044 110 33.2 
Pt 2 50.1 0.046 106 32.1 16.2 0.037 56 0.4 
Pt 2 50.1 0.046 106 32.1 35.6 0.051 66 15.2 
Pt 2 50.1 0.046 106 32.1 41.7 0.046 90 17.9 
Pt 2 50.1 0.046 106 32.1 44.3 0.044 64 24.2 
Pt 3 57.5 0.067 149 41.6 46.1 0.055 78 17.3 
Pt 4 77.8 0.078 175 51.3 142.6 0.138 171 62.6 
Pt 5 78.6 0.075 200 45.0 98.3 0.087 207 49.1 
Pt 6 78.3 0.079 165 43.0 88.6 0.109 124 31.3 
Pt 7 79.9 0.070 235 60.7 111.4 0.104 213 63.8 
Pt 7 79.9 0.070 235 60.7 105.8 0.104 151 51.0 
Pt 8 65.3 0.052 139 50.0 49.3 0.098 78 27.6 
Pt 9 23.8 0.046 12 3.8 11.1 0.046 1 0.2 
Pt 10 19.2 0.018 7 1.4 16.2 0.019 2 0.4 
Pt 10 19.2 0.018 7 1.4 21.5 0.025 7 1.5 
Pt 10 19.2 0.018 7 1.4 21.0 0.030 13 2.7 
Pt 10 19.2 0.018 7 1.4 24.8 0.029 20 5.3 
Pt 10 19.2 0.018 7 1.4 18.3 0.019 7 1.4 
Pt 10 19.2 0.018 7 1.4 23.0 0.025 20 4.4 
Pt 10 19.2 0.018 7 1.4 22.2 0.025 17 3.7 
Pt 10 19.2 0.018 7 1.4 17.2 0.019 9 2.0 
Pt 10 19.2 0.018 7 1.4 23.4 0.026 18 4.0 
Pt 10 19.2 0.018 7 1.4 18.7 0.025 12 2.6 
Pt 10 19.2 0.018 7 1.4 24.5 0.027 15 3.3 
Pt 11 24.3 0.035 14 3.1 41.4 0.040 45 16.6 
Pt 11 24.3 0.035 14 3.1 37.0 0.035 43 11.5 
Pt 11 24.3 0.035 14 3.1 55.4 0.059 79 21.5 
Pt 11 24.3 0.035 14 3.1 44.9 0.051 61 16.4 
Pt 11 24.3 0.035 14 3.1 39.9 0.045 46 12.8 
Pt 11 24.3 0.035 14 3.1 69.8 0.069 104 29.4 
Pt 11 24.3 0.035 14 3.1 38.9 0.044 37 10.0 


















21.5 0.028 189 2.0 33.2 0.036 602 7.5 
Mean
Total 
38.5 0.040 65.9 18.4 45.7 0.052 64.5 17.9 
 
Table 33 BioSignal analysis RMSSD, SDNN, NN50 count, & pNN50 for 




Pt. ID Baseline HRV  
(5 minutes) 
Sub-clinical HRV  
(5 minutes) 
































Pt 1 1352 37.1 47.7 792 13 60.0  <560 <24.1 >12.3 
Pt 2 464 57.2 46.6 692 75.4 73.4 >228 >18.2 >26.8 
Pt 2 464 57.2 46.6 253 41.3 71.4 <211 <15.9 >24.8 
Pt 2 464 57.2 46.6 285 24.7 60.1 <179 <32.5 >13.5 
Pt 2 464 57.2 46.6  466 43.7 132.2 >2 <13.5 >85.6 
Pt 2 464 57.2 46.6 280 33.3 65.2 <184 >23.9 >18.6 
Pt 3 653 45.5 31.3 417 32.3 24.7 <236 <13.2 <6.6 
Pt 4 1152 53.8 39.7 2861 36.2 33.0 >1709 <17.6 <6.7 
Pt 5 981 41.6 34.1 1249 48.7 32.6 >268 >7.1 >1.5 
Pt 6 428 16.7 19.3 843 15.9 22.3 >415 <0.8 >3 
Pt 7 1769 79.6 73.1 1330 35.5 32.2 <439 <44.1 <40.9 
Pt 7 1769 79.6 73.1 2789 55.7 57.2 >1020 <23.9 <15.9 
Pt 8 617 52.9 47.6 197 8.0 8.1 <420 <44.9 <39.5 
Pt 9 56 6.1 74.2 6 0.7 6.2 <50 <5.4 <68 
Pt 10 83 63.2 56.6 66 41.3 53.3 <17 <21.9 <3.3 
Pt 10 83 63.2 56.6 155 56.1 62.2 >72 <7.1 >5.6 
Pt 10 83 63.2 56.6 108 24.7 24.1 >25 <38.5 <32.5 
Pt 10 83 63.2 56.6 209 51.1 47.4 >126 <12.1 <9.2 
Pt 10 83 63.2 56.6 72 46.0 39.2 <11 <17.2 <17.4 
Pt 10 83 63.2 56.6 137 48.7 51.6 >54 <14.5 <5 
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Pt 10 83 63.2 56.6 125 43.8 78.1 >42 <19.4 >21.5 
Pt 10 83 63.2 56.6 59 38.9 38.6 <24 <24.3 <18 
Pt 10 83 63.2 56.6 135 42.9 47.8 >52 <20.3 <8.8 
Pt 10 83 63.2 56.6 58 21.5 19.0 <25 <41.7 <37.6 
Pt 10 83 63.2 56.6 91 30.9 37.4 >8 <32.3 <19.2 
Pt 11 79 14 30.3 270 41.2 36.6 >191 >27.2 >6.3 
Pt 11 79 14 30.3 289 51.7 50.1 >210 >37.7 >19.8 
Pt 11 79 14 30.3 372 30.0 22.8 >293 >16 <7.5 
Pt 11 79 14 30.3 235 24.6 20.1 >156 >10.6 <10.2 
Pt 11 79 14 30.3 212 26.1 23.0 >133 >12.1 <7.3 
Pt 11 79 14 30.3 600 37.8 28.3 >521 >23.8 <2 
Pt 11 79 14 30.3 233 28.8 28.4 >154 >14.8 <1.9 
















89 24.3 44.8 185 32.8 26.9 >96 >8.5 <17.9 
Mean
Total 
383.1 45.6 46.6 489 36.3 43.3 >105.9 <9.3 <3.35 
 
Table 34 BioSignal analysis HFms2, HF% & HFnu for baseline and sub-
clinical 5minute data 
 
LF% & VLF% HRV Spectral Frequencies 
LF% HRV is considered to represent sympathetic and to some extent 
includes parasympathetic activity. VLF% HRV physiological representation 
is largely unexplained but considered to be indicative of rennin-angiotensin-
aldosterone hormonal interplay on the autonomic nervous system.  Data for 
LF% and VLF% are not presented briefly in this study. An increase in LF% 
HRV occurs during generalised sub-clinical seizures 51.4 ± 14.8 compared to 
Section Three 
 477 
baseline measurements 26.1 ± 0.56. In contrast, decreases in LF% are noted 
during right sub-clinical seizures 38.4 ± 31.45 compared to baseline 48.14 ± 
8.14 and left sub-clinical seizures 22.17 ± 26.16 compared to baseline 31.32 ± 
25.6. Statistical significance is not demonstrated for LF% in any group (Table 
42). VLF% data demonstrates no statistically significant results  
3.7.3 RMSSD, SDNN  
RMSSD is the square root of the mean squared differences of successive NN 
intervals and is an estimate of short term HRV.  All groups show an increase 
































Total 5min Subclinical RMSSD vs Total 5min Baseline RMSSD
 
Figure 106 Scatterplot of baseline RMSSD versus sub-clinical RMSSD for 
total mean 5minute data. 
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Total 5min log RMSSD Diff B-S vs Total 5min log RMSSD Ave B+S
 
Figure 107 Bland & Altman scatterplot of difference (baseline minus sub-
clinical) RMSSD versus average RMSSD for total mean 5minute data 
 
Limits of agreement from Bland & Altman analysis for 5 min HRV RMSSD 
derived during total sub-clinical seizures (Figure 107) are (–0.8) and 0.3 with 
antilog of 0.4 and 1.4. Limits of agreement of 5 min HRV RMSSD derived 
during right temporal lobe sub-clinical seizures (–0.6) and 0.3 with antilog of 
0.5 and 1.4 (range 0.9). Limits of agreement of 5 mn HRV RMSSD derived 
during left temporal lobe sub-clinical seizures are (–0.3) and 0.3 with antilog 
of 0.7 and 1.3 (range 0.6). Limits of agreement of 5 min HRV RMSSD derived 
during generalised sub-clinical seizures are (–0.8) and 0.2 with antilog of 0.4 
and 1.2 (range 0.8). This result indicates similar short term variability for all 
categories of sub-clinical seizures compared to baseline data. 
Generalised baseline RMSSD increases from 21.5 to sub-clinical 33.2msec, 
right baseline RMSSD increases from 60.8 to sub-clinical 68.7msec and left 
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baseline RMSSD increases from 70.6 to sub-clinical 79.8msec (Table 33). 
Differences between baseline and sub-clinical RMSSD limits of agreement 
again have the smallest range from generalised data of 0.7 (limits of 
agreement are 0.4 and 1.2), (Figure 107) compared to right temporal 0.9 
(limits of agreement are 0.5 and 1.4) and left temporal 0.6 (limits of 
agreement are 0.7 and 1.3) similar to counted data (Table 8). However, the 
ranges are reduced for all data when using 5minute epoch compared to 
counted data and are considered to be more accurate over 5minute epochs. 
Standard Deviation of Normal-to-Normal beat variation (SDNN)  
5minutes HRV 
SDNN is the square root of variance and is mathematically equal to the total 
power of spectral analysis and represents all the cyclic components 
contributing to HRV. It is appropriate to compare 5minute baseline studies 


























Total 5min Subclinical SDNN vs Total 5min Baseline SDNN
 
Figure 108 Scatterplot of baseline SDNN versus sub-clinical SDNN for total 
mean 5minute data. 
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Total 5min log SDNN Diff B-S vs Total 5min log SDNN Ave B+S
 
Figure 109 Bland & Altman scatterplot of difference (baseline minus sub-
clinical) log SDNN versus average log SDNN for total mean 5minute data 
 
Limits of agreement from Bland & Altman analysis of 5 min HRV SDNN 
derived for total sub-clinical seizures (Figure 109) are (–0.7) and 0.2 with 
antilog 0.5 and 1.2. Limits of agreement of 5 min HRV SDNN derived during 
right temporal sub-clinical seizures are (–0.2) and 0.2 with antilog of 0.8 and 
1.2 (range 0.4). Limits of agreement of 5 min HRV SDNN derived during left 
temporal sub-clinical seizures are (–0.6) and 0.0 with antilog of 0.5 and 1.0 
(range 0.5). Limits of agreement of 5 min HRV SDNN derived during 
generalised sub-clinical seizures are (–0.5) and 0.0 with antilog of these 
values are 0.6 and 1.0 (range 0.4). 
Overall variability during 5 min HRV is seen for right and left temporal sub-




3.7.4 HFms2 Power & HF% 5 minutes HRV 
 































Total 5min Subclinical HFms vs Total Baseline HFms
Figure 110 Scatterplot baseline HFms2 versus sub-clinical HFms2 for total 
mean 5minute data. 


































Total 5min log ln HFms Diff B-S vs Total 5min log ln HF ms Ave B+S
Figure 111 Bland & Altman scatterplot of difference (B-S) log lnHFms2 versus 
average log lnHFms2 for total mean 5minute data.  
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Limits of agreement of 5 min HRV log ln HFms derived from total sub-
clinical seizures (Figure 111) are (–0.4) and 0.2. The ln (natural log) of these 
values are 0.7 and 1.2 (p=0.144). Limits of agreement of 5 min HRV log ln 
HFms derived during right temporal sub-clinical seizures are (–0.1) and 0.1. 
The ln (natural log) of these values are 0.9 and 1.1 (p=0.363), (range is 0.2) 
Limits of agreement of 5 min HRV log ln HFms derived during left temporal 
sub-clinical seizures are (–0.1) and 0.8. The ln (natural log) of these values are 
0.9 and 2.2 (p=0.584), (range is 1.3). Limits of agreement of 5 min HRV log ln 
HFms derived during generalised sub-clinical seizures are (–0.4) and 0.1. The 
ln (natural log) of these values are 0.7 and 1.1 (p=0.317), (range 0.4).  
HF% 5min HRV 
 

































Total 5min HF% Subclinical vs Total 5min HF% Baseline
 
































Total 5min HF% Diff B-S vs Total 5min HF% Ave B+S
 
Figure 113 Bland & Altman scatterplot of difference (B-S) HF% versus 
average HF% for total mean 5minute data. 
Bland & Altman analysis of limits of agreement for 5 min HF% HRV derived 
during total sub-clinical seizures (Figure 113) are (-34.4) and 44.9. Limits of 
agreement for 5 minHF% HRV derived during right temporal sub-clinical 
seizures are (–18.2) and 32.5 (range 50.7%). Limits of agreement for 5 min 
HF% HRV derived during left temporal sub-clinical seizures are 0.8 and 44.9 
(range 44.1%). Limits of agreement for 5 min HF% HRV derived during 
generalised sub-clinical seizures are (–37.7) and 41.7 (range 79.4%).  
5 minute HF%HRV shows that there is more parasympathetic activity during 
generalised sub-clinical seizures indicating reduced heart rate during 
generalised sub-clinical seizures compared to baseline data than during right 
or left temporal lobe sub-clinical seizures 
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Bland & Altman plots analysing the 5minute epoch differences in baseline 
minus sub-clinical data for each group show impressively similar mean 
differences to counted data. Caution is used in comparing different epochs 
for HF% but is investigated in this instance to investigate further reasons 
why the results have changed for generalised data when using a longer 
epoch. Right mean HF% difference is 11.9 ± 30.9 (counted mean difference 9.6 
± 36.3) with limits of agreement (-18.2) and 32.5 (Figure 113). Left mean HF% 
difference is 23.8 ± 41.6, (counted mean difference 24.7 ± 43.6) with limits of 
agreement 0.8 and 44.9. Generalised mean difference is 4.2 ± 48.9 (counted 
mean difference 4.1 ± 33) with limits of agreement (-37.7) and 41.7. Even 
though the mean difference for generalised data is practically identical, the 
limits of agreement are wider using 5 minute epochs (-37.7 and 41.7) 
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HF% HRV is believed to represent parasympathetic activity. Statistical 
significance is seen from 5 minutes HF% data when comparing mean 
baseline with mean sub-clinical studies for total data There is a reduction of 
parasympathetic activity from total baseline HF% measurements 45.6 ± 23.0 
compared to total sub-clinical seizures 36.3 ± 15.2, (p=0.026). For right 
temporal lobe sub-clinical seizure data there is a decrease in baseline HF% 
51.6 ± 8 reducing to sub-clinical HF% 39.6 ± 17.2, (p=0.042). Left temporal lobe 
sub-clinical seizure data similarly reduces from baseline HF% 47.0 ± 34.5 to 
sub-clinical HF% 23.2 ± 22.4, (p=0.062).  However, generalised data shows an 
increase in parasympathetic activity from baseline HF% 42.5 ± 25.0 to sub-















Total Mean HRV HF% Baseline, Total Mean HRV HF% Subclinical
 














Boxplot of HFms 5min Baseline, HFms 5min Subclinical






























Total Mean 5min HRV HF% Baseline, Total Mean 5min HRV HF% Subclinical
Figure 116 Histogram of HF% baseline, HF% sub-clinical 5minute HRV total 
mean data. Wilcoxon p=0.026. This histogram is very similar to CIPA & 


























Histogram of HFms 5min Baseline, HFms 5min Subclinical
Normal 
 
Figure 117 Histogram of HFms2 baseline, HFms2 sub-clinical 5minute HRV 
total mean data. Wilcoxon p= 0.472. This histogram is not concordant with 




































Total 5min lnHF% Diff B-S vs Total 5min lnHF% Ave B+S
 
Figure 118 Bland & Altman scatterplot of difference (B-Sl) lnHF% versus 




Bland & Altman plot analysis of 5 min lnHF% HRV derived from total sub-
clinical seizures compared to baseline data (Figure 118) with limits of 
agreement (-1.3) and 1.0 and antilog of 0.3 and 2.8. Limits of agreement of 5 
min lnHF% HRV derived from right temporal sub-clinical seizures are (-0.3) 
and 1.1 with antilog 0.8 and 2.8 (range 2.0). Limits of agreement of 5 min 
lnHF% HRV derived from left temporal sub-clinical seizures are 0.1 and 2.2 
with antilog 1.0 and 8.7 (range 7.7). Limits of agreement of 5 min lnHF% 
HRV derived from generalised sub-clinical seizures are (-1.3) and 1.1 with 
antilog of 0.3 and 3.0 (range 2.7).  
 







































Total Mean 5min log lnHF% Diff B-S vs Total Mean 5min log lnHF% Ave B+S
 
Figure 119 Bland & Altman scatterplot of difference (B-S) log lnHF% versus 






Bland & Altman plot analysis of 5 min log lnHF% HRV derived during total 
sub-clinical seizures compared to baseline data (Figure 119) has limits of 
agreement of (–0.4) and 0.6 with (natural log) of 0.7 and 2.0. Limits of 
agreement of 5 min log lnHF%HRV derived during right temporal sub-
clinical seizures are (-0.1) and 0.3 with ln (natural log) of 0.9 and 1.3 (range 
0.4%). Limits of agreement of 5 min log lnHF%HRV derived during left 
temporal sub-clinical seizures are 0.0 and 0.2 with ln (natural log) of 1.0 and 
1.2 (range 0.2%). Limits of agreement of 5 min log lnHF%HRV derived 
during generalised sub-clinical seizures are (–0.4) and 0.3 with ln (natural 
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Table 36 Descriptive statistics for differences (baseline minus sub-clinical) in 








5 min HRV 
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Table 37 Bland & Altman limits of agreement for log RMSSD, log SDNN, 
HF%, lnHF% & log lnHF% in total, right, left and generalised 5minute data 
 
 
3.7.5 Relationship between NeuroScope data and BioSignal HF% 
& HFms2 
 
The High Frequency (HF) band of heart rate variability frequency domain 
analysis is considered to represent cardiac vagal activity. This is the closest 
equivalent to CIPA in measuring vagal tone. Like mean CIPA (p=0.233). 
(Table 8) & Counted HF% (p=0.049), (Table 30) a decrease in 5minute HF% 
(p=0.026), (Table 37) indicates a reduction of cardiac vagal tone and tends to 
result in an increase in heart rate and vice versa. This is not concordant with 
HFms2 indicating a slight increase in vagal activity for total HFms2 baseline 





























HF% Counted Diff B-S HFms Counted Diff B-S
HF% 5min Diff B-S HFms 5min Diff B-S
HF% Counted , HFms Counted, HF% 5min, HFms 5min vs CIPA Diff B-S
 
Figure 120 Pearson correlation analysis of counted HF% & 5minute HF% 
(BioSignal) data with CIPA (NeuroScope) data. 
 
The closest Pearson correlation is CIPA versus 5min HRV HF% of p<0.001, 
followed by CIPA versus Counted HF% (p=0.002). CIPA is least correlated to 
5minute HRV HFms2 (p=0.359), followed by Counted HFms2 (p=0.025). 
Due to closest data correlation found between CIPA and HF%, more detailed 
analysis was performed examining seizure type using HF% rather than 
HFms2  (Figure 120). Additionally, HFms2 could not be used for the purposes 
of this study due to the huge standard deviation compared to the mean 
baseline 383.1 ± 982.8 and mean sub-clinical 489 ± 1364 (derived from Table 
34) With a study of 33 mean totals a disproportionate standard deviation 








Table 38 Baseline & sub-clinical 5minute R-R interval & coefficient of 
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Table 39 Baseline & sub-clinical 5minute R-R interval & coefficient of 
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   0.001 
Patient 10 493 625           4.1 481 625           4.7    0.038 
Patient 10 493 625           4.1 514 615           5.3    0.052 
Patient 10 493 625           4.1 381 635           5.7    0.001 
Patient 10 493 625           4.1 495 635           3.3    0.001 
Patient 10 493 625           4.1 458 650           4.1    0.001 
Patient 10 493 625           4.1 461 645           5.8    0.001 
Patient 10 493 625           4.1 456 655           3.2    0.001 
Patient 10 493 625           4.1 453 660           4.8    0.001 
Patient 10 493 625           4.1 514 655           4.8    0.001 
















   0.365 
Patient 11 454 675           5.8 383 805            5.3    0.001 
Patient 11 454 675           5.8 376 800            5.0    0.001 
Patient 11 454 675           5.8 368 820            7.4    0.001 
Patient 11 454 675           5.8 373 830            6.6    0.001 
Patient 11 454 675           5.8 360 840            5.6     0.001 
Patient 11 454 675           5.8 355 850            8.3     0.001 
Patient 11 454 675           5.8 370 810            6.1     0.001 
Patient 11 454 675           5.8 350 860            4.8    0.001 
Total 
Patient 11 
3632 675           5.8 2935 830            6.6    0.001 
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Table 40 (above) Baseline & sub-clinical 5minute R-R interval & coefficient of 




























































































Right, Left & Generalised Baseline & Subclinical Coef. Var. 5min HRV HF%
Figure 121 Boxplot of baseline & sub-clinical coefficient of variation for right, 
left & generalised 5minute data 
 








     Generalised 
 
n=19 
CIPA Mean Difference 
(Baseline minus sub-
clinical) 
3.7 4.4 -1.6 





9.6 24.7 4.1 
HF% (Counted) 
Average 
47.3           38.5 39.0 
HF% (5min) Difference 
(Baseline minus sub-
clinical) 
11.9 23.8 4.24 
HF% (5min) Average 45.6 35.1 40.36 
Table 41 Difference (baseline minus sub-clinical) in mean CIPA, HF% in 


















CIPA during Total 
data. 
 
8.2 ± 6.3 
 





CIPA during Right 
temporal lobe data. 
 
12.7 ± 5.3 
 





CIPA during Left 
temporal lobe data. 
 
14.3 ± 6.8 
 








3.7 ± 1.5 
 





HRV %HF (& %LF) 
during Total baseline 
& sub-clinical data 
45.6 ± 23.0 
(38.0±17.9) 






HRV %HF% (& %LF) 
during Right 
temporal lobe activity 
37.8 ± 8.0 
(48.1 ± 8.1) 
28.0 ± 17.4 





HRV %HF (& %LF) 
during Left temporal 
lobe activity 
47.2 ± 34.5 
(31.32 ± 
25.6) 






HRV %HF (& %LF) 
during Generalised 
activity 
24.3 ± 25.0 
(26.1 ± 0.6) 
32.8 ± 10.6 





SDNN (& RMSSD) 
during Total data 
0.04 ± 0.02 
(38.5 ± 23.1) 
0.05 ± 0.03 





SDNN (& RMSSD) 
during Right 
temporal lobe activity 
0.06 ± 0.017 
(59.8 ± 
13.09) 
0.068 ± 0.03 





SDNN (& RMSSD) 
during Left temporal 
lobe activity 
0.1 ± 0.01 
(65.4 ± 
24.07) 
0.09 ± 0.02 




SDNN (& RMSSD) 
during Generalised 
activity 
0.03 ± 0.02 
(30.53 ± 
20.9) 









during total data  
 
65.9 ± 76.3 
 







temporal lobe activity 
 
133.2 ± 35.9 
 






during Left temporal 
lobe activity 
 
157.2 ± 91.6 
 







 SDNN50 during 
Generalised activity 
     
9.94 ± 0.815 
    








Table 42 Comparison of CIPA, HRV HF%, LF%, SDNN, RMSSD & SDNN50 
derived during 33 subclinical seizures and 33 matched baseline studies. 
Statistically significant differences are seen for total sub-clinical seizures 0.05 
± 0.03 compared to baseline measurements 0.04 ± 0.02 (p<0.001) and 
Generalised sub-clinical seizures 0.046 ± 0.029 (p<0.001) compared to baseline 
measurements 0.03 ± 0.018 after Bonferroni correction. SDNN for right 
(p=0.304) and left (p=0.02) temporal lobe seizures are not considered 
statistically significant after correction for multiple measurements (Table 42). 
When SDNN50 mean counts are considered for all patients there is no 
significant difference between total baseline counts (65.9 ± 76.3) and sub-
clinical seizure (64.5 ± 58.2) data (p=0.932). However, differences are detected 
when sub-clinical seizure types are analysed separately. There are generally 
smaller counts during baseline and sub-clinical seizure counts for patients 
with refractory generalised epilepsy compared to analysis of counts for 
patients with temporal lobe seizures. Baseline mean counts of SDNN50 for 
right temporal sub-clinical seizures for baseline measurements (133.2 ± 35.9) 
reduce to sub-clinical (106.4 ± 51.8), (p=0.016). Left temporal lobe sub-clinical 
seizures SDNN50 shows a similar reduction from baseline (157.2 ± 91.6) to 
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sub-clinical (113.4 ± 79.6), (p=0.029). Generalised sub-clinical seizures are 
comparatively much lower SDNN50 counts compared to temporal lobe 
counts with baseline SDNN50 (9.947 ± 0.815) to sub-clinical (31.68 ± 27.29), 
(p<0.001) and this would indicate that there is generally less beat-beat 
variability in this group (Table 42). 
Following Bonferroni correction, the only statistically significant change 
(p=0.003) is attributed to generalised sub-clinical seizures 40.3 ± 30.5 
compared to baseline measurements 30.5 ± 20.9. Right temporal lobe sub-
clinical seizures 60.2 ± 38.2 compared to baseline 59.8 ± 13.1 (p=0.97) and left 
temporal lobe sub-clinical seizures 73.2 ± 42.3 compared to baseline 

















3.7.7 Comparison of Adult HF% and Paediatric HF% (5min) 









































Total Adult Mean 5min HF% Diff B-S vs Total Adult Mean 5min HF% Ave B+S
Figure 122 Bland & Altman scatterplot difference (baseline minus sub-
clinical) HF% versus HF% average in adult 5 minutes HRV data. Limits of 
agreement are 44.9 and 0.8. Wilcoxon p=1.0    











































Total Paediatric Mean 5min HF% Diff B-S vs Total Paediatric Mean 5min HF% Ave B+S
Figure 123 Bland & Altman scatterplot difference (baseline minus sub-
clinical) HF% versus HF% average in paediatric 5 minutes HRV data. Limits 




Adult HF% and Paediatric HF% (5min) 
Mean difference in HF% baseline minus sub-clinical was calculated for 
paediatrics (n=5) and adults (n=6) for 5 minute epochs HRV. The mean 
difference for paediatrics data was 7.5 ± 47.9 (p=0.28) with limits of 
agreement (-37.7) and 44.1 (range 81.8), (Figure 123). Adult mean difference 
is 17.7 ± 31.5 (p=1.0) with limits of agreement 0.8 and 44.9 (range 44.1), 
(Figure 122). Standard deviation is smaller for adult data (6 patients and 6 
sub-clinical seizures) compared to paediatrics (5 patients, 27 sub-clinical 
seizures).  
Poor statistically significant differences in HF% are demonstrated when total 
adults and total paediatric mean HF% data are analysed separately for either 
counted or for 5minute HF%. Total adult mean counted HF% difference is (-
4.4) ± 83.4 (limits of agreement -77.8 and 44) range 121.8, p=0.917 (Figure 160). 
Total paediatric mean counted HF% difference is 6.5 ± 31.1 (limits of 
agreement -15 and 35.7) range 50.7, (p=0.648), (Figure 85). Total adult mean 
5minute HF% difference is 17.7 ± 31.5 (limits of agreement 0.8 and 44.9) range 
44.1, (p=1.0), (Figure 122). Total paediatric mean 5minute HF% difference is 
7.5 ± 47.9 (limits of agreement -37.7 and 44.1) range 81.8, (p=0.28), (Figure 
123). 
When data is grouped into paediatric and adult data, poor significance is 
demonstrated for differences in HF% from baseline to sub-clinical. Results 
are clearly different when the data is analysed in terms of type of sub-clinical 
seizure. In this study, age effect on results of HF% would appear to be non-







Relationship of NeuroScope CIPA and BioSignal HF% (5minutes) 
 
3.8.1 Total Sub-clinical Seizures 
Mean data per event is limiting and can only be useful for trend 
interpretation for CIPA and HF. There are obvious scale differences between 
CIPA, log CIPA, HF%, lnHF% and log lnHF% data and direct comparisons 
are limited. However, similar representation of parasympathetic 
measurements are found in data distribution for baseline, sub-clinical and 
visually proportional differences are present between baseline and sub-
clinical values for NeuroScope CIPA and BioSignal HF% data. Comparisons 
are made between the two systems to determine whether it might be possible 
















CIPA Diff, HF% Diff, In HF% Diff, ln CIPA Diff, log ln Diff
 
Figure 124 Boxplot of difference (baseline minus sub-clinical) in CIPA, HF%, 




HF% mean difference of baseline minus sub-clinical (n=33) for 5 min data is 
9.3 ± 22.4, (p=0.026), (Figure 113.Table 35) but is on a larger scale compared to 
mean CIPA. CIPA mean difference (n=33) is 0.8 ± 3.6, (p=0.233), (Figure 15, 
Table 8). By using log lnHF%, the HF% data is scaled down to a mean 
difference 0.1 ± 1.0, (p=204), (Figure 119, Table 36) with a closer relationship 


















Boxplot of CIPA Diff, 5 min.HF% Diff
 

















Boxplot of CIPA Diff, 5 min.In HF% Diff
















Boxplot of ln CIPA Diff,5min. In HF% Diff















Boxplot of ln CIPA Diff, 5min log ln HF% Diff
Closest to scale comparison. 
Figure 128 Boxplot of difference (baseline minus sub-clinical) log CIPA & log 
lnHF% 5minute HRV total data. 
 
 




































5min HF% Diff (B-S) -CIPA Diff (B-S)vs 5min HF% Ave (B+S) +CIPA Ave (B+S)
Figure 129 Bland & Altman scatterplot of difference (HF% difference minus 
CIPA difference) versus average for total 5minute data 
Limits of agreement are (–32.2) and 41.44. Range is 73.6 
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Bland & Altman plots HF% difference (baseline minus sub-clinical) minus 
CIPA difference (baseline minus sub-clinical) versus HF% & CIPA average 
allows us to look at what the difference is between the data represented by 
BioSignal and the NeuroScope. The mean difference is 8.5 ± 41 with limits of 
agreement (-32.2) and 41.4 (range 73.6), (Figure 129). Clinically, this is 
difficult to interpret, as it is the wrong scale for HF%. In order to look at the 
scale closer to CIPA, the natural log of HF% is analysed. 
 
































CIPADiff -lnHF% 5min Diff vs CIPA Ave+lnHF% 5min Ave
 
Figure 130 Bland & Altman scatterplot of difference (CIPA difference minus 
lnHF% difference) versus average for total 5minute data 
Limits of agreement are (–5.992) and 5.879. Range is 11.871 
 
CIPA difference (baseline minus sub-clinical) minus lnHF% difference 
(baseline minus sub-clinical) versus CIPA & lnHF% average again allows us 
to look at the difference between data represented by the NeuroScope and 
BioSignal but on a more comparable scale. The mean difference between data 
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from the NeuroScope CIPA and BioSignal lnHF% is (-0.4) ± 7.5 with limits of 
agreement (-6.0) and 5.9 (range 11.9), (Figure 130). 












































5min lnHFDiff (B-S)- logCIPA Diff (B-S) vs 5min lnHF% Ave (B+S)+ logCIPA Ave(B+S)
 
Figure 131 Bland & Altman scatterplot of difference (lnHF% difference minus 
log CIPA difference) versus average for total 5minute data 
Limits of agreement are (-0.9) and 1.3. The Antilog of these values are 0.4 and 
3.5 (range is 2.2). When lnHF% is compared to log CIPA, there is a mean 











































5min log lnHF% Diff-log CIPA Diff vs 5min log lnHF% Ave + log CIPA Ave
 
Figure 132 Bland & Altman scatterplot of difference (log lnHF% difference 
minus log CIPA difference) versus average for total 5minute data 
 
Limits of agreement are (-0.3) and 0.5.The Antilog of these values are 0.7 and 
1.6 (range is 0.9). 
However, the closest comparable values are found when log lnHF% and log 
CIPA are used with a mean difference of 0.1 ± 0.6 with limits of agreement 
0.7 and 1.6 (range 0.9), (Figure 132, Table 37). This would indicate that a 
difference of 10% would exist between the NeuroScope CIPA and BioSignal 









































































































































Table 43 Bland & Altman limits of agreement between NeuroScope & 










Pearson Correlation of log CIPA Difference (baseline minus sub-clinical) 














Counted log ln HF% Diff
5min log lnHF% Diff
Scatterplot of Counted log ln HF%Diff, 5min log lnHF% Diff vs log CIPA Diff
 
 
Figure 133 Scatterplot with regression log lnHF%(counted data) & log lnHF%  
(5minute data) on the Y-axis versus log CIPA.  
 
High Pearson correlation is found for log CIPA Difference (baseline minus 
sub-clinical) and Counted log lnHF% Difference (baseline minus sub-
clinical), (p=0.006). However, log CIPA Difference (baseline minus sub-
clinical) is more closely correlated to 5minute log lnHF% Difference (baseline 
minus sub-clinical), (p<0.001). 
Different epochs measuring heart rate variability should not be compared 
but the purpose of one of the aims of this study is to deliberately ascertain if 
similar information can be achieved by using a shorter “counted” epoch 
compared to that of traditional short 5minute HRV. HRV HF% information 
has then been directly compared to CIPA to determine any similarity of 
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results to allow comparison of two different systems. CIPA and “counted 
HRV” are R-R matched and qualifies for direct comparison. There are 
limitations comparing data in this way and only general observations should 
be made. The agreement has been investigated by using Bland & Altman 
plots and the correlation co-efficient have been tested because a change in 
scale of measurement does not affect correlation but it does effect agreement. 
Section Three  
3.10.1 Discussion  
Mortality rate is 2-3 times higher in a patient with epilepsy due to epilepsy 
related deaths compared to someone in the general population (Ansakorpi et 
al 2002, Nouri et al 2004). One thousand epilepsy-related deaths a year occur 
in the United Kingdom of which 60% is believed to be SUDEP (Hanna et al 
2002). It is considered that pathogenic mechanisms underlying Sudden 
Unexpected Death in Epilepsy (SUDEP) are multi-factorial and are thought 
to include cortical control of the autonomic nervous system such as ictal 
bradyarrythmia and respiratory mechanisms such as ictal apnoea (Algra et al 
1993, Nashef & Shorvon 1997, Al-Aweel et al 1999, Ansakorpi et al 2002, 
Leung et al 2006, Mameli et al 2006). Mameli et al (2006) concluded that 
cortical control of the autonomic nervous system appears to be the main 
factor in SUDEP. It has also been postulated that a predisposed patient could 
become a victim of SUDEP if there is a combination of reduced sympathetic 
tone during sleep, ictal bradyarrthymia or extreme fluctuations in heart rate 
resulting in autonomic instability. Ictal bradyarrthmia and sinus arrest have 
vagally mediated involvement during seizure discharges (Vaughn et al 1997). 
The “lockstep phenomenon” was proposed by Lathers et al (1987) and 
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proved synchronization between epileptogenic “sub-convulsant” discharges 
with abnormal sympathetic and vagal neural discharges with cardiac 
arrhythmia in anaesthetised cats. They believed that the lockstep 
phenomenon of synchronization of epileptogenic discharge with cardiac 
sympathetic neural discharge could be a contributing factor of SUDEP.  
Variability of successive R-R intervals is generally considered to be an 
important protective mechanism of the autonomic nervous system being able 
to respond to sudden cardiovascular demands (Hohnloser et al 1994, Miller 
et al 2004). Loss of this variability increases the risk of sudden cardiac death 
and reduced HRV is a measure of risk stratification for myocardial infarction 
patients (Bigger et al 1984, Kleiger et al 1987, Malpas 2002, Miller et al 2004) 
of 2.5 years for approximately 50% of patients. Reduced vagal activity 
following myocardial infarction is believed to be due to the necrotic scar 
from the infarct altering the geometry of the beating heart. This altered 
geometry increases sympathetic afferent fibres in response to damage of 
sensory endings and inhibits vagal effect (Hohnloser et al 1994).  
Heart rate variability is lost completely in brain death due to loss of central 
control where acute traumatic lesions have occurred in the brainstem 
compared with deep coma patients (Freitas et al 2000). These authors 
advocate that HRV could be used as part of the brain death criteria as HRV is 
fully sensitive and specific in this situation. 
Other disease processes are increasingly being investigated using HRV 
parameters including diabetes (Miller et al 2004, Seyd et al 2008) and sleep 
apnoea (Park et al 2008). A large epidemiological study by Algra et al (1993) 
investigated 6,693 patients attending Rotterdam hospitals for 24hour 
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electrocardiography (ECG) who were followed up two years later. They 
concluded that patients with either low short-term (5minute) or low long-
term (24hour) variation in HRV have double the risk of sudden death 
compared to patients with high HRV, independent from other risk factors. 
The Framingham Heart Study (Tsuji et al 1996) indicates that low heart rate 
variability is an independent marker for all causes of mortality in coronary 
events. Bilchick & Berger (2006) hypothesized that mortality from reduced 
HRV culminates from a combination of increased sympathetic tone and 
vagal withdrawal, increasing the risk of ventricular fibrillation. Applications 
of HRV analysis are also being applied to other areas such as anaesthesia, 
biofeedback and fitness training and Miller et al (2004) believe that the ability 
to monitor HRV as a non-invasive medical tool is a major breakthrough in 
patient welfare.  
Very little research is present in the literature investigating loss of heart rate 
variability during epileptic discharges as a possible contributing factor of 
SUDEP. This is perhaps due to the difficulties of vagal measurement during 
a clinical seizure and the impossible interpretation of large alterations in 
autonomic control during what is a very physical event altering sympathetic 
and parasympathetic responses to the clinical seizure including changes in 
sleep to wake states, physical demand, body position (orthostatic), 
temperature changes etc. In this study, sub-clinical seizures were identified 
specifically to eliminate any physical element that a clinical seizure would 
have on vagal tone. Cardiac vagal tone measured during sub-clinical seizures 
and baseline studies selected from the same stage of sleep with regular 
respiration permitted patients to act as their own controls. This comparison 
of baseline and sub-clinical data aimed to give an indication of any alteration 
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of the parasympathetic activity being a result of direct neural influences from 
electro-cerebral seizure discharge on cardiac control.  
Sub-clinical seizures are defined as “electrographic seizures without 
subjective or obvious objective neurological or somatic manifestation” (Babb 
et al 1987, Sperling & O’Connor 1990, Binnie & Marston 1992, Zangaladze et 
al 2008). A further definition of sub-clinical seizures is given by Weil et al 
(2005) “EEG seizure patterns not associated with any disturbances of sensory 
phenomena, motor functions, or consciousness in the wake patient, with any 
movements during sleep or arousals on EEG.” Sub-clinical seizures were 
investigated in this study because even brief epileptiform discharges are 
suspected to cause changes in cardiac parameters (Wannamaker, 1958), are 
easily identified by EEG (electroencephalographic) video-EEG telemetry, 
originate from the same cortical area as clinical seizures (Zangaladze et al 
2008) and have no clinical component to complicate the interpretation of any 
changes in vagal tone.  
In some cases of SUDEP, the victim does not appear to have suffered a 
physical seizure but has died suddenly in the absence of any other pathology 
(Nashef & Shorvon 1997). This raises the question of a fatal arrthyhmia 
arising as a result of a sub-clinical seizure in a pre-disposed individual.   
Heart rate variability reflects the dynamic interplay between cardiovascular 
function and the dynamic response of the cardiovascular regulatory systems 
(Algra et al 1993, Task Force of the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology 1996, Malpas 2002, 
Bilchick & Berger 2006) and can be used as a quantitative marker. 
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An analogy of HRV is offered by Bilchick & Berger “one learns only about 
the overall power from a star by measuring the intensity of light emanating 
from it, but by separating the light into its component colours with a prism, 
one may learn about the composition of chemical reactions within the star. 
HRV may similarly be broken into the frequency components that compose 
the overall variability.” 
A decrease in heart rate is not solely due to parasympathetic activity because 
heart rate is dually influenced by both the sympathetic and parasympathetic 
autonomic nervous system (Wittling et al 1998, Denver et al 2007, Nolan 
2010). Brief changes in heart rate are also influenced by respiratory sinus 
arrhythmia (Denver et al, 2007). During inhalation, the vagus nerve is 
impeded and heart rate increases and then the situation reversed during 
exhalation (Katona & Jih 1975, Nolan 2010). Heart rate is mainly influenced 
by baroreceptor feedback from pulse stimulation at the aorta and carotid 
arteries to the medulla oblongata’s nucleus ambiguus controlling signals to 
the sino-atrial node via the vagus nerve altering the level of inhibition and 
modulating heart rate.  
The Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology 1996 states that efferent 
vagal activity is a major contributor to the HF component. Malpas (2002) 
exercises a word of caution in the interpretation of this parameter, as other 
influencing factors should be considered such as differences in vasculature 
but agrees that baroreceptors, brainstem and vagal activity are central to 
neural control and fundamental to changes in the heart rate tachogram. The 
time domain tachogram is then mathematically manipulated (MacArthur 
(1997) by representing the signal by a combination of sine and cosine waves 
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(usually following interpolation of the signal) with different amplitudes and 
frequencies by Fourier transform. The spectrum displays power densities of 
three main peaks known as Very Low Frequency, Low frequency (LF) and 
High Frequency (HF) for heart rate variability frequency domain analysis. 
Low frequency (LF) components of heart rate variability are more 
controversial as to what they represent physiologically. Many scientists 
argue that LF does not simply reflect sympathetic activity as it also includes 
parasympathetic and renin-angiotensin hormonal changes (Akselrod 1981, 
Malpas 2002). Some studies advocate for LF/HF ratio to look at the sypatho-
vagal balance of the autonomic nervous system (Miyashita et al 2003, 
Everingul et al 2005, Persson et al 2007)). This is generally considered to be 
an over-simplified interpretation of many complex biological processes and 
LF/HF ratio was not applied to this study. 
Akselrod et al (1981) proved the HF power spectrum as parasympathetic 
activity when they abolished it by administering glycopyrrolate (0.01mg/kg) 
blocking muscarinic parasympathetic transmission in dogs. They also 
blocked sympathetic B-adrenergic receptors by administering propranolol 
(0.1mg/kg). They concluded that LF components are influenced by both 
sympathetic and parasympathetic activity but HF components are only 
parasympathetic. This is reinforced by the biological fact that the 
parasympathetic nervous system reacts rapidly, constituting high 
frequencies compared to slower sympathetic changes, which cannot 
contribute to the HF signal.  
A study by Casadei et al (1995) examined the measure of HF and LF spectral 
analysis during exercise observed that the HF component fell at the 
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beginning of exercise consistent with a reduction on cardiac vagal activity 
but LF components diminished until no longer detectable during severe 
exercise. This adds to the controversy around what biological processes are 
represented by LF signal of the HRV. 
Dexter (1997) explained how the HF signal may be affected 
pharmacologically during fast heart rates.  Pulsed blood pressure causes 
oscillations in efferent vagal activity resulting in oscillations of acetylcholine 
release from postganglionic parasympathetic neurons. This in turn causes 
oscillations in the concentration of acetylcholine at sinus node neuroeffector 
junctions. Anticholinesterase prolongs the time required for acetylcholine to 
be broken down. This takes longer than the next cycle, which he believes 
decreases the magnitude of acetylcholine at these neuroeffector junctions and 
is expected to pharmacodynamically cause a decrease in high frequency 
variability. This may be a consideration during fast heart rates reducing HF 
HRV during clinical seizures. However, this is an unlikely scenario during 
sub-clinical seizures in this study, as heart rates are not elevated to the same 
heart rates as expected during clinical focal or generalised tonic clonic 
seizures. Taking Dexter’s observation forward, a resultant decreased vagal 
effect at the neuroeffector junctions at the time of increased heart rate would 
prevent the intended autonomic control of slowing heart rate at critical or 
prolonged times of elevated heart rates during a clinical seizure and this may 
also be a contributing factor of SUDEP.  
In this study HRV HF% was mainly analysed as it alters as a proportion with 
LF (incorporating sympathetic activity and VLF components. Hfms2 is often 
quoted in HRV studies but the standard deviations compared to the mean 
values in this study were very large (mean baseline 383.1 ± 982.8 and mean 
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sub-clinical 489 ± 1364) making any interpretation of the mean values 
meaningless. Standard deviation is expected to improve with increased 
observations and HFms2 may be useful in a much larger study. Additionally, 
5minute HFms2 were least correlated to CIPA (p=0.359) compared to 5minute 
HF% correlation to CIPA (p<0.001). 
In 1876, Mayer recorded the first physiologically measured oscillations in 
blood pressure from anaethetised rabbits. Much later, Guyton & Harris 
(1951) described “vasomotor” waves as slow oscillations in blood pressure 
not related to respiration. Wittling et al’s (1998) study, of 45 subjects, 
examined hemisphere asymmetry in parasympathetic control of the heart 
and monitored respiration. They concluded that HF power was uninfluenced 
by differences in respiration rate. However, Malik & Camm (1973) amongst 
other researchers do believe that HF power is directly affected by respiration. 
Baroreceptors monitor changes in blood pressure and relay this information 
to the medulla oblongata, which then sends the signal via the vagus nerve to 
the sino-atrial node in the myocardium. An important distinction between 
baroreflex sensitivity and heart rate variability is that baroreceptor sensitivity 
measures reflex vagal activity and heart rate variability quantifies mainly 
tonic vagal activity (Malik & Camm 1973, Hohnloser et al 1994). Studies have 
shown vagal blockade with atropine abolishes this neural signal oscillation 
(Julu, 1992) rapidly controlling heart rate on a beat-by-beat basis. Julu et al 
claims that output from the NeuroScope is independent from respiration and 
heart rate.  
Distinct from baroreflex measurement, Porges (2009) claims that in 1992, he 
proposed an estimate of vagal tone from measuring respiratory sinus 
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arrhythmia (RSA) using time series analyses to extract the amplitude of the 
RSA for an accurate index of vagal activity, representing the tonic functional 
outflow from the vagus to the heart. Denver et al (2007) showed in their 
study that respiratory sinus arrhythmia amplitude is not affected by 
respiration frequency. Grossman & Taylor (2007) describes the distinction 
between RSA and vagal tone as RSA being “phasic” and vagal tone being 
“tonic.” They gave an example whereby respiration rate increased resulting 
in an increase in magnitude of RSA but the mean vagal discharge remained 
the same. Conversely, Bilchick & Berger (2006) and Tanaka et al (2004) 
amongst others describe the magnitude of HF power being highly dependent 
on respiration and suggest that respiration should be taken into account. 
In this study, HRV measurements are selected during slow wave sleep where 
respiration is regular. Vanoli et al (1995) examined HRV over 5minute epochs 
and describe increased vagal tone during NREM sleep compared to 
wakefulness and REM sleep. These authors suggest that studies investigating 
HRV should also monitor sleep staging for interpretation of changes in HRV 
parameters. Paediatric studies of HRV by Grossman & Taylor (2007) did not 
use strict criteria in monitoring sleep stages electrographically.  
The NeuroScope is based on the theoretical model proposed by Katona (Julu 
1992). Chest respiration was not recorded in this study, as NeuroScope 
measures are independent from breathing and heart rates. However, in the 
case that HRV BioSignal HF signal is affected by respiration, chest 
respiration was not considered necessary in this particular study, as altered 
breathing rate during sub-clinical seizures is unlikely. Additionally, 
respiration rate is regular during slow wave sleep, equivalent or better than 
‘paced breathing techniques’ suggested by Grossman & Taylor (2007) to 
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standardise respiratory rate during HRV studies. Therefore changes in HF% 
and CIPA in this study are more likely to be attributed to the effects of sub-
clinical seizures rather than to altered respiration rate.  
In animal studies (without myocardial infarction) baroreceptor 
measurements were more sensitive than HRV in showing risk of ischaemia 
induced ventricular fibrillation from increases in arterial blood pressure 
(Hohnloser et al 1994). The NeuroScope in this study also appeared to be 
more sensitive than “counted” HRV in terms of indicating vagal 
measurement over shorter epochs. More similar results to the NeuroScope 
are found from 5minute HRV as recommended by the Task Force of the 
European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology (1996) for HRV standardisation 
Heart rate variability of different epochs should not be compared but the 
purpose of one of the aims of this study was to deliberately ascertain if 
similar information could be achieved by using a shorter “counted” epoch 
compared to that of traditional short 5minute HRV. HF% baseline compared 
to sub-clinical HF% for counted data showed a significant decrease in vagal 
tone for total data (p=0.049) and similarly but statistically more significant for 
5minute HRV HF% for total data (p=0.026).  
HRV HF% “counted” and 5minute data were then directly compared to 
CIPA to determine any similarity of results comparing two different systems. 
CIPA and “counted HRV” are R-R matched and qualified for direct epoch 
comparison under the recommendations from the Task Force of the 
European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology (1996) for HRV matched epoch duration for data 
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standardisation. There are limitations comparing CIPA data in this way due 
to the necessity of calculating mean values to compare to HF% mean values 
and only general observations can be made. CIPA and 5minute HF% HRV 
are not epoch matched but this was a deliberate comparison to discover 
whether similar information could be provided by CIPA over shorter epochs 
compared to 5minute HF% HRV epochs. Pearson correlation was limited to 
the final comparison as it is generally misused in scientific papers. A high 
correlation between two methods does not always mean that the two 
methods necessarily “agree” but do have a relationship. This relationship 
could be poor but it would still show a correlation Data agreement has been 
investigated in this study by using Bland & Altman plots in this thesis and 
the correlation co-efficient was tested because a change in scale measurement 
does not affect correlation but it does effect agreement (Bland & Altman 
1986). Closer comparisons of results were found between CIPA and 5minute 
HRV data.  High Pearson correlation was found for log CIPA and Counted 
log lnHF% (p=0.006). However, log CIPA is more closely correlated to 
5minute log lnHF% (p<0.001). 
A limiting factor in comparing CIPA with HRV HF% is that CIPA measures 
efferent vagal tone from baroreceptor feedback and HRV HF% measures 
modulations of afferent parasympathetic activity. In extreme circumstances 
of vagal blockade or over-saturation effect on the sinus node by persistent 
high vagal tone can lead to a situation where an increase in high frequency 
components do not reflect increased vagal tone or vice versa (Malik and 
Camm 1993). However, in this study parameters were not measured during 
such extreme states. 
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For “counted” R-R analysis in this study, the sub-clinical data was clipped 
one minute prior to the onset of electrographic sub-clinical seizure activity 
and continued until the sub-clinical seizure had ended and the trace had 
resumed the previous resting trace. For “5 minute” R-R analysis, the sub-
clinical seizure was sited in the middle of the clip as far as possible within the 
constraints of selecting data within the same sleep stage. Baseline clipped 
data for “counted” and 5minute data were selected from any section of the 
patient’s trace that was in the same sleep stage for comparison to the sub-
clinical clipped data. In a study by Novak et al (1999) clinical seizures were 
found to change time frequency analysis several minutes prior to the attack 
with rapid parasympathetic withdrawal approximately 30 seconds prior to 
the start of the seizure. It is difficult to estimate how long to analyse data 
prior to a sub-clinical seizure where relatively small populations of local 
neurons increase their firing rate (Babb et al 1987). One minute prior to the 
sub-clinical seizure was considered practical and likely to capture any 
parasympathetic changes that may have occurred prior to the electrographic 
change detected by full head coverage of scalp electrodes. 
A null hypothesis of this study was that no changes in vagal tone would 
occur during sub-clinical seizures compared to baseline studies given that no 
obvious clinical changes occur or physical demands altering resting heart 
rate variability. However, clear altered vagal tone is observed during sub-
clinical seizures compared to baseline studies in both CIPA (p<0.001) and 
5minute HRV HF% (p=0.026) and “counted” HRV HF% (p=0.049) Therefore, 
statistically significant results are seen in HF% during even brief sub-clinical 
seizures when 5minute epochs are used and the same sub-clinical seizure 
data shows a slightly less statistically significant change of HF% HRV over a 
shorter “counted” epochs. CIPA showed the most statistically significant 
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change (p<0.001) in vagal tone over matched shorter epochs compared to 
counted HF% HRV (p=0.049). 
In a study by Adjei et al (2009), mean HRV did not change during or after 
sub-clinical patterns. “Minimal” changes were described with “lower HRV” 
from left sub-clinical seizures than from right sub-clinical seizures. However, 
the study by this group is methodologically limited as 10 seconds HRV is too 
short a duration to quantify HRV fully unless vagal tone is measured using 
the NeuroScope (Hamilton et al 2004). Additionally, the SDNN was also 
calculated over 10 seconds in Adjei’s study (2009) which is too short a 
duration to perform this time domain analysis effectively. As the period of 
monitoring decreases, SDNN will estimate a shorter cycle length (Task Force 
of the European Society of Cardiology & the North American Society of 
Pacing and Electrophysiology, 1996).   
It is only since the 1970’s that more precise stimulation techniques such as 
axonal tracer methods have been introduced to delineate cortical regions that 
have a direct effect on the autonomic nervous system Cechetto and Saper 
(1990) cite many authors who have performed this mapping. Prefrontal 
cortex and insular cortex have direct projections to areas of the amygdala, 
hypothalamus, brainstem and spinal cord that are involved in autonomic 
control. Stimulation of the insular cortex causes many changes including 
altered blood pressure, heart rate and respiration depending on the 
stimulation frequency. During seizures involving the insular cortex, often 
diagnosed as temporal lobe epilepsy but the seizure source is insular 
(Brotherstone, 2002), epigastric or gustatory symptoms are experienced and 
this is replicated by stimulation of the dysgranular insular area. Stimulation 
techniques of the posterior insular cortex are well described of the right 
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insular resulting in increased heart rate and the left insular causing 
decreased heart rate (Oppenheimer et al 1992). The amygdala receives direct 
projection from the insular cortex. Frysinger and Harper (1986) have shown a 
relationship between neuronal firing from the medial pre-frontal cortex to 
cardio-respiratory firing rate.  
In a study of amygdaloid kindling in rats (Healy et al, 1995), increased vagal 
activity produced bradycardia and reduced heart rate variability. These 
authors postulate that prolonged bradycardia may be indicative of sinus 
node impairment and if there is no atrio-ventricular junctional pacemaker 
escape following significant delay of depolarisations at the sino-atrial node 
then sinus arrest may occur. 
Do generalised sub-clinical seizures pose a greater risk of autonomic 
nervous system deregulation than temporal lobe seizures? 
Persson et al (2007) analysed long term 24 hour HRV of 22 newly diagnosed 
epileptic untreated patients with a control group and found no statistically 
significant differences between the two groups. However, repeated seizures 
over a longer term are reported to have an effect on autonomic cardiac 
regulation and are associated with higher morbidity and SUDEP mortality in 
epileptic patients (Everingul et al 2005, Harnod et al 2008). From their study 
analysing heart rate variability in children with refractory generalised 
epilepsy they concluded that lower HRV was found during the inter-ictal 
period. Bulent et al (2010) also describe how long term abnormalities in the 
autonomic nervous system from repetitive seizures can cause a temporary 
impairment in autonomic functions by each epileptic discharge having an 
effect upon limbic structures, amygdala and periamygdaloid piriform cortex. 
Additionally, this group found that autonomic dysfunction became more 
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marked in the post-ictal period compounding an already existing 
dysfunction. Nouri et al (2004) describe how damage to the myocardium can 
occur when exposed to frequent increases of plasma catecholamines. This 
damage to the myocardium can then cause areas of fibrosis and render the 
myocardium more likely to trigger cardiac arrhythmias. 
Al-Aweel et al (1999) reported a ringing effect lasting two to six minutes 
from low frequency heart rate oscillations following 11 partial seizures (2 
with secondary generalisation) in 5 patients. They describe an increase in 
heart rate between 28-88/min and hypothesize that the ringing effect (not 
seen at any other time) could be the result of unstable cardiopulmonary 
dynamics as heart rate seeks to find equilibrium following the seizures. 
Cardiac arrhythmia is suspected in witnessed SUDEP victims, when the 
seizures have clearly ended, but the patient then suddenly collapses and 
dies.   
Concordant with Everingul et al (2005) and Harnod et al (2008)), this study 
demonstrated inter-ictal or “baseline” HRV HF% lower in children with 
generalised epilepsy (faster baseline heart rate) compared to all other 
patients in this study for counted and 5minute epochs. R-R interval data 
during generalised sub-clinical seizures is different compared with R-R 
interval data during right or left temporal lobe sub-clinical seizures. 
Generalised sub-clinical seizures show a mean increase in R-R interval 628.9 
to 686.95msec (p<0.001), indicating a decrease in heart rate with a mean 
difference of (-58) ± 138msec of baseline minus sub-clinical data. Generalised 
sub-clinical seizures also demonstrate a much tighter co-efficient of variation 
(scatter of data) of R-R interval data (n=9176) compared to right temporal 
lobe seizure data (n=5376) and left temporal lobe seizure data (n=2614). 
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Generalised baseline data has coefficient of variation (6.9%), which is 
approximately half or less than half of that seen during right temporal lobe 
baseline data (12.8%) and left temporal lobe baseline data (15.1%). All data 
shows an overall increase in coefficient of variation during sub-clinical 
seizures compared to baseline measurement but generalised data still 
remains much tighter with an average value of 12.9% compared to right 
temporal sub-clinical seizures (18.1%) and left temporal sub-clinical seizures 
(19.5%). Generalised sub-clinical seizures demonstrate less variable R-R 
interval data compared to focal sub-clinical data. This finding would need to 
be further analysed in a larger study including generalised sub-clinical 
seizure data from adults. Paediatric baseline heart rates are higher and this 
may have influenced results. However Analysis of Variance (ANOVA) 
compared baseline variance between individuals and within individuals. The 
data from paediatric patients with generalised sub-clinical seizures were not 
inherently different to the other patients. 
A proposed SUDEP mechanism.  
Autonomic instability and reduced variability of successive beats may put a 
pre-disposed individual at more risk during sleep (Shorvon 1997) when 
vagal tone is already increased, especially with generalised seizures. Instead 
of responding with a decrease in vagal tone and increased heart rate ready to 
meet the physical demands of the seizure, there could be instead an initial 
further increase in vagal tone resulting in a further initial decrease in heart 
rate (as indicated from this study’s findings and described by others) 
potentially leading to ictal bradyarrythmia. Clinical generalised seizures are 
then characteristically followed by a massive acceleration of heart rate 
(sudden vagal withdrawal) and marked catecholaminergic sympathetic 
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activity with resultant effect on the myocardium. This initial mismatch 
between vagal tone and seizure demand could make the myocardium 
vulnerable leading to possible SUDEP in some pre-disposed individuals with 
low heart rate variability. Massive sympathetic discharge can trigger fatal 
cardiac arrhythmias during seizures (Noval 1999, Nouri 2004). O’Regan & 
Brown (2005) also describe a rapid but short lived rise in cardiac vagal tone 
associated with some seizures but consider that this may be an inbuilt 
mechanism to protect the myocardium from possible fatal cardiac 
arrhythmias caused by unbridled sympathetic or massive catecholamine 
activity. Delamont et al (1999) also describe an increase in cardiac 
parasympathetic activity just prior to secondary generalised complex partial 
seizures and proposed that pre-ictal elevation of cardiac parasympathetic 
activity may be a marker for secondary generalised seizures.  
A study by Vaughn et al (1997) recorded asystole lasting 3-17 seconds during 
five generalised tonic clonic seizures in an infant. They found increases in 
both sympathetic and parasympathetic spectral frequencies and therefore 
suggested epileptic induced asystole resulted from both arms of autonomic 
outflow. However, it is not clear from Vaughn et al’s study at which point in 
the clinical seizure the 10 seconds epoch selected, whether artefact-free ECG 
was possible during a clinical seizure and how interpretation of HRV 
analysis was possible during a clinical epileptic seizure when complicated by 
physical exertion , change in body position and temperature alteration and 
only 10 seconds epochs were selected despite being too short for HRV 
traditional methods of 5 minute epochs as recommended by The Task Force 
of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology (1996).  In this study, increased vagal tone is 
described in generalised seizures also but low frequency HRV was not 
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analysed due to the controversy of what contributes to the LF frequency. 
Vaughn et al (last author) produced a further paper in 2003 examining the 
“lockstep relationship” between scalp electroencephalographic spikes and 
alteration in the R-R interval at that moment, comparing spike discharges 
from the right and left hemispheres. Due to normal sinus arrhythmia I would 
have expected this group to examine R-R intervals from samples of the 
recording that did not have any electrographic spike discharges to quantify 
the effects of RSA on their sampling methodology. 
Leung et al (2006) and Hiroso et al (2005) consider that a channelopathy is 
involved as a possible mechanism of SUDEP particularly for generalised 
epilepsy leading to both seizure and cardiac arrhythmia. Activation 
techniques of hypothalamic and mesencephalic epileptic foci, induced a 
significant increase in vagal nerve firing that was strictly correlated to ECG 
impairments and hypotension in hemipherectomized rats (Mameli et al 
2006). In Mameli et al’s study when both the hypothalamic and 
mesencephalic epileptic foci were co-activated, 25% of rats had vagal 
hypertone, cardiac arrhythmia leading to hyperkalemia, acidosis, pulmonary 
hypertension and death. The authors could not establish why some animals 
developed severe clinical symptoms leading to death and others did not. 
They hypothesized that the non-surviving animals had a low threshold of 
excitability whose central structures were unable, during an epileptic seizure, 
to maintain a balanced ratio between sympathetic and parasympathetic 
activities. De-regulation of the autonomic nervous system is believed to have 
a functional cause rather than a cause due to structural abnormality of the 
hippocampus (Ansakorpi et al 2004). A group of patients with temporal lobe 
epilepsy, some of whom had hippocampal sclerosis had no significant 
differences in HRV compared to a control group. 
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The comparison of the NeuroScope & BioSignal HRV.  
One of the main aims of this study was to compare the cardiac index of 
parasympathetic activity (CIPA) produced by the NeuroScope that gives a 
continuous cardiac vagal tone measurement on a beat-by-beat basis with a 
more traditional measure of cardiac vagal (high frequency spectral analysis) 
Heart Rate Variability as produced by BioSignal software. This is useful if the 
NeuroScope is to be considered as another reliable method of measuring 
parasympathetic activity instead of more traditional methods of HRV in 
clinical practice. However, only mean values per study are produced by 
BioSignal heart rate variability software and therefore mean CIPA was 
calculated to allow a direct comparison. By using mean values, less data is 
available for statistical analysis as the amount of data is greatly reduced, 
compared to total CIPA results. CIPA derived during right temporal lobe 
sub-clinical seizures analysed a total of 2688 beats for baseline and a total of 
2688 beats for sub-clinical data. For comparison to BioSignal HF%, only one 
mean value was calculated per baseline study and for each sub-clinical 
seizure study. Therefore data was greatly reduced to a total of 9 values 
instead of 2688 for right temporal sub-clinical seizures. CIPA derived during 
left temporal lobe sub-clinical seizures included a total of 1307 baseline and 
1307 sub-clinical data but became a mean output of 5 matched data values 
CIPA derived during generalised sub-clinical seizures included 4588 beats 
for baseline and 4588 beats for sub-clinical data became 19 mean data values 
to allow direct comparison to BioSignal data. Due to this restricting effect of 
using mean values only general comparisons can be made and a much larger 
study would be required to be analysed in order to give adequate 
quantitative comparison between the NeuroScope and BioSignal software. 
Despite this restricting effect of using mean values for CIPA to compare to 
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BioSignal HF%, clear similarities in all results were found in both sets of 
data.  
The NeuroScope uses an index of parasympathetic activity giving 
proportional representation on a scale of 1-10 (and above in this study and 
reported by others). BioSignal quantifies High Frequency as HF% proportion 
of total HRV, essentially also providing an index of 1-100%. 
An obvious scale difference was encountered when comparing data from the 
NeuroScope to that of HF% HRV BioSignal software. This scale difference 
had to be mathematically altered to bring the outputs closer to allow 
comparison of results from the two systems that had identical input data.  
A second question was whether cardiac vagal tone could be measured over 
shorter ‘counted’ epochs rather than 5 minutes as determined by traditional 
HRV methods. 
By systematic analysis of mathematically altering scale, log CIPA data was 
similar in magnitude to that of ‘counted’ log lnHF% with a mean difference 
of 0.02 ± 1.0. Similarly, the closest comparison of scale between the 
NeuroScope CIPA and BioSignal for 5 minute data was also log CIPA and 
log lnHF%. Mean difference is 0.1 ± 0.6. 
The comparison of results from both systems after scale adjustment in this 
limited study suggest that  there is a 2% difference between NeuroScope log 
CIPA and BioSignal log lnHF% for short ‘counted’ epochs. This difference 
increases to 10% for 5 minute epochs. This result is based on limited data 
from this pilot study and can only be used as general observation for 
comparing NeuroScope and BioSignal data. 
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CIPA results for grouped data derived during right, left and generalised sub-
clinical seizures, show similar findings to an HF% HRV parameter but CIPA 
is able to do this over a shorter epoch. Generally, some patients are 
considered to be more pre-disposed to cardiac arrhythmia and sudden death 
than others. A study by Schwartz et al (1988) demonstrated that a group of 
susceptible myocardial post infarction dogs had reduced baroreflex 
sensitivity prior to the infarction compared to resistant surviving dogs. La 
Rovere et al (1998) concluded from a large prospective study 30 days post-
infarction, that baroreflex sensitivity was a powerful predictor of mortality 
for these patients over the following 2 years. 
Counted SDNN HRV data.  
The SDNN is the standard deviation of the NN intervals, which is the square 
root of variance and is an overall estimate of HRV. It is possible to compare 
counted baseline studies and matched counted sub-clinical studies as they 
are of equal number of NN intervals. It is inappropriate to compare 
individual patient SDNN studies as each event is of a different duration. 
Using Bland & Altman plots to analyse the difference versus the average for 
matched total counted baseline R-R studies and total counted sub-clinical R-
R studies, the smallest range in limits of agreement for SDNN is seen in 
association with generalised sub-clinical seizures 0.5 and 0.8 (range 0.3) 
indicating the smallest variability, compared to SDNN derived during right 
temporal lobe sub-clinical seizures with limits of agreement 0.7 and 2.0 
(range 1.3) and SDNN derived during left temporal lobe sub-clinical seizures 
with limits of agreement 0.5 and 1.2 (range 0.7) sub-clinical seizure 
manifestations in HRV. Generalised sub-clinical seizures again are 
characteristically different for SDNN50 and pNN50 compared to sub-clinical 
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seizures derived during either the right or left temporal lobes. NN50 and 
pNN50 data approximately halve during right temporal sub-clinical (NN50 
1064 to 626, pNN50 39.7 to 23.3) and left temporal sub-clinical (NN50 615 to 
356, pNN50 47.2 to 27.3) but generalised sub-clinical seizures increase 
markedly (NN50 64 to 315, pNN50 1.4 to 6.9). 
5minute HRV SDNN data.  
Generalised data again shows the smallest SDNN limits of agreement 0.6 and 
1.0 (range 0.4) compared to SDNN derived during right temporal sub-clinical 
seizures limits of agreement 0.8 and 1.2 (range 0.4) and SDNN derived 
during left temporal sub-clinical seizures limits of agreement 0.5 and 1.0 
(range 0.5). However, all groups show more similar limits of agreement for 
SDNN when using 5minute epochs compared to results from counted 
SDNN. This demonstrates that analysing the SDNN variability during sub-
clinical seizures is diminished over longer epochs i.e. ‘averaged out’ as it is 
combined with non-event data. In this case the counted HF% may be more 
sensitive than 5minute epochs. 
The NN50 count and pNN50 during generalised sub-clinical seizures is low 
during both baseline and sub-clinical data compared to temporal lobe data. 
This reflects less variability between successive beats from patients with 
generalised epilepsy in the study compared to temporal lobe epilepsy. 
A study by Murray et al (2001), recruited 50 subjects to assess and compare 
traditional heart rate variability measures with output from the NeuroScope. 
They concluded that the short-term reproducibility of a 5minute recording of 
CIPA is moderate and better than simple time domain but not frequency 
domain measures of HRV. They felt that the NeuroScope provided a simple 
Section Three 
 534 
alternative for measuring parasympathetic activity and may have a 
widespread application if the clinical usefulness of its measure can be 
established. 
Where HRV measures are standardised to 5minute epochs as the spectral 
analyses requires stationarity to analyse its component parts, it would be 
useful to be able to use a shorter epoch for more transient phenomenon. 
Hamilton et al 2004 measured three epochs of 10 seconds within a 5minute 
sample of R-R interval using the NeuroScope in fifty patients. They 
concluded that results (RMSSD) from 10 seconds of CIPA were highly 
correlated to and predictive of data from 5minute epochs. This would 
suggest the NeuroScope could produce heart rate variability measures over 
epochs as short as 10 seconds unlike traditional methods of 5minute or 
24hour heart rate variability software. 
Age effect on cardiac vagal tone.  
Loss of heart rate variability occurs with increasing adult age (De Meersman 
& Stein 2007). These authors have shown that increasing level of fitness, 
particularly of post-menopausal women and elderly men improves vagal 
modulation. Numbers are small in this study so alternatively data was 
divided into paediatric and adults and re-analysed. Statistically significant 
differences were found comparing baseline and sub-clinical mean data for 
counted epochs for each group but this was not the case for data of 5minute 
epochs. Changes in baseline CIPA to sub-clinical CIPA were more marked in 
adults (p<0.001) than in paediatrics (p=0.203) with a mean difference of 6.5 
(adults) compared to 0.4 (paediatrics). When data was analysed over 5minute 
epoch significant differences were lost. Mean difference in HF% baseline 
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minus sub-clinical was calculated for paediatrics (n=27) and adults (n=6) for 
5minute epochs HRV. The mean difference for paediatrics data was 7.5 ± 47.9 
(p=0.28) Adult mean difference is 17.7 ± 31.5 (p=1.0) Therefore, when data is 
analysed over a 5minute epoch, no statistical significance is demonstrated 
comparing adult data with paediatric data. Age Effect on CIPA & HRV HF 
Data could not be assessed in this study because of small group data. Normal 
data for standardised HRV has not been sufficiently established in 
paediatrics in all age ranges. It has been reported (Finley & Nugent 1993, 
Goto et al 1997) that there is an age-related alteration in cardiac vagal tone of 
an increase in cardiac vagal tone between the ages of 3 to 6 years and then a 
decrease from 6 to 15 years. However, numbers of patients included in this 
normal data are also small and do not give account of the wide intra and 
inter-subject variation in HF (Grossman & Taylor 2007) and these studies did 
not use strict criteria in monitoring sleep stages electrographically. The 
generalised data derived from two patients in this study (aged 5 years) had 
lower cardiac vagal tone compared to the other patients but they had severe 
generalised epilepsy and therefore their data may not be comparable to 
normal data. Case studies of these two patients are supplied in the appendix. 
Harnod et al (2008) compared heart rate variability in children who had 
refractory generalised epilepsy with a control group. They reported 
decreased resting HRV (faster resting heart rate) in the epileptic children and 
postulated that this was due to reduced vagal tone. They believed that 
epileptic adults have reduced HRV via a different mechanism of increased 
sympathetic activity. Generalised sub-clinical seizures were not recorded in 
adults in this study and therefore a comparison could not be made between 
paediatrics and adults.  
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Limitations of the study  
This study included eleven patients due to strict inclusion criteria. Manual 
measuring of 27,151 R-R intervals (33 sub-clinical seizures with 5minute 
matched baselines) also presented time limitations of what is possible during 
this research period. Most studies use automated peak detection software to 
identify and measure R-R intervals. Automated peak detection software was 
considered for 5 minute R-R interval but when checked and re-measured 
manually, there were marked errors and so manual measurement was 
preferred. No statistical differences were found between R-R measurements 
made either by Inter-observer analysis (p=0.809) or intra-observer analysis 
(p=0.976). Some authors advocate for manual measurement due to automated 
peak detection software unreliability but manual measurements are 
particularly time consuming and will limit performing a larger study in this 
way. In a report by the American Heart Association (1990), a consortium of 
European investigators found systematic errors in measurement of 16 
computer programs for ECG analysis. 
Comparison of reflex vagal tone and modulated tonic vagal tone. 
A limiting factor in comparing CIPA with HRV HF%, is that CIPA measures 
efferent vagal tone from baroreceptor feedback and HRV HF% measures 
overall modulations of parasympathetic activity and they have a different 
basis for parasympathetic measurement. Respiration rate effects this 
modulation of HF frequency whereas CIPA is independent from changes in 
respiration due to series of low and high pass filters during data acquisition. 
In the study, data was analysed during slow wave sleep where respiration 
rate is constant and believed to be more constant than paced breathing. In 
extreme circumstances of vagal blockade or over-saturation effect on the 
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sinus node by persistent high vagal tone leads to a situation where an 
increase in high frequency components do not reflect increased vagal tone or 
vice versa (Malik and Camm 1993). However, for the purposes of this study 
parameters are not measured during such extreme states. 
Effects of anti-epileptic drugs and CIPA 
The patient receiving topitamate and phenobarbitone polytherapy has a low 
mean CIPA (4.2 and ranges from 0.9 - 5.2).This result indicates that this 
patient has an elevated resting heart rate and in the main study was also 
found to have low beat-to-beat variability. This child would be considered to 
have risk factors associated with low heart rate variability (HRV), Bilchick & 
Berger (2006). However, this finding is impossible to relate specifically to 
medication as only one patient is being treated on these drugs in this study. 
The results may instead be due to his refractory generalized epilepsy with 
the effect on his autonomic nervous system from repeated frequent seizures. 
Bulent et al (2010). 
To the other extreme, those patients receiving carbamazepine have a high 
mean CIPA (16.2 and ranges from 4.2 to 50.3). Maximum CIPA for this group 
is much higher than any group receiving other AED’s. The autonomic 
nervous system is finely balanced on a beat-to-beat basis. Any extremes 
whether transient or long-term can cause cardiovascular imbalance. 
Sustained tachycardia can lead to hypertension and low HRV as a 
consequence of down-regulation of cardiac sympathetic receptors. La Rovere 
et al (1998). At the other extreme, bradycardia due to high vagal tone can 
lead to cardiac arrhythmia if combined with other contributing factors e.g 
seizures and sudden increases in heart rate where cardiac hysteresis may 
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cause a ‘lag’ effect of the Q-T shortening/re-polarising and too slow for the 
tachycardiac sinus rhythm. Bradycardia itself can also lead to Early After 
Depolarisations (EADs), occurring in late stages of ventricular re-polarisation 
and can occur due to partial inhibition of K channels as a result from 
hypokalemia. If the sinus pace-maker occurs at the same time as ventricular 
re-polarisation then this can be pro-arrhythmic and trigger ventricular 
fibrillation Bers (2001). 
Ansakorpi et al (2002) did not find any alteration in heart rate variability in 
their study of patients with temporal lobe seizures compared to normal 
controls in relation to AEDs but still suspected some changes may be found 
in some patients due to blocking of sodium channels from AED medication.  
In this study, one patient receiving Topiramate and Phenobarbitone 
polytherapy had very low cardiac index of vagal tone and indicated a high 
resting heart rate and low beat-beat variability. The multivariate analysis also 
indicated that patients in this group being treated with carbamazepine tend 
to have a high index of cardiac vagal tone. Bradycardia is not a risk factor in 
itself but can lead to cardiac arrhythmias during a seizure where sudden 
increases in heart rate may give rise to cardiac hysteresis where the ventricles 
are slow to repolarise proportionally for rate and Early After Depolarisations 
may lead to cardiac arrhythmia especially if there are contributing factors of 
ionic disturbance e.g Na channel blockade hypothetically resulting from 
carbamazepine especially during acidosis from hypoxia during a seizure.  
It is difficult to know just what true contributing effects of medication have 
on an individual and maybe a pre-disposed individual in the physiological 
extremes of seizures and when particularly prolonged. There may not be 
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many clues in patients who are studied while at rest or during brief sub-
clinical seizures. This is perhaps one of the reasons why SUDEP remains 
unexplained to date. This pilot study is small in terms of numbers of patients 
are no clear correlations between the index of cardiac vagal tone and AEDs 
was possible. 
Ansakorpi et al (2002) did not find any changes in heart rate variability from 
effects of anti-epileptic drugs (AED) in their study of temporal lobe epilepsy 
patients compared to controls but they acknowledge that AED are 
anticipated to cause changes in cardiovascular regulatory function in some 
patients due to blocking of sodium channels. Any effects of AED cannot be 
fully evaluated in this study due to the limited number of patients. 
CIPA in relation to Gender  
Differences in cardiac vagal tone and Gender were assessed by ANOVA and 
no differences in CIPA were found. A study by Valladares et al (2008) 
showed the only gender difference in nocturnal vagal tone occurred in men 
during REM sleep where there was a marked increase in cardiac sympathetic 
drive. The data in this study was sampled during slow wave sleep only. 
3.9.2 Further studies  
Indications from this study have offered a good basis for further 
investigation of the differences between generalised and temporal lobe sub-
clinical seizures in the continued investigation of possible autonomic 
mechanisms of SUDEP. Nouri et al (2004) underlines the importance of 
evaluating autonomic cardiovascular and respiratory reflexes in people with 
epilepsy and believes that it will provide invaluable insight into some of the 
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mechanisms of SUDEP. Further verification is also required for the 
comparison of the NeuroScope with traditional heart rate variability software 
with a larger study. An increase in cardiac vagal tone is measured during 
generalised sub-clinical seizures but not in temporal lobe sub-clinical 
seizures in this study. Further investigation is required for evaluating cardiac 
vagal tone in line with European HRV standards in people with epilepsy to 
allow quantification and comparisons of cardiac vagal tone and HRV to other 
diseases. The Task Force of the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology 1996 believe that 
the task of assessing transient changes in HRV seem to be more important 
than further refinements of HRV technology.  
3.9.3 Conclusion 
One of the main aims of this study was to investigate if there were any 
changes in parasympathetic activity during sub-clinical seizures.  This study 
involved a small number of patients (11) but a large amount of R-R interval 
(27,151) manual measurement for 33 sub-clinical seizures and baseline 
studies. It has shown increased vagal tone and low R-R variability during 
generalised sub-clinical seizures compared to decreased vagal tone and 
higher R-R variability during temporal lobe sub-clinical seizures. This study 
has also demonstrated a good relationship between NeuroScope log CIPA 












It is documented that sleep itself increases the occurrence of seizures with 10-
45% of patients with epilepsy having seizures that may occur predominantly 
or exclusively in sleep or in relation to sleep deprivation’ (Walker et al 2004). 
Undetected prolonged nocturnal seizures can be fatal or result in significant 
morbidity due to hypoxic brain damage (Brown & Hussain 1991). 
Some seizures resulting in death are accidental and death could have been 
avoided if someone was alerted to the situation and intervened with rescue 
medication and body re-positioning to prevent an obstructive airway 
(Langan et al 2000). 
However, other seizures resulting in death from SUDEP may not have been 
prevented even with intervention (Dasheif & Dickinson 1986). 
The knowledge that we are dealing with two separate problems which both 
result in death in patients with epilepsy, namely ‘extrinsic factors’ of 
circumstantial compromise e.g. suffocation due to obstructive apnoea or 
drowning and ‘intrinsic factors’ of SUDEP, have been considered for over 
one hundred years. ‘Epileptologists at the turn of the century were well 
aware of the dangers from seizures and recognised that seizure deaths could 
be accidental or due to intrinsic mechanisms during a single seizure or serial 
seizures and status’ (Nashef 2000). However, very little is understood of 
what exactly happens during these ‘intrinsic mechanisms.’  
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In this thesis, a novel epilepsy alarm system is proposed and two possible 
intrinsic mechanisms of SUDEP were investigated. In the first section, the 
main aim was to determine whether epileptic seizures could be 
distinguished from normal events using percentage heart rate change and 
oxygen saturation measurement. In section two, a possible intrinsic 
mechanism of SUDEP was investigated to discover if clinically significant 
lengthening of the corrected Q-T occurred during seizures. The main aim of 
section three was to measure parasympathetic activity during sub-clinical 
seizures to discover whether altered cardiac vagal tone and heart rate 
variability was detected in any particular type of sub-clinical seizure. 
Altogether, approximately 180,000 manual measurements were made from 
527 seizures in the investigation of percentage heart rate change and oxygen 
saturation, Q-T interval analysis, cardiac vagal tone and heart rate variability. 
A reliable alarm system may not prevent true SUDEP cases but many 
seizures that are amenable to intervention, if detected, will be prevented 
from causing bodily injury, hypoxic brain damage and in some cases death. 
My view is supported by others ‘ timely assistance at the time of a seizure is 
likely to reduce the risk of death or injury’ and ‘un-witnessed seizures carry a 
higher risk of death’ (Nashef 2000) and ‘positioning of the patient or 
stimulation of respiration may prevent a fatal outcome in some cases. This 
raises the important issue of supervision’ (Langan et al 2000). 
Percentage Heart Rate Change and Oxygen Saturation. 
In this study, my main aim was to discover if epileptic seizures could be 
distinguished from normal events using heart rate percentage change and 
oxygen saturation measurement. I compared manually measured 
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consecutive R-R intervals (approximately 99,200 measurements) and 
calculated percentage heart rate changes and oxygen saturation before and 
during 527 epileptic events and 496 normal events using 9second epochs. 
Diagnostic testing of this data gives a sensitivity of 79% and specificity of 
75% of distinguishing epileptic events from normal events with a trigger 
level of 25.5% percentage heart rate change. Combined percentage heart rate 
change and oxygen saturation increases the sensitivity to 86%. The same 
trigger level is optimum for the detection of temporal lobe seizures with a 
sensitivity of 75% and specificity of 75%. Frontal lobe seizure detection 
trigger level is optimum at 30.5% percentage heart rate change to give a 
sensitivity of 83% and specification of 82%. For the detection of generalised 
tonic clonic seizures, the trigger level is 32.5% percentage heart rate change. 
Diagnostic testing suggests a sensitivity of 88% and specificity of 85%.  
An alarm system based on these parameters can be set to trigger for 
individual seizure types depending on the patient’s habitual seizures. A 
second trigger level is proposed which is not adjustable and would indicate a 
life threatening status of the patient if pulse is lost and oxygen saturation 
drops to severe hypoxic levels. Abnormal pulse and reduced pulse oximetry 
are listed as part of the identified risk factors for cardiac arrest (Hodgetts et al 
2002). This second trigger level would act as a ‘safety net’ and both types of 
alarms would alert parents or carers via an audible alarm and/or a radio 
page receiver unit.  
Nocturnal Seizures and SUDEP 
Sudden and extreme changes in heart rate can occur during nocturnal 
seizures. This seizure induced cardiac instability during sleep may cause 
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sudden and extreme fluctuations in autonomic tone, which may precipitate 
lethal cardiac arrhythmias and be one of the causes of SUDEP. (Nei et al 
2004), Nei et al reported 14/21 people died from SUDEP in sleep and 
studying seizure EEG/ECG data of these patients retrospectively discovered 
that much higher increases in heart rate occurred during seizures arising 
from sleep than from wakefulness in the SUDEP group compared to the non-
SUDEP group. Additionally, ‘Ictal cardiac re-polarization and rhythm 
abnormalities occurred in 56% of SUDEP.’ Forced awakening occurs during 
nocturnal seizures and the effects of sudden waking with associated increase 
in heart rate is compounded by the seizure itself at a time of suspected 
autonomic instability and therefore could leave some pre-disposed 
individuals more vulnerable to an induced cardiac arrhythmia during early 
waking hours. 
Marked changes in T-wave morphology, signalling an alteration in 
ventricular re-polarisation was demonstrated when subjects were 
unexpectedly woken from deep sleep (Dweck et al 2006). Increased 
autonomic instability is described during early waking hours corresponding 
to a reported period of increased vulnerability to ventricular tachycardia and 
sudden death (Pater 2005). Cardiological effects during seizures can be the 
result of autonomic instability because of a nocturnal seizure presenting 
when vagal tone is high or an undiscovered channelopathy triggered by the 
seizure, directly affecting the heart (Lathers et al 1987, Wannamaker 1985, 
Cheung & Hachinski 2000, Ansakorpi et al 2004). Another consideration is 
that some susceptible individuals may develop an intracellular ionic flux 
disturbance in the myocyte because of changes in ionic environment due to 
the physiological demands of the seizure. This disturbance in ionic flux may 
Final Discussion 
 545 
deteriorate over time in cases of undetected prolonged nocturnal seizures 
and this could also be a contributing factor in some cases of SUDEP.  
Corrected Q-T Analysis 
Lengthening of the corrected Q-T was investigated in this study as cardiac 
arrhythmia is considered to have a possible role in SUDEP (Soonhak et al 
2003, Tavernor 1996). Prolonged corrected Q-T re-polarisation time can lead 
to fatal cardiac arrhythmias (Morganroth and Pyper 2001, Tavernor et al 
1996). 
A total of 156 seizures had consecutive R-R and Q-T intervals manually 
measured (approximately 49,920 measurements) and Q-T corrected for rate 
according to Bazett’s (Bazett 1920), Hodges (Hodges 1997), Fridericia’s 
(Fridericia 1920) and Framingham’s (Sagie et al 1992) corrective formulae, 
before and during each epileptic seizure. The 156 analysed seizures were 
composed of:- generalised tonic-clonic seizures (9), absences (34), tonic 
seizures (12), temporal lobe seizures (27), frontal lobe seizures (58) and 16 
sub-clinical seizure events were clinically and electrographically identified.  
There were only two patients who were identified by all four corrective 
formulae as having prolongation of the corrected Q-T during epileptic 
seizures. The corrected Q-T prolongation occurred as the seizure progressed 
and as the heart rate changed each formulae demonstrated prolongation 
during different epochs within the same seizure The first patient (9M) was a 
2 years old male during a right sub-clinical seizure with prolonged QTc  
(Bazett’s 492 milliseconds (heart rate 119.5/min), Hodge’s 475 milliseconds 
(heart rate 127.3/min), Fridericia’s 454 milliseconds (heart rate 92.8/min) and 
Framingham’s 451 milliseconds (heart rate 88.8/min). The second patient 
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(20M) was a 21 years old male during a right temporal lobe seizure with 
prolonged QTc (Bazett’s 495 milliseconds (heart rate 66.7/min), Hodge’s 479 
milliseconds (heart rate 66.7/min), Fridericia’s 463 milliseconds (heart rate 
65.9/min) and Framingham’s 462 milliseconds (heart rate 65.9/min). 
One of the main aims of this study was to determine if there was any 
lengthening of the corrected Q-T during epileptic seizures. This study has 
indicated that significant lengthening of the corrected Q-T beyond normal 
limits in children and adults transiently occurs during some epileptic 
seizures. Prolonged corrected Q-T is associated with an increased risk of 
cardiac arrhythmia and this study supports the possibility that this 
cardiological mechanism may be involved in SUDEP. 
Cardiac vagal tone & Heart Rate Variability 
A measure of autonomic changes during different types of seizures may give 
some insight as to a possible mechanism involved during sudden 
unexpected death in epilepsy. It has also been postulated that a predisposed 
patient could become a victim of SUDEP if there is a combination of reduced 
sympathetic tone during sleep, ictal bradyarrthymia or extreme fluctuations 
in heart rate resulting in autonomic instability. Ictal bradyarrthmia and/or 
sinus arrest have vagally mediated involvement during seizure discharges 
(Vaughn et al 1997). The “lockstep phenomenon” was proposed by Lathers et 
al (1987) proved synchronization between epileptogenic “sub-convulsant” 
discharges with abnormal sympathetic and vagal neural discharges with 
cardiac arrhythmia in anaethetised cats. They believed that the lockstep 
phenomenon of synchronization of epileptogenic discharge with cardiac 
sympathetic neural discharge could be a contributing factor of SUDEP.  
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Variability of successive R-R intervals is generally considered to be an 
important protective mechanism of the autonomic nervous system being able 
to respond to sudden cardiovascular demands (Hohnloser et al 1994, Miller 
et al 2004). Loss of this variability increases the risk of sudden cardiac death 
and reduced HRV is a measure of risk stratification for myocardial infarction 
patients (Bigger et al 1984, Kleiger et al 1987, Malpas 2002, Miller et al 2004) 
of 2.5 years for approximately 50% of patients. Reduced vagal activity 
following myocardial infarction is believed to be due to the necrotic scar 
from the infarct altering the geometry of the beating heart. This altered 
geometry increases sympathetic afferent fibres in response to damage of 
sensory endings and inhibits vagal effect (Hohnloser et al 1994). 
One of the main aims of this study was to investigate if there were any 
changes in parasympathetic activity during sub-clinical seizures.  This study 
involved a small number of patients (11) but a large amount of R-R interval 
(27,151) manual measurement for 33 sub-clinical seizures and baseline 
studies. It has shown increased vagal tone and low R-R variability during 
generalised sub-clinical seizures compared to decreased vagal tone and 
higher R-R variability during temporal lobe sub-clinical seizures. This study 
has also demonstrated a good relationship between NeuroScope (Julu & 
Little 2002) log CIPA data with lnHF% Heart Rate Variability (HRV) 
BioSignal (Niskanen et al 2002) data of 2% difference in CIPA and HF% for 
short ‘counted ‘epochs and 10% difference for 5 min epochs. 
Conclusion 
SUDEP mechanisms have yet to be proven by experts in epilepsy. Proposed 
mechanisms underlying SUDEP of lengthening of the corrected Q-T and 
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altered parasympathetic activity have been investigated during epileptic 
seizures in this study. Significant changes have been identified in each 
section but none of the study patients have become a victim of SUDEP (to 
date). SUDEP is believed to be multi-factorial and may only occur in 
individuals who have a pre-disposition of physiological vulnerability. A total 
of fifty patients took part in this study, three patients would be categorised as 
“at risk” from lengthened corrected Q-T or altered parasympathetic activity. 
It may be the case that none of them are predisposed and are physiologically 
able to cope with the effects of seizures and will hopefully not become a 
SUDEP victim.  
Pre-disposition of individuals can alter over time with aging effect and the 
accumulative damage to cardiac myocardium and autonomic nervous 
system from repetitive seizures (Everingul et al 2005, Harnod et al 2008). 
Re-polarisation disturbances are accepted as risk factors for sudden death in 
various diseases. Reduced heart rate variability is used in risk stratification in 
myocardial infarction patients. Most researchers and experts in SUDEP 
believe there has to be intrinsic cardio-respiratory mechanisms involved.  
This study describes significant transient lengthening in the corrected Q-T 
during right temporal lobe seizures (Brotherstone et al, 2010, appendix), 
increased cardiac vagal tone and reduced co-efficient of variation during 
generalised sub-clinical seizures compared to right or left temporal sub-
clinical seizures (paper accepted for publication, appendix) and created a 
patent sensitive method for an epileptic seizure alarm system that will 
distinguish clinically significant epileptic seizures from normal events using 
heart rate percentage change and oxygen saturation trigger levels. 
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As an outcome from this thesis, the proposed seizure alarm device method is 
being patented by NHS Lothian. Grant applications are being submitted to 
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